Clinical Annotation ID	Variant/Haplotypes	Gene	Level of Evidence	Level Override	Level Modifiers	Score	Phenotype Category	PMID Count	Evidence Count	Drug(s)	Phenotype(s)	Latest History Date (YYYY-MM-DD)	URL	Specialty Population
981755803	rs75527207	CFTR	1A		Rare Variant; Tier 1 VIP	234.875	Efficacy	28	30	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981755803	Pediatric
1449311190	rs4149056	SLCO1B1	3		Tier 1 VIP	2.0	Dosage	1	1	mercaptopurine;methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449311190	Pediatric
981204774	rs1799971	OPRM1	4			-2.0	Efficacy	2	3	Drugs used in nicotine dependence;nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204774	
1449191690	rs141033578	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191690	
1449191746	rs78769542	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191746	
981419532	rs4693075	COQ2	3			3.25	Toxicity	3	3	atorvastatin;hmg coa reductase inhibitors;rosuvastatin	Muscular Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981419532	
1449566379	rs11065987		3			2.5	Efficacy	1	1	hydrochlorothiazide	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449566379	
981419266	HLA-B*15:02:01	HLA-B	1A		Tier 1 VIP	315.75	Toxicity	18	23	phenytoin	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome	2022-06-22	https://www.pharmgkb.org/clinicalAnnotation/981419266	Pediatric
1451259580	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	1A		Tier 1 VIP	211.375	Toxicity	6	9	amitriptyline	Depressive Disorder	2021-04-23	https://www.pharmgkb.org/clinicalAnnotation/1451259580	
1451265560	CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN, CYP2D6*4, CYP2D6*5	CYP2D6	1A		Tier 1 VIP	208.125	Dosage	3	6	imipramine	Depressive Disorder	2021-04-23	https://www.pharmgkb.org/clinicalAnnotation/1451265560	
1451288200	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN	CYP2D6	1A		Tier 1 VIP	203.625	Toxicity	8	11	codeine	Pain	2021-04-23	https://www.pharmgkb.org/clinicalAnnotation/1451288200	Pediatric
1451282240	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6	CYP2D6	1A		Tier 1 VIP	201.75	Toxicity	2	4	atomoxetine	Attention Deficit Disorder with Hyperactivity	2021-04-29	https://www.pharmgkb.org/clinicalAnnotation/1451282240	
1451285240	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*9, CYP2D6*10, CYP2D6*10x2, CYP2D6*11, CYP2D6*17, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	1A		Tier 1 VIP	226.5625	Efficacy	56	143	tamoxifen	Breast Neoplasms	2021-04-29	https://www.pharmgkb.org/clinicalAnnotation/1451285240	
1451226160	rs4680	COMT	3		Tier 1 VIP	2.25	Toxicity	2	3	methadone	Neonatal Abstinence Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451226160	Pediatric
1451226166	rs4680	COMT	3		Tier 1 VIP	0.0	Toxicity	1	1	methadone	Neonatal Abstinence Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451226166	
1451226200	rs4732636	PNOC	3			0.0	Toxicity	1	1	buprenorphine	Neonatal Abstinence Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451226200	Pediatric
1451226206	rs4732636	PNOC	3			0.0	Toxicity	1	1	methadone	Neonatal Abstinence Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451226206	Pediatric
1451226212	rs740603	COMT	3		Tier 1 VIP	0.0	Toxicity	1	1	buprenorphine	Neonatal Abstinence Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451226212	
1451226220	rs740603	COMT	3		Tier 1 VIP	0.0	Toxicity	1	1	methadone	Neonatal Abstinence Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451226220	
1451340300	UGT1A3*1, UGT1A3*2, UGT1A3*3	UGT1A3	3			4.0	Metabolism/PK	1	2	telmisartan		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451340300	
1451340320	rs60140950	SLCO1B3	3			1.5	Metabolism/PK	1	1	telmisartan		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451340320	
1450930839	rs1948	CHRNB4	3			3.0	Toxicity	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450930839	
1451356840	rs696	NFKBIA	3			1.75	Dosage	1	1	sufentanil	Pain, Postoperative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451356840	
1451225360	rs4680	COMT	3		Tier 1 VIP	2.5	Toxicity	1	2	buprenorphine	Neonatal Abstinence Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451225360	Pediatric
1450930464	rs16917234	BDNF;BDNF-AS	3			2.25	Other	1	1	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450930464	
1451290960	rs5219	KCNJ11	3			3.75	Efficacy	2	2	gliclazide	Diabetes Mellitus	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451290960	
1451356520	rs4149056	SLCO1B1	3		Tier 1 VIP	2.25	Efficacy	11	12	simvastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451356520	
655386913	CYP2C19*1, CYP2C19*17	CYP2C19	3		Tier 1 VIP	6.0	Toxicity	15	16	clopidogrel	Acute coronary syndrome;Coronary Artery Disease;Hemorrhage;Myocardial Infarction	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386913	
1451356180	rs28379954	NFIB	3			0.0	Metabolism/PK	1	1	clozapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451356180	
1451151506	rs61974485	ARID4A	3			1.5	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451151506	
1451356356	rs11265549	NECTIN4	3			1.0	Toxicity	1	1	methadone	Opioid-Related Disorders;Pruritus	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451356356	
1451356386	rs11265549	NECTIN4	3			2.25	Metabolism/PK	1	1	methadone	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451356386	
1451225320	rs4680	COMT	3		Tier 1 VIP	0.0	Toxicity	1	1	buprenorphine	Neonatal Abstinence Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451225320	
1451356380	rs11265549	NECTIN4	3			2.75	Dosage	1	1	methadone	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451356380	
1451240740	rs2228001	TMEM43;XPC	3			2.75	Toxicity	1	1	cisplatin	Neutropenia;Urinary Bladder Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451240740	
1451240746	rs2228001	TMEM43;XPC	3			2.75	Toxicity	1	1	cisplatin	Drug Toxicity;Urinary Bladder Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451240746	
1450815092	rs2636697	PPA2	3			0.0	Efficacy	1	1	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450815092	
1451240880	HLA-B*15:02:01	HLA-B	3		Tier 1 VIP	4.0	Toxicity	1	2	dapsone	severe cutaneous adverse reactions;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451240880	
1451351160	rs1799971	OPRM1	3			2.0	Toxicity	1	1	opioids	Sleep Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451351160	
1451277440	rs1414334	HTR2C	3			6.875	Toxicity	5	5	risperidone	Metabolic Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451277440	
1451244680	rs4149056	SLCO1B1	3		Tier 1 VIP	2.0	Metabolism/PK	1	1	lovastatin acid		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451244680	
1451351240	rs79910351	OPRM1	3		Rare Variant	0.25	Efficacy	1	1	fentanyl		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451351240	Pediatric
1451121880	rs11615	ERCC1	3			3.25	Toxicity	6	6	cisplatin	Drug Toxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451121880	
1451351260	rs79910351	OPRM1	3		Rare Variant	0.25	Efficacy	1	1	remifentanil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451351260	Pediatric
1451350801	HLA-B*55:01:01	HLA-B	3		Tier 1 VIP	2.5	Toxicity	1	1	penicillin g;penicillin v	Drug Hypersensitivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451350801	
1451350944	rs1799971	OPRM1	3			1.75	Toxicity	1	1	morphine	Sleep Apnea Syndromes	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451350944	
1451325840	rs671	ALDH2	3		Rare Variant	2.0	Metabolism/PK	1	1	acetaldehyde		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451325840	
1450375701	rs4659982	GREM2	3			0.0	Efficacy	1	1	allopurinol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450375701	
1451357200	rs4149056	SLCO1B1	1A		Tier 1 VIP	105.5	Toxicity	8	9	rosuvastatin	statin-related myopathy	2022-02-10	https://www.pharmgkb.org/clinicalAnnotation/1451357200	
1451244720	rs4149056	SLCO1B1	1A		Tier 1 VIP	101.25	Toxicity	2	3	fluvastatin	statin-related myopathy	2022-02-10	https://www.pharmgkb.org/clinicalAnnotation/1451244720	
1450810357	rs3778156	OPRM1	3			3.25	Toxicity	1	1	cocaine	Cocaine-Related Disorders	2021-12-03	https://www.pharmgkb.org/clinicalAnnotation/1450810357	
1451244700	rs4149056	SLCO1B1	1A		Tier 1 VIP	101.875	Metabolism/PK	2	3	fluvastatin		2022-02-10	https://www.pharmgkb.org/clinicalAnnotation/1451244700	
1451241320	NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*12, NAT2*13	NAT2	3		Tier 1 VIP	2.0	Toxicity	1	1	Antivirals for treatment of HIV infections, combinations;Drugs For Treatment Of Tuberculosis	drug-induced liver injury;HIV Infections;Tuberculosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451241320	
1450375047	rs1050565	BLMH	3			4.5	Toxicity	1	2	bleomycin;cisplatin;etoposide	Alopecia;Pain;Testicular Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450375047	
1451357763	rs6990851	CSMD1	3			0.0	Efficacy	1	1	anastrozole	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451357763	
1451357759	rs1437153		3			0.0	Efficacy	1	1	anastrozole	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451357759	
1451357783	rs2449598	DLG2	3			0.0	Efficacy	1	1	anastrozole	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451357783	
1451357790	rs6981827	CSMD1	3			0.0	Efficacy	1	1	anastrozole	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451357790	
1451238460	rs4680	COMT	3		Tier 1 VIP	0.0	Toxicity	1	2	buprenorphine;fentanyl;tramadol	Exanthema;Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451238460	
1451123780	rs778068631	CES1	3		Rare Variant	0.0	Metabolism/PK	1	1	clopidogrel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451123780	
1448256712	rs7574296	UGT1A9	3			1.75	Toxicity	1	1	sorafenib	Carcinoma, Hepatocellular;hand-foot syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448256712	
1451328325	rs10455872	LPA	3			7.0	Toxicity	2	3	hmg coa reductase inhibitors	Coronary Artery Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451328325	
1451344820	rs74497159		3			0.0	Toxicity	1	1	taxanes	Peripheral Nervous System Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451344820	
1451353040	rs72547529	VKORC1	3		Rare Variant; Tier 1 VIP	1.0	Dosage;Efficacy	4	4	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451353040	
1451238365	rs495491	OPRM1	3			3.5	Toxicity	1	1	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451238365	
1451328500	rs1800629	TNF	3			5.375	Efficacy	5	5	Tumor necrosis factor alpha (TNF-alpha) inhibitors		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451328500	
1451237983	rs7905446	HTR7;RPP30	3			2.5	Efficacy	1	1	antidepressants	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451237983	
1451238020	rs7905446	HTR7;RPP30	3			2.5	Efficacy	1	1	paroxetine	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451238020	
1451238040	rs7905446	HTR7;RPP30	3			2.75	Efficacy	1	1	escitalopram	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451238040	
1451336020	rs34059508	SLC22A1	3			2.25	Metabolism/PK	1	1	olanzapine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451336020	
1451336026	rs3842	ABCB1	3		Tier 1 VIP	1.25	Metabolism/PK	1	1	olanzapine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451336026	
1451336041	rs10248420	ABCB1	3		Tier 1 VIP	1.75	Toxicity	1	1	olanzapine	somnolence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451336041	
1451336047	CYP3A5*1, CYP3A5*3	CYP3A5	3		Tier 1 VIP	1.75	Toxicity	1	1	olanzapine	somnolence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451336047	
1451336060	rs5128	APOC3	3			0.0	Metabolism/PK	1	1	olanzapine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451336060	
1451245960	rs10455872	LPA	3			0.0	Efficacy	1	1	rosuvastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451245960	
1451336074	rs4728709	ABCB1	3		Tier 1 VIP	1.75	Toxicity	1	1	olanzapine	Asthenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451336074	
1451336100	rs3842	ABCB1	3		Tier 1 VIP	1.75	Toxicity	1	1	olanzapine	Arrhythmias, Cardiac	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451336100	
1451246040	rs4680	COMT	3		Tier 1 VIP	1.5	Toxicity	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451246040	
1450377208	rs1799930	NAT2	3		Tier 1 VIP	2.25	Toxicity	1	1	isoniazid;phenytoin	Drug interaction with drug;Drug Toxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450377208	
1451139080	CYP2C9*1, CYP2C9*3	CYP2C9	3		Tier 1 VIP	0.0	Metabolism/PK	1	1	dipyrone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451139080	
1451245600	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	3		Tier 1 VIP	8.5	Efficacy	1	3	clobazam	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451245600	
1451245620	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	3		Tier 1 VIP	1.0	Dosage	1	1	clobazam	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451245620	
1451352140	rs6517442	KCNJ6	3			2.5	Dosage	1	1	opioids	Low Back Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451352140	
1451352146	rs1045642	ABCB1	3		Tier 1 VIP	2.5	Toxicity	1	1	opioids	Low Back Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451352146	
1451253880	rs1051740	EPHX1	3			5.75	Dosage	4	5	carbamazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451253880	
1451163868	UGT1A1*1, UGT1A1*28	UGT1A1	3		Tier 1 VIP	3.75	Toxicity	2	3	indinavir	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451163868	
1451228945	CYP2B6*1, CYP2B6*6	CYP2B6	3		Tier 1 VIP	2.0	Efficacy	1	1	methadone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451228945	
1451228940	CYP2B6*1, CYP2B6*6	CYP2B6	3		Tier 1 VIP	2.5	Toxicity	1	1	methadone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451228940	
1450934061	rs28656907	ABCB1;RUNDC3B	3		Tier 1 VIP	0.0	Dosage	1	1	imatinib	Drug Toxicity;Gastrointestinal Stromal Tumors	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450934061	
1450934169	rs1567817380	SCN4A	3			0.0	Efficacy	1	1	mexiletine	Myotonic Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450934169	
1450934181	rs121908560	SCN4A	3			0.0	Efficacy	1	1	mexiletine	Myotonic Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450934181	
1451359886	rs4680	COMT	3		Tier 1 VIP	0.0	Efficacy	2	2	propranolol	Temporomandibular joint-pain-dysfunction syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451359886	
1451351302	rs11322783	IFNL4	3			1.75	Efficacy	1	1	sofosbuvir	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451351302	
1451244869	rs4680	COMT	3		Tier 1 VIP	0.0	Efficacy	1	1	fentanyl	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451244869	
1451244900	rs4680	COMT	3		Tier 1 VIP	5.0	Efficacy	1	2	remifentanil	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451244900	Pediatric
1451359601	rs1611114	DBH	3			3.0	Toxicity	1	1	heroin	Heroin Dependence;Memory Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451359601	
1451244980	rs4680	COMT	3		Tier 1 VIP	2.0	Efficacy	1	1	oxycodone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451244980	
1451245004	rs4680	COMT	3		Tier 1 VIP	2.75	Dosage	6	6	opioids	Pain;Pain, Postoperative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451245004	Pediatric
981204995	rs1799793	ERCC2	4			-0.75	Efficacy;Toxicity	11	15	Platinum compounds	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204995	Pediatric
1451121940	rs11615	ERCC1	3			3.75	Efficacy	3	3	cisplatin	Esophageal Neoplasms;Ovarian Neoplasms;Stomach Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451121940	
1451245081	rs4680	COMT	3		Tier 1 VIP	2.25	Efficacy	4	5	morphine	Pain	2021-04-09	https://www.pharmgkb.org/clinicalAnnotation/1451245081	Pediatric
1451244920	rs4680	COMT	3		Tier 1 VIP	0.0	Dosage	2	2	sufentanil		2021-05-19	https://www.pharmgkb.org/clinicalAnnotation/1451244920	Pediatric
1451245764	NUDT15*1, NUDT15*4, NUDT15*5, NUDT15*6	NUDT15	3		Tier 1 VIP	5.5	Toxicity	2	2	mercaptopurine	Leukopenia	2021-05-24	https://www.pharmgkb.org/clinicalAnnotation/1451245764	Pediatric
1451245800	NUDT15*1, NUDT15*6	NUDT15	3		Tier 1 VIP	2.75	Toxicity	1	1	mercaptopurine	Neutropenia	2021-05-24	https://www.pharmgkb.org/clinicalAnnotation/1451245800	Pediatric
1451254580	rs11045879	SLCO1B1	3		Tier 1 VIP	1.5	Metabolism/PK	6	6	methotrexate	Neoplasms	2021-06-24	https://www.pharmgkb.org/clinicalAnnotation/1451254580	Pediatric
1451245925	rs1042713	ADRB2	3		Tier 1 VIP	3.75	Efficacy	5	5	salbutamol	Asthma	2021-10-27	https://www.pharmgkb.org/clinicalAnnotation/1451245925	Pediatric
1451237820	CYP3A4*1, CYP3A4*36	CYP3A4	3		Tier 1 VIP	2.0	Metabolism/PK	1	1	sufentanil		2022-03-23	https://www.pharmgkb.org/clinicalAnnotation/1451237820	
981237878	rs1105879	UGT1A6	3			5.0	Dosage	2	3	valproic acid	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981237878	
981238234	rs1360780	FKBP5	3			2.5	Toxicity	1	2	clomipramine;nefazodone;paroxetine;venlafaxine	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981238234	
981239568	rs104894542	VKORC1	3		Rare Variant; Tier 1 VIP	0.25	Dosage	2	2	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981239568	
1449718265	rs12248560	CYP2C19	3		Tier 1 VIP	2.25	Toxicity	1	1	cyclophosphamide;doxorubicin;fluorouracil	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449718265	
1451245040	rs4680	COMT	3		Tier 1 VIP	1.25	Efficacy	1	1	opioids	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451245040	Pediatric
1451289620	rs3814637	CYP2C19	3		Tier 1 VIP	2.75	Toxicity	1	1	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451289620	
1451257000	rs1057868	POR	3			0.5	Metabolism/PK	15	15	tacrolimus	Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451257000	Pediatric
1451330460	CYP2D6*1, CYP2D6*10	CYP2D6	3		Tier 1 VIP	1.5	Efficacy	1	1	propafenone	Arrhythmias, Cardiac	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451330460	
1451354640	rs1386493	TPH2	3			2.25	Dosage	1	1	methadone	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451354640	
1449716213	rs6961071		3			0.0	Efficacy	1	1	fentanyl	Pain, Postoperative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449716213	
1451354647	rs2229205	OPRL1	3			2.25	Dosage	1	1	methadone	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451354647	
1451354700	rs16974799	CYP2B6	3		Tier 1 VIP	2.75	Dosage	1	1	methadone	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451354700	
1450813849	rs3758987	HTR3B	3			3.0	Toxicity	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450813849	
1451150004	rs1402398		3			1.5	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451150004	
1451338440	rs11322783	IFNL4	3			6.0	Efficacy	4	4	direct acting antivirals	sustained virological response (svr)	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451338440	
1451150066	rs75967634	ADH1B	3		Rare Variant	1.5	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451150066	
1451354560	rs806368	CNR1	3			2.75	Dosage	1	1	methadone	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451354560	
1451346385	rs71647871	CES1	3		Rare Variant	1.75	Dosage	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451346385	Pediatric
981201387	rs2236225	MTHFD1	3			1.0	Efficacy	4	4	methotrexate	Mesothelioma;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-09-27	https://www.pharmgkb.org/clinicalAnnotation/981201387	Pediatric
1451329580	UGT1A1*1, UGT1A1*6	UGT1A1	3		Tier 1 VIP	1.5	Dosage	2	2	irinotecan		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451329580	
827836551	rs20417	PTGS2	3			1.0	Efficacy	2	2	ibuprofen		2021-04-08	https://www.pharmgkb.org/clinicalAnnotation/827836551	
1449576301	rs35123024		3			0.0	Efficacy	1	1	atenolol;hydrochlorothiazide	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449576301	
1451337885	rs1041983	NAT2	3		Tier 1 VIP	3.0	Toxicity	1	1	isoniazid;pyrazinamide;rifampin	Toxic liver disease;Tuberculosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451337885	
1450936284	rs758145522	SULT1A1	3		Rare Variant	0.0	Metabolism/PK	1	1	acetaminophen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936284	
1450935813	rs762081829	CYP2C9	3		Rare Variant; Tier 1 VIP	1.5	Metabolism/PK	1	2	tolbutamide		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450935813	
1450935826	rs761895497	CYP2C9	3		Rare Variant; Tier 1 VIP	1.0	Metabolism/PK	1	2	tolbutamide		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450935826	
1451223506	rs1801133	MTHFR	3		Tier 1 VIP	2.125	Efficacy	11	11	methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2022-02-25	https://www.pharmgkb.org/clinicalAnnotation/1451223506	Pediatric
1451337408	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	3		Tier 1 VIP	2.5	Efficacy	2	4	sulfonamides, urea derivatives	Diabetes Mellitus	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451337408	
655384558	rs10932125	NRP2	3			2.5	Other	1	2	daunorubicin	Drug Toxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384558	
827847725	rs9981861	DSCAM	3			0.0	Efficacy	1	1	carboplatin;paclitaxel	Carcinoma, Non-Small-Cell Lung;Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827847725	
827847759	rs963468	DRD3	3			2.0	Efficacy	1	1	duloxetine	Anxiety Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827847759	
827848740	rs9340799	ESR1	3			2.0	Efficacy	1	1	leflunomide	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827848740	
827848751	rs9340799	ESR1	3			2.5	Efficacy	1	1	conjugated estrogens;medroxyprogesterone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827848751	
981201549	rs2298383	ADORA2A	3			2.25	Toxicity	2	2	caffeine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981201549	
827848762	rs9332239	CYP2C9	3		Rare Variant; Tier 1 VIP	0.0	Other	1	1	tolbutamide		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827848762	
827848365	rs1801133	MTHFR	2A		Tier 1 VIP	23.25	Toxicity	32	35	methotrexate	Drug Toxicity;hematotoxicity;Leukopenia;Lymphoma;mucositis;Neoplasms;Neutropenia;Osteosarcoma;Precursor Cell Lymphoblastic Leukemia-Lymphoma;primary central nervous system lymphoma;Thrombocytopenia;Toxic liver disease	2022-02-25	https://www.pharmgkb.org/clinicalAnnotation/827848365	Pediatric
1450935819	rs771237265	CYP2C9	3		Rare Variant; Tier 1 VIP	1.5	Metabolism/PK	1	2	tolbutamide		2021-12-03	https://www.pharmgkb.org/clinicalAnnotation/1450935819	
981201642	rs11280056	ENOSF1;TYMS	3		Tier 1 VIP	0.0	Efficacy	1	1	methotrexate	Arthritis, Rheumatoid;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-10-19	https://www.pharmgkb.org/clinicalAnnotation/981201642	Pediatric
827848785	rs9316233	HTR2A	3			2.75	Efficacy	1	1	escitalopram	Depressive Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827848785	
827863928	rs1051375	CACNA1C	3			3.0	Efficacy	1	3	atenolol;verapamil	Coronary Artery Disease;Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827863928	
981201408	rs2278294	IMPDH1	3			2.25	Efficacy	5	6	mycophenolate mofetil	Kidney Transplantation;Organ Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981201408	
981201424	rs2278294	IMPDH1	3			0.75	Toxicity	2	2	mycophenolate mofetil	Leukopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981201424	
981201443	rs2070744	NOS3	3			3.25	Efficacy	1	1	Antihypertensives;Antihypertensives And Diuretics In Combination;diuretics	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981201443	
981201455	rs2284017	CACNG2	3			2.0	Efficacy	2	2	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981201455	
981201571	rs3215400	CDA	3			4.0	Toxicity	6	8	cytarabine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981201571	Pediatric
981201584	rs3215400	CDA	3			2.0	Toxicity	2	2	capecitabine	hand-foot syndrome;Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981201584	
981201770	rs4149117	SLCO1B3	3			4.75	Dosage;Toxicity	4	7	mycophenolate mofetil	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981201770	
981201788	rs2740574	CYP3A;CYP3A4	3		Tier 1 VIP	0.75	Other	2	2	efavirenz	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981201788	
981201797	rs28399433	CYP2A6	3		Tier 1 VIP	4.5	Other	3	3	nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981201797	
981201805	rs28399433	CYP2A6	3		Tier 1 VIP	4.0	Other	3	3	coumarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981201805	
981201827	rs28399468	CYP2A6	3		Rare Variant; Tier 1 VIP	0.125	Other	2	2	nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981201827	
981201881	rs3093726	LST1;LTA;LTB	3			0.0	Toxicity	1	1	abacavir	Drug Hypersensitivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981201881	
981201854	rs28399499	CYP2B6	3		Tier 1 VIP	5.25	Metabolism/PK	7	7	nevirapine	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981201854	
981201637	rs11280056	TYMS	4		Tier 1 VIP	-2.5	Toxicity	5	5	methotrexate	Arthritis, Rheumatoid;Drug Toxicity;hematopoietic stem cell transplantation;Psoriasis;Toxic liver disease	2021-12-01	https://www.pharmgkb.org/clinicalAnnotation/981201637	
1450935838	rs183701923	CYP2C19	3		Rare Variant; Tier 1 VIP	1.0	Metabolism/PK	1	2	mephenytoin		2021-12-06	https://www.pharmgkb.org/clinicalAnnotation/1450935838	
827848732	rs9344	CCND1	3			1.25	Toxicity	2	2	methotrexate	Lymphoma;Osteosarcoma;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2022-01-04	https://www.pharmgkb.org/clinicalAnnotation/827848732	Pediatric
827864513	rs2230345	GRK5	4			-3.25	Efficacy	6	9	Beta Blocking Agents	Heart Failure	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827864513	
981201888	rs2069514	CYP1A2	4			-0.875	Toxicity	2	2	antipsychotics	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981201888	
981202090	rs71647871	CES1	3		Rare Variant	1.5	Metabolism/PK	2	2	methylphenidate		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981202090	
981202103	rs7297610	YEATS4	3			4.5	Efficacy	2	2	hydrochlorothiazide	Essential hypertension;Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981202103	
981202240	rs11280056	TYMS	3		Tier 1 VIP	3.5	Efficacy	1	1	fluorouracil	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981202240	
981202334	rs3745274	CYP2B6	3		Tier 1 VIP	2.5	Toxicity	1	1	cyclophosphamide	Hepatic Veno-Occlusive Disease;Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981202334	
981202356	rs3745274	CYP2B6	3		Tier 1 VIP	2.0	Dosage	1	1	cyclophosphamide;doxorubicin	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981202356	
981202366	rs3758149	GGH	3			3.75	Efficacy	2	2	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981202366	
981202440	rs396991	FCGR3A	3			1.25	Efficacy	6	6	cetuximab	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981202440	
981202520	rs4149601	NEDD4L	3			2.5	Efficacy	2	2	hydrochlorothiazide	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981202520	
981202551	rs4244285	CYP2C19	3		Tier 1 VIP	3.0	Efficacy	2	2	cyclophosphamide;doxorubicin	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981202551	
981202562	rs4244285	CYP2C19	3		Tier 1 VIP	6.75	Toxicity	2	3	cyclophosphamide	Lupus Erythematosus, Systemic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981202562	
981237704	rs1805087	MTR	4			-0.75	Toxicity	4	4	methotrexate	Brain Diseases;Drug Toxicity;Osteosarcoma;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2022-01-04	https://www.pharmgkb.org/clinicalAnnotation/981237704	Pediatric
981202646	rs4680	COMT	3		Tier 1 VIP	1.5	Toxicity	1	1	antipsychotics	tardive dyskinesia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981202646	
981202674	rs4680	COMT	3		Tier 1 VIP	1.75	Other	1	1	antipsychotics	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981202674	
981204525	rs1801131	MTHFR	3		Tier 1 VIP	2.75	Efficacy	4	4	bevacizumab;carboplatin;cisplatin;cyanocobalamin;folic acid;pemetrexed	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204525	
981204864	rs1801131	MTHFR	3		Tier 1 VIP	4.75	Efficacy	4	4	capecitabine;fluorouracil;leucovorin;oxaliplatin	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204864	
981204874	rs16969968	CHRNA5	3			2.5	Efficacy	7	11	bupropion;Drugs used in nicotine dependence;nicotine;varenicline	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204874	
981238057	rs2032582	ABCB1	3		Tier 1 VIP	1.25	Other	1	1	doxorubicin	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981238057	
981238092	rs2032582	ABCB1	3		Tier 1 VIP	2.0	Dosage;Efficacy	4	8	antiepileptics;carbamazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981238092	
981238108	rs2032582	ABCB1	3		Tier 1 VIP	1.0	Other	2	2	digoxin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981238108	
981238562	rs1051266	SLC19A1	4		Tier 1 VIP	-2.375	Metabolism/PK	14	14	methotrexate	Burkitt Lymphoma;Leukemia;Lymphoma, T-Cell;Neoplasms;Osteosarcoma;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-10-21	https://www.pharmgkb.org/clinicalAnnotation/981238562	Pediatric
981238910	rs5219	KCNJ11	3			2.5	Efficacy	1	1	metformin;sulfonamides, urea derivatives	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981238910	
981345277	rs25487	XRCC1	3			3.0	Efficacy	1	2	fluorouracil	Colonic Neoplasms;Colorectal Neoplasms;Neoplasms;Rectal Neoplasms;Uterine Cervical Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981345277	
981202046	rs5031016	CYP2A6	3		Rare Variant; Tier 1 VIP	0.125	Metabolism/PK	3	3	nicotine		2022-02-08	https://www.pharmgkb.org/clinicalAnnotation/981202046	
981345285	rs25487	XRCC1	4			-0.25	Efficacy;Toxicity	2	4	cyclophosphamide	Neoplasms;Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981345285	
1448256098	rs2413739	PACSIN2	3			4.5	Toxicity	2	2	mercaptopurine	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-05-20	https://www.pharmgkb.org/clinicalAnnotation/1448256098	Pediatric
981345311	rs4149056	SLCO1B1	3		Tier 1 VIP	0.0	Metabolism/PK	1	1	atorvastatin;rifampin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981345311	
1184654135	HLA-B*48:01	HLA-B	3		Tier 1 VIP	0.75	Toxicity	4	4	allopurinol	Drug Hypersensitivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184654135	
1447814482	rs2298805	FCER1A	3		Rare Variant	2.0	Efficacy	1	1	desloratadine;mizolastine	Urticaria	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447814482	
1447943646	rs2177370	CHAT	3			2.0	Efficacy	1	1	galantamine	Alzheimer Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447943646	
1448100370	rs17839843	TPMT	3		Rare Variant; Tier 1 VIP	0.0	Other	1	1	mercaptopurine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100370	
1448100382	rs3931660	TPMT	3		Tier 1 VIP	0.0	Other	1	1	mercaptopurine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100382	
1448100389	rs1415744	EPM2A	3			2.5	Efficacy	1	1	chlorpromazine;clozapine;haloperidol;olanzapine;quetiapine;risperidone;trifluoperazine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100389	
1448100396	rs13393173	CERS6	3			2.25	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100396	
1448100404	rs1130864	CRP	3			2.25	Efficacy	1	1	adalimumab		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100404	
1448100426	rs9373839	ATG5	3			2.25	Efficacy	1	1	adalimumab	Inflammatory Bowel Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100426	
1448104131	rs14158	LDLR	3			2.0	Efficacy	1	2	peginterferon alfa-2a;peginterferon alfa-2b;ribavirin	Hepatitis C, Chronic;HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448104131	
1448264442	rs11322783	IFNL4	3			3.25	Efficacy	1	1	peginterferon alfa-2a;peginterferon alfa-2b;ribavirin;simeprevir	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448264442	
1448573512	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	3		Tier 1 VIP	0.5	Toxicity	1	1	3,4-methylenedioxymethamphetamine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448573512	
1448616845	rs2072671	CDA	3			0.5	Toxicity	3	3	capecitabine	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448616845	
1448616870	rs2279199	UMPS	3			2.75	Toxicity	1	1	capecitabine	Nausea;Vomiting	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448616870	
1448616910	rs2853741	TYMS	3		Tier 1 VIP	3.25	Toxicity	1	1	capecitabine	Diarrhea;Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448616910	
1448624459	rs12050587	PIGB	3			0.5	Toxicity	1	2	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Leukopenia;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448624459	
1449144358	rs3919583		3			0.0	Efficacy	1	1	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449144358	
1449144370	rs209474		3			0.0	Efficacy	1	1	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449144370	
1449144376	rs1521470	ADCY1	3			0.0	Efficacy	1	1	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449144376	
1449144382	rs79403677	FAM177A1	3			0.0	Efficacy	1	1	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449144382	
1449144396	rs2298881	ERCC1	3			2.5	Efficacy	1	1	fluorouracil;Platinum compounds;radiotherapy	Stomach Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449144396	
1449155607	rs8177374	TIRAP	3			3.0	Efficacy	1	1	ustekinumab	Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449155607	
981202230	rs11280056	TYMS	3		Tier 1 VIP	1.25	Toxicity	5	5	fluorouracil;FOLFOX	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981202230	
1449155614	rs11465996	LY96	3			3.25	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449155614	
1449155625	rs5744174	TLR5	3			3.0	Efficacy	1	1	ustekinumab	Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449155625	
1449155631	rs1143627	IL1B	3			3.75	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors;ustekinumab	Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449155631	
1449155637	rs1143623	IL1B	3			3.75	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors;ustekinumab	Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449155637	
1449155643	rs352139	TLR9	3			2.75	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449155643	
1449155649	rs4696480	TLR2	3			3.25	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449155649	
1449156117	HLA-B*15:12	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156117	
1449164603	rs1883112	NCF4	3			2.5	Efficacy	1	1	idarubicin	Leukemia, Myeloid, Acute	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449164603	
1449192303	rs113993960	CFTR	3		Rare Variant; Tier 1 VIP	1.5	Efficacy	3	3	lumacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449192303	
1449566691	rs10817464	SLC31A1	3			1.75	Toxicity	1	2	Platinum compounds	Anemia;Leukopenia;Nausea;Neutropenia;Thrombocytopenia;Vomiting	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449566691	
1449575745	rs1045642	ABCB1	4		Tier 1 VIP	-1.5	Dosage	4	4	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449575745	
1449576622	rs3857532	EYS	3			1.0	Toxicity	1	1	hmg coa reductase inhibitors	Rhabdomyolysis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449576622	
1449713649	rs2070096	BARD1	3			2.5	Efficacy	1	1	carboplatin;docetaxel;trastuzumab	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449713649	
1449713660	rs2284922	RNF8	3			2.5	Efficacy	1	1	carboplatin;docetaxel;trastuzumab	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449713660	
1449713666	rs2229046	ERBB3	3			3.0	Efficacy	1	1	carboplatin;docetaxel;trastuzumab	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449713666	
1449713676	rs773123	ERBB3	3			2.5	Efficacy	1	1	carboplatin;docetaxel;trastuzumab	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449713676	
981238437	rs1057910	CYP2C9	3		Tier 1 VIP	3.5	Toxicity	2	2	Antiinflammatory agents, non-steroids;celecoxib;diclofenac		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981238437	
1449191740	rs202179988	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191740	
1449713682	rs1136201	ERBB2	3			2.5	Efficacy	1	1	carboplatin;docetaxel;trastuzumab	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449713682	
1450373589	rs628031	SLC22A1	3			1.5	Efficacy;Toxicity;Metabolism/PK	4	4	imatinib	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450373589	
1450373595	rs1202283	ABCB4	3			2.5	Efficacy	1	1	imatinib	Gastrointestinal Stromal Tumors	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450373595	
1450373604	rs2273697	ABCC2	3			2.0	Efficacy	1	1	imatinib	Gastrointestinal Stromal Tumors	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450373604	
1450814557	rs2236256	OPRM1	3			1.5	Toxicity	1	1	cocaine	Cocaine-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450814557	
1450814659	rs363225	SLC18A2	3			2.75	Efficacy	1	1	bupropion	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450814659	
1450814665	rs363226	SLC18A2	3			2.25	Efficacy	1	1	bupropion	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450814665	
1450814822	rs717620	ABCC2	3			1.5	Metabolism/PK	1	1	pitavastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450814822	
1450814923	rs1801282	PPARG	3			1.25	Efficacy	2	2	pioglitazone	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450814923	
1450815142	rs17742120	MIR582;PDE4D	3			0.0	Efficacy	1	1	quetiapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450815142	
1450815166	rs7395555		3			0.0	Efficacy	1	1	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450815166	
1451323336	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*6	CYP2D6	4		Tier 1 VIP	-1.625	Efficacy	9	11	oxycodone	Pain	2022-01-11	https://www.pharmgkb.org/clinicalAnnotation/1451323336	
1449004733	rs2273697	ABCC2	3			0.0	Efficacy	1	1	cisplatin;pemetrexed	Mesothelioma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449004733	
1449004739	rs13181	ERCC2;KLC3	3			0.0	Efficacy	1	1	cisplatin;gemcitabine	Mesothelioma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449004739	
1449004745	rs3212986	CD3EAP;ERCC1;PPP1R13L	3			0.0	Efficacy	1	1	cisplatin;gemcitabine	Mesothelioma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449004745	
1449005041	rs776746	CYP3A;CYP3A5;ZSCAN25	3		Tier 1 VIP	0.0	Metabolism/PK	1	2	lumefantrine	Malaria	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449005041	
1449005047	rs2740574	CYP3A4	3		Tier 1 VIP	1.75	Efficacy;Metabolism/PK	1	2	lumefantrine	Malaria	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449005047	
1449645432	rs762151655	SULT1A3	3		Rare Variant	0.0	Metabolism/PK	1	1	acetaminophen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645432	
1449645438	rs762151655	SULT1A3	3		Rare Variant	0.0	Metabolism/PK	1	1	morphine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645438	
1449645444	rs762151655	SULT1A3	3		Rare Variant	0.0	Metabolism/PK	1	1	tapentadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645444	
1449645450	rs762151655	SULT1A3	3		Rare Variant	0.0	Metabolism/PK	1	1	o-desmethyltramadol;tramadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645450	
1449645456	rs750575779	SULT1A3	3		Rare Variant	0.0	Metabolism/PK	1	1	acetaminophen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645456	
1449645462	rs750575779	SULT1A3	3		Rare Variant	0.0	Metabolism/PK	1	1	tapentadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645462	
1449645468	rs750575779	SULT1A3	3		Rare Variant	0.0	Metabolism/PK	1	1	o-desmethyltramadol;tramadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645468	
1449645474	rs553050853	SULT1A3	3		Rare Variant	0.0	Metabolism/PK	1	1	acetaminophen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645474	
1449645480	rs553050853	SULT1A3	3		Rare Variant	0.0	Metabolism/PK	1	1	morphine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645480	
1449645486	rs553050853	SULT1A3	3		Rare Variant	0.0	Metabolism/PK	1	1	tapentadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645486	
1449645492	rs553050853	SULT1A3	3		Rare Variant	0.0	Metabolism/PK	1	1	o-desmethyltramadol;tramadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645492	
1449645498	rs751527244	SULT1A3	3		Rare Variant	0.0	Metabolism/PK	1	2	acetaminophen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645498	
1449645507	rs751527244	SULT1A3	3		Rare Variant	0.0	Metabolism/PK	1	1	morphine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645507	
1449645513	rs751527244	SULT1A3	3		Rare Variant	0.0	Metabolism/PK	1	2	tapentadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645513	
1449645522	rs751527244	SULT1A3	3		Rare Variant	0.0	Metabolism/PK	1	2	o-desmethyltramadol;tramadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645522	
1449645531	rs1293732453	SULT1A3	3		Rare Variant	0.0	Metabolism/PK	1	1	acetaminophen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645531	
1449645537	rs1293732453	SULT1A3	3		Rare Variant	0.0	Metabolism/PK	1	1	morphine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645537	
1449718242	rs1056836	CYP1B1	3			2.25	Toxicity	1	1	cyclophosphamide;doxorubicin;fluorouracil	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449718242	
1449718248	rs2231142	ABCG2	3		Tier 1 VIP	2.75	Toxicity	1	1	cyclophosphamide;doxorubicin;fluorouracil	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449718248	
1449718259	rs714368	SLC22A16	3			4.25	Efficacy;Toxicity	2	2	cyclophosphamide;doxorubicin;fluorouracil	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449718259	
1451228960	CYP3A5*1, CYP3A5*3	CYP3A5	4		Tier 1 VIP	-0.375	Metabolism/PK	4	4	methadone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451228960	
1451229400	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	4		Tier 1 VIP	-2.0	Metabolism/PK	4	5	methadone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451229400	
1451323205	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*6	CYP2D6	4		Tier 1 VIP	-5.625	Toxicity	6	9	oxycodone	cns depression;Drug Toxicity	2021-04-23	https://www.pharmgkb.org/clinicalAnnotation/1451323205	Pediatric
1451352420	rs1799971	OPRM1	4			-0.5	Toxicity	3	3	sufentanil	adverse events;Pain, Postoperative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451352420	
1451229340	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	4		Tier 1 VIP	-2.0	Metabolism/PK	4	5	methadone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451229340	
1451358900	rs4149056	SLCO1B1	4		Tier 1 VIP	-3.0	Efficacy	4	4	rosuvastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451358900	
1451244740	rs4149056	SLCO1B1	1A		Tier 1 VIP	102.0	Toxicity	3	5	pravastatin	statin-related myopathy	2022-02-15	https://www.pharmgkb.org/clinicalAnnotation/1451244740	
1451253200	CYP2C19*1, CYP2C19*2	CYP2C19	4		Tier 1 VIP	-2.125	Efficacy	3	3	venlafaxine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451253200	
1451350580	rs8187710	ABCC2	4			-2.25	Toxicity	3	3	tenofovir	Fanconi Syndrome;HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451350580	
1451254826	rs1051266	SLC19A1	4		Tier 1 VIP	-2.25	Efficacy	5	5	methotrexate	Neoplasms;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-09-28	https://www.pharmgkb.org/clinicalAnnotation/1451254826	Pediatric
1451254820	rs1051266	SLC19A1	4		Tier 1 VIP	-0.5	Toxicity	12	12	methotrexate	Neoplasms	2021-10-21	https://www.pharmgkb.org/clinicalAnnotation/1451254820	Pediatric
1449167568	rs1061115	PYROXD2	3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-25	https://www.pharmgkb.org/clinicalAnnotation/1449167568	Pediatric
1449005195	rs4072879	VKORC1L1	3			2.5	Dosage	1	1	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449005195	
1449167086	rs6090041	OPRL1;RGS19	3			0.5	Toxicity	1	2	opioids	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449167086	
1449167093	rs6090043	LKAAEAR1;OPRL1	3			0.5	Toxicity	1	2	opioids	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449167093	
1449168307	rs4437856		3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168307	
1449168314	rs2419128		3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168314	
1449168621	rs61908410	ANO2	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168621	
1450375674	rs61816456	NTNG1	3			0.0	Efficacy	1	1	allopurinol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450375674	
1450375680	rs77567654	GREM2	3			0.0	Efficacy	1	1	allopurinol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450375680	
1450375686	rs10802887	GREM2	3			0.0	Efficacy	1	1	allopurinol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450375686	
1450376133	rs795484	TAOK3	3			0.0	Dosage;Efficacy	1	1	morphine	Pain, Postoperative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450376133	Pediatric
1450810451	rs671	ALDH2	2B		Rare Variant	4.75	Toxicity	2	2	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450810451	
1450044809	rs2273697	ABCC2	3			0.25	Metabolism/PK	1	1	ceftriaxone	Central Nervous System Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450044809	
1450112772	rs4148324	UGT1A1;UGT1A10;UGT1A3;UGT1A4;UGT1A5;UGT1A6;UGT1A7;UGT1A8;UGT1A9	3		Tier 1 VIP	0.0	Metabolism/PK	1	1	methotrexate	Osteosarcoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450112772	
1450112778	rs12505410	ABCG2	3		Tier 1 VIP	2.0	Metabolism/PK	1	1	methotrexate	Osteosarcoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450112778	
1450112789	rs13120400	ABCG2	3		Tier 1 VIP	2.0	Metabolism/PK	1	1	methotrexate	Osteosarcoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450112789	
1450820971	rs3787138	CHRNA4	3			0.0	Toxicity	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450820971	
1450928829	rs2036527	CHRNA5	3			2.25	Efficacy	1	1	bupropion	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450928829	
1451397762	rs4240803	SLC7A5	3			2.75	Toxicity	1	1	gabapentin	adverse events;neuropathic pain	2021-03-26	https://www.pharmgkb.org/clinicalAnnotation/1451397762	
1449753234	rs887829	UGT1A1	3		Tier 1 VIP	1.75	Toxicity	1	1	risperidone	Hyperprolactinemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449753234	Pediatric
1451397780	rs4240803	SLC7A5	3			2.75	Toxicity	1	1	pregabalin	adverse events;neuropathic pain	2021-03-26	https://www.pharmgkb.org/clinicalAnnotation/1451397780	
1450806874	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*9, CYP2C19*17	CYP2C19	1A		Tier 1 VIP	214.9375	Metabolism/PK	9	16	lansoprazole	Gastroesophageal Reflux	2021-04-26	https://www.pharmgkb.org/clinicalAnnotation/1450806874	Pediatric
1451400040	CYP2C8*1, CYP2C8*2, CYP2C8*3, CYP2C8*4	CYP2C8	4		Tier 1 VIP	-0.75	Efficacy	2	2	ibuprofen	Pain, Postoperative	2021-05-18	https://www.pharmgkb.org/clinicalAnnotation/1451400040	
981237959	rs13181	ERCC2	3			5.75	Efficacy;Toxicity	3	3	fluorouracil;leucovorin;oxaliplatin	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981237959	
981478131	rs10919035	NOS1AP	3			3.0	Toxicity	1	2	amiodarone	Long QT Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981478131	
1449715584	rs4587017	UGT2B7	3			0.0	Efficacy	1	1	fentanyl	Pain, Postoperative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449715584	
1450376188	rs5219	KCNJ11	3			2.75	Toxicity	1	1	tacrolimus	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450376188	
1450932697	rs2234918	OPRD1	3			2.75	Toxicity	1	1	buprenorphine;fentanyl;tramadol	Opioid-Related Disorders;Sexual Dysfunctions, Psychological	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450932697	
1450934506	rs28935195	GLA	3		Rare Variant	0.0	Efficacy	1	1	migalastat	Fabry Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450934506	
1450934515	rs1569304898	GLA	3			0.0	Efficacy	1	1	migalastat	Fabry Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450934515	
1450934525	rs104894827	GLA	3		Rare Variant	0.0	Efficacy	1	1	migalastat	Fabry Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450934525	
1450934678	rs727505292	GLA	3			0.0	Efficacy	1	1	migalastat	Fabry Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450934678	
1450934761	rs746071566	NUDT15	3		Rare Variant; Tier 1 VIP	2.5	Toxicity	1	1	azathioprine;mercaptopurine	Pancytopenia;Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450934761	
1450935844	rs145119820	CYP2C19	3		Rare Variant; Tier 1 VIP	1.0	Metabolism/PK	1	1	mephenytoin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450935844	
1450936242	rs1042008	SULT1A1	3		Rare Variant	0.0	Metabolism/PK	1	1	tapentadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936242	
1450936747	rs1229976	ADH1A	3			1.5	Metabolism/PK	1	1	acetaldehyde		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936747	
1451397860	rs4240803	SLC7A5	3			3.25	Efficacy	1	1	gabapentin	neuropathic pain	2021-03-26	https://www.pharmgkb.org/clinicalAnnotation/1451397860	
981204641	rs1799971	OPRM1	3			4.5	Toxicity	15	15	ethanol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204641	
981204941	rs1801019	UMPS	3			5.0	Toxicity	2	2	tegafur	Drug Toxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204941	
1450935832	rs61311738	CYP2C19	3		Rare Variant; Tier 1 VIP	1.0	Metabolism/PK	1	2	mephenytoin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450935832	
1450935850	rs1187513719	CYP2C19	3		Rare Variant; Tier 1 VIP	0.125	Metabolism/PK	1	1	mephenytoin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450935850	
1450935917	rs4430924	XPO1	3			2.25	Toxicity	1	1	Drugs For Treatment Of Tuberculosis	Drug Toxicity;Tuberculosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450935917	
1450936195	rs1042028	SULT1A1	3			0.0	Metabolism/PK	1	1	tapentadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936195	
1450936260	rs767487725	SULT1A1	3		Rare Variant	0.0	Metabolism/PK	1	1	tapentadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936260	
1450936296	rs544820732	SULT1A1	3		Rare Variant	0.0	Metabolism/PK	1	1	desmethylnaproxen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936296	
1450936563	rs1049305	AQP1	3			2.0	Toxicity	1	1	cisplatin	Leukopenia;Mesothelioma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936563	
1451397880	rs4240803	SLC7A5	3			3.25	Efficacy	1	1	pregabalin	neuropathic pain	2021-03-26	https://www.pharmgkb.org/clinicalAnnotation/1451397880	
982031741	rs7439366	UGT2B7	4			-0.5	Metabolism/PK	3	4	valproic acid	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982031741	Pediatric
982030998	rs9376230	MAP3K5	3			2.0	Efficacy	1	1	hydroxyurea	Thalassemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982030998	
982040494	rs6265	BDNF	3			1.0	Efficacy	2	2	paroxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982040494	
1043880476	rs5186	AGTR1	3			2.5	Efficacy;Toxicity	1	1	Ace Inhibitors, Plain	Coronary Artery Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880476	
982032756	rs1801260	CLOCK	4			-1.5	Toxicity	2	2	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982032756	
982034111	rs11676382	GGCX	4			-3.5	Dosage	4	4	acenocoumarol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982034111	
982037571	rs2242480	CYP3A4	4		Tier 1 VIP	-6.75	Efficacy	8	8	clopidogrel	Coronary Artery Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982037571	
1451397872	rs4240803	SLC7A5	3			2.25	Dosage	1	1	gabapentin	neuropathic pain	2021-03-26	https://www.pharmgkb.org/clinicalAnnotation/1451397872	
1043858980	rs6065	GP1BA	3			3.75	Efficacy	2	2	aspirin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043858980	
1183617979	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7	CYP2D6	2A		Tier 1 VIP	12.4375	Metabolism/PK	10	11	oxycodone	Pain	2022-01-13	https://www.pharmgkb.org/clinicalAnnotation/1183617979	
1043880659	rs2207396	ESR1	3			2.5	Toxicity	1	1	Alkylating Agents;cisplatin	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880659	
1043880680	rs5030655	CYP2D6	3		Rare Variant; Tier 1 VIP	3.25	Toxicity	1	1	antipsychotics		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880680	
1127092670	rs2500535	UST	3			0.0	Efficacy	1	1	nortriptyline	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1127092670	
1153928101	rs1143684	NQO2	3			1.0	Efficacy	2	2	cyclophosphamide;doxorubicin	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1153928101	
1183491157	rs776746	CYP3A5	3		Tier 1 VIP	1.5	Efficacy	1	1	lovastatin	Arteriosclerosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183491157	
1183491278	CYP3A5*1, CYP3A5*3	CYP3A5	3		Tier 1 VIP	1.0	Efficacy;Toxicity	3	4	atorvastatin	Myalgia unspecified	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183491278	
1183491380	rs1922242	ABCB1	3		Tier 1 VIP	1.75	Efficacy	1	1	fluvastatin	Hypercholesterolemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183491380	
1183681866	rs12041331	PEAR1	3			2.25	Toxicity	1	1	aspirin	Myocardial Infarction	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183681866	
1183682421	CYP2C19*2	CYP2C19	3		Tier 1 VIP	0.125	Metabolism/PK	1	1	venlafaxine	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183682421	
1451397900	HLA-B*38:02:01	HLA-B	3		Tier 1 VIP	3.0	Toxicity	2	2	propylthiouracil	Agranulocytosis;Graves Disease	2021-03-26	https://www.pharmgkb.org/clinicalAnnotation/1451397900	
1183614605	rs1799998	CYP11B2	3			1.5	Efficacy	1	2	benazepril;imidapril	Essential hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614605	
1183630286	rs12659	SLC19A1	3		Tier 1 VIP	1.5	Efficacy	1	1	carboplatin;cisplatin;fluorouracil	Uterine Cervical Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183630286	
1183631480	rs1045642	ABCB1	3		Tier 1 VIP	1.5	Other	1	1	talinolol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183631480	
1183693390	HLA-B*13:01:01	HLA-B	3		Tier 1 VIP	3.0	Toxicity	3	4	phenytoin	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183693390	
1183693395	HLA-B*58:01	HLA-B	3		Tier 1 VIP	2.5	Toxicity	1	1	antiepileptics	Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183693395	
1183697747	rs2282143	SLC22A1	3			1.25	Metabolism/PK	1	1	metformin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183697747	
1183697752	rs316019	SLC22A2	3			2.125	Other	2	2	metformin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183697752	
1183698846	rs2631372	SLC22A5	3			2.25	Efficacy	1	1	imatinib	Gastrointestinal Stromal Tumors	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183698846	
1183700503	rs11600347	KCNJ1	3			3.75	Toxicity	1	1	hydrochlorothiazide	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183700503	
1183700536	rs10757274	CDKN2B-AS1	3			3.25	Toxicity	1	1	Antiinflammatory agents, non-steroids	Acute coronary syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183700536	
1183689114	CYP2D6*2, CYP2D6*10	CYP2D6	3		Tier 1 VIP	0.25	Toxicity	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-04-23	https://www.pharmgkb.org/clinicalAnnotation/1183689114	Pediatric
1451397920	CYP2D6*1, CYP2D6*4	CYP2D6	3		Tier 1 VIP	2.5	Dosage	1	1	sertraline	Depression	2021-04-23	https://www.pharmgkb.org/clinicalAnnotation/1451397920	
1183700383	rs1042713	ADRB2	3		Tier 1 VIP	1.75	Efficacy	2	2	corticosteroids	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183700383	Pediatric
1183700522	rs1105525	DHFR	3			2.75	Efficacy	1	1	methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183700522	Pediatric
1183701234	HLA-B*51:01:01	HLA-B	3		Tier 1 VIP	3.5	Toxicity	1	1	phenobarbital	Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183701234	
1183700891	rs6265	BDNF	4			-0.5	Other	3	5	heroin;methamphetamine	Substance-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183700891	
1183700410	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*14	CYP2D6	1A		Tier 1 VIP	103.4375	Metabolism/PK	10	13	fluvoxamine	Depressive Disorder	2021-04-23	https://www.pharmgkb.org/clinicalAnnotation/1183700410	
982029857	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	1A		Tier 1 VIP	107.9375	Metabolism/PK	12	19	tamoxifen	Breast Neoplasms	2021-04-29	https://www.pharmgkb.org/clinicalAnnotation/982029857	
1451401800	rs4149081	SLCO1B1	3		Tier 1 VIP	1.25	Metabolism/PK	5	5	methotrexate	Osteosarcoma;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-12-13	https://www.pharmgkb.org/clinicalAnnotation/1451401800	Pediatric
982030732	rs762551	CYP1A2	3			2.0	Efficacy	2	2	clopidogrel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982030732	
982030873	rs10036156	GABRP	3			0.0	Efficacy	1	1	antidepressants;Selective serotonin reuptake inhibitors;venlafaxine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982030873	
982031855	rs588765	CHRNA5	3			2.5	Efficacy	2	4	Drugs used in nicotine dependence;nicotine;varenicline	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982031855	
982032763	rs1800532	TPH1	3			0.0	Efficacy	1	1	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982032763	
982036328	rs1799752	ACE	3		Tier 1 VIP	2.25	Efficacy	1	1	spironolactone	Heart Failure	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982036328	
982046386	rs61767072	ADRA2C	3			2.0	Efficacy	1	1	bucindolol	Heart Failure	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982046386	
1123915607	rs11749035	DRD1	3			3.5	Efficacy	1	1	bupropion;nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1123915607	
1451397981	rs1801252	ADRB1	3		Tier 1 VIP	0.75	Efficacy	2	2	carvedilol		2021-03-26	https://www.pharmgkb.org/clinicalAnnotation/1451397981	
1451398000	rs1801253	ADRB1	3		Tier 1 VIP	2.25	Dosage	1	1	carvedilol	Heart Failure	2021-03-26	https://www.pharmgkb.org/clinicalAnnotation/1451398000	
1043880098	rs7311358	SLCO1B3	3			1.0	Other	2	3	mycophenolate mofetil	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880098	
1043880276	rs1799752	ACE	3		Tier 1 VIP	4.5	Efficacy	1	3	atorvastatin;quinapril	Coronary Artery Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880276	
1043880293	rs3211371	CYP2B6	3		Tier 1 VIP	0.0	Toxicity	1	1	cyclophosphamide;doxorubicin	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880293	
1043880323	rs1051685	XRCC5	3			1.5	Efficacy	1	1	thalidomide	Multiple Myeloma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880323	
1043880402	rs61162043	VKORC1	3		Tier 1 VIP	2.75	Dosage	1	1	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880402	
1043880454	rs4986790	TLR4	3			0.5	Efficacy	1	2	pravastatin	Coronary Artery Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880454	
1043880644	rs495828	ABO	3			3.25	Toxicity	1	1	Ace Inhibitors, Plain		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880644	
1140655380	rs1045642	ABCB1	3		Tier 1 VIP	1.0	Toxicity	2	2	atorvastatin	Coronary Artery Disease;Myalgia unspecified	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1140655380	
1152661500	rs2032582	ABCB1	3		Tier 1 VIP	1.0	Toxicity	2	2	simvastatin	Hypercholesterolemia;Myalgia unspecified	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1152661500	
1183490952	rs2244613	CES1	3			4.25	Toxicity	2	3	dabigatran	Atrial Fibrillation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183490952	
1183491359	rs4783961	CETP	3			1.75	Efficacy	1	1	fluvastatin	Hypercholesterolemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183491359	
1183491403	rs428785	ADAMTS1	3			4.0	Efficacy	1	1	pravastatin	Coronary Disease;Myocardial Infarction	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183491403	
1183631470	rs4253728	PPARA	3			1.75	Efficacy	1	1	simvastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183631470	
1183630246	rs1042858	RRM1	4			-0.5	Efficacy	3	4	gemcitabine	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183630246	
1183632170	rs10426377	SULT2B1	4			-1.5	Toxicity	2	2	anthracyclines and related substances	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183632170	Pediatric
1451398106	rs4713916	FKBP5	3			1.75	Efficacy	1	1	fluoxetine	Mood Disorders	2021-03-26	https://www.pharmgkb.org/clinicalAnnotation/1451398106	
1183617832	rs6295	HTR1A	3			5.25	Efficacy	4	4	paroxetine	Panic Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183617832	
1183616718	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*36, CYP2D6*41	CYP2D6	1A		Tier 1 VIP	216.0625	Metabolism/PK	19	35	codeine		2021-11-01	https://www.pharmgkb.org/clinicalAnnotation/1183616718	Pediatric
1183689931	CYP3A4*1, CYP3A4*18, CYP3A4*20, CYP3A4*22, CYP3A4*36	CYP3A4	1B		Tier 1 VIP	34.25	Metabolism/PK	37	43	tacrolimus	heart transplantation;Kidney Transplantation;laparoscopic sleeve gastrectomy;liver transplantation;lung transplantation	2022-03-23	https://www.pharmgkb.org/clinicalAnnotation/1183689931	Pediatric
1183684162	rs2515641	CYP2E1	3			2.75	Toxicity	1	1	cytarabine;fludarabine;gemtuzumab ozogamicin;idarubicin	Leukemia, Myeloid, Acute	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183684162	
1183689987	rs2740574	CYP3A4	3		Tier 1 VIP	2.25	Other	1	1	sirolimus	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183689987	
1183693433	rs1594160	XDH	3			1.75	Toxicity	1	1	didanosine	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183693433	
1183689409	rs1799724	TNF	4			-1.125	Efficacy	6	7	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Arthritis, Rheumatoid;Crohn Disease;Psoriasis;Spondylitis, Ankylosing	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183689409	
1451398120	rs4713916	FKBP5	3			1.75	Efficacy	1	1	mirtazapine	Mood Disorders	2021-03-26	https://www.pharmgkb.org/clinicalAnnotation/1451398120	
1183681792	HLA-B*13:01:01	HLA-B	2A		Tier 1 VIP	22.25	Toxicity	6	8	dapsone	Drug Hypersensitivity;drug reaction with eosinophilia and systemic symptoms;Leprosy;Maculopapular Exanthema;severe cutaneous adverse reactions;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183681792	
982047840	rs761142	GCLC	3			6.25	Toxicity	1	2	sulfamethoxazole	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982047840	
982047910	rs1799752	ACE	3		Tier 1 VIP	6.75	Efficacy	8	8	enalapril	Arteriosclerosis;Coronary Disease;Essential hypertension;glomerular disease;Glomerulonephritis, IGA;Kidney Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982047910	
1183491026	rs8187710	ABCC2	3			0.75	Efficacy	2	2	lopinavir	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183491026	
1183533945	rs3740066	ABCC2	3			1.0	Toxicity	1	2	irinotecan	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183533945	
1183533950	rs3025000	VEGFA	3			6.5	Efficacy	1	2	bevacizumab;ranibizumab	Macular Degeneration	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183533950	
1183533966	rs2305089	TBXT	3			3.0	Efficacy	1	1	flunisolide	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183533966	
1183556309	rs7787082	ABCB1	3		Tier 1 VIP	2.25	Efficacy	1	1	clozapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183556309	
1183604793	rs2245705	SACM1L	3			0.0	Toxicity	1	1	bupropion	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183604793	
1183612432	rs2227310	CASP7	3			5.5	Efficacy	1	2	docetaxel;gemcitabine;paclitaxel;Platinum compounds;vinorelbine	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183612432	
1183612731	rs2106809	ACE2	3			0.5	Efficacy	1	2	captopril	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183612731	
1183614499	rs1801133	MTHFR	3		Tier 1 VIP	2.0	Efficacy	1	1	disulfiram	Cocaine-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614499	
1183614855	rs1042640	UGT1A	3			0.0	Other	1	1	acetaminophen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614855	
1183615135	rs1414334	HTR2C	3			2.25	Toxicity	1	1	olanzapine	Mental Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183615135	
1183615621	rs2229437	PRCP	3			3.5	Efficacy	1	1	benazepril	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183615621	
1183619864	rs1050828	G6PD	3		Tier 1 VIP	0.0	Toxicity	1	1	amodiaquine;pyrimethamine;sulfadoxine	Malaria;Malaria, Falciparum	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183619864	Pediatric
1183631404	rs11960832	SV2C	3			2.0	Efficacy	1	1	olanzapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183631404	
1183697592	rs2306283	SLCO1B1	3		Tier 1 VIP	2.25	Metabolism/PK	4	4	methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-12-13	https://www.pharmgkb.org/clinicalAnnotation/1183697592	Pediatric
1183679828	rs17574269	DCBLD1	3			0.0	Efficacy	1	1	cisplatin;irinotecan	Carcinoma, Small Cell	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183679828	
1183679848	rs17060812	SLC39A14	3			2.75	Efficacy	1	1	nortriptyline	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183679848	
1183680570	rs12819210	OASL	3			2.25	Efficacy	1	1	peginterferon alfa-2b;ribavirin	Hepatitis C	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183680570	
1183697557	rs602950	CDA	3			3.0	Toxicity	1	3	capecitabine	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183697557	
1451398140	rs1695	GSTP1	3		Tier 1 VIP	2.0	Efficacy	1	1	cyclophosphamide;epirubicin	Breast Neoplasms	2021-03-26	https://www.pharmgkb.org/clinicalAnnotation/1451398140	
1183679122	rs1719247		3			1.75	Toxicity	1	1	hmg coa reductase inhibitors		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183679122	
1183681861	rs12041331	PEAR1	3			2.25	Efficacy;Toxicity	1	3	aspirin;clopidogrel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183681861	
1183689585	rs28401781	ABCB1	3		Tier 1 VIP	0.0	Efficacy	1	1	citalopram;fluoxetine;paroxetine;sertraline	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183689585	
1183689914	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	3		Tier 1 VIP	4.875	Metabolism/PK	5	6	tolterodine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183689914	
1183693443	rs11191561	NT5C2	3			2.25	Toxicity	1	1	didanosine	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183693443	
1183699226	rs2494752	AKT1	3			2.0	Efficacy	1	1	carboplatin;cisplatin	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183699226	
1183700243	rs1265138	RRM2B	3			1.75	Efficacy	1	1	cladribine;cytarabine	Leukemia, Myeloid, Acute	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183700243	Pediatric
1183700279	rs7194667	ABCC11	3			3.0	Toxicity	1	1	fluorouracil	Leukopenia;Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183700279	
1183700396	rs1042713	ADRB2	3		Tier 1 VIP	3.75	Efficacy	3	3	corticosteroids;selective beta-2-adrenoreceptor agonists	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183700396	Pediatric
1183700527	rs10919563	PTPRC	3			2.0	Efficacy	2	2	adalimumab;etanercept;infliximab;Tumor necrosis factor alpha (TNF-alpha) inhibitors	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183700527	
1183698531	rs2304016	SCN2A	3		Rare Variant	3.25	Efficacy	1	1	antiepileptics	Epilepsy	2021-11-30	https://www.pharmgkb.org/clinicalAnnotation/1183698531	
1451398160	rs1695	GSTP1	3		Tier 1 VIP	2.5	Toxicity	1	1	cyclophosphamide;epirubicin	Breast Neoplasms;Drug Toxicity	2021-03-26	https://www.pharmgkb.org/clinicalAnnotation/1451398160	
1183698868	rs4124874	UGT1A1	4		Tier 1 VIP	-1.75	Toxicity	6	7	irinotecan	Lymphoma;Neoplasms	2021-06-23	https://www.pharmgkb.org/clinicalAnnotation/1183698868	Pediatric
1183491318	CYP3A4*1, CYP3A4*36	CYP3A4	3		Tier 1 VIP	6.5	Efficacy	1	3	atorvastatin	Hyperlipidemias	2022-03-23	https://www.pharmgkb.org/clinicalAnnotation/1183491318	
982031026	rs7787082	ABCB1	3		Tier 1 VIP	2.75	Efficacy	1	1	amitriptyline;citalopram;paroxetine;venlafaxine	Depressive Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982031026	
982032567	rs7118900	ANKK1	3			0.0	Dosage	1	1	methadone	Heroin Dependence;Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982032567	
982032727	rs2071427	NR1D1;THRA	3			0.25	Efficacy	2	3	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982032727	
982037796	rs1137101	LEPR	3			2.25	Efficacy	1	1	simvastatin	Coronary Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982037796	
1043859346	CYP2B6*1, CYP2B6*5	CYP2B6	3		Tier 1 VIP	2.5	Efficacy	1	1	clopidogrel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043859346	
1043859380	rs2228478	MC1R	3			2.25	Efficacy	1	1	desipramine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043859380	
1043880205	rs708272	CETP	3			2.75	Efficacy	1	1	lovastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880205	
1043880308	rs2266780	FMO3	3			2.0	Other	1	1	olanzapine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880308	
1043880318	rs735482	ERCC1	3			2.0	Efficacy	1	1	thalidomide	Multiple Myeloma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880318	
1043880328	rs4630	GSTT1	3			1.5	Toxicity	1	1	thalidomide	Multiple Myeloma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880328	
1043880841	rs1979277	SHMT1	3			4.0	Efficacy	1	2	bevacizumab;fluorouracil;irinotecan;leucovorin	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880841	
1043880433	rs12487736	SCAP	4			-1.25	Other	1	2	atorvastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880433	
1183491162	rs776746	CYP3A5	4		Tier 1 VIP	-6.375	Other	7	10	simvastatin	Hypercholesterolemia;Myalgia unspecified	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183491162	
1451398180	rs1695	GSTP1	3		Tier 1 VIP	2.5	Toxicity	1	1	cyclophosphamide;epirubicin	Breast Neoplasms;Neutropenia	2021-03-26	https://www.pharmgkb.org/clinicalAnnotation/1451398180	
982030222	NAT2*4, NAT2*5A, NAT2*5B, NAT2*5C, NAT2*6A, NAT2*6B, NAT2*6J, NAT2*6O, NAT2*7A, NAT2*7B, NAT2*7G, NAT2*12A, NAT2*13A, NAT2*14A	NAT2	2A		Tier 1 VIP	16.6875	Metabolism/PK	13	15	isoniazid	Tuberculosis	2022-06-15	https://www.pharmgkb.org/clinicalAnnotation/982030222	Pediatric
1183492035	rs662799	APOA5	3			4.5	Efficacy	2	2	atorvastatin;lovastatin;simvastatin	Hyperlipidemias	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183492035	
982030805	rs71647871	CES1	2B		Rare Variant	4.0	Metabolism/PK	3	3	clopidogrel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982030805	
1043880802	rs4149056	SLCO1B1	3		Tier 1 VIP	7.25	Efficacy	10	11	pravastatin		2021-05-26	https://www.pharmgkb.org/clinicalAnnotation/1043880802	Pediatric
1043858965	rs5186	AGTR1	3			1.75	Efficacy	1	1	captopril	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043858965	
1183562698	rs62205366	GNAS	3		Rare Variant	2.25	Efficacy	1	2	dobutamine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183562698	
1183603764	rs2497538	HTR2C	3			2.25	Toxicity	1	1	olanzapine	Weight gain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183603764	
1183607901	rs2230806	ABCA1	3			4.5	Efficacy	1	2	fenofibrate	Hypertriglyceridemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183607901	
1183614761	rs1128503	ABCB1	3		Tier 1 VIP	2.25	Toxicity	1	1	sirolimus	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614761	
1183615261	rs2276302	HTR3A	3			2.5	Efficacy	1	1	clozapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183615261	
1183615359	rs1800471	TGFB1	3			3.25	Efficacy	1	1	rituximab	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183615359	
1183615367	rs3740556	EIF3A	3		Rare Variant	4.25	Efficacy	1	3	carboplatin;cisplatin	Lung Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183615367	
1183615424	rs767455	TNFRSF1A	3			0.5	Efficacy	1	2	adalimumab;etanercept;infliximab	Arthritis, Psoriatic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183615424	
1183618924	rs6314	HTR2A	3			6.5	Efficacy	3	4	antidepressants	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183618924	
1183629315	rs2235067	ABCB1	3		Tier 1 VIP	2.75	Efficacy	1	1	amitriptyline;citalopram;paroxetine;venlafaxine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183629315	
1183632145	rs880054	WNK1	3			2.5	Efficacy	1	1	hydrochlorothiazide	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183632145	
1183632165	rs10423928	GIPR	3			4.0	Toxicity	2	2	olanzapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183632165	
1451398187	rs1695	GSTP1	3		Tier 1 VIP	2.75	Efficacy	1	1	capecitabine;epirubicin;platinum	Colorectal Neoplasms	2021-03-26	https://www.pharmgkb.org/clinicalAnnotation/1451398187	
1183679135	rs1346268		3			3.5	Toxicity	1	1	simvastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183679135	
1183689961	CYP3A4*1, CYP3A4*36	CYP3A4	3		Tier 1 VIP	0.5	Other	1	2	tacrolimus	liver transplantation	2022-03-23	https://www.pharmgkb.org/clinicalAnnotation/1183689961	
1183533955	rs3024530	IL4R	3			2.5	Efficacy	1	1	pitrakinra	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183533955	
1183601914	rs3091244	CRP	3			4.5	Efficacy	1	2	fenofibrate	Metabolic Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183601914	
1183602560	rs2742435	SACM1L	3			0.0	Toxicity	1	1	bupropion	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183602560	
1183614466	rs1805087	MTR	3			1.0	Efficacy	1	2	benazepril	Essential hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614466	
1183614600	rs1799998	CYP11B2	3			2.5	Efficacy	1	1	candesartan	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614600	
1183615587	rs669	A2M	3			4.0	Efficacy	1	1	Enzymes	Stroke	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183615587	
1183617618	rs2235040	ABCB1	3		Tier 1 VIP	3.25	Toxicity	1	1	antidepressants;citalopram;fluvoxamine;paroxetine;sertraline;venlafaxine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183617618	
1183617644	rs2472304	CYP1A2	3			2.0	Efficacy	1	1	paroxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183617644	
1183621972	CYP2C9*1, CYP2C9*3	CYP2C9	3		Tier 1 VIP	1.0	Other	1	1	trimipramine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183621972	
1183622527	rs2069521		3			4.5	Toxicity	1	3	escitalopram	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183622527	
1183622622	rs4646425	CYP1A2	3			4.5	Toxicity	1	3	escitalopram	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183622622	
1183629310	rs4148740	ABCB1	3		Tier 1 VIP	2.75	Efficacy	1	1	amitriptyline;citalopram;paroxetine;venlafaxine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183629310	
1183684153	rs2302948	SULT2B1	3			2.75	Toxicity	1	1	cytarabine;fludarabine;gemtuzumab ozogamicin;idarubicin	Leukemia, Myeloid, Acute	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183684153	
1183697540	rs2306283	SLCO1B1	3		Tier 1 VIP	2.5	Efficacy	1	1	irinotecan	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183697540	
1183698808	rs5063	NPPA-AS1	3			1.75	Efficacy	1	1	bumetanide;furosemide;torasemide		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183698808	
1183698831	rs1800795	IL6	3			1.5	Efficacy	1	1	fenofibrate	Cardiovascular Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183698831	
1451398240	rs1800566	NQO1	3			3.0	Efficacy	1	1	epirubicin;fluorouracil;oxaliplatin	Neoplasm Metastasis;Stomach Neoplasms	2021-03-26	https://www.pharmgkb.org/clinicalAnnotation/1451398240	
1183617724	rs4713916	FKBP5	3			4.5	Efficacy	2	2	antidepressants;Selective serotonin reuptake inhibitors	Depressive Disorder;Mood Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183617724	
1183617478	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	1A		Tier 1 VIP	101.6875	Metabolism/PK	2	3	zuclopenthixol	Schizophrenia	2021-05-04	https://www.pharmgkb.org/clinicalAnnotation/1183617478	
1183701210	HLA-A*33:03	HLA-A	2B			12.75	Toxicity	6	7	allopurinol	Drug Hypersensitivity;Stevens-Johnson Syndrome	2022-10-19	https://www.pharmgkb.org/clinicalAnnotation/1183701210	
1183690410	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	3		Tier 1 VIP	1.75	Other	2	2	timolol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183690410	
1183693382	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	3		Tier 1 VIP	1.125	Other	2	2	icotinib		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183693382	
1183698786	rs28371759	CYP3A4	3		Rare Variant; Tier 1 VIP	1.25	Other	1	1	cyclosporine	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183698786	
1183698818	rs4148323	UGT1A1	3		Rare Variant; Tier 1 VIP	2.25	Toxicity	1	1	indinavir	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183698818	
1183700230	rs1130609	RRM2	3			1.5	Efficacy	1	1	cladribine;cytarabine	Leukemia, Myeloid, Acute	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183700230	Pediatric
1183700238	rs5030743	RRM2	3			1.75	Efficacy	1	1	cladribine;cytarabine	Leukemia, Myeloid, Acute	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183700238	Pediatric
1183700248	rs2898950	RRM1	3			1.75	Efficacy	1	1	cladribine;cytarabine	Leukemia, Myeloid, Acute	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183700248	Pediatric
1183700253	rs1561876	RRM1	3			2.75	Efficacy	1	1	cladribine;cytarabine	Leukemia, Myeloid, Acute	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183700253	Pediatric
1183700258	rs1042919	RRM1	3			2.25	Efficacy	1	1	cladribine;cytarabine	Leukemia, Myeloid, Acute	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183700258	Pediatric
1183700512	rs11189381	SFRP5	3			0.0	Toxicity	1	1	Bisphosphonates	Osteonecrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183700512	
1183700812	rs1080985	CYP2D6	3		Tier 1 VIP	1.75	Other	1	1	debrisoquine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183700812	
1183701068	rs1080985	CYP2D6	3		Tier 1 VIP	1.25	Other	1	1	thioridazine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183701068	
1183700477	CYP2D6*1, CYP2D6*10	CYP2D6	4		Tier 1 VIP	-0.3125	Other	2	4	propranolol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183700477	
1451398300	rs1800566	NQO1	3			3.0	Efficacy	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms	2021-03-26	https://www.pharmgkb.org/clinicalAnnotation/1451398300	
1451398340	rs17782313	MC4R	3			1.5	Toxicity	1	1	quetiapine	Weight gain	2021-03-26	https://www.pharmgkb.org/clinicalAnnotation/1451398340	
1183700488	rs1532624	CETP	3			3.5	Efficacy	1	1	hmg coa reductase inhibitors	Hyperlipidemias	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183700488	
982047500	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*8, CYP2C9*11, CYP2C9*13, CYP2C9*14, CYP2C9*16, CYP2C9*29, CYP2C9*31, CYP2C9*33, CYP2C9*37, CYP2C9*39, CYP2C9*42, CYP2C9*43, CYP2C9*45, CYP2C9*50, CYP2C9*52, CYP2C9*55	CYP2C9	1A		Tier 1 VIP	337.125	Metabolism/PK	19	52	phenytoin	Epilepsy	2021-10-14	https://www.pharmgkb.org/clinicalAnnotation/982047500	Pediatric
982030907	rs502434	GRIA3	3			2.5	Efficacy	1	1	antidepressants;Selective serotonin reuptake inhibitors;venlafaxine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982030907	
982030990	rs9483947	MAP3K5	3			1.5	Efficacy	1	1	hydroxyurea	Thalassemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982030990	
982031767	rs762551	CYP1A2	3			4.5	Dosage;Toxicity	2	3	paroxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982031767	
982031864	rs1051730	CHRNA3	3			1.75	Efficacy	2	2	Drugs used in nicotine dependence;nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982031864	
982032257	rs7934165	BDNF	3			0.0	Dosage	1	1	methadone	Heroin Dependence;Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982032257	
982032396	rs2289658	NTRK2	3			0.0	Dosage	1	1	methadone	Heroin Dependence;Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982032396	
982036556	rs4148416	ABCC3	3			1.5	Efficacy	1	1	cisplatin;cyclophosphamide;doxorubicin;methotrexate;vincristine	Osteosarcoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982036556	
982037368	rs5918	ITGB3	3			3.75	Efficacy	6	6	clopidogrel	Coronary Artery Disease;Myocardial Infarction	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982037368	
1148480056	rs2070676	CYP2E1	3			1.25	Efficacy;Toxicity	1	2	cisplatin;cyclophosphamide	Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1148480056	
982037603	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	4		Tier 1 VIP	-3.0	Efficacy	9	13	clopidogrel	Acute coronary syndrome;Coronary Artery Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982037603	
982040423	rs6785930	P2RY12	4			-2.25	Efficacy;Toxicity	3	3	clopidogrel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982040423	
1451398281	rs1801253	ADRB1	3		Tier 1 VIP	4.5	Efficacy	2	2	bucindolol	Heart Failure	2021-03-26	https://www.pharmgkb.org/clinicalAnnotation/1451398281	
1451398293	rs17782313	MC4R	3			1.5	Toxicity	1	1	paliperidone	Weight gain	2021-03-26	https://www.pharmgkb.org/clinicalAnnotation/1451398293	
1183607419	rs2231137	ABCG2	3		Tier 1 VIP	1.0	Toxicity	1	2	irinotecan	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183607419	
1183607656	rs2230808	ABCA1	3			3.25	Efficacy	1	1	fenofibrate	Hypertriglyceridemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183607656	
1183574175	rs2952768		3			0.0	Efficacy	1	1	opioids	Pain, Postoperative	2022-04-11	https://www.pharmgkb.org/clinicalAnnotation/1183574175	
1156738774	rs2231142	ABCG2	3		Tier 1 VIP	1.5	Metabolism/PK	1	1	simvastatin		2021-12-03	https://www.pharmgkb.org/clinicalAnnotation/1156738774	
1183614504	rs1801020	F12	3			3.5	Efficacy	1	1	Enzymes	Stroke	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614504	
1183614802	rs1110470	IL4R	3			2.0	Efficacy	1	1	pitrakinra	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614802	
1183614989	CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*7	CYP2B6	3		Tier 1 VIP	1.5	Other	1	1	mirtazapine	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614989	
1043858656	rs2243250	IL4	3			1.75	Toxicity	1	1	aspirin	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043858656	
1043859297	rs10306114	PTGS1	3			3.5	Efficacy	1	1	aspirin;clopidogrel	Myocardial Infarction	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043859297	
1043859386	rs72551330	UGT1A9	3		Rare Variant	3.5	Toxicity	1	3	mycophenolate mofetil	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043859386	
1043880303	rs12720462	FMO1	3			1.75	Other	1	1	olanzapine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880303	
1043880367	rs1800566	NQO1	3			2.25	Dosage	2	2	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880367	
1143176298	rs1045642	ABCB1	3		Tier 1 VIP	1.0	Toxicity	2	2	simvastatin	Hypercholesterolemia;Myalgia unspecified	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1143176298	
1146391450	rs4713916	FKBP5	3			2.75	Efficacy	1	1	corticosteroids	Crohn Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1146391450	
1148995043	rs2032582	ABCB1	3		Tier 1 VIP	5.0	Efficacy	4	5	atorvastatin	Hypercholesterolemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1148995043	
1183491021	rs8187710	ABCC2	3			0.0	Other	1	1	calcein;lopinavir		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183491021	
1183532599	rs5888	SCARB1	3			2.75	Efficacy	1	1	atorvastatin	Hypercholesterolemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183532599	
1183619312	rs11983225	ABCB1	3		Tier 1 VIP	2.75	Efficacy	1	1	amitriptyline;citalopram;paroxetine;venlafaxine	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183619312	
1183564259	rs5370	EDN1	3			0.75	Efficacy	1	3	atenolol;irbesartan	Essential hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183564259	
1183623069	rs1051640	ABCC3	3			2.0	Toxicity	5	5	cisplatin	Drug Toxicity;Neoplasms;Ototoxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183623069	Pediatric
1183629480	rs1806201	GRIN2B	3			1.75	Toxicity	1	1	risperidone	Drug Toxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183629480	
1183631536	rs544093	OPRM1	3			2.5	Toxicity	1	1	carboplatin;docetaxel;paclitaxel	Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183631536	
1183631564	rs4483927	HRH4	3			1.25	Efficacy	2	2	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183631564	
1183631782	rs9552679		3			0.0	Efficacy	1	1	salbutamol	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183631782	
1183679813	rs17626122	PARD3B	3			0.0	Toxicity	1	1	fluorouracil;oxaliplatin	Colorectal Neoplasms;Drug Toxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183679813	
1451398307	rs489693	MC4R	3			2.0	Toxicity	1	1	haloperidol	Hypertriglyceridemia;schizoaffective disorder;Schizophrenia;Weight gain	2021-03-26	https://www.pharmgkb.org/clinicalAnnotation/1451398307	Pediatric
1451398314	rs489693	MC4R	3			3.25	Toxicity	2	2	quetiapine	Hypertriglyceridemia;schizoaffective disorder;Schizophrenia;Weight gain	2021-03-26	https://www.pharmgkb.org/clinicalAnnotation/1451398314	Pediatric
1183492249	rs7412	APOE	2B			12.5	Efficacy	5	5	atorvastatin	Coronary Disease;Hyperlipidemias	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183492249	
1183679833	rs17376848	DPYD	1A		Tier 1 VIP	94.5	Toxicity	11	13	fluorouracil	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183679833	
1183617651	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	1A		Tier 1 VIP	213.0	Metabolism/PK	10	19	amitriptyline	Depressive Disorder;Mental Disorders	2021-04-23	https://www.pharmgkb.org/clinicalAnnotation/1183617651	
1183617701	rs4646427	CYP1A2	3			4.5	Efficacy	1	2	paroxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183617701	
1183620959	G6PD A- 202A_376G, G6PD B (wildtype)	G6PD	3		Tier 1 VIP	1.125	Efficacy;Toxicity	18	18	methylene blue	Anemia, Hemolytic;Hemolysis;Protein Deficiency	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183620959	Pediatric
1183622263	rs3737224	PEAR1	3			1.5	Efficacy	1	1	prasugrel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183622263	
1183680531	rs13266634	SLC30A8	3			1.5	Efficacy	1	1	repaglinide	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183680531	
1451398287	rs489693	MC4R	3			1.25	Efficacy	1	1	paliperidone	Weight gain	2021-03-26	https://www.pharmgkb.org/clinicalAnnotation/1451398287	
1183632108	rs16960228	PRKCA	3			0.0	Efficacy	1	1	hydrochlorothiazide	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183632108	
1183693532	rs11872992	MC4R	3			0.0	Toxicity	1	1	clozapine	Schizophrenia	2021-12-03	https://www.pharmgkb.org/clinicalAnnotation/1183693532	
1183679853	rs17024608	RBMS3	3			0.0	Efficacy	1	1	Bisphosphonates	Osteonecrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183679853	
1183679858	rs16950650	ABCC4	3			0.0	Efficacy	1	1	cisplatin;irinotecan	Carcinoma, Small Cell	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183679858	
1183684144	rs2070673	CYP2E1	3			2.75	Toxicity	1	1	cytarabine;fludarabine;gemtuzumab ozogamicin;idarubicin	Leukemia, Myeloid, Acute	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183684144	
1183684167	rs4149056	SLCO1B1	3		Tier 1 VIP	2.75	Toxicity	1	1	cytarabine;fludarabine;gemtuzumab ozogamicin;idarubicin	Leukemia, Myeloid, Acute	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183684167	
1183693438	rs1429376	XDH	3			1.75	Toxicity	1	1	didanosine	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183693438	
1183693448	rs11598702	NT5C2	3			2.25	Toxicity	1	1	didanosine	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183693448	
1183697388	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	3		Tier 1 VIP	1.5	Other	1	1	lovastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183697388	
1183679823	rs17583889	HNMT	4			-1.5	Toxicity	2	2	anthracyclines and related substances	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183679823	Pediatric
1451398347	rs489693	MC4R	3			2.25	Toxicity	3	3	risperidone	Weight gain	2021-03-26	https://www.pharmgkb.org/clinicalAnnotation/1451398347	Pediatric
1451403400	rs11030096	BDNF-AS	3			2.0	Toxicity	1	1	opioids	Opioid-Related Disorders	2021-04-05	https://www.pharmgkb.org/clinicalAnnotation/1451403400	
1451403420	rs4906902	GABRB3	3			2.0	Toxicity	1	1	opioids	Opioid-Related Disorders	2021-04-05	https://www.pharmgkb.org/clinicalAnnotation/1451403420	
1183690892	rs1045642	ABCB1	3		Tier 1 VIP	2.25	Efficacy	1	1	highly active antiretroviral therapy (haart)	HIV Infections	2022-05-17	https://www.pharmgkb.org/clinicalAnnotation/1183690892	
1183697278	rs1934969	CYP2C9	3		Tier 1 VIP	2.75	Other	2	2	losartan		2022-09-29	https://www.pharmgkb.org/clinicalAnnotation/1183697278	
1183680546	rs12979860	IFNL3;IFNL4	1A			213.25	Efficacy	5	7	boceprevir;peginterferon alfa-2a;peginterferon alfa-2b;ribavirin	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183680546	
1183689079	CYP2D6*1, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*10, CYP2D6*17, CYP2D6*92, CYP2D6*96	CYP2D6	1A		Tier 1 VIP	210.8125	Metabolism/PK	9	15	atomoxetine	Attention Deficit Disorder with Hyperactivity	2021-04-29	https://www.pharmgkb.org/clinicalAnnotation/1183689079	Pediatric
982031330	rs2826494		3			0.0	Efficacy	1	1	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982031330	
982032721	rs2769605		3			2.25	Efficacy	1	1	lithium;valproic acid	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982032721	
982036604	rs1128503	ABCB1	3		Tier 1 VIP	0.0	Efficacy	2	2	cisplatin;cyclophosphamide;doxorubicin;methotrexate;vincristine	Osteosarcoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982036604	
982037753	rs1137101	LEPR	3			1.75	Efficacy	1	1	simvastatin	Hyperlipidemias	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982037753	
982038273	rs7997012	HTR2A	3			4.5	Efficacy	1	2	venlafaxine	Anxiety Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982038273	
982045124	rs9934438	VKORC1	3		Tier 1 VIP	6.0	Efficacy	1	2	fluindione	Thromboembolism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982045124	
1043858685	rs1143627	IL1B	3			1.5	Toxicity	1	1	aspirin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043858685	
1043858840	rs9332096	CYP2C9	3		Tier 1 VIP	2.75	Dosage	1	1	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043858840	
1183697531	rs1051266	SLC19A1	3		Tier 1 VIP	2.5	Efficacy	1	1	irinotecan	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183697531	
1183697570	rs1045642	ABCB1	3		Tier 1 VIP	2.0	Efficacy	1	2	tamoxifen	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183697570	
1183697670	UGT2B15*1, UGT2B15*2	UGT2B15	3			4.25	Efficacy	2	2	sipoglitazar		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183697670	
1183698841	rs1050152	SLC22A4	3			3.75	Efficacy	2	5	imatinib	Gastrointestinal Stromal Tumors;Leukemia, Myelogenous, Chronic, BCR-ABL Positive	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183698841	
1043858632	rs1800532	TPH1	4			-1.0	Efficacy	4	6	antidepressants;citalopram;escitalopram;fluoxetine;paroxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043858632	
1183697623	rs833069	VEGFA	4			-2.0	Efficacy	2	4	ranibizumab	Macular Degeneration	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183697623	
1451398299	rs17782313	MC4R	3			1.5	Toxicity	1	1	risperidone	Weight gain	2021-03-26	https://www.pharmgkb.org/clinicalAnnotation/1451398299	
1451403428	rs1079596	DRD2	3		Tier 1 VIP	2.0	Toxicity	1	1	opioids	Opioid-Related Disorders	2021-04-05	https://www.pharmgkb.org/clinicalAnnotation/1451403428	
1183697575	rs1801131	MTHFR	4		Tier 1 VIP	-1.75	Efficacy	11	11	methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-09-28	https://www.pharmgkb.org/clinicalAnnotation/1183697575	Pediatric
1043858882	rs731236	VDR	3			2.25	Efficacy	1	1	calcium		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043858882	
1043859365	rs2228479	MC1R	3			2.25	Efficacy	1	1	desipramine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043859365	
1043873003	rs135550	PPARA	3			2.5	Efficacy	1	1	fenofibrate		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043873003	
1043880165	rs4680	COMT	3		Tier 1 VIP	1.5	Efficacy	3	4	venlafaxine	Anxiety Disorders;Depressive Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880165	
1043880649	rs4459610		3			2.25	Toxicity	1	1	Ace Inhibitors, Plain	Cough	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880649	
1127445681	rs28365062	UGT2B7	3			1.5	Other	1	1	zidovudine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1127445681	
1131245975	rs11568695	ABCC4	3			0.125	Other	1	1	zidovudine	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1131245975	
1183491298	rs1801368	MAD1L1	3			0.75	Efficacy	1	1	carboplatin;paclitaxel	Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183491298	
1183491385	rs5882	CETP	3			0.0	Efficacy	1	1	fluvastatin	Hypercholesterolemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183491385	
1183533882	rs328	LPL	3			2.75	Efficacy	1	1	pravastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183533882	
1183533972	rs2301339	GNB3	3			9.25	Efficacy	1	3	atenolol	Essential hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183533972	
1183589777	rs4961	ADD1	3			1.75	Efficacy	1	1	bumetanide;furosemide;torasemide		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183589777	
1183614687	rs16965962		3			0.0	Toxicity	1	1	citalopram	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614687	
1183614701	rs153549	REEP5	3			3.0	Efficacy	1	1	citalopram;fluoxetine;paroxetine;sertraline	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614701	
1183615383	rs9561765	ABCC4	3			2.25	Efficacy	1	1	imatinib	Gastrointestinal Stromal Tumors	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183615383	
1183615450	CYP2C19*1, CYP2C19*2	CYP2C19	3		Tier 1 VIP	1.25	Dosage	1	2	tacrolimus	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183615450	
1183620032	G6PD A- 202A_376G, G6PD B (wildtype)	G6PD	3		Tier 1 VIP	0.5	Toxicity	2	2	glyburide	Anemia, Hemolytic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183620032	
1183630271	rs10981694	SLC31A1	3			1.0	Toxicity	2	2	cisplatin	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183630271	
1043859430	CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*35xN, CYP2D6*41	CYP2D6	1A		Tier 1 VIP	216.125	Metabolism/PK	6	16	doxepin		2021-04-23	https://www.pharmgkb.org/clinicalAnnotation/1043859430	
1183631545	rs879207		3			3.0	Toxicity	1	1	carboplatin;docetaxel;paclitaxel	Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183631545	
1183632160	rs2061051	GABRG3	3			3.0	Toxicity	1	1	antipsychotics	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183632160	
1183634192	rs28399433	CYP2A6	3		Tier 1 VIP	5.375	Other	6	6	efavirenz	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183634192	Pediatric
1183679775	rs762551	CYP1A2	3			3.5	Toxicity	1	2	antipsychotics;chlorpromazine;fluphenazine;thioridazine;trifluoperazine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183679775	
1183679799	rs17868320	UGT1A9	3			1.75	Toxicity	1	1	sorafenib	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183679799	
1451398380	rs489693	MC4R	3			3.25	Toxicity	2	2	amisulpride	Hypertriglyceridemia;Weight gain	2021-03-26	https://www.pharmgkb.org/clinicalAnnotation/1451398380	Pediatric
1451403440	rs1125394	DRD2	3		Tier 1 VIP	2.0	Toxicity	1	1	opioids	Opioid-Related Disorders	2021-04-05	https://www.pharmgkb.org/clinicalAnnotation/1451403440	
1183631507	rs4149601	NEDD4L	3			3.0	Efficacy	3	4	diuretics;hydrochlorothiazide	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183631507	
1183621261	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*14, CYP2D6*41	CYP2D6	1A		Tier 1 VIP	220.25	Metabolism/PK	21	38	paroxetine		2021-04-29	https://www.pharmgkb.org/clinicalAnnotation/1183621261	Pediatric
1183679808	rs17751934	MEX3C	3			0.0	Toxicity	1	1	Bisphosphonates	Osteonecrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183679808	
1183684132	rs11231825	SLC22A12	3			2.75	Toxicity	1	1	cytarabine;fludarabine;gemtuzumab ozogamicin;idarubicin	Leukemia, Myeloid, Acute	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183684132	
1451398387	rs17782313	MC4R	3			1.5	Toxicity	1	1	amisulpride	Weight gain	2021-03-26	https://www.pharmgkb.org/clinicalAnnotation/1451398387	
1451398394	rs489693	MC4R	3			2.0	Toxicity	1	1	aripiprazole	Weight gain	2021-03-26	https://www.pharmgkb.org/clinicalAnnotation/1451398394	Pediatric
1183689492	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	3		Tier 1 VIP	2.0	Toxicity	1	1	olanzapine	Schizophrenia;Weight gain	2021-04-23	https://www.pharmgkb.org/clinicalAnnotation/1183689492	
1183682148	rs7668258	UGT2B7	3			2.75	Metabolism/PK	5	5	lamotrigine	Epilepsy	2021-11-03	https://www.pharmgkb.org/clinicalAnnotation/1183682148	Pediatric
1183693378	HLA-B*40:01:01	HLA-B	2A		Tier 1 VIP	8.25	Toxicity	6	6	carbamazepine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome	2022-01-10	https://www.pharmgkb.org/clinicalAnnotation/1183693378	
1043859063	rs4238001	SCARB1	3			3.5	Efficacy	1	1	fenofibrate	Hypertriglyceridemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043859063	
1183491044	rs3745274	CYP2B6	3		Tier 1 VIP	3.5	Other	1	2	mitotane	Adrenocortical Carcinoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183491044	
1183594148	rs4291	ACE	3		Tier 1 VIP	2.0	Efficacy	1	1	amlodipine;chlorthalidone;lisinopril	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183594148	
1183603970	rs2440390	DRD2	3		Tier 1 VIP	2.0	Toxicity	1	1	olanzapine	Mental Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183603970	
1183614807	rs11064426	GNB3	3			9.25	Efficacy	1	3	atenolol	Essential hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614807	
1183615242	rs1799752	ACE	4		Tier 1 VIP	-0.25	Efficacy	2	2	lisinopril	Diabetes Mellitus, Type 1;Heart Failure	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183615242	
1183615268	rs11615	ERCC1	3			0.75	Toxicity	2	2	fluorouracil;leucovorin;oxaliplatin	Colonic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183615268	
1183615317	rs2273697	ABCC2	3			1.25	Other	1	1	irinotecan	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183615317	
1183624570	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	3		Tier 1 VIP	3.0	Efficacy	38	58	rabeprazole	Gastroesophageal Reflux;Helicobacter Infections;Peptic Ulcer	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183624570	
1183693527	rs1124493	DRD2	3		Tier 1 VIP	1.75	Other	1	1	olanzapine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183693527	
1183697628	rs776746	CYP3A5	3		Tier 1 VIP	2.0	Other	1	1	nifedipine	Pregnancy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183697628	
1183697633	rs1042713	ADRB2	3		Tier 1 VIP	2.75	Efficacy	1	1	methacholine	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183697633	
1183698813	rs4148323	UGT1A1	3		Rare Variant; Tier 1 VIP	1.0	Other	1	1	carvedilol	Angina Pectoris;Heart Failure	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183698813	
1451403437	rs2654754	DRD3	3			2.0	Toxicity	1	1	opioids	Opioid-Related Disorders	2021-04-05	https://www.pharmgkb.org/clinicalAnnotation/1451403437	
1183689558	rs6025	F5	1A		Tier 1 VIP	107.0	Toxicity	6	7	hormonal contraceptives for systemic use	Thrombosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183689558	
1183688999	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	3		Tier 1 VIP	1.75	Metabolism/PK	1	1	diazepam		2021-09-09	https://www.pharmgkb.org/clinicalAnnotation/1183688999	
1183700483	rs9626730	PPARA	3			2.5	Efficacy	1	1	fenofibrate		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183700483	
1183700493	rs13273672	GATA4	3			2.25	Efficacy	1	1	Drugs used in alcohol dependence	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183700493	
1183700857	rs25648	VEGFA	3			2.75	Efficacy	1	1	cisplatin;fluorouracil;oxaliplatin	Stomach Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183700857	
1183701206	HLA-A*02:07:01	HLA-A	3			3.0	Toxicity	1	1	zonisamide	Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183701206	
1183701224	HLA-A*31:01:02	HLA-A	1A			142.875	Toxicity	16	28	carbamazepine	Drug Hypersensitivity;drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Maculopapular Exanthema;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183701224	Pediatric
1451403454	rs9288993	DRD3	3			2.0	Toxicity	1	1	opioids	Opioid-Related Disorders	2021-04-05	https://www.pharmgkb.org/clinicalAnnotation/1451403454	
1451403500	rs510769	OPRM1	3			1.25	Toxicity	2	2	opioids	Opioid-Related Disorders	2021-04-05	https://www.pharmgkb.org/clinicalAnnotation/1451403500	
981238570	rs1050828	G6PD;IKBKG	3		Tier 1 VIP	5.5	Toxicity	1	2	artesunate;primaquine;pyrimethamine;sulfadoxine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981238570	Pediatric
982009415	rs1137617	KCNH2	3			2.75	Efficacy	1	1	calcium channel blockers;nitrendipine	Essential hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982009415	
1451403476	rs7597593	ZNF804A	3			2.0	Toxicity	1	1	opioids	Opioid-Related Disorders	2021-04-05	https://www.pharmgkb.org/clinicalAnnotation/1451403476	
981239773	rs8099917	IFNL3	1B	Yes: Assigned level 1B because variant is not part of the CPIC guideline recommendation, this variant is in high LD with CPIC variant rs12979860.		93.75	Efficacy	45	59	interferons;peginterferon alfa-2a;peginterferon alfa-2b;ribavirin	Hepatitis C, Chronic	2021-03-29	https://www.pharmgkb.org/clinicalAnnotation/981239773	Pediatric
1451403467	rs735668	TACR1	3			2.0	Toxicity	1	1	opioids	Opioid-Related Disorders	2021-04-05	https://www.pharmgkb.org/clinicalAnnotation/1451403467	
1450375074	rs3212986	ERCC1	3			2.5	Toxicity	1	1	bleomycin;cisplatin;etoposide	Testicular Neoplasms;Vomiting	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450375074	
1450811417	rs1051660	OPRK1	3			0.0	Toxicity	1	1	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450811417	
1156076089	rs2231142	ABCG2	3		Tier 1 VIP	1.5	Metabolism/PK	1	1	fluvastatin		2022-02-15	https://www.pharmgkb.org/clinicalAnnotation/1156076089	
1043880701	SLCO1B1*1, SLCO1B1*5, SLCO1B1*9, SLCO1B1*14, SLCO1B1*15, SLCO1B1*37	SLCO1B1	1A		Tier 1 VIP	114.125	Metabolism/PK	14	20	rosuvastatin		2022-02-14	https://www.pharmgkb.org/clinicalAnnotation/1043880701	Pediatric
1043880520	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15	SLCO1B1	1A		Tier 1 VIP	107.5	Metabolism/PK	6	10	pravastatin		2022-02-10	https://www.pharmgkb.org/clinicalAnnotation/1043880520	Pediatric
982031013	rs8192440	CRY1	3			0.0	Efficacy	1	1	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982031013	
982031125	rs35599367	CYP3A4	3		Tier 1 VIP	1.0	Other	1	1	erythromycin	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982031125	
982032512	rs4877900	NTRK2	3			0.0	Dosage	1	1	methadone	Heroin Dependence;Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982032512	
982032657	rs558025	OPRM1	3			0.0	Dosage	1	1	methadone	Heroin Dependence;Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982032657	
982034831	rs1045642	ABCB1	3		Tier 1 VIP	2.5	Efficacy	1	1	oxaliplatin	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982034831	
982045698	rs2270777	CDK4	3			2.0	Other	1	1	somatropin recombinant		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982045698	Pediatric
1043858887	rs717620	ABCC2	3			1.5	Other	1	1	erythromycin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043858887	
1043880077	rs1800629	TNF	3			2.5	Efficacy	1	1	cyclosporine;mycophenolate mofetil	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880077	
1043880362	rs17886199	PRSS53;VKORC1	3		Tier 1 VIP	2.0	Dosage	1	1	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880362	
1043880467	rs4986790	TLR4	3			2.5	Toxicity	1	1	folic acid;methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880467	
1043880567	rs2306283	SLCO1B1	3		Tier 1 VIP	1.0	Other	1	1	pitavastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880567	
1043880654	rs4267385		3			2.25	Toxicity	1	1	Ace Inhibitors, Plain	Cough	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880654	
1043880792	rs5443	GNB3	3			4.5	Efficacy	2	3	atenolol	Essential hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880792	
1043880828	rs55754655	AOX1	3			2.5	Efficacy	1	1	azathioprine	Inflammatory Bowel Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880828	
1050579065	rs1800591	MTTP	3			0.0	Efficacy	1	1	pravastatin	Coronary Artery Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1050579065	
1156497684	rs72547516	CYP1A2	3		Rare Variant	0.0	Other	1	1	clozapine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1156497684	
1183490994	rs702553	PDE4D	3			2.5	Efficacy	1	1	diuretics	Nephrosclerosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183490994	
1183491746	rs17244841	HMGCR	3			3.5	Efficacy	1	2	pravastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183491746	
1183492181	rs7412	APOE	3			6.5	Efficacy	3	3	pravastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183492181	
982030283	GSTT1 non-null, GSTT1 null	GSTT1	4			-8.0	Toxicity	11	13	Drugs For Treatment Of Tuberculosis;ethambutol;isoniazid;pyrazinamide;rifampin;streptomycin	Tuberculosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982030283	
982030308	GSTM1 non-null, GSTM1 null	GSTM1	4			-5.0	Toxicity	12	14	Drugs For Treatment Of Tuberculosis;ethambutol;isoniazid;pyrazinamide;rifampin;streptomycin	Tuberculosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982030308	
982037307	rs5918	ITGB3	4			-6.25	Efficacy	14	14	aspirin	Acute coronary syndrome;Coronary Artery Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982037307	
1142234402	rs1045642	ABCB1	4		Tier 1 VIP	-0.5	Efficacy	3	3	simvastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1142234402	
1154959505	rs11706052	IMPDH2	4			-3.0	Efficacy	6	10	cyclosporine;mycophenolate mofetil	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1154959505	
1150414901	rs2032582	ABCB1	3		Tier 1 VIP	5.25	Efficacy	2	3	simvastatin	Hypercholesterolemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1150414901	
982032442	rs4358872	NTRK2	3			0.0	Dosage	1	1	methadone	Heroin Dependence;Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982032442	
982034869	rs1128503	ABCB1	3		Tier 1 VIP	6.0	Efficacy	1	2	oxaliplatin	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982034869	
1183618209	rs35167514	SLC22A1	3			1.5	Other	1	1	tramadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183618209	
1451403484	rs2023239	CNR1	3			2.0	Toxicity	1	1	opioids	Opioid-Related Disorders	2021-04-05	https://www.pharmgkb.org/clinicalAnnotation/1451403484	
982030369	rs12777823		1A			109.25	Dosage	5	7	warfarin		2021-04-12	https://www.pharmgkb.org/clinicalAnnotation/982030369	
1183616940	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	1A		Tier 1 VIP	205.8125	Metabolism/PK	9	12	imipramine	Depressive Disorder, Major;Mental Disorders	2021-04-23	https://www.pharmgkb.org/clinicalAnnotation/1183616940	
1183621866	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	1A		Tier 1 VIP	107.5625	Metabolism/PK	4	7	trimipramine	Mental Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183621866	
1183621726	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*21, CYP2D6*36	CYP2D6	1A		Tier 1 VIP	104.125	Metabolism/PK	4	5	flecainide	Arrhythmias, Cardiac	2021-04-29	https://www.pharmgkb.org/clinicalAnnotation/1183621726	
1183617103	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	1A		Tier 1 VIP	212.0	Metabolism/PK	6	11	imipramine	Depressive Disorder;Depressive Disorder, Major	2021-05-03	https://www.pharmgkb.org/clinicalAnnotation/1183617103	
982037811	rs708272	CETP	3			4.75	Efficacy	3	6	pravastatin	Coronary Artery Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982037811	
982040619	rs2032582	ABCB1	3		Tier 1 VIP	2.5	Efficacy	1	1	cyclosporine;mycophenolate mofetil	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982040619	
1043858877	rs10030044		3			0.0	Efficacy	1	1	raloxifene;tamoxifen	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043858877	
1043858975	rs4523	TBXA2R	3			5.0	Efficacy	2	2	aspirin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043858975	
1043859494	rs6318	HTR2C	3			1.5	Efficacy	1	1	escitalopram	neuropathic pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043859494	
1043873013	rs12903202	ALDH1A2	3			0.0	Efficacy	1	1	Bisphosphonates	Osteonecrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043873013	
1043880039	rs4680	COMT	3		Tier 1 VIP	1.0	Efficacy	1	1	fluvoxamine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880039	
1043880426	rs12487736	SCAP	3			1.75	Efficacy	1	1	simvastatin	Hypercholesterolemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880426	
1157204541	rs1150226	HTR3A	3			0.0	Efficacy	1	1	clozapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1157204541	
982040676	rs17868320	UGT1A9	4			-1.25	Efficacy	2	4	mycophenolate mofetil	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982040676	
1451403580	rs6928499	CNR1	3			2.0	Toxicity	1	1	opioids	Opioid-Related Disorders	2021-04-05	https://www.pharmgkb.org/clinicalAnnotation/1451403580	
1043880397	rs4917639	CYP2C9	3		Tier 1 VIP	5.5	Dosage	3	3	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880397	
1183491004	rs1800566	NQO1	3			2.75	Efficacy	3	3	Platinum compounds	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183491004	
982046070	CYP2C8*1, CYP2C8*2, CYP2C8*3	CYP2C8	3		Tier 1 VIP	4.375	Other	2	6	pioglitazone		2021-05-18	https://www.pharmgkb.org/clinicalAnnotation/982046070	
1183618725	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17	CYP2D6	1A		Tier 1 VIP	228.375	Metabolism/PK	16	34	nortriptyline	Depressive Disorder, Major	2021-04-23	https://www.pharmgkb.org/clinicalAnnotation/1183618725	
1183621987	CYP2C19*1, CYP2C19*2	CYP2C19	1A		Tier 1 VIP	103.5625	Metabolism/PK	2	4	trimipramine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183621987	
1183491364	rs1801133	MTHFR	3		Tier 1 VIP	5.0	Efficacy	1	2	folic acid;vitamin b-complex, plain		2022-02-25	https://www.pharmgkb.org/clinicalAnnotation/1183491364	
1043859020	rs5051	AGT	3			1.75	Efficacy	1	2	atenolol	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043859020	
1043859046	rs4253778	PPARA	3			2.5	Efficacy	1	1	fenofibrate	Diabetes Mellitus	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043859046	
1183491055	rs6787801	P2RY12	3			0.5	Efficacy	1	1	cangrelor		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183491055	
1183491098	rs11887534	ABCG8	3			0.25	Efficacy	3	4	atorvastatin	Coronary Artery Disease;Hypercholesterolemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183491098	
1183491262	rs1042173	SLC6A4	3			2.25	Efficacy	1	1	ondansetron	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183491262	
1183491310	CYP3A4*1, CYP3A4*4	CYP3A4	3		Tier 1 VIP	2.0	Efficacy	1	1	simvastatin	Hyperlipidemias	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183491310	
1183630057	GSTM1 non-null, GSTM1 null	GSTM1	3			0.0	Toxicity	1	1	sulfamethoxazole / trimethoprim	Acquired Immunodeficiency Syndrome	2022-03-03	https://www.pharmgkb.org/clinicalAnnotation/1183630057	
1183491390	rs5882	CETP	3			2.0	Efficacy	1	1	simvastatin	Hypercholesterolemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183491390	
1183491541	rs17238540	HMGCR	3			3.625	Efficacy	4	5	pravastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183491541	
1183602693	rs2742423	SACM1L	3			0.0	Toxicity	1	1	bupropion	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183602693	
1183604439	rs2251954	SACM1L	3			0.0	Toxicity	1	1	bupropion	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183604439	
1183614711	rs1344706	ZNF804A	3			2.0	Efficacy	1	1	antipsychotics	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614711	
1183614726	rs6313	HTR2A	3			2.5	Toxicity	1	1	efavirenz	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614726	
1183614860	rs1042640	UGT1A	3			1.75	Toxicity	1	1	acetaminophen	Liver Failure, Acute	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614860	
1183615140	rs717620	ABCC2	3			2.25	Toxicity	1	1	fluorouracil;leucovorin;oxaliplatin	Colonic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183615140	
1183615273	rs11615	ERCC1	3			1.5	Efficacy	2	2	fluorouracil;leucovorin;oxaliplatin	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183615273	
1183617783	rs57098334	SLC6A4	3			4.0	Efficacy;Toxicity	1	2	antidepressants	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183617783	
1183619037	CYP2D6*1, CYP2D6*4	CYP2D6	3		Tier 1 VIP	2.5	Dosage	1	1	Selective serotonin reuptake inhibitors	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183619037	
1183622368	rs822442	PEAR1	3			1.5	Efficacy	1	1	prasugrel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183622368	
1183622651	rs4646427	CYP1A2	3			4.5	Toxicity	1	3	escitalopram	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183622651	
1183629305	rs4148739	ABCB1	3		Tier 1 VIP	2.75	Efficacy	2	2	amitriptyline;citalopram;fluoxetine;paroxetine;sertraline;venlafaxine	Depression;Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183629305	
1183629475	rs1806201	GRIN2B	3			1.75	Toxicity	1	2	quetiapine	Drug Toxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183629475	
1183533961	rs2740574	CYP3A4	4		Tier 1 VIP	-1.75	Efficacy	1	4	amlodipine	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183533961	
1183615208	rs3832043	UGT1A9	4			-2.75	Toxicity	2	5	irinotecan	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183615208	
1183619225	rs6265	BDNF	4			-0.75	Toxicity	1	2	fluoxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183619225	
1183620242	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	4		Tier 1 VIP	-2.125	Toxicity	3	4	citalopram	Depressive Disorder, Major	2021-04-29	https://www.pharmgkb.org/clinicalAnnotation/1183620242	
1451403608	rs6280	DRD3	3			2.5	Toxicity	1	1	opioids	Opioid-Related Disorders	2021-04-05	https://www.pharmgkb.org/clinicalAnnotation/1451403608	
1451403621	rs1065852	CYP2D6	3		Tier 1 VIP	2.0	Toxicity	1	1	opioids	Opioid-Related Disorders	2021-04-05	https://www.pharmgkb.org/clinicalAnnotation/1451403621	
1451403720	rs1384401	TACR3	3			2.0	Toxicity	1	1	opioids	Opioid-Related Disorders	2021-04-05	https://www.pharmgkb.org/clinicalAnnotation/1451403720	
1183533940	rs4149015	SLCO1B1	3		Tier 1 VIP	0.5	Toxicity	1	2	irinotecan	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183533940	
1183592332	rs4353229	CASP7	3			3.5	Efficacy	1	3	docetaxel;gemcitabine;paclitaxel;Platinum compounds;vinorelbine	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183592332	
1183614766	rs1127687	CASP7	3			2.0	Efficacy	1	1	paclitaxel;Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614766	
1183615177	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	3		Tier 1 VIP	1.375	Metabolism/PK	2	3	amlodipine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183615177	
1183615400	rs66878317	DCK	3		Rare Variant	1.0	Other	1	1	gemcitabine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183615400	
1183631460	rs1523130	NR1I2	3			2.0	Other	1	1	memantine	Dementia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183631460	
1183631787	rs915120	GRK5	3			0.0	Efficacy	1	1	citalopram;escitalopram	Depressive Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183631787	
1183632073	rs238		3			0.0	Efficacy	1	1	hydrochlorothiazide	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183632073	
1183632190	rs1045642	ABCB1	3		Tier 1 VIP	1.75	Efficacy	1	1	anthracyclines and related substances;taxanes	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183632190	
1183679780	rs7588295	CSRNP3	3			0.0	Toxicity	1	1	Bisphosphonates	Osteonecrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183679780	
1183679818	rs1760217	DPYD	3		Tier 1 VIP	2.5	Efficacy	1	1	antineoplastic agents	Pancreatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183679818	
1183679843	rs17091162	SERPINA3	3			2.5	Efficacy	1	1	antineoplastic agents	Pancreatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183679843	
1183679863	rs1678387	ABCC4	3			0.0	Toxicity	1	1	Bisphosphonates	Osteonecrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183679863	
1183680415	rs16944	IL1B	3			2.5	Efficacy	3	4	lansoprazole;omeprazole;rabeprazole	Helicobacter Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183680415	
1183680516	rs1423515		3			0.0	Efficacy	1	1	salbutamol	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183680516	
1183680555	rs12946454	PLCD3	3			3.0	Efficacy	1	1	diltiazem	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183680555	
1183680560	rs12943590	SLC47A2	3			4.375	Efficacy	4	5	metformin	Diabetes Mellitus	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183680560	
1183680565	rs12943590	SLC47A2	3			1.375	Metabolism/PK	4	6	metformin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183680565	
1183680575	rs12210538	SLC22A16	3			1.75	Toxicity	2	2	cyclophosphamide;doxorubicin	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183680575	
1183680665	rs4253728	PPARA	3			1.0	Toxicity	2	2	tacrolimus	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183680665	Pediatric
1451403600	rs3745274	CYP2A7P1;CYP2B6	3		Tier 1 VIP	2.0	Toxicity	1	1	opioids	Opioid-Related Disorders	2021-04-05	https://www.pharmgkb.org/clinicalAnnotation/1451403600	
1183680511	rs1517114	C8orf34	3			0.0	Toxicity	1	1	irinotecan	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183680511	
1183680526	rs13306278	COMT	3		Tier 1 VIP	2.5	Efficacy	1	1	Selective serotonin reuptake inhibitors	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183680526	
1450377339	rs290487	TCF7L2	3			2.0	Toxicity	1	1	tacrolimus	liver transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450377339	
1450814641	rs8075924	ACE	3		Tier 1 VIP	2.75	Efficacy	1	1	bupropion	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450814641	
1450814647	rs2770296	HTR2A	3			2.25	Efficacy	1	1	bupropion	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450814647	
1450822023	rs1799971	OPRM1	3			0.5	Toxicity	2	2	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450822023	
1451403680	rs324029	DRD3	3			2.0	Toxicity	1	1	opioids	Opioid-Related Disorders	2021-04-05	https://www.pharmgkb.org/clinicalAnnotation/1451403680	
1451403687	rs718656	EXOC4	3			2.0	Toxicity	1	1	opioids	Opioid-Related Disorders	2021-04-05	https://www.pharmgkb.org/clinicalAnnotation/1451403687	
982031106	rs35599367	CYP3A4	3		Tier 1 VIP	3.75	Other	2	2	midazolam	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982031106	
982031517	rs352428		3			6.0	Efficacy	1	2	citalopram;escitalopram	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982031517	
982032329	rs2120266	NTRK2	3			0.0	Dosage	1	1	methadone	Heroin Dependence;Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982032329	
982032477	rs1948308	NTRK2	3			0.0	Dosage	1	1	methadone	Heroin Dependence;Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982032477	
982032672	rs2239622	NGF	3			0.75	Dosage	2	2	methadone	Heroin Dependence;Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982032672	
982034400	rs2301149	KCNIP1;KCNMB1	3			2.5	Efficacy	1	1	verapamil	Coronary Artery Disease;Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982034400	
982034888	rs1799752	ACE	3		Tier 1 VIP	1.75	Efficacy	1	1	acetylcholine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982034888	
982045076	rs11252394		3			0.0	Efficacy	1	1	salbutamol	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982045076	
1043858661	rs2228079	ADORA1	3			2.25	Toxicity	1	1	aspirin	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043858661	
1043858680	rs11587213	FCER1G	3			4.5	Toxicity	2	2	aspirin	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043858680	
1043858722	rs2768759	NTRK1	3			0.0	Efficacy	1	1	aspirin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043858722	
1043858845	rs833061	VEGFA	3			2.0	Toxicity	1	1	sunitinib		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043858845	
1043873008	rs1364043	HTR1A	3			2.0	Efficacy	1	1	fluvoxamine;milnacipran;paroxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043873008	
1043873023	rs12795437	KCNJ1	3			3.75	Toxicity	1	1	hydrochlorothiazide	Diabetes Mellitus;Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043873023	
1043873028	rs12782374	CYP2C9	3		Tier 1 VIP	2.0	Dosage	1	3	phenytoin	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043873028	
1043880298	rs12721655	CYP2B6	3		Rare Variant; Tier 1 VIP	1.0	Efficacy	2	2	cyclophosphamide;doxorubicin	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880298	
1043880723	rs4606	RGS2	3			2.0	Toxicity	1	1	antipsychotics	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880723	
1043880750	rs324420	FAAH	3			2.25	Toxicity	2	2	aripiprazole;clozapine;haloperidol;olanzapine;quetiapine;risperidone	Psychotic Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880750	Pediatric
1043880900	rs2306283	SLCO1B1	3		Tier 1 VIP	0.5	Toxicity	4	4	hmg coa reductase inhibitors	Coronary Artery Disease;Diabetes Mellitus;Hypercholesterolemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880900	
1043880630	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15, SLCO1B1*37	SLCO1B1	1A		Tier 1 VIP	105.5	Metabolism/PK	9	10	atorvastatin		2022-02-10	https://www.pharmgkb.org/clinicalAnnotation/1043880630	
1183490957	rs9922316	PRKCB	3			1.5	Other	1	1	dexmedetomidine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183490957	
1135389481	rs6714486	UGT1A9	4			-3.5	Efficacy	4	6	mycophenolate mofetil	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1135389481	
1451403740	rs4530637		3			2.0	Toxicity	1	1	opioids	Opioid-Related Disorders	2021-04-05	https://www.pharmgkb.org/clinicalAnnotation/1451403740	
1043858794	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*10, CYP2C19*17, CYP2C19*19, CYP2C19*25, CYP2C19*26	CYP2C19	1A		Tier 1 VIP	220.875	Metabolism/PK	17	21	clopidogrel		2021-05-10	https://www.pharmgkb.org/clinicalAnnotation/1043858794	
1183491792	rs352046	CXCL5	3			4.5	Efficacy	1	2	hmg coa reductase inhibitors	Acute coronary syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183491792	
1183491822	rs3917643	F3	3			1.75	Efficacy	1	1	simvastatin	Myocardial Ischemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183491822	
1183492023	rs61764370	KRAS	3			2.75	Efficacy	6	6	cetuximab;panitumumab	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183492023	
1183549413	rs8330	UGT1A;UGT1A9	3			1.75	Toxicity	2	2	acetaminophen	Liver Failure, Acute	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183549413	
1183605282	rs2239347	IL4R	3			2.0	Efficacy	1	1	pitrakinra	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183605282	
1183607013	rs2237895	KCNQ1	3			2.0	Efficacy	1	1	repaglinide	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183607013	
1183607142	rs2237892	KCNQ1	3			1.5	Efficacy	1	1	repaglinide	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183607142	
1183614716	rs2231142	ABCG2	3		Tier 1 VIP	3.0	Toxicity	1	1	efavirenz	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614716	
1183614816	rs10929303	UGT1A	3			0.0	Other	1	1	acetaminophen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614816	
1183614825	rs10929303	UGT1A	3			1.75	Toxicity	1	1	acetaminophen	Liver Failure, Acute	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614825	
1183614830	rs1065852	CYP2D6	3		Tier 1 VIP	1.0	Toxicity	1	1	iloperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614830	
1183614835	rs1048943	CYP1A1	3			2.25	Efficacy	1	1	capecitabine;docetaxel	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614835	
1183622348	rs822441	PEAR1	3			1.5	Efficacy	1	1	prasugrel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183622348	
1183629489	rs6313	HTR2A	3			2.25	Toxicity	1	1	risperidone	Drug Toxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183629489	
1183618159	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10	CYP2D6	2A		Tier 1 VIP	22.875	Dosage	8	14	tramadol	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183618159	
1183619154	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	2A		Tier 1 VIP	8.75	Metabolism/PK	5	10	mirtazapine		2021-04-23	https://www.pharmgkb.org/clinicalAnnotation/1183619154	
1183631061	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*17	CYP2D6	1A		Tier 1 VIP	107.4375	Metabolism/PK	14	20	haloperidol	Schizophrenia	2021-05-03	https://www.pharmgkb.org/clinicalAnnotation/1183631061	Pediatric
982014094	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*35xN	CYP2D6	1A		Tier 1 VIP	102.25	Efficacy	3	5	ondansetron	Vomiting	2021-09-16	https://www.pharmgkb.org/clinicalAnnotation/982014094	
1183614682	rs17135437	COL26A1	3			0.0	Toxicity	1	1	citalopram	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614682	
1183614886	rs10248420	ABCB1	3		Tier 1 VIP	2.25	Efficacy	1	1	clozapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614886	
1183615041	CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*7	CYP2B6	3		Tier 1 VIP	1.5	Efficacy	1	1	mirtazapine	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183615041	
1183631422	rs316019	SLC22A2	3			1.5	Other	1	1	l-tryptophan		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183631422	
1183680463	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	3		Tier 1 VIP	4.125	Efficacy	13	20	esomeprazole	Gastroesophageal Reflux;Helicobacter Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183680463	
1183680521	rs13306673	SLC12A3	3			2.25	Efficacy	1	1	Thiazides, plain	Essential hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183680521	
1448640327	TPMT*1, TPMT*3B, TPMT*3C	TPMT	3		Tier 1 VIP	4.5	Efficacy	1	2	fluorouracil	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448640327	
1183533986	rs2246709	CYP3A4	4		Tier 1 VIP	-3.0	Efficacy	1	4	amlodipine	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183533986	
1183679117	rs9806699	GATM	4			-1.75	Toxicity	2	4	hmg coa reductase inhibitors;simvastatin	Myocardial Infarction	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183679117	
1183614676	rs17782313	MC4R	3			3.5	Toxicity	3	3	antipsychotics	Weight gain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614676	
1183621997	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*14	CYP2D6	1A		Tier 1 VIP	125.875	Metabolism/PK	23	32	risperidone	Psychotic Disorders;Schizophrenia	2021-04-30	https://www.pharmgkb.org/clinicalAnnotation/1183621997	Pediatric
982034197	rs1799971	OPRM1	3			4.25	Dosage	16	16	morphine	Pain;Pain, Postoperative	2022-01-14	https://www.pharmgkb.org/clinicalAnnotation/982034197	Pediatric
982030757	rs2297480	FDPS	3			1.75	Toxicity	1	1	zoledronate	Neoplasms;Osteonecrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982030757	
982030887	rs3761555	GRIA3	3			2.5	Efficacy	1	1	antidepressants;Selective serotonin reuptake inhibitors;venlafaxine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982030887	
982030900	rs3761554	GRIA3	3			2.5	Efficacy	1	1	antidepressants;Selective serotonin reuptake inhibitors;venlafaxine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982030900	
982031241	rs3794271	SLCO1C1	3			1.75	Efficacy	3	3	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Arthritis, Psoriatic;Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982031241	
982032306	rs1491850	BDNF	3			0.0	Dosage	1	1	methadone	Heroin Dependence;Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982032306	
982034899	rs1799752	ACE	3		Tier 1 VIP	1.75	Efficacy	1	1	nitroprusside		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982034899	
982030381	rs1954787	GRIK4	3			2.75	Efficacy	3	4	antidepressants	Depressive Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982030381	
982044867	rs9344	CCND1	3			3.25	Efficacy	1	1	fluorouracil	Colonic Neoplasms	2021-12-03	https://www.pharmgkb.org/clinicalAnnotation/982044867	
982045137	rs1801262	NEUROD1	3			4.0	Efficacy	1	2	repaglinide	Diabetes Mellitus	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982045137	
1043858698	rs1131882	TBXA2R	3			2.25	Toxicity	1	1	aspirin	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043858698	
1043880066	rs1800872	IL10	3			3.0	Efficacy	1	1	cyclosporine;mycophenolate mofetil	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880066	
1043880082	rs1042597	UGT1A8	3			3.5	Toxicity	1	3	cyclosporine;mycophenolate mofetil;sirolimus;tacrolimus	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880082	
1051394394	rs1800591	MTTP	3			0.0	Efficacy	1	2	atorvastatin	Hyperlipoproteinemia Type II	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1051394394	
1139265477	rs1045642	ABCB1	3		Tier 1 VIP	0.25	Efficacy	4	4	atorvastatin	Coronary Artery Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1139265477	
1158793019	rs4149081	SLCO1B1	3		Tier 1 VIP	4.5	Efficacy	1	2	rosuvastatin	Coronary Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1158793019	
1183491214	rs1057868	POR	3			4.5	Other	2	2	midazolam		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183491214	
1183491333	rs4673	CYBA	3			2.25	Other	1	1	simvastatin	Hypercholesterolemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183491333	
1183491809	rs1800629	TNF	3			2.25	Other	1	1	atorvastatin	Acute coronary syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183491809	
1183532521	rs12003906	ABCA1	3			3.5	Efficacy	1	1	atorvastatin;pravastatin;simvastatin	Hyperlipidemias	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183532521	
1183617623	rs2470890	CYP1A2	3			3.0	Efficacy	1	1	paroxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183617623	
1183617685	rs4646425	CYP1A2	3			7.0	Efficacy	1	3	paroxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183617685	
1043880170	rs708272	CETP	4			-3.25	Efficacy	2	3	simvastatin	Hypercholesterolemia;Hyperlipoproteinemia Type II	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880170	
1043858905	rs7903146	TCF7L2	3			4.75	Efficacy	2	2	sulfonamides, urea derivatives		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043858905	
982035703	rs2884737	VKORC1	2A		Tier 1 VIP	11.25	Dosage	5	5	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982035703	
1183619004	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	1A		Tier 1 VIP	206.625	Metabolism/PK	5	10	sertraline	Mental Disorders	2021-04-26	https://www.pharmgkb.org/clinicalAnnotation/1183619004	
982037423	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10	CYP2D6	1A		Tier 1 VIP	117.5	Metabolism/PK	12	18	venlafaxine	Depressive Disorder;Obsessive-Compulsive Disorder	2021-05-03	https://www.pharmgkb.org/clinicalAnnotation/982037423	
1183619068	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	1A		Tier 1 VIP	105.875	Metabolism/PK	7	11	aripiprazole	Psychotic Disorders;schizoaffective disorder;Schizophrenia	2021-10-19	https://www.pharmgkb.org/clinicalAnnotation/1183619068	
1183620386	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	1A		Tier 1 VIP	224.75	Metabolism/PK	14	25	citalopram	Depressive Disorder;Depressive Disorder, Major	2022-03-11	https://www.pharmgkb.org/clinicalAnnotation/1183620386	
1183547855	rs8330	UGT1A	3			0.0	Other	1	1	acetaminophen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183547855	
1183603016	rs2742417	SACM1L	3			0.0	Toxicity	1	1	bupropion	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183603016	
1183614476	rs1805010	IL4R	3			2.0	Efficacy	1	1	pitrakinra	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614476	
1183615328	rs45445694	TYMS	3		Tier 1 VIP	1.75	Toxicity	1	1	irinotecan;raltitrexed	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183615328	
1183619292	rs10248420	ABCB1	3		Tier 1 VIP	2.75	Efficacy	1	1	amitriptyline;citalopram;paroxetine;venlafaxine	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183619292	
1183619303	rs10280101	ABCB1	3		Tier 1 VIP	2.75	Efficacy	1	1	amitriptyline;citalopram;paroxetine;venlafaxine	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183619303	
1183619317	rs12720067	ABCB1	3		Tier 1 VIP	2.75	Efficacy	1	1	amitriptyline;citalopram;paroxetine;venlafaxine	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183619317	
1183632117	rs4815273		3			0.0	Efficacy	1	1	hydrochlorothiazide	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183632117	
1183632180	rs1043620	HSPA1A;HSPA1L	3			2.0	Toxicity	1	1	carbamazepine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183632180	
1183614850	rs1042713	ADRB2	4		Tier 1 VIP	-1.0	Efficacy	1	3	benazepril	Essential hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614850	
1183632195	rs1045642	ABCB1	3		Tier 1 VIP	4.5	Efficacy	2	2	ondansetron	Postoperative Nausea and Vomiting;Vomiting	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183632195	
1183620575	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*36	CYP2D6	1A		Tier 1 VIP	103.5	Metabolism/PK	3	4	propafenone	Arrhythmias, Cardiac;Tachycardia	2021-05-03	https://www.pharmgkb.org/clinicalAnnotation/1183620575	
981204549	rs1799752	ACE	3		Tier 1 VIP	3.0	Efficacy	2	3	hydrochlorothiazide	Essential hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204549	
981204851	rs1800497	ANKK1	3			4.5	Efficacy	4	4	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204851	
981237871	rs11045585	SLCO1B3	3			4.25	Toxicity	2	3	docetaxel	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981237871	
981237930	rs11615	ERCC1	3			1.25	Toxicity	2	2	cisplatin;cyclophosphamide	Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981237930	
981238415	rs1127354	ITPA	3			2.5	Efficacy;Toxicity	8	9	methotrexate	Arthritis, Rheumatoid;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981238415	Pediatric
1451288220	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*17, CYP2D6*40	CYP2D6	1A		Tier 1 VIP	210.25	Efficacy	7	12	codeine	Pain	2022-01-11	https://www.pharmgkb.org/clinicalAnnotation/1451288220	Pediatric
1183615535	rs1128503	ABCB1	3		Tier 1 VIP	0.0	Other	1	1	digoxin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183615535	
1183629972	GSTM1 non-null, GSTM1 null	GSTM1	3			1.25	Toxicity	2	2	cisplatin	Deafness;Ototoxicity;Testicular Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183629972	Pediatric
1183680506	rs1522113	CLOCK	3			0.0	Efficacy	1	1	salbutamol	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183680506	
1449164857	rs2242446	SLC6A2	3			1.0	Other	1	1	3,4-methylenedioxymethamphetamine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449164857	
1449713231	rs2205986	IRF6	3			3.5	Toxicity	1	1	interferon beta-1a;interferon beta-1b	drug-induced liver injury;Multiple Sclerosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449713231	
1449752810	rs701829	HLA-DRB1	3			3.0	Toxicity	1	1	dapsone	Drug Hypersensitivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449752810	
981204210	rs17602729	AMPD1	4			-0.75	Efficacy;Toxicity	7	7	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204210	
1183630118	GSTT1 non-null, GSTT1 null	GSTT1	4			-3.5	Toxicity	4	4	cisplatin	Deafness;Neoplasms;Ototoxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183630118	Pediatric
1183679838	rs1736557	FMO3	4			-1.5	Toxicity	2	2	anthracyclines and related substances	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183679838	Pediatric
1183615480	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10	CYP2D6	3		Tier 1 VIP	7.5	Metabolism/PK	4	11	carvedilol	Heart Diseases	2021-04-22	https://www.pharmgkb.org/clinicalAnnotation/1183615480	
981238550	rs1051740	EPHX1	3			4.75	Metabolism/PK	3	3	carbamazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981238550	
1450373520	rs1143634	IL1B	3			3.0	Dosage;Efficacy	1	1	morphine	Pain, Postoperative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450373520	
1450373622	rs305968	CYP2F1	3			1.5	Toxicity	1	1	imatinib	Gastrointestinal Stromal Tumors	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450373622	
1451404212	rs7967354	SLCO1A2	3			0.0	Dosage	1	1	rocuronium		2021-04-06	https://www.pharmgkb.org/clinicalAnnotation/1451404212	
1451404219	rs11045995	IAPP;SLCO1A2	3			0.0	Dosage	1	1	rocuronium		2021-04-06	https://www.pharmgkb.org/clinicalAnnotation/1451404219	
981239532	rs104894539	VKORC1	3		Rare Variant; Tier 1 VIP	0.25	Dosage	2	2	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981239532	
981239556	rs104894541	VKORC1	3		Tier 1 VIP	0.25	Dosage	2	2	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981239556	
981204902	rs16969968	CHRNA5	2B			11.5	Toxicity	17	19	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204902	
981238501	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	1A		Tier 1 VIP	243.25	Toxicity	21	33	phenytoin	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981238501	Pediatric
981419263	HLA-B*15:02:01, HLA-B*15:11:01	HLA-B	1A		Tier 1 VIP	413.5	Toxicity	49	59	carbamazepine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Maculopapular Exanthema;severe cutaneous adverse reactions;Stevens-Johnson Syndrome	2022-03-03	https://www.pharmgkb.org/clinicalAnnotation/981419263	Pediatric
655387745	rs11188072	CYP2C19	3		Tier 1 VIP	2.0	Dosage	1	1	mephenytoin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655387745	
981419487	rs118192172	RYR1	3		Rare Variant; Tier 1 VIP	0.0	Toxicity	1	1	hmg coa reductase inhibitors	Muscular Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981419487	
981419550	rs2819742	RYR2	3			0.0	Toxicity	1	1	cerivastatin	Rhabdomyolysis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981419550	
981478113	rs10800397	NOS1AP	3			5.0	Toxicity	1	2	amiodarone	Long QT Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981478113	
981419257	HLA-B*57:01:01	HLA-B	1A		Tier 1 VIP	325.75	Toxicity	11	14	abacavir	Drug Hypersensitivity;HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981419257	
981419260	HLA-B*58:01	HLA-B	1A		Tier 1 VIP	181.375	Toxicity	38	41	allopurinol	Drug Hypersensitivity;drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981419260	Pediatric
1449167328	rs4902333	CHURC1	3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449167328	Pediatric
1449168072	rs2933304		3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168072	
1449168079	rs9873889	ZNF385D	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168079	
1449167453	rs9032	STRBP	3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-25	https://www.pharmgkb.org/clinicalAnnotation/1449167453	Pediatric
982029652	rs324420	FAAH	3			5.25	Other	2	3	methamphetamine	Substance-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982029652	
982030862	rs1992647	GABRA6	3			0.0	Efficacy	1	1	antidepressants;Selective serotonin reuptake inhibitors;venlafaxine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982030862	
982030971	rs9859552	P2RY12	3			0.5	Efficacy	1	1	cangrelor		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982030971	
982031308	rs4532	DRD1	3			0.0	Efficacy	1	1	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982031308	
982031346	rs2499984	OR52J2P;OR52J3	3			2.5	Efficacy	1	1	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982031346	
982031374	rs2314339	NR1D1;THRA	3			2.5	Efficacy	1	1	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982031374	
982031407	rs2284018	CACNG2	3			2.0	Efficacy	1	1	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982031407	
982031795	rs568408	IL12A	3			3.0	Toxicity	1	1	mycophenolate mofetil	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982031795	
982032228	rs10835210	BDNF	3			0.0	Dosage	1	1	methadone	Heroin Dependence;Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982032228	
982032638	rs2283265	DRD2	3		Tier 1 VIP	0.0	Dosage	1	1	methadone	Heroin Dependence;Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982032638	
982029578	rs699947	VEGFA	4			-3.5	Efficacy	3	4	ranibizumab	Macular Degeneration	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982029578	
982030916	rs948854	GAL	3			3.0	Efficacy	1	2	antidepressants;benzodiazepine derivatives;mirtazapine;Selective serotonin reuptake inhibitors	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982030916	
982031034	rs6809699	P2RY12	3			2.75	Efficacy	4	6	clopidogrel	Coronary Artery Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982031034	
982035482	rs17880887	VKORC1	3		Tier 1 VIP	2.25	Dosage	1	1	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982035482	
982036238	rs1045642	ABCB1	3		Tier 1 VIP	1.0	Other	1	1	verapamil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982036238	
982037378	rs1126643	ITGA2	3			1.0	Efficacy	5	5	aspirin;clopidogrel	Coronary Artery Disease;Coronary Disease;Myocardial Infarction	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982037378	
982045674	rs2069502	CDK4	3			2.0	Other	1	1	somatropin recombinant	Turner Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982045674	Pediatric
1451406523	rs1799971	OPRM1	3			2.5	Efficacy	1	1	tramadol	Pain, Postoperative	2021-04-08	https://www.pharmgkb.org/clinicalAnnotation/1451406523	
982045082	rs6988229	COL22A1	3			0.0	Efficacy	1	1	salbutamol	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982045082	
982033279	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	1B		Tier 1 VIP	61.25	Dosage	35	57	acenocoumarol		2021-10-05	https://www.pharmgkb.org/clinicalAnnotation/982033279	
982032743	rs2032582	ABCB1	3		Tier 1 VIP	1.25	Toxicity	1	1	clomipramine;lithium;nefazodone;paroxetine;venlafaxine	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982032743	
1043858606	rs6265	BDNF	3			1.0	Efficacy	7	7	antidepressants;citalopram;paroxetine	Depressive Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043858606	
1043858642	rs7179742	FSIP1	3			2.5	Toxicity	1	1	aspirin	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043858642	
1043858651	rs3856806	PPARG	3			5.5	Toxicity	1	2	aspirin	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043858651	
1043858666	rs16851030	ADORA1	3			3.25	Toxicity	1	1	aspirin	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043858666	
1043858872	rs8060157	ZNF423	3			0.0	Efficacy	1	1	raloxifene;tamoxifen	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043858872	
1043859119	rs9380524	FKBP5	3			0.0	Efficacy	1	1	citalopram;escitalopram	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043859119	
1043858990	rs10306114	PTGS1	3			6.0	Efficacy	2	2	aspirin	Coronary Artery Disease;Myocardial Infarction	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043858990	
1183490999	rs10494366	NOS1AP	3			2.0	Toxicity	1	1	dolasetron;granisetron		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183490999	
1043880357	rs11150606	VKORC1	3		Tier 1 VIP	2.0	Dosage	1	1	warfarin		2021-12-03	https://www.pharmgkb.org/clinicalAnnotation/1043880357	
1155598159	rs2231142	ABCG2	3		Tier 1 VIP	1.5	Other	1	1	atorvastatin		2022-02-15	https://www.pharmgkb.org/clinicalAnnotation/1155598159	
982030399	rs3810651	GABRQ	3			3.0	Efficacy	1	1	venlafaxine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982030399	
982045146	rs114202595	PAX4	3		Rare Variant	1.5	Efficacy	1	1	repaglinide	Diabetes Mellitus	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982045146	
1043859269	rs6787801	P2RY12	3			2.5	Efficacy	1	1	clopidogrel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043859269	
1043859462	CYP2C9*1, CYP2C9*3	CYP2C9	3		Tier 1 VIP	1.0	Efficacy	1	1	doxepin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043859462	
1043872998	rs135543	PPARA	3			2.5	Efficacy	1	1	fenofibrate		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043872998	
1043880214	rs35068180	MMP3	3			4.5	Efficacy	1	2	pravastatin	Coronary Artery Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880214	
1043880229	rs35068180	MMP3	3			6.0	Efficacy	1	2	chlorthalidone;lisinopril	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880229	
1043880234	rs1799752	ACE	3		Tier 1 VIP	3.25	Efficacy	1	2	fluvastatin	Coronary Artery Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880234	
1043880255	rs1799752	ACE	3		Tier 1 VIP	1.75	Efficacy	1	1	pravastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880255	
1043880313	rs7877	FMO1	3			1.75	Other	1	1	olanzapine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880313	
1043880337	rs10509680	CYP2C9	3		Tier 1 VIP	3.0	Dosage	1	1	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880337	
1043880409	rs60282872	SREBF1	3			1.5	Efficacy	1	2	fluvastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880409	
1043880447	rs8016905	BDKRB2	3			3.25	Toxicity	1	1	Ace Inhibitors, Plain	Cough	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880447	
1043880669	rs2281617	OPRM1	3			1.5	Other	1	1	amphetamine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880669	
1043880823	rs3808607	CYP7A1	3			5.25	Efficacy	4	4	atorvastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880823	
1043880872	rs2168631	DRD1	3			3.5	Efficacy	1	1	bupropion;nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880872	
1043880818	rs4149056	SLCO1B1	1A		Tier 1 VIP	207.25	Toxicity	17	19	atorvastatin	statin-related myopathy	2022-02-15	https://www.pharmgkb.org/clinicalAnnotation/1043880818	
1048764135	rs16944	IL1B	3			1.5	Efficacy	1	3	pravastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1048764135	
1124035501	rs11746641	DRD1	3			3.5	Efficacy	1	1	bupropion;nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1124035501	
1145963221	rs7160796	DCAF4	3			2.0	Efficacy	1	1	corticosteroids	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1145963221	
1147261601	rs6413432	CYP2E1	3			1.75	Efficacy	1	1	cisplatin;cyclophosphamide	Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1147261601	
1155650524	rs72547517	CYP1A2	3		Rare Variant	0.0	Other	1	1	clozapine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1155650524	
1157877076	rs776746	CYP3A5	3		Tier 1 VIP	1.0	Dosage;Toxicity	2	2	sunitinib	Carcinoma, Renal Cell	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1157877076	
1183490967	rs2283265	DRD2	3		Tier 1 VIP	2.25	Efficacy	1	1	disulfiram	Cocaine-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183490967	
1183490978	rs1800497	ANKK1	3			2.25	Efficacy	1	1	disulfiram	Cocaine-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183490978	
1183491035	rs1801394	MTRR	3			2.5	Efficacy	1	1	folic acid;vitamin b-complex, plain	Migraine with Aura	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183491035	
1183491140	rs776746	CYP3A5	3		Tier 1 VIP	6.25	Efficacy	3	3	atorvastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183491140	
1043880192	rs708272	CETP	4			-1.75	Efficacy;Toxicity	3	4	atorvastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880192	
1183491189	rs17161788	CYP3A5	3		Rare Variant; Tier 1 VIP	1.75	Efficacy	1	1	atorvastatin	Hypercholesterolemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183491189	
1183491354	rs2298826	SLC6A5	3			2.5	Toxicity	1	1	haloperidol	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183491354	
1183491617	rs17238540	HMGCR	3			6.0	Efficacy	2	2	simvastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183491617	
1183491741	rs17244841	HMGCR	3			2.5	Efficacy	1	1	simvastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183491741	
1183491775	rs1801133	MTHFR	3		Tier 1 VIP	2.5	Efficacy	1	1	pravastatin	Coronary Artery Disease;Myocardial Infarction	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183491775	
1183492030	rs2279020	GABRA1	3			4.5	Efficacy	1	2	carbamazepine;phenytoin;valproic acid	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183492030	
1183492128	rs7412	APOE	3			1.625	Efficacy	2	2	fluvastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183492128	
1183492235	rs2230806	ABCA1	3			2.25	Efficacy	1	1	pravastatin	Coronary Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183492235	
1183614547	rs12948783	RHBDF2	3			0.0	Efficacy	1	1	fentanyl;morphine;opioids;oxycodone	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614547	
1183614624	rs3812718	SCN1A	3			4.75	Efficacy	5	5	carbamazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614624	
1183614578	rs17183814	SCN2A	4			-2.5	Efficacy	4	5	antiepileptics;carbamazepine;phenobarbital;phenytoin;valproic acid	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614578	
1183614591	rs2298771	SCN1A	4			-2.5	Efficacy	3	5	carbamazepine;oxcarbazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614591	
1183614776	rs8192726	CYP2A6	4		Tier 1 VIP	-0.5	Other	6	6	efavirenz	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614776	
1154221922	rs2231142	ABCG2	2A		Tier 1 VIP	10.75	Efficacy	4	4	rosuvastatin	Hypercholesterolemia;Myocardial Infarction	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1154221922	
1183615573	rs699	AGT	3			1.875	Efficacy	4	4	irbesartan	Hypertension;Hypertrophy, Left Ventricular	2021-09-09	https://www.pharmgkb.org/clinicalAnnotation/1183615573	
1183618199	rs12208357	SLC22A1	3			1.5	Metabolism/PK	1	1	tramadol		2021-12-03	https://www.pharmgkb.org/clinicalAnnotation/1183618199	
982031323	rs334558	GSK3B	3			0.5	Efficacy	2	3	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982031323	
982032495	rs2378676	NTRK2	3			0.0	Dosage	1	1	methadone	Heroin Dependence;Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982032495	
982032734	rs6438552	GSK3B	3			1.25	Efficacy	2	3	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982032734	
982047849	rs6280	DRD3	3			2.75	Efficacy	1	1	paroxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982047849	
1043858637	rs7572857	CEP68	3			6.5	Toxicity	1	2	aspirin	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043858637	
1043858675	rs1613662	GP6	3			2.5	Efficacy	1	1	aspirin	Coronary Artery Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043858675	
1043858703	rs1062535	ITGA2	3			2.25	Efficacy	1	1	aspirin	Myocardial Infarction	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043858703	
1183590959	rs495794	SRP19	3			2.5	Efficacy	1	1	citalopram;fluoxetine;paroxetine;sertraline	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183590959	
1183614696	rs153560	REEP5	3			3.0	Efficacy	1	1	citalopram;fluoxetine;paroxetine;sertraline	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614696	
1183614721	rs13432159		3			0.0	Toxicity	1	1	sertraline	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614721	
1183616495	rs12407843	PEAR1	3			1.5	Efficacy	1	1	prasugrel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183616495	
1183616511	rs77235035	PEAR1	3			1.5	Efficacy	1	1	prasugrel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183616511	
1183617565	rs130058	HTR1B	3			0.75	Other	1	1	paroxetine	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183617565	
1183617765	rs57098334	SLC6A4	3			3.75	Efficacy	3	3	fluoxetine	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183617765	
1183618859	rs6313	HTR2A	3			4.0	Toxicity	3	3	paroxetine	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183618859	
1448999816	CYP2D6*1, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*97, CYP2D6*98	CYP2D6	3		Tier 1 VIP	0.0	Metabolism/PK	1	1	amitriptyline		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448999816	
1043858615	rs5443	GNB3	4			-0.625	Efficacy	1	3	antidepressants	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043858615	
1043858892	rs7089580	CYP2C9	3		Tier 1 VIP	5.75	Dosage	2	4	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043858892	
1183617854	CYP2C19*1, CYP2C19*2	CYP2C19	1A		Tier 1 VIP	102.0	Metabolism/PK	1	2	doxepin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183617854	
1183616699	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	1A		Tier 1 VIP	206.0	Metabolism/PK	4	8	clomipramine	Mental Disorders	2021-05-03	https://www.pharmgkb.org/clinicalAnnotation/1183616699	
1043859029	rs430397	HSPA5	3			10.5	Efficacy	1	4	Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043859029	
1183545767	rs964184	APOA1	3			3.5	Efficacy	1	1	fenofibrate	Hypertriglyceridemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183545767	
1183556815	rs776746	CYP3A5	3		Tier 1 VIP	2.25	Other	1	1	ondansetron		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183556815	
1183563324	rs5443	GNB3	3			2.75	Efficacy	1	1	bumetanide;furosemide;torasemide		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183563324	
1183620349	rs5030868	G6PD	3		Rare Variant; Tier 1 VIP	0.25	Toxicity	1	1	glyburide	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183620349	
1183622321	rs41273215	PEAR1	3			1.5	Efficacy	1	1	prasugrel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183622321	
1183622557	rs2069526	CYP1A2	3			1.5	Toxicity	1	1	escitalopram	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183622557	
1183624306	rs324026	DRD3	3			2.0	Efficacy	1	1	duloxetine	Anxiety Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183624306	
1183624313	rs324023	DRD3	3			2.0	Efficacy	1	1	duloxetine	Anxiety Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183624313	
1183624328	rs167770	DRD3	3			2.0	Efficacy	1	1	duloxetine	Anxiety Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183624328	
1183624421	rs130058	HTR1B	3			2.25	Toxicity	1	1	clomipramine;liothyronine;lithium;nefazodone;venlafaxine	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183624421	
1183630276	rs1130214	AKT1	3			2.0	Efficacy	1	1	carboplatin;cisplatin	Lung Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183630276	
1451406840	rs16952570	FTO	3			4.0	Toxicity	2	3	azathioprine	Colitis, Ulcerative;Crohn Disease;Irritable Bowel Syndrome;Leukopenia;Neutropenia	2021-04-08	https://www.pharmgkb.org/clinicalAnnotation/1451406840	
1183624646	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17	CYP2D6	3		Tier 1 VIP	5.0	Metabolism/PK	10	18	fluoxetine	Depressive Disorder, Major;Mental Disorders	2021-04-23	https://www.pharmgkb.org/clinicalAnnotation/1183624646	Pediatric
1183622099	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10	CYP2D6	1A		Tier 1 VIP	116.625	Metabolism/PK	12	18	desipramine	Depressive Disorder, Major;Mental Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183622099	
1183621000	G6PD A- 202A_376G, G6PD B (wildtype), G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham	G6PD	1A		Tier 1 VIP	103.0	Toxicity	21	23	rasburicase	Hemolysis;Methemoglobinemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183621000	Pediatric
982036249	rs2032582	ABCB1	3		Tier 1 VIP	1.0	Other	1	1	verapamil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982036249	
1043858970	rs5985	F13A1	3			1.5	Efficacy	1	1	aspirin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043858970	
1043859274	rs1062535	ITGA2	3			2.25	Efficacy	1	1	aspirin;clopidogrel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043859274	
1043872993	rs861539	XRCC3	3			0.5	Efficacy	2	3	Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043872993	
1043876904	rs242941	CRHR1	3			1.75	Efficacy	1	1	fluoxetine	Anxiety Disorders;Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043876904	
1043880438	rs6755571	UGT1A4	3			1.5	Other	1	1	ABT-751	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880438	
1043880608	rs2306283	SLCO1B1	3		Tier 1 VIP	4.25	Efficacy	4	4	atorvastatin	Hypercholesterolemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880608	
1043880664	rs510769	OPRM1	3			1.0	Efficacy	1	1	amphetamine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880664	
1043880783	rs11039149	NR1H3	3			2.75	Toxicity	1	1	atenolol;verapamil	Coronary Artery Disease;Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880783	
1043880812	UGT1A3*1, UGT1A3*2	UGT1A3	3			3.0	Efficacy	1	2	atorvastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880812	
1043880851	rs4553808	CTLA4	3			1.5	Toxicity	1	2	bortezomib;dexamethasone;melphalan;prednisone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880851	
1143918642	rs12721226	AGTR1	3		Rare Variant	0.0	Efficacy	1	1	losartan		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1143918642	
1183490962	rs1800544	ADRA2A	3			2.0	Other	1	1	dexmedetomidine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183490962	
1183492244	rs17655652	NPC1L1	3			5.5	Efficacy	1	2	pravastatin	Diabetes Mellitus;Hypertension;Vascular Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183492244	
1183533592	rs12654264	HMGCR	3			5.5	Other	1	3	hmg coa reductase inhibitors	Colonic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183533592	
1183533981	rs2290732	GABRA1	3			2.75	Efficacy	1	1	carbamazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183533981	
1183603158	rs2742390	SACM1L	3			0.0	Toxicity	1	1	bupropion	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183603158	
1183614509	rs1800545	ADRA2A	3			2.0	Efficacy	1	1	atenolol	Hypertrophy, Left Ventricular	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614509	
1183614614	rs1799752	ACE	3		Tier 1 VIP	2.25	Efficacy	1	1	bumetanide;furosemide;torasemide		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614614	
1183614752	rs12082710	TGFBR3	3			2.5	Efficacy	1	1	antidepressants	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614752	
1183614845	rs1042714	ADRB2	3		Tier 1 VIP	2.0	Efficacy	1	1	enalapril	Hypertrophy, Left Ventricular	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614845	
1183614891	rs10042486	HTR1A	3			3.0	Efficacy	1	1	amisulpride;antipsychotics;olanzapine;quetiapine;risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614891	
1183615150	rs7079	AGT	3			3.5	Efficacy	1	1	benazepril	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183615150	
1183615213	rs1801133	MTHFR	3		Tier 1 VIP	4.25	Efficacy	2	3	benazepril	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183615213	
1183615410	rs60369023	CDA	3		Rare Variant	0.0	Other	1	1	cytarabine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183615410	
1183615415	rs767455	TNFRSF1A	3			2.75	Efficacy	2	3	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183615415	
982037557	rs11706052	IMPDH2	4			-3.0	Efficacy;Toxicity	6	10	mycophenolate mofetil;mycophenolic acid	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982037557	
1451406860	rs16952570	FTO	3			4.0	Toxicity	2	3	mercaptopurine	Colitis, Ulcerative;Crohn Disease;Irritable Bowel Syndrome;Leukopenia;Neutropenia	2021-04-08	https://www.pharmgkb.org/clinicalAnnotation/1451406860	
1183617714	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	1A		Tier 1 VIP	119.5	Metabolism/PK	9	22	amitriptyline	Depressive Disorder, Major;Mental Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183617714	
1183615582	rs699	AGT	3			0.25	Efficacy	3	4	atenolol	Hypertension;Hypertrophy, Left Ventricular	2021-09-09	https://www.pharmgkb.org/clinicalAnnotation/1183615582	
982031045	rs1799983	NOS3	3			2.0	Toxicity	1	1	aspirin;Beta Blocking Agents;clopidogrel;hmg coa reductase inhibitors	Coronary Artery Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982031045	
982031956	rs8832	IL4R	3			3.0	Efficacy	1	1	pitrakinra	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982031956	
982036595	rs4148737	ABCB1	3		Tier 1 VIP	0.0	Efficacy	2	2	cisplatin;cyclophosphamide;doxorubicin;methotrexate;vincristine	Osteosarcoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982036595	
1183564845	rs5186	AGTR1	3			3.75	Efficacy	1	3	candesartan	Heart Failure	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183564845	
1183614481	rs1801701	APOB	3			2.0	Efficacy	1	1	irbesartan	Hypertrophy, Left Ventricular	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614481	
1183614486	rs1801253	ADRB1	3		Tier 1 VIP	4.25	Efficacy	1	3	dobutamine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614486	
1183614619	rs1799752	ACE	3		Tier 1 VIP	2.75	Efficacy	2	3	benazepril;perindopril	Diabetes Mellitus	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614619	
1183614706	rs1417938	CRP	3			2.75	Efficacy	1	1	fenofibrate	Metabolic Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614706	
1183614771	rs1127687	CASP7	3			2.0	Efficacy	1	1	gemcitabine;Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614771	
1183614840	rs1045642	ABCB1	3		Tier 1 VIP	4.5	Toxicity	1	2	sirolimus	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614840	
1183614881	rs1029489	IL4R	3			3.0	Efficacy	1	1	pitrakinra	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614881	
1183614970	rs7412	APOE	3			2.5	Efficacy	1	1	fenofibrate	Hypertriglyceridemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614970	
1183615145	rs717620	ABCC2	3			0.0	Toxicity	1	1	fluorouracil;leucovorin;oxaliplatin	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183615145	
1183615186	rs4149056	SLCO1B1	3		Tier 1 VIP	0.0	Toxicity	2	3	irinotecan	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183615186	
1183543916	rs2241883	FABP1	4			-1.5	Efficacy	1	3	fenofibrate	Hypertriglyceridemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183543916	
1183615288	rs1062613	HTR3A	3			2.5	Efficacy	1	1	clozapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183615288	
1183615373	rs2066844	NOD2	3			0.75	Efficacy	1	1	tacrolimus	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183615373	
1183619322	rs2235040	ABCB1	3		Tier 1 VIP	2.75	Efficacy	1	1	amitriptyline;citalopram;paroxetine;venlafaxine	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183619322	
1183629403	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	3		Tier 1 VIP	1.75	Metabolism/PK	3	3	esomeprazole		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183629403	
1183630065	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*9, CYP2C19*10, CYP2C19*17, CYP2C19*24, CYP2C19*26	CYP2C19	1A		Tier 1 VIP	228.8125	Metabolism/PK	28	38	omeprazole	Gastroesophageal Reflux	2021-05-03	https://www.pharmgkb.org/clinicalAnnotation/1183630065	Pediatric
1183624491	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	1A		Tier 1 VIP	209.3125	Metabolism/PK	7	11	pantoprazole		2021-04-26	https://www.pharmgkb.org/clinicalAnnotation/1183624491	Pediatric
1043858733	rs1050891	HNMT	3			2.25	Toxicity	1	1	aspirin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043858733	
1043859108	rs4149056	SLCO1B1	3		Tier 1 VIP	2.0	Dosage	1	1	SN-38	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043859108	
1043880059	rs3832043	UGT1A9	3			2.5	Other	1	2	mycophenolate mofetil	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880059	
1183554425	rs7921977	CASP7	3			0.5	Efficacy	1	2	docetaxel;gemcitabine;paclitaxel;Platinum compounds;vinorelbine	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183554425	
1183602849	rs2742421	SACM1L	3			0.0	Toxicity	1	1	bupropion	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183602849	
1183613866	rs1969624	SACM1L	3			0.0	Toxicity	1	1	bupropion	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183613866	
1183615435	CYP2C19*1, CYP2C19*2	CYP2C19	3		Tier 1 VIP	1.25	Efficacy	1	1	tacrolimus	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183615435	
1183615199	rs3832043	UGT1A9	3			4.25	Metabolism/PK	3	3	SN-38	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183615199	
1183630036	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	1A		Tier 1 VIP	264.5	Efficacy	27	57	omeprazole	Esophagitis;Gastroesophageal Reflux;Helicobacter Infections;Peptic Ulcer	2021-05-03	https://www.pharmgkb.org/clinicalAnnotation/1183630036	
1183624499	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	1A		Tier 1 VIP	218.75	Efficacy	6	13	pantoprazole	Helicobacter Infections;Ulcer	2021-05-03	https://www.pharmgkb.org/clinicalAnnotation/1183624499	
1183629373	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	2A		Tier 1 VIP	10.625	Metabolism/PK	10	16	rabeprazole		2021-05-03	https://www.pharmgkb.org/clinicalAnnotation/1183629373	
1183629796	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	1A		Tier 1 VIP	256.75	Efficacy	22	57	lansoprazole	Gastroesophageal Reflux;Helicobacter Infections	2021-05-03	https://www.pharmgkb.org/clinicalAnnotation/1183629796	
982030948	rs962369	BDNF	3			2.5	Toxicity	1	1	escitalopram;nortriptyline	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982030948	
982040598	rs4244285	CYP2C19	3		Tier 1 VIP	2.5	Efficacy	2	4	prasugrel	Acute coronary syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982040598	
982040717	rs1065776	P2RY1	3			1.875	Efficacy	3	4	aspirin	Myocardial Infarction	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982040717	
1183631465	rs4823613	PPARA	3			0.0	Efficacy	2	2	simvastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183631465	
1183631554	rs2849380	BCL2	3			3.0	Toxicity	1	1	carboplatin;docetaxel;paclitaxel	Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183631554	
1183631559	rs139887	SOX10	3			3.0	Toxicity	1	1	carboplatin;docetaxel;paclitaxel	Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183631559	
1183632078	rs2776546		3			0.0	Efficacy	1	1	hydrochlorothiazide	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183632078	
1183632091	rs4791040	PRKCA	3			0.0	Efficacy	1	1	hydrochlorothiazide	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183632091	
982047862	rs1799752	ACE	2A		Tier 1 VIP	13.5	Efficacy	7	8	captopril	Diabetes Mellitus, Type 2;Heart Failure;Pulmonary Disease, Chronic Obstructive	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982047862	
1183632150	rs878949	HSPG2	3			2.0	Toxicity	1	1	antipsychotics	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183632150	
1183632155	rs2445142	HSPG2	3			2.5	Toxicity	1	1	antipsychotics	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183632155	
1183632175	rs1042713	ADRB2	3		Tier 1 VIP	3.0	Toxicity	1	1	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183632175	
1451407200	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	3			1.75	Toxicity	1	1	sertraline	Depressive Disorder, Major;Sexual Dysfunctions, Psychological	2021-04-09	https://www.pharmgkb.org/clinicalAnnotation/1451407200	
1183632140	rs885004	SLC28A3	3			2.0	Toxicity	2	2	anthracyclines and related substances	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183632140	Pediatric
1183614735	rs12415607	CASP7	3			4.0	Efficacy	1	3	docetaxel;gemcitabine;paclitaxel;Platinum compounds;vinorelbine	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614735	
1183614793	rs11269124	ADRA2C	3			2.25	Efficacy	1	1	clonidine	Liver Cirrhosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183614793	
1448636930	rs10515074	PIK3R1	3			5.0	Toxicity	1	2	everolimus	Breast Neoplasms;Hyperglycemia;Leukopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448636930	
1451407348	rs6311	HTR2A	3			2.25	Toxicity	1	1	sertraline	Depressive Disorder, Major;Sexual Dysfunctions, Psychological	2021-04-09	https://www.pharmgkb.org/clinicalAnnotation/1451407348	
1451407321	rs6313	HTR2A	3			0.0	Toxicity	1	1	sertraline	Depressive Disorder, Major;Sexual Dysfunctions, Psychological	2021-04-09	https://www.pharmgkb.org/clinicalAnnotation/1451407321	
1451407329	rs6313	HTR2A	3			1.75	Toxicity	1	1	citalopram	Depressive Disorder, Major;Sexual Dysfunctions, Psychological	2021-04-09	https://www.pharmgkb.org/clinicalAnnotation/1451407329	
1451407341	rs6311	HTR2A	3			2.25	Toxicity	1	1	citalopram	Depressive Disorder, Major;Sexual Dysfunctions, Psychological	2021-04-09	https://www.pharmgkb.org/clinicalAnnotation/1451407341	
1448999385	CYP2D6*1, CYP2D6*24	CYP2D6	3		Tier 1 VIP	0.0	Metabolism/PK	2	3	codeine;dextromethorphan;n-desmethyltamoxifen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448999385	
1448999559	CYP2D6*1, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*97, CYP2D6*98	CYP2D6	3		Tier 1 VIP	0.0	Metabolism/PK	1	3	atomoxetine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448999559	
1449003934	rs652888	EHMT2	3			0.0	Toxicity	1	1	Antithyroid Preparations	Agranulocytosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449003934	
1449003956	rs11125883	XPO1	3			0.75	Toxicity	2	2	isoniazid	drug-induced liver injury;Toxic liver disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449003956	
1449003995	rs1800888	ADRB2	3		Rare Variant; Tier 1 VIP	0.0	Other	1	1	salbutamol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449003995	
1449165479	rs1801274	FCGR2A	3			6.75	Efficacy	4	4	cetuximab	Colorectal Neoplasms;Head and Neck Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449165479	
1449157773	rs118192168	RYR1	1A		Rare Variant; Tier 1 VIP	101.25	Toxicity	12	13	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449157773	Pediatric
1449752825	rs17211071	HLA-DRB1	3		Rare Variant	3.0	Toxicity	1	1	dapsone	Drug Hypersensitivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449752825	
1451407962	rs702764	OPRK1	3			0.0	Efficacy	1	1	butorphanol		2021-04-09	https://www.pharmgkb.org/clinicalAnnotation/1451407962	
1450810236	rs511435	OPRM1	3			6.75	Toxicity	2	2	heroin;opioids	Heroin Dependence;Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450810236	Pediatric
1450931416	rs4807493	PIP5K1C	3			0.0	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450931416	
1451407981	rs6269	COMT	3		Tier 1 VIP	2.5	Efficacy	1	1	morphine		2021-04-09	https://www.pharmgkb.org/clinicalAnnotation/1451407981	
1451408000	rs6269	COMT	4		Tier 1 VIP	-1.5	Dosage	2	2	morphine	Neoplasms;Pain;Pain, Postoperative	2021-04-09	https://www.pharmgkb.org/clinicalAnnotation/1451408000	
1449716056	rs2275913	IL17A	3			2.75	Dosage	1	1	opioids	Pain, Postoperative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449716056	
1449716178	rs9397685	OPRM1	3		Rare Variant	2.25	Toxicity	1	1	fentanyl	Nausea;Pain, Postoperative;Vomiting	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449716178	
1450810351	rs3778156	OPRM1	3			3.25	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450810351	Pediatric
1450810381	rs495491	OPRM1	3			3.25	Toxicity	1	1	cocaine	Cocaine-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450810381	Pediatric
1450811972	rs1461773	OPRM1	3			3.25	Efficacy	1	1	ethanol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450811972	
1449191379	rs368505753	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191379	
1449191385	rs115545701	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191385	
1449191367	rs397508328	CFTR	3		Rare Variant; Tier 1 VIP	0.0	Efficacy	1	1	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191367	
1449191401	rs397508537	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191401	
1449716207	rs13093031		3			0.0	Efficacy	1	1	fentanyl	Pain, Postoperative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449716207	
1449191395	rs121908751	CFTR	3		Rare Variant; Tier 1 VIP	0.0	Efficacy	1	1	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191395	
1449270967	rs4968187	TP53	3			0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449270967	
1449750773	rs2236947	RASSF1	3			2.75	Efficacy	1	1	cetuximab	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449750773	
1449750832	rs4261893	ZNF385D	3			3.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449750832	
1449750838	rs117986340	KMT2E	3			2.5	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449750838	
1449750843	rs2303377	NCAM1	3			3.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449750843	
1449191407	rs113993958	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191407	
1449191413	rs77834169	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191413	
1449191424	rs397508759	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191424	
1449191430	rs121908752	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191430	
1449163934	rs762551	CYP1A2	3			5.625	Metabolism/PK	4	4	caffeine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449163934	
1449169484	rs7668258	UGT2B7	3			2.25	Metabolism/PK	3	4	valproic acid	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449169484	Pediatric
1449169546	rs11568732	CYP2C19	3		Tier 1 VIP	0.0	Toxicity	1	1	clopidogrel	Hemorrhage;Myocardial Infarction	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449169546	
1449169601	rs1799722	BDKRB2	3			2.25	Metabolism/PK	1	1	atorvastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449169601	
1449169675	rs1105879	UGT1A6	3			0.0	Efficacy	1	1	aspirin	Colonic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449169675	
1451408008	rs4633	COMT	3		Tier 1 VIP	2.0	Efficacy	1	1	butorphanol		2021-04-09	https://www.pharmgkb.org/clinicalAnnotation/1451408008	
1449564720	rs7270101	ITPA	3			3.25	Dosage;Toxicity	1	1	mercaptopurine;methotrexate	Leukopenia;Neutropenia;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449564720	Pediatric
1449566673	rs4979223	SLC31A1	3			5.75	Efficacy;Toxicity	1	2	Platinum compounds	overall survival;Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449566673	
1449566679	rs4978536	SLC31A1	3			2.5	Toxicity	1	1	Platinum compounds	Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449566679	
1449566685	rs2233914	SLC31A1	3			5.5	Efficacy;Toxicity	1	2	Platinum compounds	Drug Toxicity;overall survival	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449566685	
1450044803	rs13120400	ABCG2	3		Tier 1 VIP	1.0	Metabolism/PK	1	1	ceftriaxone	Central Nervous System Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450044803	
1450813484	rs1800497	ANKK1;DRD2	3		Tier 1 VIP	2.5	Toxicity	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450813484	
1450928835	rs2036527	CHRNA5	3			2.25	Efficacy	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450928835	
1450929015	rs1277441	TAOK3	3			0.0	Efficacy	1	1	opioids	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450929015	
1450929025	rs1277441	TAOK3	3			2.0	Dosage	1	1	opioids	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450929025	
1450929816	rs1045642	ABCB1	3		Tier 1 VIP	1.0	Efficacy	2	2	tramadol	Fractures, Bone;Pain;Pain, Postoperative	2021-04-08	https://www.pharmgkb.org/clinicalAnnotation/1450929816	
1451408023	rs6269	COMT	3		Tier 1 VIP	2.0	Efficacy	1	1	butorphanol		2021-04-09	https://www.pharmgkb.org/clinicalAnnotation/1451408023	
1450929851	CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN	CYP2D6	1A		Tier 1 VIP	103.25	Efficacy	1	2	tropisetron	Vomiting	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450929851	
1450930536	rs7606603	XIRP2	3			2.25	Efficacy	1	1	atenolol	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450930536	
1449000317	CYP2D6*1, CYP2D6*87, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*95, CYP2D6*98	CYP2D6	3		Tier 1 VIP	0.0	Metabolism/PK	1	1	tamoxifen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449000317	
1449005372	rs3888190	SH2B1	3			2.25	Toxicity	1	1	amisulpride;aripiprazole;clozapine;lithium;mirtazapine;olanzapine;paliperidone;quetiapine;risperidone;valproic acid	Bipolar Disorder;Depressive Disorder;Psychotic Disorders;schizoaffective disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449005372	
1448821500	rs2231142	ABCG2	3		Tier 1 VIP	1.75	Metabolism/PK	1	1	tenofovir	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448821500	
1449164681	rs1801278	IRS1	3			1.25	Efficacy	1	1	Drugs Used In Diabetes	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449164681	
1449171114	rs8192709	CYP2B6	3		Tier 1 VIP	1.75	Metabolism/PK	1	1	methadone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449171114	
1449171120	rs3211371	CYP2B6	3		Tier 1 VIP	1.75	Metabolism/PK	1	1	methadone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449171120	
1449192313	rs121909047	CFTR	3		Rare Variant; Tier 1 VIP	1.5	Efficacy	1	1	lumacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449192313	
1449718300	rs2228100	ALDH3A1	3			2.75	Toxicity	1	1	cyclophosphamide;doxorubicin;fluorouracil	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449718300	
1450821128	rs3890011	CYP4A11	3			2.0	Efficacy	1	1	spironolactone	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450821128	
1450928486	rs362267	HTT;MSANTD1	3			0.0	Efficacy	1	1	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450928486	
1451408961	rs2230806	ABCA1	3			3.25	Efficacy	1	1	atorvastatin		2021-04-12	https://www.pharmgkb.org/clinicalAnnotation/1451408961	
1451409020	rs2230806	ABCA1	3			3.25	Efficacy	1	1	rosuvastatin		2021-04-12	https://www.pharmgkb.org/clinicalAnnotation/1451409020	
1451409026	rs2230806	ABCA1	3			3.25	Efficacy	1	1	simvastatin		2021-04-12	https://www.pharmgkb.org/clinicalAnnotation/1451409026	
1448995134	rs2231142	ABCG2	3		Tier 1 VIP	1.5	Metabolism/PK	1	1	dolutegravir	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448995134	
1449157530	rs3131003	PSORS1C1	3			3.0	Toxicity	1	1	allopurinol	severe cutaneous adverse reactions	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449157530	
1450820856	rs1800497	ANKK1;DRD2	3		Tier 1 VIP	1.75	Efficacy	1	1	prochlorperazine	Nausea	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450820856	
1450820863	rs1079597	DRD2	3		Tier 1 VIP	1.75	Efficacy	1	1	prochlorperazine	Nausea	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450820863	
1450820963	rs6090378	CHRNA4	3			0.0	Toxicity	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450820963	
1450821349	rs9479757	OPRM1	3			2.75	Toxicity	1	1	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450821349	
1451409080	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	3		Tier 1 VIP	2.25	Efficacy	1	2	atorvastatin		2021-04-12	https://www.pharmgkb.org/clinicalAnnotation/1451409080	
1449167289	rs17712523	CDH23	3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449167289	Pediatric
1449167300	rs2799018	ARHGAP12	3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449167300	Pediatric
1449167317	rs12409352	PIGM	3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449167317	Pediatric
1449167339	rs2295490	TRIB3	3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449167339	Pediatric
1449167350	rs4627790	CMTM8	3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449167350	Pediatric
1449167361	rs1048786	PDIA2	3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449167361	Pediatric
1449167409	rs751655	OPCML	3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449167409	Pediatric
1449167420	rs11559290	ETFDH	3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449167420	Pediatric
1449167431	rs7858	NFIB	3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449167431	Pediatric
1449167442	rs929740	ARHGEF28	3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449167442	Pediatric
1451409101	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	3		Tier 1 VIP	2.25	Efficacy	1	2	rosuvastatin		2021-04-12	https://www.pharmgkb.org/clinicalAnnotation/1451409101	
1449168364	rs12630569	ZNF385D	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168364	
1449168371	rs9824595	ZNF385D	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168371	
1449168378	rs4334661	ZNF385D	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168378	
1449168385	rs7625956		3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168385	
1449168392	rs4858478		3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168392	
1449168399	rs12502866		3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168399	
1449168405	rs61692318		3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168405	
1449168412	rs10007051		3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168412	
1449168419	rs11933890		3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168419	
1449168426	rs62319299		3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168426	
1449168433	rs56229625		3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168433	
1449168440	rs55881666		3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168440	
1449168447	rs12657120	TTC37	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168447	
1451409127	CYP2D6*1, CYP2D6*4	CYP2D6	3		Tier 1 VIP	0.25	Efficacy	1	1	fluvastatin		2021-04-12	https://www.pharmgkb.org/clinicalAnnotation/1451409127	
1451409120	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	3		Tier 1 VIP	2.0	Efficacy	2	3	simvastatin		2021-04-12	https://www.pharmgkb.org/clinicalAnnotation/1451409120	
1451409133	rs708272	CETP	3			3.25	Efficacy	1	1	rosuvastatin		2021-04-12	https://www.pharmgkb.org/clinicalAnnotation/1451409133	
1451409141	rs5882	CETP	3			3.25	Efficacy	1	1	rosuvastatin		2021-04-12	https://www.pharmgkb.org/clinicalAnnotation/1451409141	
1449156112	HLA-B*15:01:01:01	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156112	
1449004504	rs10132552	MEG3	3			1.5	Toxicity	1	2	Platinum compounds;radiotherapy	Anemia;Dermatitis;Leukopenia;mucositis;Myelosuppression;Neutropenia;Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449004504	
1449155833	HLA-B*51:01:01	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449155833	
1449156127	HLA-B*15:25:01	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156127	
1449155838	HLA-B*51:02:01	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449155838	
1449156144	HLA-B*15:27:01	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156144	
1449155843	HLA-B*54:01:01	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449155843	
1449156149	HLA-B*15:32	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156149	
1449155848	HLA-B*55:01:01	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449155848	
1449155853	HLA-B*55:02:01	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449155853	
1449155858	HLA-B*56:01:01	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449155858	
1449155863	HLA-B*56:06	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449155863	
1449156029	rs503464	CHRNA5	3			5.0	Efficacy;Toxicity	1	2	bupropion;nicotine;varenicline	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156029	
1449156045	rs55781567	CHRNA5	3			2.75	Toxicity	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156045	
1449156061	HLA-B*78:01:01	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156061	
1449156066	HLA-B*13:02:01	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156066	
1449156071	HLA-B*38:01:01	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156071	
1449156089	HLA-B*39:05:01	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156089	
1449156094	HLA-B*39:06:01	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156094	
1449156099	HLA-B*39:09	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156099	
1449156107	HLA-B*57:01:01	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156107	
1449156157	HLA-B*15:35	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156157	
1449156162	HLA-B*52:01:01:01	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156162	
1449156189	HLA-C*04:03	HLA-C	3			0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156189	
1449156194	HLA-C*04:06	HLA-C	3			0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156194	
1449156199	HLA-C*04:07	HLA-C	3			0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156199	
1449156204	HLA-C*05:01:01:01	HLA-C	3			0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156204	
1449156209	HLA-C*05:09:01	HLA-C	3			0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156209	
1449156214	HLA-C*18:01	HLA-C	3			0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156214	
1449156231	HLA-DRB1*01:03	HLA-DRB1	3			0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156231	
1449156236	HLA-DRB1*04:04:01	HLA-DRB1	3			0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156236	
1449156241	HLA-DRB1*08:01:01	HLA-DRB1	3			0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156241	
1449156249	HLA-DRB1*10:01:01	HLA-DRB1	3			0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156249	
1450377187	rs1801280	NAT2	3		Tier 1 VIP	2.25	Toxicity	1	1	isoniazid;phenytoin	Drug interaction with drug;Drug Toxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450377187	
1450810255	rs524731	OPRM1	3			2.75	Toxicity	1	1	cocaine	Cocaine-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450810255	Pediatric
1450930470	rs4654327	OPRD1	3			1.0	Toxicity	2	2	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450930470	
1450934632	rs397515870	GLA	3		Rare Variant	0.0	Efficacy	1	1	migalastat	Fabry Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450934632	
1450934693	rs104894828	GLA	3		Rare Variant	0.0	Efficacy	1	1	migalastat	Fabry Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450934693	
1450934717	rs190347120	GLA	3		Rare Variant	0.0	Efficacy	1	1	migalastat	Fabry Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450934717	
1450929867	CYP2D6*1, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10	CYP2D6	1A		Tier 1 VIP	103.5	Metabolism/PK	2	5	tropisetron		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450929867	
1449155310	rs4149117	SLCO1B3	3			2.5	Efficacy	1	1	sunitinib	Gastrointestinal Stromal Tumors	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449155310	
1450807912	rs4680	COMT	3		Tier 1 VIP	1.0	Toxicity	2	2	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450807912	
1450812417	rs2239050	CACNA1C	3			1.5	Efficacy	1	1	nimodipine		2022-08-15	https://www.pharmgkb.org/clinicalAnnotation/1450812417	
1449270961	rs77769901	CCNK	3		Rare Variant	0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449270961	
1450934684	rs869312399	GLA	3			0.0	Efficacy	1	1	migalastat	Fabry Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450934684	
1449154729	rs113993960	CFTR	1A		Rare Variant; Tier 1 VIP	108.75	Efficacy	3	4	ivacaftor / tezacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449154729	Pediatric
1450373854	rs6517442	KCNJ6	3			5.0	Efficacy	1	2	morphine	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450373854	Pediatric
1451409760	rs12471326	UGT1A9	3			1.25	Metabolism/PK	1	1	cotinine glucuronide		2021-04-13	https://www.pharmgkb.org/clinicalAnnotation/1451409760	
1449168684	rs10771999		3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168684	
1449171162	rs5746136	SOD2	3			0.5	Toxicity	1	2	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449171162	
1449271051	rs145623321	PIK3R2	3		Rare Variant	0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449271051	
1450928430	rs362306	HTT;MSANTD1	3			0.0	Efficacy	1	1	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450928430	
1450928499	rs2515641	CYP2E1	3			0.0	Efficacy	1	1	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450928499	
1449171168	rs2758339	SOD2	3			3.0	Toxicity	1	1	heroin	Heroin Dependence	2021-09-10	https://www.pharmgkb.org/clinicalAnnotation/1449171168	
1451409780	rs145014075	CYP2A6	3		Rare Variant; Tier 1 VIP	1.25	Metabolism/PK	1	1	nicotine		2021-04-13	https://www.pharmgkb.org/clinicalAnnotation/1451409780	
1450932674	rs1799971	OPRM1	3			3.5	Toxicity	1	4	buprenorphine;fentanyl;tramadol	adverse events;Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450932674	
1450928528	rs4633	COMT	4		Tier 1 VIP	-1.5	Efficacy	2	2	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450928528	
1450933017	rs731236	VDR	3			2.0	Efficacy	1	1	deferasirox	beta-Thalassemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450933017	
1449713738	rs1061622	TNFRSF1B	3			2.0	Efficacy	1	1	etanercept	Spondylitis, Ankylosing	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449713738	
1449717941	rs2231142	ABCG2	3		Tier 1 VIP	3.0	Efficacy	1	1	Opioid anesthetics;Other general anesthetics;volatile anesthetics		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449717941	
1450813869	rs11969064		3			0.0	Toxicity	1	1	azathioprine;mercaptopurine;thioguanine	Inflammatory Bowel Diseases;Myelosuppression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450813869	
1449732040	rs1045642	ABCB1	4		Tier 1 VIP	-1.125	Metabolism/PK	4	4	risperidone	Bipolar Disorder;Depression;Psychotic Disorders;Schizophrenia;Substance-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449732040	
1451410200	CYP3A4*1, CYP3A4*22	CYP3A4	4		Tier 1 VIP	-0.125	Metabolism/PK	3	3	everolimus	Breast Neoplasms;Kidney Neoplasms;Kidney Transplantation;Neuroendocrine Tumors	2021-04-13	https://www.pharmgkb.org/clinicalAnnotation/1451410200	
1450813881	rs7164594	HYKK	3			2.75	Efficacy	1	1	varenicline	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450813881	
1450813994	rs4680	COMT	3		Tier 1 VIP	2.0	Efficacy	1	1	modafinil	methamphetamine dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450813994	
1449565066	rs780668	SLC29A3	4			-0.25	Efficacy	1	3	gemcitabine	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449565066	
1451410221	CYP3A5*1, CYP3A5*3	CYP3A5	3		Tier 1 VIP	0.375	Metabolism/PK	6	6	everolimus	Breast Neoplasms;heart transplantation;Kidney Neoplasms;Kidney Transplantation;lung transplantation;Neuroendocrine Tumors	2021-04-13	https://www.pharmgkb.org/clinicalAnnotation/1451410221	
1448820584	rs9200	C6	3			1.0	Metabolism/PK	1	2	tacrolimus	liver transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448820584	
1448820590	rs10052999	C6	3			1.5	Metabolism/PK	1	2	tacrolimus	liver transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448820590	
1449157883	rs2266780	FMO3	3			4.25	Metabolism/PK	1	2	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449157883	
1449296290	rs762551	CYP1A2	3			0.25	Toxicity	1	1	caffeine	insomnia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449296290	
1449296320	rs2162145	CPA6	3			0.0	Efficacy	1	1	metformin	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449296320	
1449296326	rs57081354	NBEA	3			0.0	Efficacy	1	1	metformin	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449296326	
1449296332	rs254271	PRPF31	3			0.0	Efficacy	1	1	metformin	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449296332	
1449565060	rs2231142	ABCG2	3		Tier 1 VIP	3.5	Efficacy;Toxicity	1	4	gemcitabine	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449565060	
1449565184	rs1976391		3			0.0	Metabolism/PK	1	2	oxazepam		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449565184	Pediatric
1450824479	rs3778150	OPRM1	3			2.75	Dosage	1	1	ethanol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450824479	
1449563861	rs772226819	CACNA1S	1A		Rare Variant; Tier 1 VIP	100.25	Toxicity	2	3	desflurane	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449563861	
1449004841	rs4149056	SLCO1B1	3		Tier 1 VIP	1.75	Efficacy	2	2	methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-09-28	https://www.pharmgkb.org/clinicalAnnotation/1449004841	Pediatric
1449165169	rs2273697	ABCC2	4			-1.25	Toxicity	3	3	methotrexate	Arthritis, Rheumatoid	2021-12-16	https://www.pharmgkb.org/clinicalAnnotation/1449165169	Pediatric
1449165158	rs1128503	ABCB1	4		Tier 1 VIP	-0.25	Toxicity	2	2	methotrexate	Arthritis, Rheumatoid	2021-12-16	https://www.pharmgkb.org/clinicalAnnotation/1449165158	
1450810228	rs511435	OPRM1	3			3.25	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450810228	Pediatric
1450810283	rs3823010	OPRM1	3			3.25	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450810283	Pediatric
1450810289	rs3823010	OPRM1	3			3.25	Toxicity	1	1	cocaine	Cocaine-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450810289	Pediatric
1450810369	rs609148	OPRM1	3			2.75	Toxicity	1	1	opioids	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450810369	Pediatric
1450810393	rs548646	OPRM1	3			2.25	Toxicity	1	1	opioids	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450810393	Pediatric
1450934647	rs28935490	GLA	3		Rare Variant	0.0	Efficacy	1	1	migalastat	Fabry Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450934647	
1450935242	CYP2C8*1, CYP2C8*3	CYP2C8	3		Tier 1 VIP	4.125	Metabolism/PK	5	6	ibuprofen		2021-05-18	https://www.pharmgkb.org/clinicalAnnotation/1450935242	
1449715596	rs10028494	UGT2B7	3			2.25	Efficacy	1	1	fentanyl	Pain, Postoperative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449715596	
1449715626	rs1799971	OPRM1	3			2.0	Toxicity	1	1	alfentanil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449715626	
1451410280	rs2024627	MTOR	3			1.5	Efficacy	1	1	everolimus	Breast Neoplasms;Kidney Neoplasms;Neuroendocrine Tumors	2021-04-13	https://www.pharmgkb.org/clinicalAnnotation/1451410280	
1449715423	CYP3A4*1, CYP3A4*36	CYP3A4	3		Tier 1 VIP	3.5	Dosage	5	5	sufentanil	Pain	2022-03-23	https://www.pharmgkb.org/clinicalAnnotation/1449715423	
1450373489	rs3192723	OPRM1	3			0.0	Efficacy	1	1	methadone	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450373489	
1449003976	rs2070401	BACH1	3			0.75	Toxicity	2	2	isoniazid	drug-induced liver injury;Toxic liver disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449003976	
1449161127	rs231775	CTLA4	3			2.0	Toxicity	1	1	Antiinflammatory agents, non-steroids		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449161127	
1449161156	rs9933632		3			3.5	Toxicity	1	1	acetaminophen;ibuprofen;loxoprofen;salicylamide		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449161156	
1449161162	rs6500265		3			3.5	Toxicity	1	1	acetaminophen;ibuprofen;loxoprofen;salicylamide		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449161162	
1450374101	rs1902023	UGT2B15	3			1.75	Efficacy	1	1	acetaminophen	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450374101	
1450375059	rs1799793	ERCC2	3			2.5	Toxicity	1	1	bleomycin;cisplatin;etoposide	Anemia;Testicular Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450375059	
1450375734	rs4148157	ABCG2	3		Tier 1 VIP	0.0	Efficacy	1	1	allopurinol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450375734	
1450931447	rs1476592	PIP5K1C	3			0.0	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450931447	
1450931822	rs1799971	OPRM1	3			2.0	Toxicity	1	1	fentanyl	somnolence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450931822	
1450932389	rs10516440		3			0.0	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450932389	
1450932703	rs1045280	ARRB2	3			2.25	Toxicity	1	1	buprenorphine;fentanyl;tramadol	adverse events;Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450932703	
1450932995	rs887829	UGT1A1	3		Tier 1 VIP	2.5	Efficacy	1	1	deferasirox	beta-Thalassemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450932995	
1451410900	HLA-C*12:03:01:01	HLA-C	3			1.75	Toxicity	1	1	infliximab	drug-induced liver injury	2021-04-14	https://www.pharmgkb.org/clinicalAnnotation/1451410900	
1451410920	HLA-DQB1*02:01:01	HLA-DQB1	3			2.75	Toxicity	1	1	infliximab	drug-induced liver injury	2021-04-14	https://www.pharmgkb.org/clinicalAnnotation/1451410920	
1451410860	HLA-B*08:01:01, HLA-B*39:01:01:01	HLA-B	3		Tier 1 VIP	4.5	Toxicity	1	2	infliximab	drug-induced liver injury	2021-04-14	https://www.pharmgkb.org/clinicalAnnotation/1451410860	
1451411000	HLA-DRB1*03:01, HLA-DRB1*04:04:01	HLA-DRB1	3			4.0	Toxicity	1	2	infliximab	drug-induced liver injury	2021-04-14	https://www.pharmgkb.org/clinicalAnnotation/1451411000	
1451410960	HLA-DPB1*10:01	HLA-DPB1	3			1.75	Toxicity	1	1	infliximab	drug-induced liver injury	2021-04-14	https://www.pharmgkb.org/clinicalAnnotation/1451410960	
1450375710	rs79663562	MYT1L	3			0.0	Efficacy	1	1	allopurinol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450375710	
1450813988	rs6265	BDNF	3			1.5	Toxicity	1	1	methamphetamine	methamphetamine dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450813988	
1450929031	rs795484	TAOK3	3			2.0	Efficacy	1	1	opioids	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450929031	
1450934049	rs762551	CYP1A2	3			3.75	Dosage	1	1	imatinib	Gastrointestinal Stromal Tumors	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450934049	
1451412140	rs3219489	MUTYH	3			3.75	Efficacy	1	1	cisplatin;fluorouracil;radiotherapy	Carcinoma, Squamous Cell;progression-free survival	2021-04-15	https://www.pharmgkb.org/clinicalAnnotation/1451412140	
1449566697	rs10759637	SLC31A1	3			2.75	Efficacy	1	1	Platinum compounds	overall survival;Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449566697	Pediatric
1449753229	rs1976391	UGT1A1	3		Tier 1 VIP	1.75	Toxicity	1	1	risperidone	Hyperprolactinemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449753229	Pediatric
1450042856	rs73208473	SORCS2	3			2.625	Metabolism/PK	2	2	atazanavir	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450042856	
1450934175	rs1567817380	SCN4A	3			0.0	Efficacy	1	1	flecainide	Myotonic Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450934175	
1450934494	rs398123212	GLA	3			0.0	Efficacy	1	1	migalastat	Fabry Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450934494	
1450934533	rs372966991	GLA	3		Rare Variant	0.0	Efficacy	1	1	migalastat	Fabry Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450934533	
1449718271	rs4244285	CYP2C19	3		Tier 1 VIP	2.75	Toxicity	1	1	cyclophosphamide;doxorubicin;fluorouracil	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449718271	
1449718277	rs2273697	ABCC2	3			2.75	Toxicity	1	1	cyclophosphamide;doxorubicin;fluorouracil	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449718277	
1449718283	rs3740066	ABCC2	3			5.5	Toxicity	1	2	cyclophosphamide;doxorubicin;fluorouracil	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449718283	
1449718289	rs1801516	ATM	3			5.5	Toxicity	1	2	cyclophosphamide;doxorubicin;fluorouracil	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449718289	
1449718311	rs3212986	ERCC1	3			3.25	Toxicity	1	1	cyclophosphamide;doxorubicin;fluorouracil	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449718311	
1449718317	rs11615	ERCC1	3			3.25	Toxicity	1	1	cyclophosphamide;doxorubicin;fluorouracil	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449718317	
1449718323	rs20572	CBR1	3			3.25	Toxicity	1	1	cyclophosphamide;doxorubicin;fluorouracil	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449718323	
1449718331	rs25487	XRCC1	3			2.75	Toxicity	1	1	cyclophosphamide;doxorubicin;fluorouracil	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449718331	
1449718337	rs1695	GSTP1	3		Tier 1 VIP	2.25	Toxicity	1	1	cyclophosphamide;doxorubicin;fluorouracil	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449718337	
1449718343	rs1045642	ABCB1	3		Tier 1 VIP	2.75	Toxicity	1	1	cyclophosphamide;doxorubicin;fluorouracil	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449718343	
1450374095	rs224534	TRPV1	3			1.75	Efficacy	1	1	acetaminophen	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450374095	
1450374917	rs2283265	DRD2	3		Tier 1 VIP	2.5	Toxicity	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450374917	Pediatric
1450375041	rs1695	GSTP1	3		Tier 1 VIP	5.0	Toxicity	1	2	bleomycin;cisplatin;etoposide	Infection;Nausea;Testicular Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450375041	
1450375080	rs11615	ERCC1	3			2.5	Toxicity	1	1	bleomycin;cisplatin;etoposide	febrile neutropenia;Testicular Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450375080	
1450375746	rs4148155	ABCG2	3		Tier 1 VIP	0.0	Efficacy	1	1	allopurinol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450375746	
1450376139	rs1277441	TAOK3	3			0.0	Dosage;Efficacy	1	1	morphine	Pain, Postoperative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450376139	Pediatric
1451411080	rs1051792	MICA	3			6.0	Efficacy	1	2	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Arthritis, Rheumatoid	2021-04-14	https://www.pharmgkb.org/clinicalAnnotation/1451411080	
1451412069	rs1799782	XRCC1	3			2.75	Efficacy	1	1	cisplatin;fluorouracil;radiotherapy	Carcinoma, Squamous Cell;overall survival	2021-04-15	https://www.pharmgkb.org/clinicalAnnotation/1451412069	
1450934209	rs121908547	SCN4A	3		Rare Variant	0.0	Efficacy	1	1	flecainide	Myotonic Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450934209	
1450934539	rs869312146	GLA	3			0.0	Efficacy	1	1	migalastat	Fabry Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450934539	
1450934641	rs398123223	GLA	3			0.0	Efficacy	1	1	migalastat	Fabry Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450934641	
1451412100	rs1760944	APEX1;OSGEP	3			2.25	Efficacy	1	1	cisplatin;fluorouracil;radiotherapy	Carcinoma, Squamous Cell;overall survival	2021-04-15	https://www.pharmgkb.org/clinicalAnnotation/1451412100	
1451411220	rs2253201	KCNMA1	3			3.0	Toxicity	1	1	Ace Inhibitors, Plain	Angioedema	2021-04-14	https://www.pharmgkb.org/clinicalAnnotation/1451411220	
1449576610	rs9342288	EYS	3			1.0	Toxicity	1	1	HMG CoA reductase inhibitors, other combinations	Cardiovascular Diseases;Rhabdomyolysis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449576610	
1449576616	rs1337512	EYS	3			1.0	Toxicity	1	1	hmg coa reductase inhibitors	Rhabdomyolysis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449576616	
1449717935	rs1799971	OPRM1	3			3.0	Efficacy	1	1	Opioid anesthetics;Other general anesthetics;volatile anesthetics		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449717935	
1451413082	rs10494366	NOS1AP	3			2.75	Toxicity	1	1	glyburide	Diabetes Mellitus, Type 2;Hypoglycemia	2021-04-16	https://www.pharmgkb.org/clinicalAnnotation/1451413082	
1449747595	rs193922768	RYR1	1A		Rare Variant; Tier 1 VIP	100.0	Toxicity	2	3	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449747595	
1449747617	rs193922762	RYR1	1A		Rare Variant; Tier 1 VIP	100.0	Toxicity	1	2	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449747617	
1449747643	rs193922748	RYR1	1A		Rare Variant; Tier 1 VIP	100.0	Toxicity	2	3	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449747643	
1451411286	rs3781727	SLCO2B1	3			0.125	Metabolism/PK	1	1	voriconazole		2021-04-14	https://www.pharmgkb.org/clinicalAnnotation/1451411286	
1450373514	rs1143634	IL1B	3			2.5	Dosage;Efficacy	1	1	morphine	Pain, Postoperative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450373514	
1450373583	rs11249454	UGT2A1	3			1.5	Toxicity	1	1	imatinib	Gastrointestinal Stromal Tumors	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450373583	
1450373745	rs471760	CDA	3			2.25	Toxicity	1	1	gemcitabine	Neutropenia;Pancreatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450373745	
1449170621	rs2229109	ABCB1	3		Tier 1 VIP	1.0	Efficacy	1	3	dexamethasone;lenalidomide	Multiple Myeloma;progression-free survival	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449170621	
1449171464	CYP3A7*1A, CYP3A7*1C	CYP3A7	3			1.0	Metabolism/PK	1	1	tacrolimus	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449171464	Pediatric
1449171921	rs890293	CYP2J2	3			2.5	Toxicity	1	1	tacrolimus	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449171921	
1449171933	rs3740066	ABCC2	3			1.5	Metabolism/PK	2	3	tacrolimus	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449171933	
1451413140	rs10494366	NOS1AP	3			2.75	Toxicity	1	1	glipizide	Diabetes Mellitus, Type 2;Hypoglycemia	2021-04-16	https://www.pharmgkb.org/clinicalAnnotation/1451413140	
1449171944	CYP2C8*1, CYP2C8*3	CYP2C8	3		Tier 1 VIP	1.5	Metabolism/PK	1	1	tacrolimus	Kidney Transplantation	2021-05-18	https://www.pharmgkb.org/clinicalAnnotation/1449171944	
1449172004	CYP2C8*1, CYP2C8*3	CYP2C8	3		Tier 1 VIP	6.0	Toxicity	3	4	tacrolimus	Kidney Transplantation	2021-05-18	https://www.pharmgkb.org/clinicalAnnotation/1449172004	
1449269612	rs2231142	ABCG2	3		Tier 1 VIP	1.5	Metabolism/PK	2	2	apixaban	Atrial Fibrillation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449269612	
1449269830	rs776746	CYP3A5	3		Tier 1 VIP	1.0	Metabolism/PK	2	2	apixaban	Atrial Fibrillation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449269830	
1449269938	rs429358	APOE	3			2.75	Toxicity	1	1	acenocoumarol;warfarin	Hemorrhage;venous thromboembolism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449269938	
1449269960	rs2108622	CYP4F2	3		Tier 1 VIP	0.125	Metabolism/PK	2	2	Vitamin K		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449269960	
1451413120	rs10494366	NOS1AP	3			2.75	Toxicity	1	1	glimepiride	Diabetes Mellitus, Type 2;Hypoglycemia	2021-04-16	https://www.pharmgkb.org/clinicalAnnotation/1451413120	
1451411555	rs17004921	ADORA2A-AS1	3			2.0	Efficacy	1	1	methotrexate	Arthritis, Rheumatoid	2021-04-14	https://www.pharmgkb.org/clinicalAnnotation/1451411555	
1449155302	rs1057868	POR	3			3.0	Efficacy	1	1	sunitinib	Gastrointestinal Stromal Tumors	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449155302	
1449271045	rs148013902	PIK3R2	3		Rare Variant	0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449271045	
1449271349	rs1799972	OPRM1	3			3.0	Toxicity	1	1	cocaine;ethanol;nicotine	Substance-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449271349	
1449748187	rs20455	KIF6	3			1.0	Efficacy	2	4	simvastatin	Hypercholesterolemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449748187	
1450808938	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12	CYP2A6	3		Tier 1 VIP	1.5	Toxicity	2	5	nicotine	Tobacco Use Disorder	2022-09-29	https://www.pharmgkb.org/clinicalAnnotation/1450808938	
1450811273	rs1044394	CHRNA4	3			0.0	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450811273	
1450812235	rs3758987	HTR3B	3			0.0	Toxicity	1	1	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450812235	
1450808951	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*46	CYP2A6	3		Tier 1 VIP	7.625	Dosage	4	4	nicotine	Tobacco Use Disorder	2022-09-29	https://www.pharmgkb.org/clinicalAnnotation/1450808951	
1450812748	rs2337980	CHRNA7	3			1.5	Efficacy	1	1	nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450812748	
1450812998	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	3			2.75	Efficacy	1	1	bupropion	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450812998	
1449188526	rs1043550	CALU	3			3.0	Dosage	2	2	acenocoumarol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449188526	
1449188545	rs7294	VKORC1	3		Tier 1 VIP	2.0	Other	1	1	acenocoumarol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449188545	
1449188673	rs1074287	OPRM1	3			2.25	Metabolism/PK	1	1	cotinine;nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449188673	
1449188701	rs510769	OPRM1	3			2.25	Metabolism/PK	1	1	cotinine;nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449188701	
1449188707	rs3798676	OPRM1	3			2.25	Metabolism/PK	1	1	cotinine;nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449188707	
1449188713	rs553202	OPRM1	3			1.75	Metabolism/PK	1	1	cotinine;nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449188713	
1449188719	rs7748401	OPRM1	3			2.25	Metabolism/PK	1	1	cotinine;nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449188719	
1449188725	rs495491	OPRM1	3			2.25	Metabolism/PK	1	1	cotinine;nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449188725	
1449188731	rs10457090	OPRM1	3			2.25	Metabolism/PK	1	1	cotinine;nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449188731	
1449188743	rs3778152	OPRM1	3			2.25	Metabolism/PK	1	1	cotinine;nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449188743	
655385392	rs9934438	VKORC1	1B	Yes: Assigned level 1B because variant is not specifically mentioned in clinical guidelines or labels, in high LD with rs9923231	Tier 1 VIP	109.625	Dosage	49	52	warfarin		2021-11-19	https://www.pharmgkb.org/clinicalAnnotation/655385392	Pediatric
655385462	rs1045642	ABCB1	3		Tier 1 VIP	4.25	Efficacy;Toxicity	8	8	methotrexate	Arthritis, Rheumatoid	2021-12-16	https://www.pharmgkb.org/clinicalAnnotation/655385462	Pediatric
655385379	rs2276307	HTR3B	3			2.5	Toxicity	1	1	atorvastatin;pravastatin;simvastatin	Myalgia unspecified	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385379	
655385388	rs762551	CYP1A2	3			0.0	Toxicity	1	2	caffeine	Myocardial Infarction	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385388	
655385404	rs688	LDLR	3			0.5	Efficacy	1	2	atenolol	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385404	
655385418	rs165599	COMT	3		Tier 1 VIP	2.75	Efficacy	1	1	bupropion	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385418	
655385426	rs1935349	HTR7	3			2.0	Toxicity	1	1	atorvastatin;hmg coa reductase inhibitors;pravastatin;simvastatin	Myalgia unspecified	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385426	
655385466	rs7992226	NALCN	3			0.0	Other	1	1	methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385466	Pediatric
655385471	rs10821936	ARID5B	3		Rare Variant	1.5	Other	1	1	methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385471	
655385475	rs4846051	MTHFR	3		Tier 1 VIP	1.5	Toxicity	1	1	methotrexate	Arthritis, Rheumatoid;Drug Toxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385475	
655385479	rs1800909	GGH	3			2.5	Efficacy	1	1	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385479	
655385483	rs1079598	DRD2	3		Tier 1 VIP	2.25	Toxicity	1	1	antipsychotics;clozapine;olanzapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385483	
655385491	rs6277	DRD2	3		Tier 1 VIP	1.75	Toxicity	1	1	antipsychotics;clozapine;olanzapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385491	
655385579	rs2070744	NOS3	3			5.75	Efficacy	2	2	Antihypertensives And Diuretics In Combination		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385579	
655385604	rs762551	CYP1A2	3			0.5	Efficacy	2	2	olanzapine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385604	
655385613	rs7997012	HTR2A	3			1.5	Toxicity	1	1	olanzapine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385613	
655385701	rs1045642	ABCB1	3		Tier 1 VIP	5.75	Efficacy;Toxicity	6	8	efavirenz;nelfinavir	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385701	
655385705	rs61888800	BDNF	3			2.5	Efficacy	1	1	antidepressants;desipramine;fluoxetine	Depression;Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385705	
655385749	rs12721627	CYP3A4	3		Rare Variant; Tier 1 VIP	0.0	Other	1	1	midazolam		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385749	
655385763	rs290487	TCF7L2	3			1.5	Efficacy	1	1	repaglinide	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385763	
655385818	rs1800629	LTA;TNF	3			2.25	Toxicity	1	1	carbamazepine	Hypersensitivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385818	
655385856	rs2032582	ABCB1	3		Tier 1 VIP	3.75	Efficacy	2	2	paclitaxel	Breast Neoplasms;Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385856	
655385969	rs13058338	RAC2	3			2.25	Toxicity	5	5	doxorubicin;idarubicin	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385969	
655385973	rs17222723	ABCC2	3			2.25	Toxicity	1	1	doxorubicin	Arrhythmias, Cardiac;Drug Toxicity;Lymphoma, Non-Hodgkin	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385973	
655385977	rs1883112	NCF4	3			3.75	Toxicity	5	5	doxorubicin;idarubicin	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385977	
655385981	rs45511401	ABCC1	3			3.25	Toxicity	1	1	doxorubicin	Arrhythmias, Cardiac;Drug Toxicity;Lymphoma, Non-Hodgkin	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385981	
655385985	rs4673	CYBA	3			5.25	Toxicity	3	3	doxorubicin;idarubicin	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385985	
655385989	rs1051740	EPHX1	3			2.0	Toxicity	1	1	phenytoin	Congenital Abnormalities;Craniofacial Abnormalities	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385989	
655385993	rs2234922	EPHX1	3			2.0	Toxicity	1	1	phenytoin	Congenital Abnormalities;Craniofacial Abnormalities	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385993	
655385997	rs2784917	SLIT1	3			1.75	Toxicity	1	1	etoposide		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385997	
655385814	rs2273697	ABCC2	4			-6.25	Toxicity	8	10	antiepileptics;carbamazepine;oxcarbazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385814	Pediatric
655385422	rs1800497	ANKK1	3			2.0	Efficacy	6	6	bupropion	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385422	
655385495	rs1800497	ANKK1;DRD2	3		Tier 1 VIP	2.25	Toxicity	3	3	risperidone	Hyperprolactinemia;Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385495	
655385674	rs1414334	HTR2C	3			6.875	Toxicity	5	5	clozapine	Metabolic Syndrome;Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385674	
655385400	rs2108622	CYP4F2	1A		Tier 1 VIP	170.0	Dosage	69	72	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385400	Pediatric
655385384	rs5443	GNB3	3			2.0	Efficacy	1	1	hmg coa reductase inhibitors	Hypercholesterolemia;Myocardial Infarction	2021-06-10	https://www.pharmgkb.org/clinicalAnnotation/655385384	
655386421	rs1051266	SLC19A1	3		Tier 1 VIP	7.5	Toxicity	6	6	methotrexate	Arthritis, Rheumatoid;Drug Toxicity	2021-12-16	https://www.pharmgkb.org/clinicalAnnotation/655386421	Pediatric
655386436	rs1801131	MTHFR	3		Tier 1 VIP	4.75	Toxicity	9	9	methotrexate	Arthritis, Rheumatoid	2021-12-16	https://www.pharmgkb.org/clinicalAnnotation/655386436	Pediatric
655386002	rs6539870		3			1.25	Toxicity	1	1	etoposide		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386002	
655386028	rs1045642	ABCB1	3		Tier 1 VIP	1.25	Dosage	2	2	fexofenadine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386028	
655386070	rs9024	CBR1	3			5.75	Dosage;Metabolism/PK	2	5	doxorubicin	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386070	
655386079	rs8187710	ABCC2	3			2.25	Toxicity	1	1	doxorubicin	Lymphoma, Non-Hodgkin	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386079	
655386083	rs714368	SLC22A16	3			3.75	Other	2	3	doxorubicin;doxorubicinol	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386083	
655386088	rs20572	CBR1	3			3.5	Metabolism/PK	1	3	doxorubicin;doxorubicinol	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386088	
655386093	rs7769719	PPARD	3			2.0	Efficacy	1	1	docetaxel;thalidomide	Prostatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386093	
655386099	rs730720	CHST3	3			2.0	Efficacy	1	1	docetaxel;thalidomide	Prostatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386099	
655386104	rs6922548	PPARD	3			2.0	Efficacy	1	1	docetaxel;thalidomide	Prostatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386104	
655386109	rs4646487	CYP4B1	3			2.0	Toxicity	1	1	docetaxel;thalidomide	Prostatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386109	
655386114	rs4148950	CHST3	3			3.5	Efficacy;Toxicity	1	2	docetaxel;thalidomide	Prostatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386114	
655386120	rs4148947	CHST3	3			2.0	Efficacy	1	1	docetaxel;thalidomide	Prostatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386120	
655386126	rs4148945	CHST3	3			3.5	Efficacy;Toxicity	1	2	docetaxel;thalidomide	Prostatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386126	
655386131	rs4148943	CHST3	3			2.0	Efficacy	1	1	docetaxel;thalidomide	Prostatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386131	
655386136	rs3734254	PPARD	3			2.0	Efficacy	1	1	docetaxel;thalidomide	Prostatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386136	
655386141	rs2301159	SLC10A2	3			2.0	Toxicity	1	1	docetaxel;thalidomide	Prostatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386141	
655386146	rs2292954	SPG7	3			2.0	Toxicity	1	1	docetaxel;thalidomide	Prostatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386146	
655386151	rs2238472	ABCC6	3			2.0	Toxicity	1	1	docetaxel;thalidomide	Prostatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386151	
655386156	rs2227291	ATP7A	3			2.0	Toxicity	1	1	docetaxel;thalidomide	Prostatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386156	
655386161	rs2016520	PPARD	3			2.0	Efficacy	1	1	docetaxel;thalidomide	Prostatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386161	
655386166	rs1883322	PPARD	3			2.0	Efficacy	1	1	docetaxel;thalidomide	Prostatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386166	
655386171	rs1871450	CHST3	3			3.5	Efficacy;Toxicity	1	2	docetaxel;thalidomide	Prostatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386171	
655386176	rs1799931	NAT2	3		Tier 1 VIP	2.0	Toxicity	1	1	docetaxel;thalidomide	Prostatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386176	
655386181	rs1402467	SULT1C4	3			2.0	Efficacy	1	1	docetaxel;thalidomide	Prostatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386181	
655386186	rs12960	RPL13;SNORD68;SPG7	3			2.0	Toxicity	1	1	docetaxel;thalidomide	Prostatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386186	
655386191	rs12418	CHST3	3			2.0	Efficacy	1	1	docetaxel;thalidomide	Prostatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386191	
655386212	rs2070995	KCNJ6	3			3.75	Efficacy	2	3	Analgesics	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386212	
655386310	rs870995	PIK3CA	3			0.25	Dosage	1	1	docetaxel	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386310	
655386315	rs518329	PRDX4	3			0.25	Dosage	1	1	docetaxel	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386315	
655386320	rs2234922	EPHX1	3			0.25	Dosage	1	1	docetaxel	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386320	
655386324	rs1382368	XRCC4	3			0.25	Dosage	1	1	docetaxel	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386324	
655386447	rs11042725	ADM	3			3.25	Efficacy	1	1	paroxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386447	
655386550	rs1801133	CLCN6;MTHFR	3		Tier 1 VIP	2.25	Toxicity	1	1	antipsychotics	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386550	
655386585	rs1142345	TPMT	3		Tier 1 VIP	3.0	Toxicity	6	6	cisplatin	Drug Toxicity;Neoplasms;Ototoxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386585	Pediatric
655386589	rs4646316	COMT	3		Tier 1 VIP	2.25	Toxicity	7	7	cisplatin	Drug Toxicity;Neoplasms;Ototoxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386589	Pediatric
655386593	rs12201199	TPMT	3		Tier 1 VIP	1.75	Toxicity	9	9	cisplatin	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386593	Pediatric
655386597	rs1800460	TPMT	3		Tier 1 VIP	2.25	Toxicity	6	6	cisplatin	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386597	Pediatric
655386601	rs9332377	COMT	3		Tier 1 VIP	2.75	Toxicity	8	8	cisplatin	Drug Toxicity;Neoplasms;Ototoxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386601	Pediatric
655386616	rs13181	ERCC2;KLC3	3			3.5	Efficacy	9	10	cisplatin;oxaliplatin;platinum;Platinum compounds	Colorectal Neoplasms;Esophageal Neoplasms;Osteosarcoma;Ovarian Neoplasms;Pancreatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386616	
655386649	rs1799735	GSTM3	3			2.75	Toxicity	2	5	cisplatin;cyclophosphamide	Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386649	
655386665	rs3212986	CD3EAP;ERCC1;PPP1R13L	3			2.0	Efficacy	1	1	Platinum compounds	Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386665	
655386801	rs3957357	GSTA1	3			1.75	Toxicity	1	1	cisplatin;cyclophosphamide	Anemia;Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386801	
655386830	rs60369023	CDA	3		Rare Variant	1.5	Toxicity	3	3	gemcitabine	Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386830	
655386852	rs1799889	SERPINE1	3			2.0	Efficacy	1	1	antidepressants;citalopram;fluoxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386852	
655386856	rs2227631	SERPINE1	3			2.0	Efficacy	1	1	antidepressants;citalopram;fluoxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386856	
655386869	rs1544410	VDR	3			3.75	Efficacy	2	2	alendronate	Osteoporosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386869	
655386873	rs731236	VDR	3			2.75	Efficacy	1	1	clodronate	Osteitis Deformans	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386873	
655386888	rs16944	IL1B	3			3.0	Efficacy	1	1	Bisphosphonates;clodronate;etidronic acid;risedronate;tiludronate	Osteitis Deformans	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386888	
655386244	rs1045642	ABCB1	3		Tier 1 VIP	6.25	Toxicity	3	3	nevirapine	HIV Infections;Toxic liver disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386244	
655386612	rs2228001	XPC	3			0.75	Toxicity	2	2	cisplatin	Neoplasms;Osteosarcoma;Ototoxicity;Testicular Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386612	
655386639	rs11615	ERCC1	3			3.25	Toxicity	6	6	carboplatin;cisplatin;oxaliplatin;platinum;Platinum compounds	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386639	
655386661	rs3212986	ERCC1	3			4.0	Toxicity	3	3	cisplatin	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386661	
655386657	rs25487	XRCC1	2B			11.25	Efficacy	16	19	Platinum compounds	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386657	
655387949	rs4149056	SLCO1B1	3		Tier 1 VIP	6.875	Metabolism/PK	9	9	methotrexate	Osteosarcoma;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-12-13	https://www.pharmgkb.org/clinicalAnnotation/655387949	Pediatric
655386969	rs3761422	ADORA2A	3			2.75	Toxicity	1	1	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386969	
655386981	rs2267076	ADORA2A	3			2.75	Toxicity	1	1	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386981	
655387942	rs11045879	SLCO1B1	4		Tier 1 VIP	-0.25	Toxicity	3	3	methotrexate	Lymphoma;Osteosarcoma;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2022-01-04	https://www.pharmgkb.org/clinicalAnnotation/655387942	Pediatric
655386990	rs2279343	CYP2B6	3		Tier 1 VIP	3.0	Toxicity	1	1	cyclophosphamide	Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386990	
655386995	rs2740574	CYP3A4	3		Tier 1 VIP	2.25	Toxicity	1	1	cyclophosphamide	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386995	
655386999	rs8192709	CYP2B6	3		Tier 1 VIP	2.5	Toxicity	1	1	cyclophosphamide	Cystitis;Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386999	
655387004	rs9561778	ABCC4	3			7.75	Toxicity	1	3	cyclophosphamide	Breast Neoplasms;Drug Toxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655387004	
655387009	rs1799983	NOS3	3			3.25	Efficacy	2	3	cyclophosphamide;doxorubicin;fluorouracil;methotrexate	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655387009	
655387014	rs2070744	NOS3	3			3.0	Efficacy	1	1	cyclophosphamide;doxorubicin;fluorouracil;methotrexate	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655387014	
655387023	rs2072671	CDA	3			7.0	Toxicity	7	9	cytarabine	Leukemia;Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655387023	Pediatric
655387027	rs532545	CDA	3			6.5	Efficacy	4	6	cytarabine	Leukemia, Myeloid, Acute;Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655387027	
699639332	rs1801131	MTHFR	4		Tier 1 VIP	-1.125	Toxicity	22	23	methotrexate	Burkitt Lymphoma;Lymphoma, Non-Hodgkin;Lymphoma, T-Cell;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2022-01-04	https://www.pharmgkb.org/clinicalAnnotation/699639332	Pediatric
655387221	rs6280	DRD3	3			1.5	Efficacy	1	1	risperidone	Autistic Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655387221	Pediatric
655387229	rs1128503	ABCB1	3		Tier 1 VIP	1.5	Efficacy	1	1	risperidone	Autistic Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655387229	Pediatric
655387237	rs6311	HTR2A	3			1.5	Efficacy	1	1	risperidone	Autistic Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655387237	Pediatric
655387257	rs7799039	LEP	3			6.0	Toxicity	4	4	antipsychotics;risperidone	Autism Spectrum Disorder;Mood Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655387257	Pediatric
655387672	rs1799978	DRD2	3		Tier 1 VIP	2.25	Toxicity	1	1	risperidone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655387672	
655387688	rs1800497	ANKK1	3			1.5	Toxicity	1	1	nemonapride	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655387688	
655387767	rs12248560	CYP2C19	3		Tier 1 VIP	2.0	Dosage	1	1	mephenytoin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655387767	
699639249	CYP3A5*1, CYP3A5*3	CYP3A5	3		Tier 1 VIP	2.0	Toxicity	1	1	paclitaxel	Neoplasms;Neurotoxicity Syndromes	2022-03-22	https://www.pharmgkb.org/clinicalAnnotation/699639249	
655387821	rs2853539	TYMS	3		Tier 1 VIP	3.25	Efficacy	1	1	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655387821	
655387825	rs1544105	FPGS	3			3.25	Efficacy	1	1	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655387825	
655387835	rs1801133	MTHFR	3		Tier 1 VIP	2.0	Toxicity	1	1	nitrous oxide		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655387835	
655387839	rs1801131	MTHFR	3		Tier 1 VIP	2.0	Toxicity	1	1	nitrous oxide		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655387839	
655387876	rs167771	DRD3	3			2.75	Toxicity	1	1	risperidone	Bipolar Disorder;Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655387876	
655388022	rs1045642	ABCB1	3		Tier 1 VIP	1.75	Other	1	1	prednisone;tacrolimus	Organ Transplantation;Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655388022	
655388510	rs1799732	DRD2	3		Tier 1 VIP	1.25	Efficacy	10	11	antipsychotics;aripiprazole;bromperidol;chlorpromazine;clozapine;nemonapride;olanzapine;risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655388510	
699639328	rs1113129	CYP2C8	3		Tier 1 VIP	2.0	Toxicity	1	1	paclitaxel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/699639328	
699639336	rs1801131	MTHFR	3		Tier 1 VIP	1.25	Efficacy	9	11	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/699639336	
699639343	rs2016848	MME	3			2.5	Toxicity	1	1	Ace Inhibitors, Plain	Cough;Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/699639343	
699639347	rs11209716	PTGER3	3			2.5	Toxicity	1	1	Ace Inhibitors, Plain	Cough;Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/699639347	
699639351	rs8012552	BDKRB2	3			2.0	Toxicity	1	1	Ace Inhibitors, Plain	Cough;Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/699639351	
699642190	rs10879346	TPH2	3			3.0	Efficacy	1	1	antidepressants;mirtazapine;venlafaxine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/699642190	
769143802	rs4343	ACE	3		Tier 1 VIP	2.25	Efficacy	1	1	spironolactone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/769143802	
769171387	rs1695	GSTP1	3		Tier 1 VIP	2.5	Toxicity	1	1	fluorouracil	Rectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/769171387	
769171582	rs334558	GSK3B	3			2.5	Efficacy	1	1	citalopram;fluoxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/769171582	
655387245	rs3813928	HTR2C	3			1.5	Efficacy	1	1	risperidone	Autistic Disorder	2021-03-25	https://www.pharmgkb.org/clinicalAnnotation/655387245	Pediatric
655387938	rs4149081	SLCO1B1	3		Tier 1 VIP	4.0	Toxicity	1	2	methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-04-01	https://www.pharmgkb.org/clinicalAnnotation/655387938	Pediatric
655386985	rs2236624	ADORA2A	3			1.75	Toxicity	2	2	methotrexate	adverse events;Arthritis, Rheumatoid	2021-04-14	https://www.pharmgkb.org/clinicalAnnotation/655386985	
655386961	rs2298383	ADORA2A	3			1.25	Toxicity	2	2	methotrexate	Arthritis, Rheumatoid	2021-04-14	https://www.pharmgkb.org/clinicalAnnotation/655386961	
655386945	rs7793837	CRHR2	3			2.75	Efficacy	1	3	salbutamol	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386945	Pediatric
655387053	CYP3A5*1, CYP3A5*3	CYP3A5	3		Tier 1 VIP	3.25	Dosage	3	3	cyclosporine	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655387053	
655387798	rs1902023	UGT2B15	3			2.5	Metabolism/PK	3	3	oxazepam		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655387798	Pediatric
655387895	rs70991108	DHFR	3			0.5	Toxicity	3	3	methotrexate	drug-induced liver injury;Leukopenia;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Thrombocytopenia	2021-10-19	https://www.pharmgkb.org/clinicalAnnotation/655387895	Pediatric
637879869	rs11545078	GGH	3			2.0	Toxicity	2	2	methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637879869	Pediatric
613976848	rs750332	BAG6;PRRC2A	3			3.0	Toxicity	1	1	carbamazepine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/613976848	
613977037	rs2227956	HSPA1L	3			2.25	Toxicity	1	1	carbamazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/613977037	
613977064	rs2236196	CHRNA4	3			2.0	Other	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/613977064	
613979021	rs1042714	ADRB2	3		Tier 1 VIP	5.25	Efficacy	4	4	carvedilol	Heart Failure	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/613979021	
613979403	rs5443	GNB3	3			3.0	Efficacy	1	1	sumatriptan	Cluster Headache	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/613979403	
618376538	rs2236196	CHRNA4	3			0.25	Other	2	2	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/618376538	
619523389	rs12720441	KCNH2	3		Rare Variant	0.0	Toxicity	1	1	amiodarone	Torsades de Pointes	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/619523389	
619523400	rs9937	RRM1	3			5.75	Efficacy;Toxicity	5	8	gemcitabine	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/619523400	
619523414	rs2032583	ABCB1	3		Tier 1 VIP	5.25	Efficacy	3	3	amitriptyline;antidepressants;citalopram;fluvoxamine;paroxetine;sertraline;venlafaxine	Depression;Depressive Disorder;Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/619523414	
619523422	rs2235015	ABCB1	3		Tier 1 VIP	1.0	Efficacy	2	2	amitriptyline;antidepressants;citalopram;paroxetine;venlafaxine	Depression;Depressive Disorder;Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/619523422	
637879590	rs11572080	CYP2C8	3		Tier 1 VIP	0.0	Toxicity	2	2	amodiaquine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637879590	
637879595	rs10509681	CYP2C8	3		Tier 1 VIP	0.0	Toxicity	2	2	amodiaquine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637879595	
637879637	rs1127354	ITPA	3			2.25	Efficacy	1	1	azathioprine;purine analogues	Lupus Erythematosus, Systemic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637879637	
637879864	rs5760410	ADORA2A;SPECC1L	3			3.25	Toxicity	1	1	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637879864	
637879932	rs2814707	MOB3B	3			2.25	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637879932	
637879937	rs3849942	C9orf72	3			0.0	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637879937	
637879942	rs437943	ARAP2	3			0.0	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637879942	
637879947	rs6138150	CST5	3			2.25	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637879947	
637879952	rs7046653	MOB3B	3			2.75	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637879952	
637879957	rs854555	PON1	3			2.25	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637879957	
637879962	rs854548	PON1	3			0.0	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637879962	
637879967	rs854547	PON1	3			0.0	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637879967	
637879631	rs25531	SLC6A4	4			-1.25	Efficacy	2	2	fluoxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637879631	
637879785	rs1131873	EPHX1	4			-0.75	Dosage	3	3	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637879785	
637879972	rs6028945	MAFB	3			2.75	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637879972	
637879977	rs6071980	MAFB	3			2.25	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637879977	
637879982	rs983332	CSRP3	3			2.75	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637879982	
637879987	rs774359	C9orf72	3			2.75	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637879987	
637879992	rs868856	MOB3B	3			2.75	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637879992	
637879997	rs928655	GBP6	3			0.0	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637879997	
613976757	rs2234922	EPHX1	3			4.25	Dosage	6	7	carbamazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/613976757	
613978937	rs3812718	SCN1A	3			2.25	Dosage	2	2	phenytoin	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/613978937	
613979643	rs730012	LTC4S	3			4.5	Toxicity	3	3	aspirin	Urticaria	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/613979643	
619523395	rs2297480	FDPS	3			2.5	Efficacy	2	2	Bisphosphonates	Osteoporosis;Osteoporosis, Postmenopausal	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/619523395	
637879879	rs339097	CALU	3			4.75	Dosage	3	5	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637879879	
637880014	rs2032582	ABCB1	3		Tier 1 VIP	2.5	Toxicity	1	1	Platinum compounds;taxanes	Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637880014	
655384011	rs4149056	SLCO1B1	1A		Tier 1 VIP	211.75	Toxicity	9	12	simvastatin	statin-related myopathy	2022-02-14	https://www.pharmgkb.org/clinicalAnnotation/655384011	
637880217	rs1695	GSTP1	3		Tier 1 VIP	6.0	Toxicity	6	6	cisplatin;oxaliplatin;Platinum compounds	Carcinoma, Non-Small-Cell Lung;Colorectal Neoplasms;Gastrointestinal Neoplasms;Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637880217	
637880226	rs1695	GSTP1	3		Tier 1 VIP	1.5	Efficacy	3	4	Platinum compounds	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637880226	
637880243	rs712829	EGFR	3		Rare Variant	0.0	Efficacy	1	1	erlotinib	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637880243	
637880250	rs712829	EGFR	3		Rare Variant	0.0	Efficacy	1	1	topoisomerase I inhibitors	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637880250	
637880258	rs712829	EGFR	3		Rare Variant	0.0	Efficacy	1	1	geldanamycin	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637880258	
637880263	rs712829	EGFR	3		Rare Variant	0.0	Efficacy	1	1	Alkylating Agents	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637880263	
637880267	rs712829	EGFR	3		Rare Variant	4.5	Efficacy	1	2	gefitinib	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637880267	
637880078	rs2075252	LRP2	4			-1.0	Toxicity	3	3	cisplatin	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637880078	Pediatric
637880471	rs2229109	ABCB1	3		Tier 1 VIP	0.0	Other	1	2	paclitaxel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637880471	
637880534	rs9282564	ABCB1	3		Tier 1 VIP	0.0	Other	1	2	paclitaxel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637880534	
637880563	rs72552784	ABCB1	3		Rare Variant; Tier 1 VIP	0.0	Other	1	2	paclitaxel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637880563	
652472012	rs12050217	BDKRB1	3			5.5	Efficacy	2	2	perindopril	Coronary Artery Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/652472012	
652509715	rs275651	AGTR1	3			5.5	Efficacy	2	2	perindopril	Coronary Artery Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/652509715	
652519736	rs5182	AGTR1	3			3.0	Efficacy	2	2	perindopril	Coronary Artery Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/652519736	
652595205	rs10836235	CAT	3			1.75	Toxicity	1	1	anthracyclines and related substances	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/652595205	
652882846	rs8133052	CBR3	3			5.75	Efficacy;Toxicity	1	4	doxorubicin	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/652882846	
655384474	rs2032582	ABCB1	3		Tier 1 VIP	2.5	Toxicity	1	1	Platinum compounds;taxanes	Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384474	
655384485	rs9344	CCND1	3			2.0	Efficacy	3	3	cetuximab	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384485	
655384510	rs7569963	CREB1;METTL21A	3			5.0	Efficacy;Toxicity	2	2	antidepressants;citalopram	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384510	
655384529	rs742105	DTNBP1	3			2.5	Efficacy	1	1	clozapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384529	
655384539	rs2032582	ABCB1	3		Tier 1 VIP	3.0	Efficacy	1	1	cyclosporine	Colitis, Ulcerative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384539	
655384546	rs1128503	ABCB1	3		Tier 1 VIP	2.75	Dosage	4	4	cyclosporine	Kidney Transplantation;Myasthenia Gravis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384546	
637880221	rs1695	GSTP1	3		Tier 1 VIP	7.75	Toxicity	3	3	Platinum compounds	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637880221	
637880425	rs7997012	HTR2A	3	Yes: 19077664, 16642436, 17671280 are on the STARD samples. 17671280 references 16642436 as using the same sample set and 17671280 is a larger analysis of 16642436 with increasing the discovery and replication group; set level to 3		8.25	Efficacy	4	4	citalopram	Depression;Depressive Disorder	2021-03-25	https://www.pharmgkb.org/clinicalAnnotation/637880425	
652779372	rs1056892	CBR3	3			2.75	Toxicity	2	2	anthracyclines and related substances	Heart Failure;Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/652779372	
655384534	rs4880	SOD2	3			2.5	Efficacy	1	1	cyclophosphamide	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384534	
655384738	rs17708472	VKORC1	4		Tier 1 VIP	-2.0	Dosage	7	7	warfarin		2021-11-19	https://www.pharmgkb.org/clinicalAnnotation/655384738	
655384830	CYP3A4*1, CYP3A4*17	CYP3A4	3		Tier 1 VIP	1.0	Metabolism/PK	1	1	nifedipine		2022-07-28	https://www.pharmgkb.org/clinicalAnnotation/655384830	
655384563	rs3800373	FKBP5	3			2.5	Efficacy	5	6	antidepressants	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384563	
655384568	rs1360780	FKBP5	3			5.75	Efficacy	7	9	antidepressants;citalopram;clomipramine;lithium;nefazodone;paroxetine;venlafaxine	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384568	
655384578	rs2740574	CYP3A4	3		Tier 1 VIP	3.5	Toxicity;Metabolism/PK	4	5	docetaxel	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384578	
655384582	rs11045819	SLCO1B1	3		Tier 1 VIP	3.0	Efficacy	1	1	fluvastatin	Hypercholesterolemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384582	
655384592	rs12721627	CYP3A;CYP3A4	3		Rare Variant; Tier 1 VIP	0.0	Dosage	1	1	paclitaxel	Carcinoma, Non-Small-Cell Lung;Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384592	
655384602	rs951439	RGS4	3			1.75	Efficacy	1	1	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384602	
655384607	rs951439	RGS4	3			5.0	Efficacy	1	3	antipsychotics;olanzapine;perphenazine;quetiapine;ziprasidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384607	
655384616	rs17238540	HMGCR	3			4.125	Efficacy	6	7	atorvastatin;fluvastatin;hmg coa reductase inhibitors;lovastatin;pravastatin;simvastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384616	
655384635	rs58597806	UGT1A9	3		Rare Variant	0.0	Toxicity	1	1	propofol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384635	
655384645	rs4149056	SLCO1B1	3		Tier 1 VIP	3.0	Efficacy	2	2	repaglinide		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384645	
655384670	rs7412	APOE	3			1.75	Toxicity	2	2	Antivirals for treatment of HIV infections, combinations;ritonavir	HIV Infections;Hyperlipidemias;Hypertriglyceridemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384670	
655384679	rs20417	PTGS2	3			2.5	Efficacy	1	1	rofecoxib		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384679	
655384694	rs4343	ACE	3		Tier 1 VIP	2.5	Efficacy	1	1	sildenafil	Erectile Dysfunction	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384694	
655384703	rs10811661		3			3.0	Efficacy	1	1	troglitazone	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384703	
655384724	rs4086116	CYP2C9	3		Tier 1 VIP	2.0	Dosage	1	1	acenocoumarol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384724	
655384767	rs5065	NPPA	3			2.0	Efficacy	1	3	amlodipine;chlorthalidone	Cardiovascular Diseases;Coronary Disease;Stroke	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384767	
655384772	rs6295	HTR1A	3			5.75	Efficacy	7	8	antidepressants;fluvoxamine;paroxetine;Selective serotonin reuptake inhibitors;sertraline	Depressive Disorder;Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384772	
655384781	rs4253778	PPARA	3			2.5	Efficacy	1	1	Beta Blocking Agents	Coronary Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384781	
655384794	rs1799722	BDKRB2	3			2.75	Toxicity	4	4	Ace Inhibitors, Plain	Cough	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384794	
655384804	rs2781659	ARG1	3			3.0	Efficacy	1	1	selective beta-2-adrenoreceptor agonists	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384804	
655384809	rs622342	SLC22A1	3			3.0	Efficacy	2	4	metformin	Diabetes Mellitus	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384809	
655384813	rs1801253	ADRB1	3		Tier 1 VIP	0.0	Toxicity	1	1	muraglitazar	Diabetes Mellitus;Edema;Hyperlipidemias	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384813	
655384817	rs5370	EDN1	3			2.75	Toxicity	1	1	muraglitazar	Diabetes Mellitus;Edema;Hyperlipidemias	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384817	
655384821	rs2306283	SLCO1B1	3		Tier 1 VIP	1.5	Other	1	1	repaglinide		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384821	
1184747247	HLA-A*02:01	HLA-A	3			1.75	Toxicity	3	3	allopurinol	severe cutaneous adverse reactions	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184747247	
655384587	rs11572103	CYP2C8	4		Tier 1 VIP	-1.25	Dosage	2	2	paclitaxel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384587	
655384597	rs1934951	CYP2C8	4		Tier 1 VIP	-1.25	Toxicity	2	2	Bisphosphonates;pamidronate;zoledronate	Multiple Myeloma;Osteonecrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384597	
655384611	rs17244841	HMGCR	3			3.5	Efficacy	1	2	pravastatin;simvastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384611	
655384626	rs4149015	SLCO1B1	3		Tier 1 VIP	0.0	Metabolism/PK	2	2	pravastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384626	Pediatric
655384674	rs396991	FCGR3A	3			3.0	Efficacy	4	4	rituximab		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384674	
655384799	rs1800629	TNF	2B			14.625	Efficacy	7	7	etanercept	Arthritis, Psoriatic;Arthritis, Rheumatoid;Crohn Disease;Inflammation;Psoriasis;Spondylitis, Ankylosing	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384799	
655384653	CYP2C8*1, CYP2C8*3	CYP2C8	3		Tier 1 VIP	4.5	Metabolism/PK	3	4	rosiglitazone		2021-05-18	https://www.pharmgkb.org/clinicalAnnotation/655384653	
655384621	rs20455	KIF6	2B			8.5	Efficacy	4	5	pravastatin	Coronary Disease;Myocardial Infarction	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384621	
655384966	rs518147	HTR2C	3			3.25	Toxicity	5	5	olanzapine	Schizophrenia;Weight gain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384966	
655385028	rs8050894	VKORC1	1B		Tier 1 VIP	27.0	Dosage	12	12	warfarin		2021-11-19	https://www.pharmgkb.org/clinicalAnnotation/655385028	
655384975	rs2842030	RGS4	3			2.0	Efficacy	1	1	olanzapine;perphenazine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384975	
655385012	rs9923231	VKORC1	1A		Tier 1 VIP	486.375	Dosage	86	90	warfarin		2021-11-19	https://www.pharmgkb.org/clinicalAnnotation/655385012	Pediatric
655384834	rs11572080	CYP2C8	3		Tier 1 VIP	0.75	Other	2	2	paclitaxel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384834	
655384838	rs10509681	CYP2C8	3		Tier 1 VIP	1.5	Other	1	1	paclitaxel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384838	
655384842	rs11572080	CYP2C8	3		Tier 1 VIP	2.0	Toxicity	1	1	paclitaxel	Drug Toxicity;Neurotoxicity Syndromes	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384842	
655384846	rs1045642	ABCB1	3		Tier 1 VIP	1.75	Toxicity	1	1	nortriptyline	Depression;Depressive Disorder;Depressive Disorder, Major;Hypotension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384846	
655384850	rs1045642	ABCB1	3		Tier 1 VIP	1.0	Metabolism/PK	1	1	lansoprazole;tacrolimus	Gastroesophageal Reflux;Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384850	
655384854	rs2740574	CYP3A4	3		Tier 1 VIP	1.0	Other	1	1	indinavir	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384854	
655384862	rs10042486	HTR1A	3			2.5	Efficacy	1	1	fluvoxamine;milnacipran;paroxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384862	
655384866	rs909706	DTNBP1	3			0.0	Efficacy	1	1	haloperidol	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384866	
655384878	rs4933824	NRG3	3			0.0	Toxicity	1	1	iloperidone	Acquired Long QT Syndrome (aLQTS)	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384878	
655384882	rs7142881	NUBPL	3			0.0	Toxicity	1	1	iloperidone	Acquired Long QT Syndrome (aLQTS)	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384882	
655384886	rs4799915	CELF4	3			0.0	Toxicity	1	1	iloperidone	Acquired Long QT Syndrome (aLQTS)	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384886	
655384890	rs993648	CERKL	3			0.0	Toxicity	1	1	iloperidone	Acquired Long QT Syndrome (aLQTS)	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384890	
655384894	rs10918594	NOS1AP	3			0.0	Toxicity	1	1	verapamil	Acquired Long QT Syndrome (aLQTS)	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384894	
655384898	rs10494366	NOS1AP	3			3.0	Toxicity	1	1	verapamil	Acquired Long QT Syndrome (aLQTS)	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384898	
655384902	rs762551	CYP1A2	4			-0.75	Toxicity	2	2	leflunomide	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384902	
655384906	rs3213422	DHODH	3			0.0	Efficacy	1	1	leflunomide	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384906	
655384914	rs3775291	TLR3	3			2.0	Efficacy	1	1	Measles vaccines		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384914	
655384918	rs2076369	PICK1	3			2.25	Toxicity	1	1	methamphetamine	Psychotic Disorders;Substance-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384918	
655384922	rs3213207	DTNBP1	3			2.75	Toxicity	1	1	methamphetamine	Psychotic Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384922	
655384926	rs2619538	DTNBP1	3			0.0	Toxicity	1	1	methamphetamine	Psychotic Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384926	
655384930	rs2115819	ALOX5	3			1.75	Efficacy	1	1	montelukast	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384930	
655384934	rs2660845	LTA4H	3			2.25	Efficacy	1	1	montelukast	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384934	
655384938	rs730012	LTC4S	3			2.25	Efficacy	1	1	montelukast	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384938	
655384942	rs5443	GNB3	3			2.0	Toxicity	1	1	olanzapine	Schizophrenia;Weight gain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384942	
655384946	rs6313	HTR2A	3			2.5	Toxicity	1	1	olanzapine	Schizophrenia;Weight gain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384946	
655384950	rs6313	HTR2A	3			0.0	Efficacy	1	1	olanzapine;risperidone	Alzheimer Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384950	
655384954	rs6318	HTR2C	3			1.25	Toxicity	5	5	risperidone	Schizophrenia;Weight gain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384954	Pediatric
655384958	rs4994	ADRB3	3			2.0	Toxicity	1	1	olanzapine	Schizophrenia;Weight gain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384958	
655384962	rs6280	DRD3	3			1.75	Efficacy	1	1	olanzapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384962	
655384979	rs2842030	RGS4	3			0.0	Efficacy	1	1	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384979	
655384983	rs4731426	LEP	3			2.5	Toxicity	1	1	olanzapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384983	
655384987	rs1123617	SLC14A2	3			4.5	Efficacy	1	2	nifedipine	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384987	
655384991	rs3745009	SLC14A2	3			4.5	Efficacy	1	2	nifedipine	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384991	
655385041	rs2306283	SLCO1B1	4		Tier 1 VIP	-0.75	Efficacy	2	2	pravastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385041	
655385054	rs1800497	ANKK1;DRD2	4		Tier 1 VIP	-0.75	Efficacy	3	3	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385054	
655385016	rs10871454	STX4	3			0.0	Dosage	1	1	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385016	
655385033	rs1136201	ERBB2	3			2.25	Toxicity	1	1	trastuzumab	Breast Neoplasms;Drug Toxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385033	
655385037	rs6280	DRD3	3			1.5	Efficacy	1	1	pramipexole	Parkinson Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385037	
655385045	rs2472677	NR1I2	3			1.5	Other	1	1	rifampin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385045	
655385050	rs2661319	RGS4	3			2.5	Efficacy	1	1	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385050	
655385062	rs2494732	AKT1	3			0.25	Efficacy	2	2	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385062	
655385067	rs3803300	AKT1	3			0.25	Efficacy	2	2	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385067	
655385072	rs165599	COMT	3		Tier 1 VIP	2.0	Efficacy	1	1	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385072	
655385077	rs724226	GRM3	3			2.0	Efficacy	1	1	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385077	
655385082	rs2854117	APOC3	3			4.25	Toxicity	2	2	ritonavir	HIV Infections;Hyperlipidemias	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385082	
655385087	rs2854116	APOC3	3			2.5	Toxicity	1	1	ritonavir	HIV Infections;Hyperlipidemias	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385087	
655385092	rs5128	APOC3	3			2.5	Toxicity	1	1	ritonavir	HIV Infections;Hyperlipidemias	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385092	
655385097	rs10192566	LPIN1	3			2.75	Efficacy	1	1	rosiglitazone	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385097	
655385110	rs2267715	CRHR2	3			0.75	Efficacy	1	2	salbutamol;selective beta-2-adrenoreceptor agonists	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385110	Pediatric
1451414840	rs1045642	ABCB1	3		Tier 1 VIP	3.5	Toxicity	2	2	oseltamivir		2021-04-20	https://www.pharmgkb.org/clinicalAnnotation/1451414840	Pediatric
655384971	rs3813929	HTR2C	3			1.5	Toxicity	3	3	antipsychotics	Mental Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384971	
655385004	rs61750900	UGT2B10	3			3.0	Metabolism/PK	3	3	nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385004	
655385102	rs1042713	ADRB2	2A		Tier 1 VIP	11.75	Efficacy	7	7	salmeterol	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385102	Pediatric
655385144	rs2273697	ABCC2	3			0.25	Metabolism/PK	2	2	talinolol		2021-12-03	https://www.pharmgkb.org/clinicalAnnotation/655385144	
655385164	rs1138272	GSTP1	3		Tier 1 VIP	1.5	Metabolism/PK	1	1	thiotepa	Neoplasms	2021-12-03	https://www.pharmgkb.org/clinicalAnnotation/655385164	
655385134	rs12255372	TCF7L2	3			3.0	Efficacy	1	1	sulfonamides, urea derivatives	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385134	
655385139	rs5219	KCNJ11	3			1.5	Efficacy	1	1	repaglinide	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385139	
655385159	rs1751034	ABCC4	3			0.5	Metabolism/PK	5	5	tenofovir	HIV Infections	2022-04-22	https://www.pharmgkb.org/clinicalAnnotation/655385159	
655385149	rs4986938	ESR2	3			1.25	Toxicity	1	1	tamoxifen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385149	
655385154	rs9340799	ESR1	3			1.0	Toxicity	1	1	tamoxifen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385154	
655385307	rs1801133	MTHFR	2A		Tier 1 VIP	12.75	Toxicity	12	12	methotrexate	Arthritis, Juvenile Rheumatoid;Arthritis, Psoriatic;Arthritis, Rheumatoid;Drug Toxicity	2022-02-25	https://www.pharmgkb.org/clinicalAnnotation/655385307	Pediatric
655385168	rs1487278	TPH2	3			2.5	Efficacy	1	1	mirtazapine;venlafaxine	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385168	
655385178	rs119774	ABCC1	3			2.25	Efficacy	1	1	montelukast	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385178	
655385195	rs12422149	SLCO2B1	3			1.625	Efficacy	2	2	montelukast	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385195	
655385210	rs2368564	REN	3			2.75	Toxicity	1	1	muraglitazar	Diabetes Mellitus;Edema;Hyperlipidemias	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385210	
655385257	rs28364006	ABCC1	3		Rare Variant	2.25	Efficacy	1	1	methotrexate	Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385257	
655385262	rs2238476	ABCC1	3			5.0	Efficacy;Toxicity	1	2	methotrexate	Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385262	
655385267	rs35592	ABCC1	3			1.75	Efficacy	2	2	methotrexate	Arthritis, Rheumatoid;Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385267	
655385272	rs17731538	ABCG2	3		Tier 1 VIP	2.75	Efficacy	1	1	methotrexate	Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385272	
655385277	rs246240	ABCC1	3			2.75	Toxicity	1	1	methotrexate	Drug Toxicity;Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385277	
655385286	rs13120400	ABCG2	3		Tier 1 VIP	2.25	Efficacy	1	1	methotrexate	Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385286	
655385299	rs2372536	ATIC	3			5.75	Efficacy	11	14	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385299	
655385323	rs45445694	C18orf56;TYMS	3		Tier 1 VIP	2.0	Efficacy	1	1	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385323	
655385328	rs9345389		3			2.75	Toxicity	1	1	methotrexate	Neoplasm, Residual;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385328	Pediatric
655385333	rs4888024		3			2.75	Toxicity	1	1	methotrexate	Neoplasm, Residual;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385333	Pediatric
655385338	rs5030655	CYP2D6	3		Rare Variant; Tier 1 VIP	3.5	Efficacy	1	2	metoprolol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385338	
655385352	rs3892097	CYP2D6	3		Tier 1 VIP	2.25	Efficacy	1	1	metoprolol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385352	
655385115	rs2284220	CRHR2	4			-1.25	Efficacy	1	3	salbutamol;selective beta-2-adrenoreceptor agonists	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385115	Pediatric
655385361	rs1044396	CHRNA4	3			5.5	Other	2	3	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385361	
655385369	rs1367117	APOB	3			4.0	Efficacy	1	2	irbesartan	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385369	
655385120	rs255100	CRHR2	4			-0.75	Efficacy	1	3	salbutamol;selective beta-2-adrenoreceptor agonists	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385120	Pediatric
655385223	rs2278293	IMPDH1	4			-1.5	Toxicity	5	5	mycophenolate mofetil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385223	
655385125	rs5443	GNB3	3			3.0	Efficacy	1	1	sildenafil	Erectile Dysfunction	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385125	
655385205	rs4680	COMT	3		Tier 1 VIP	0.5	Dosage	9	9	morphine	Pain;Pain, Postoperative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385205	Pediatric
655385241	rs1799971	OPRM1	3			5.25	Efficacy	4	4	naloxone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385241	
1449575633	rs188052243	DPYD	3		Rare Variant; Tier 1 VIP	0.0	Other	2	2	fluorouracil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449575633	
1449716951	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*35, CYP2A6*46	CYP2A6	3		Tier 1 VIP	4.875	Metabolism/PK	3	3	letrozole	Breast Neoplasms	2022-09-29	https://www.pharmgkb.org/clinicalAnnotation/1449716951	
1449575668	rs748620513	DPYD	3		Rare Variant; Tier 1 VIP	0.0	Other	1	2	fluorouracil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449575668	
1449575690	rs143879757	DPYD	3		Rare Variant; Tier 1 VIP	0.0	Other	1	2	fluorouracil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449575690	
1449575696	rs1212037891	DPYD	3		Rare Variant; Tier 1 VIP	0.0	Other	1	1	fluorouracil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449575696	
1449713004	HLA-A*11:01:01	HLA-A	3			3.25	Toxicity	1	1	levetiracetam	adverse events;Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449713004	
1449575656	rs59086055	DPYD	1A		Rare Variant; Tier 1 VIP	100.0	Other	2	3	fluorouracil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449575656	
1449575662	rs148994843	DPYD	1A		Rare Variant; Tier 1 VIP	100.0	Other	2	3	fluorouracil		2021-05-25	https://www.pharmgkb.org/clinicalAnnotation/1449575662	
1449748511	rs1128503	ABCB1	3		Tier 1 VIP	2.25	Efficacy	1	1	tacrolimus	Nephrotic Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449748511	
1450371713	rs1801274	FCGR2A	3			2.25	Efficacy	1	1	rituximab	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450371713	
1450373100	rs7905446	HTR7	3			4.75	Efficacy	1	2	Selective serotonin reuptake inhibitors	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450373100	
1450373628	rs12659	SLC19A1	3		Tier 1 VIP	1.5	Toxicity	1	1	imatinib	Gastrointestinal Stromal Tumors	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450373628	
1450373634	rs1051266	SLC19A1	3		Tier 1 VIP	1.5	Toxicity	1	1	imatinib	Gastrointestinal Stromal Tumors	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450373634	
1450375692	rs1934341	GREM2	3			0.0	Efficacy	1	1	allopurinol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450375692	
981237695	rs17222723	ABCC2	3			0.5	Toxicity	2	2	tenofovir	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981237695	
981238459	rs1057910	CYP2C9	3		Tier 1 VIP	1.0	Efficacy	2	2	losartan		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981238459	
981237922	rs1128503	ABCB1	3		Tier 1 VIP	1.5	Other	1	1	phenytoin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981237922	
981237950	rs1695	GSTP1	3		Tier 1 VIP	0.5	Efficacy	2	2	cisplatin;cyclophosphamide	Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981237950	
981204890	rs1800497	ANKK1;DRD2	3		Tier 1 VIP	0.5	Toxicity	9	9	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204890	
981344897	rs4149056	SLCO1B1	3		Tier 1 VIP	3.5	Toxicity	1	1	cerivastatin	Rhabdomyolysis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981344897	
981352141	rs1050828	G6PD	4		Tier 1 VIP	-2.0	Toxicity	2	3	artesunate;chlorproguanil;dapsone	Malaria	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981352141	Pediatric
827830327	rs1127354	DDRGK1;ITPA	3			3.0	Efficacy	1	1	azathioprine	Inflammatory Bowel Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827830327	
827831021	rs532545	CDA	3			4.5	Toxicity	4	5	cytarabine	Leukemia, Myeloid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827831021	
827831123	rs712829	EGFR	3		Rare Variant	2.25	Toxicity	1	1	erlotinib	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827831123	
827831417	rs3212986	ERCC1	4			-3.875	Efficacy	5	7	Platinum compounds	Carcinoma, Non-Small-Cell Lung;Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827831417	
827831435	rs2032582	ABCB1	3		Tier 1 VIP	4.0	Dosage	3	4	cyclosporine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827831435	
827832280	rs1801253	ADRB1	3		Tier 1 VIP	7.5	Efficacy	11	12	metoprolol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827832280	
1451415425	rs7668258	UGT2B7	3			2.75	Dosage	1	1	lamotrigine	Epilepsy	2021-04-20	https://www.pharmgkb.org/clinicalAnnotation/1451415425	
827847788	rs1695	GSTP1	4		Tier 1 VIP	-1.75	Efficacy	7	7	oxaliplatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827847788	
981188336	rs45445694	TYMS	3		Tier 1 VIP	1.75	Efficacy	8	8	methotrexate	Neoplasms;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-09-27	https://www.pharmgkb.org/clinicalAnnotation/981188336	Pediatric
827847738	rs9895420	ABCC3	3			3.25	Efficacy	1	1	methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827847738	Pediatric
827847744	rs9679162	GALNT14	3			7.25	Efficacy	2	3	cisplatin;fluorouracil;mitoxantrone	Carcinoma, Hepatocellular;Liver Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827847744	
827847751	rs9657182	IDO1	3			1.5	Toxicity	1	2	interferon alfa-2a, recombinant;peginterferon alfa-2b	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827847751	
827847768	rs9597	UBE2I	3			3.0	Efficacy	1	1	cisplatin;irinotecan	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827847768	
827848563	rs943580	AGT	3			2.75	Toxicity	1	1	Antiinflammatory agents, non-steroids	Acute coronary syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827848563	
827848725	rs9349256	ABCC10	3			2.5	Toxicity	1	1	tenofovir		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827848725	
827849079	rs1042028	SULT1A1	3			0.0	Toxicity	1	1	conjugated estrogens	Endometrial Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827849079	
827849095	rs9274407	HLA-DQB1	3			0.0	Toxicity	1	1	amoxicillin;clavulanate	Drug Toxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827849095	
827848555	rs9514091	SLC10A2	4			-1.5	Toxicity	2	2	anthracyclines and related substances	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827848555	Pediatric
981201399	rs2273697	ABCC2	4			-4.5	Toxicity	5	5	tenofovir	HIV Infections;Kidney Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981201399	
827849109	rs9272105	HLA-DQA1	3			2.5	Efficacy	1	1	interferon beta-1a;interferon beta-1b		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827849109	
978639596	rs10509681	CYP2C8	3		Tier 1 VIP	1.5	Other	1	1	repaglinide		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/978639596	
981188353	rs2070959	UGT1A10;UGT1A6;UGT1A7;UGT1A8;UGT1A9	3			5.0	Dosage	2	3	valproic acid	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981188353	
981188379	rs2072671	CDA	3			1.0	Toxicity	6	6	gemcitabine	Carcinoma, Non-Small-Cell Lung;Mesothelioma;Pancreatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981188379	
981201333	rs2227983	EGFR	3			1.0	Toxicity	4	4	egfr inhibitors	Carcinoma, Non-Small-Cell Lung;Colorectal Neoplasms;Neoplasms;Pancreatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981201333	
981201817	rs28399454	CYP2A6	4		Tier 1 VIP	-6.0	Other	8	8	efavirenz	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981201817	
981201864	rs2046934	P2RY12	4			-4.5	Efficacy	19	19	clopidogrel	Acute coronary syndrome;Angina Pectoris	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981201864	
981201895	rs1045642	ABCB1	4		Tier 1 VIP	-5.75	Efficacy	15	16	antiepileptics	Epilepsies, Partial;Epilepsy;Epilepsy, Generalized	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981201895	Pediatric
981201937	rs12714145	GGCX	4			-10.75	Dosage	11	11	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981201937	
981202068	rs662	PON1	4			-37.25	Efficacy;Toxicity	29	40	clopidogrel	Angina Pectoris;Coronary Artery Disease;Myocardial Infarction;Myocardial Ischemia;Thrombosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981202068	
981202261	rs3740066	ABCC2	4			-5.0	Efficacy	4	5	antiepileptics	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981202261	
827848548	rs9561778	ABCC4	3			2.75	Toxicity	1	1	cyclophosphamide;doxorubicin;fluorouracil	Breast Neoplasms;Neoplasms	2021-12-08	https://www.pharmgkb.org/clinicalAnnotation/827848548	
978608464	rs1801133	MTHFR	3		Tier 1 VIP	4.25	Efficacy	2	2	methotrexate	Graft vs Host Disease;Leukemia;Leukemia, Myelogenous, Chronic, BCR-ABL Positive	2022-02-25	https://www.pharmgkb.org/clinicalAnnotation/978608464	
827923032	rs3745274	CYP2B6	1A		Tier 1 VIP	229.0625	Metabolism/PK	77	89	efavirenz	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827923032	Pediatric
827923042	rs3745274	CYP2B6	1A		Tier 1 VIP	109.25	Toxicity	29	31	efavirenz	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827923042	Pediatric
981201535	rs2297595	DPYD	1A	Yes: Assigned level 1A because variant is included in CPIC guideline	Tier 1 VIP	75.5	Toxicity	17	19	fluorouracil	Neoplasms	2021-03-29	https://www.pharmgkb.org/clinicalAnnotation/981201535	
981201981	rs1801265	DPYD	1A		Tier 1 VIP	93.25	Toxicity	17	19	fluorouracil	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981201981	Pediatric
981202294	rs3745274	CYP2B6	2A		Tier 1 VIP	24.625	Metabolism/PK	16	17	nevirapine	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981202294	Pediatric
981202609	rs4673993	ATIC	2B			11.875	Efficacy	5	5	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981202609	
981202714	rs4961	ADD1	2B			12.0	Efficacy	8	8	hydrochlorothiazide	Essential hypertension;Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981202714	
1451415660	HLA-DRB1*08:03:02	HLA-DRB1	3			4.25	Toxicity	2	2	Antithyroid Preparations	Agranulocytosis;Graves Disease	2021-04-20	https://www.pharmgkb.org/clinicalAnnotation/1451415660	
981755820	rs113993960	CFTR	4		Rare Variant; Tier 1 VIP	-3.25	Efficacy	9	9	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981755820	Pediatric
981204695	rs1799971	OPRM1	4			-2.125	Efficacy	16	17	naltrexone	Alcoholism;hypersexuality state;Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204695	
981237907	rs1127354	ITPA	3			6.75	Dosage	2	3	interferon alfa-2b, recombinant;ribavirin	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981237907	
1451415686	HLA-DQB1*06:01:01	HLA-DQB1	3			2.75	Toxicity	1	1	Antithyroid Preparations	Agranulocytosis;Graves Disease	2021-04-20	https://www.pharmgkb.org/clinicalAnnotation/1451415686	
1451415691	HLA-DQA1*01:03:01:01	HLA-DQA1	3			2.75	Toxicity	1	1	Antithyroid Preparations	Agranulocytosis;Graves Disease	2021-04-20	https://www.pharmgkb.org/clinicalAnnotation/1451415691	
1451415680	HLA-B*39:01:01:01	HLA-B	3		Tier 1 VIP	3.0	Toxicity	1	1	Antithyroid Preparations	Agranulocytosis;Graves Disease	2021-04-20	https://www.pharmgkb.org/clinicalAnnotation/1451415680	
1451416140	rs745364489	BCHE	3		Rare Variant	0.5	Toxicity	2	2	succinylcholine	Apnea	2021-04-21	https://www.pharmgkb.org/clinicalAnnotation/1451416140	
981238370	rs1979277	SHMT1	3			0.5	Toxicity	3	3	methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981238370	Pediatric
1451416400	rs6311	HTR2A	4			-3.0	Efficacy	3	4	antidepressants	Bipolar Disorder;Depression;Depressive Disorder, Major	2021-04-21	https://www.pharmgkb.org/clinicalAnnotation/1451416400	
1451416408	rs6311	HTR2A	3			1.125	Toxicity	1	1	antidepressants	adverse events;Bipolar Disorder;Depression;Depressive Disorder, Major	2021-04-21	https://www.pharmgkb.org/clinicalAnnotation/1451416408	
981237900	rs11212617	ATM;C11orf65	4			-2.0	Efficacy	6	6	metformin	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981237900	
1451416422	rs6313	HTR2A	3			1.5	Toxicity	1	1	antidepressants	adverse events;Bipolar Disorder;Depression;Depressive Disorder, Major	2021-04-21	https://www.pharmgkb.org/clinicalAnnotation/1451416422	
1451416434	rs7997012	HTR2A	3			1.5	Efficacy	5	6	antidepressants	Bipolar Disorder;Depression;Depressive Disorder, Major	2021-04-21	https://www.pharmgkb.org/clinicalAnnotation/1451416434	
981238025	rs2032582	ABCB1	3		Tier 1 VIP	1.5	Efficacy	2	2	cyclophosphamide;doxorubicin	Breast Neoplasms	2021-03-25	https://www.pharmgkb.org/clinicalAnnotation/981238025	
981240029	rs5219	KCNJ11	3			1.25	Efficacy	4	7	sulfonamides, urea derivatives	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981240029	
1451416940	UGT1A1*1, UGT1A1*28	UGT1A1	3		Tier 1 VIP	3.0	Toxicity	1	1	FOLFIRINOX	Pancreatic Neoplasms;Thrombocytopenia	2021-04-22	https://www.pharmgkb.org/clinicalAnnotation/1451416940	
1451416946	rs2072671	CDA	3			2.25	Toxicity	1	1	gemcitabine;paclitaxel	Nausea;Pancreatic Neoplasms	2021-04-22	https://www.pharmgkb.org/clinicalAnnotation/1451416946	
1451417123	rs1128503	ABCB1	3		Tier 1 VIP	1.25	Metabolism/PK	1	1	temozolomide	Glioma	2021-04-22	https://www.pharmgkb.org/clinicalAnnotation/1451417123	
1451418220	CYP2D6*1, CYP2D6*4, CYP2D6*10	CYP2D6	3		Tier 1 VIP	2.625	Metabolism/PK	5	5	citalopram		2021-04-22	https://www.pharmgkb.org/clinicalAnnotation/1451418220	
1451418260	CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN	CYP2D6	3		Tier 1 VIP	1.75	Efficacy	2	2	citalopram		2021-04-22	https://www.pharmgkb.org/clinicalAnnotation/1451418260	
1451418281	CYP2D6*1, CYP2D6*4	CYP2D6	3		Tier 1 VIP	2.5	Dosage	1	1	citalopram		2021-04-22	https://www.pharmgkb.org/clinicalAnnotation/1451418281	
981239544	rs104894540	VKORC1	3		Tier 1 VIP	0.25	Dosage	2	2	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981239544	
981202598	rs4444903	EGF	3			3.75	Efficacy	5	5	cetuximab	Colorectal Neoplasms;Rectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981202598	
981202618	rs4680	COMT	3		Tier 1 VIP	5.0	Efficacy	4	5	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981202618	
981220481	rs1801133	MTHFR	3		Tier 1 VIP	4.0	Toxicity	4	5	cisplatin;oxaliplatin;Platinum compounds	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981220481	Pediatric
981475986	rs11568315	EGFR	3			7.5	Efficacy	4	4	gefitinib	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981475986	
981202393	rs1801394	MTRR	3			1.75	Toxicity	2	2	methotrexate	Drug Toxicity;Lymphoma;Osteosarcoma;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2022-01-04	https://www.pharmgkb.org/clinicalAnnotation/981202393	Pediatric
981345293	rs4149056	SLCO1B1	1A		Tier 1 VIP	113.0	Metabolism/PK	13	19	pravastatin		2022-02-15	https://www.pharmgkb.org/clinicalAnnotation/981345293	Pediatric
1451264120	rs772226819	CACNA1S	1A		Rare Variant; Tier 1 VIP	100.25	Toxicity	2	3	methoxyflurane	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451264120	
1451282340	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	1A		Tier 1 VIP	384.625	Efficacy	100	159	clopidogrel	Cardiovascular Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451282340	
1451274140	rs115232898	DPYD	1A		Rare Variant; Tier 1 VIP	101.75	Other	4	5	fluorouracil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451274140	
1451282440	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4, CYP2C19*5, CYP2C19*6, CYP2C19*8, CYP2C19*17	CYP2C19	1A		Tier 1 VIP	380.25	Efficacy;Toxicity	62	117	clopidogrel	Acute coronary syndrome;Cardiovascular Diseases;Ischemic Attack, Transient;Stroke	2022-01-19	https://www.pharmgkb.org/clinicalAnnotation/1451282440	
1451282840	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4	CYP2C19	1A		Tier 1 VIP	200.375	Toxicity	7	10	citalopram	Depressive Disorder	2022-03-11	https://www.pharmgkb.org/clinicalAnnotation/1451282840	
1451286040	rs1801160	DPYD	1A		Tier 1 VIP	101.75	Toxicity	13	14	capecitabine	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451286040	
1451286320	rs1801159	DPYD	1A		Tier 1 VIP	81.25	Toxicity	12	13	capecitabine	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451286320	
1451286326	rs1801158	DPYD	1A		Tier 1 VIP	82.5	Toxicity	13	14	capecitabine	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451286326	
1451287240	rs1801265	DPYD	1A		Tier 1 VIP	93.25	Toxicity	11	13	capecitabine	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451287240	
1451287360	rs2297595	DPYD	1A		Tier 1 VIP	84.0	Toxicity	17	19	capecitabine	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451287360	
1451287440	rs17376848	DPYD	1A		Tier 1 VIP	96.25	Toxicity	9	10	capecitabine	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451287440	
1451290840	rs116855232	NUDT15	1A		Tier 1 VIP	130.375	Dosage	16	19	mercaptopurine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451290840	Pediatric
1451329460	UGT1A1*1, UGT1A1*6	UGT1A1	1B		Tier 1 VIP	34.5	Toxicity	15	21	FOLFIRI;irinotecan	Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451329460	
1451332611	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	1A		Tier 1 VIP	102.0	Toxicity	3	4	desipramine	Depressive Disorder;Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451332611	
1451288269	rs56038477	DPYD	1A		Tier 1 VIP	199.75	Toxicity	11	13	capecitabine	Neoplasms	2022-10-26	https://www.pharmgkb.org/clinicalAnnotation/1451288269	
1451289700	rs75017182	DPYD	1A		Tier 1 VIP	200.0	Other	4	6	fluorouracil		2022-10-27	https://www.pharmgkb.org/clinicalAnnotation/1451289700	
1451420300	CYP2D6*4, CYP2D6*5	CYP2D6	3		Tier 1 VIP	0.125	Metabolism/PK	1	1	atomoxetine;methylphenidate		2021-04-23	https://www.pharmgkb.org/clinicalAnnotation/1451420300	
1451265780	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	1A		Tier 1 VIP	209.375	Toxicity	5	8	clomipramine	Depressive Disorder, Major	2021-04-23	https://www.pharmgkb.org/clinicalAnnotation/1451265780	
1451285360	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10	CYP2D6	1A		Tier 1 VIP	204.875	Toxicity	6	8	nortriptyline	Depressive Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451285360	
1451282740	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	1A		Tier 1 VIP	241.875	Metabolism/PK	11	28	escitalopram	Depressive Disorder, Major;Mental Disorders	2021-05-03	https://www.pharmgkb.org/clinicalAnnotation/1451282740	
981202790	rs4961	ADD1	3			1.75	Efficacy	2	2	diuretics	Hypertension;Myocardial Infarction	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981202790	
981204258	rs1045642	ABCB1	4		Tier 1 VIP	-1.25	Toxicity	3	4	paclitaxel	Drug Toxicity;Neoplasms;Neutropenia;Peripheral Nervous System Diseases	2022-03-22	https://www.pharmgkb.org/clinicalAnnotation/981204258	
981203854	rs776746	CYP3A5	3		Tier 1 VIP	2.25	Toxicity	1	1	tacrolimus	Hyperlipidemias	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981203854	
981204026	rs9977268	SLC19A1	3		Tier 1 VIP	0.0	Efficacy	1	1	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204026	
981204116	rs2032582	ABCB1	3		Tier 1 VIP	0.5	Efficacy	2	2	tacrolimus	Colitis, Ulcerative;Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204116	
981204433	rs1045642	ABCB1	3		Tier 1 VIP	2.0	Efficacy	1	1	dexamethasone;doxorubicin;vincristine	Multiple Myeloma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204433	
981204444	rs1045642	ABCB1	3		Tier 1 VIP	1.5	Other	2	2	rhodamine 123		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204444	
981204466	rs1045642	ABCB1	3		Tier 1 VIP	0.25	Toxicity	2	2	capecitabine	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204466	
981237713	rs1805087	MTR	3			3.25	Efficacy;Toxicity	3	3	carboplatin;cisplatin	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981237713	Pediatric
981238041	rs2032582	ABCB1	3		Tier 1 VIP	2.5	Efficacy	1	1	dexamethasone;doxorubicin;vincristine	Multiple Myeloma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981238041	
981203697	rs717620	ABCC2	4			-2.5	Efficacy	5	6	antiepileptics	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981203697	
981203790	CYP3A5*1, CYP3A5*3	CYP3A5	4		Tier 1 VIP	-0.375	Toxicity	14	15	tacrolimus	nephrotoxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981203790	Pediatric
981203886	rs776746	CYP3A5	4		Tier 1 VIP	-1.375	Other	4	4	nevirapine	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981203886	
981203954	rs7439366	UGT2B7	4			-3.5	Other	5	5	efavirenz	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981203954	
981204345	rs1045642	ABCB1	4		Tier 1 VIP	-6.75	Efficacy	5	5	carbamazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204345	
981204912	rs1801133	MTHFR	4		Tier 1 VIP	-0.25	Toxicity	15	16	capecitabine;fluorouracil	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204912	
981238288	rs2032582	ABCB1	4		Tier 1 VIP	-0.25	Efficacy	4	5	efavirenz	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981238288	
981202806	rs4961	ADD1	3			3.5	Efficacy	1	1	furosemide;spironolactone	Liver Cirrhosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981202806	
981204044	rs9923231	VKORC1	1A		Tier 1 VIP	147.75	Dosage	20	25	acenocoumarol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204044	
981475450	rs121434569	EGFR	2B		Rare Variant	9.0	Efficacy	11	11	erlotinib	Adenocarcinoma;Carcinoma, Non-Small-Cell Lung;Drug Resistance;Lung Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981475450	
1451286020	rs1801160	DPYD	1A		Tier 1 VIP	108.5	Toxicity	14	15	fluorouracil	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451286020	Pediatric
1451214480	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	1A		Tier 1 VIP	421.75	Metabolism/PK	143	166	tacrolimus	heart transplantation;hematopoietic stem cell transplantation;Kidney Transplantation;lung transplantation	2022-03-11	https://www.pharmgkb.org/clinicalAnnotation/1451214480	Pediatric
981203618	rs67376798	DPYD	1A		Rare Variant; Tier 1 VIP	233.75	Toxicity	23	25	fluorouracil	Neoplasms	2021-05-24	https://www.pharmgkb.org/clinicalAnnotation/981203618	
981345382	rs4149056	SLCO1B1	2A		Tier 1 VIP	11.75	Toxicity	9	10	hmg coa reductase inhibitors	statin-related myopathy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981345382	
981420042	rs121434568	EGFR	1A		Rare Variant	190.5	Efficacy	24	45	gefitinib	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981420042	
981203518	rs5751876	ADORA2A	3			5.0	Toxicity	4	4	caffeine	Anxiety Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981203518	
981203532	rs602950	CDA	3			4.0	Toxicity	4	5	cytarabine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981203532	
1451141900	CYP2D6*5, CYP2D6*17	CYP2D6	1A		Tier 1 VIP	101.75	Efficacy	2	3	hydrocodone	Pain	2022-01-11	https://www.pharmgkb.org/clinicalAnnotation/1451141900	
981203578	rs6280	DRD3	3			1.25	Efficacy	2	2	clozapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981203578	
981203641	rs6759892	UGT1A10;UGT1A6;UGT1A7;UGT1A8;UGT1A9	3			5.0	Dosage	2	3	valproic acid	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981203641	
981203709	rs7412	APOE	3			1.75	Toxicity	2	2	Antivirals for treatment of HIV infections, combinations;ritonavir	HIV Infections;Hypertriglyceridemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981203709	
981204080	rs9461684	HLA-C	3			3.25	Toxicity	1	1	nevirapine	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204080	
981204090	rs9024	CBR1	3			2.25	Toxicity	1	1	anthracyclines and related substances	Cardiomyopathies;Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204090	
981204107	rs20417	PTGS2	3			1.75	Efficacy	1	2	aspirin	Coronary Artery Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204107	
1451241420	NAT2*4, NAT2*5A, NAT2*5B, NAT2*5D, NAT2*6A, NAT2*6B, NAT2*7A, NAT2*7B, NAT2*12A, NAT2*13A, NAT2*14A	NAT2	1B		Tier 1 VIP	45.75	Toxicity	33	37	Drugs For Treatment Of Tuberculosis;isoniazid	drug-induced liver injury;Hepatitis, Toxic;Toxic liver disease;Tuberculosis	2022-06-20	https://www.pharmgkb.org/clinicalAnnotation/1451241420	Pediatric
981204286	rs1045642	ABCB1	3		Tier 1 VIP	0.25	Metabolism/PK	4	4	cyclosporine	Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204286	
981204306	rs1045642	ABCB1	3		Tier 1 VIP	0.0	Efficacy	3	3	phenytoin	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204306	
981204317	rs1045642	ABCB1	3		Tier 1 VIP	0.5	Dosage	2	2	phenytoin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204317	
981204361	rs1045642	ABCB1	3		Tier 1 VIP	0.75	Efficacy;Toxicity;Metabolism/PK	28	40	clopidogrel	Acute coronary syndrome;Myocardial Infarction	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204361	
1451231100	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	1A		Tier 1 VIP	200.125	Metabolism/PK	2	4	siponimod		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451231100	
981204455	rs1045642	ABCB1	3		Tier 1 VIP	1.375	Other	2	2	dicloxacillin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204455	
981203918	rs776746	CYP3A5	4		Tier 1 VIP	-2.0	Other	6	6	efavirenz	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981203918	
981204137	rs2032582	ABCB1	4		Tier 1 VIP	-3.75	Efficacy	4	4	antiepileptics	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204137	Pediatric
981204403	rs1045642	ABCB1	4		Tier 1 VIP	-0.5	Efficacy	3	5	cisplatin;fluorouracil	Esophageal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204403	
981204414	rs1045642	ABCB1	4		Tier 1 VIP	-1.25	Toxicity	3	3	fluorouracil	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204414	
981204975	rs1801133	MTHFR	4		Tier 1 VIP	-0.5	Toxicity	3	3	mercaptopurine	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204975	Pediatric
981203808	CYP3A5*1, CYP3A5*3	CYP3A5	4		Tier 1 VIP	-3.0	Efficacy	33	34	tacrolimus	hematopoietic stem cell transplantation;Kidney Transplantation;transplant rejection	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981203808	Pediatric
981203936	CYP3A5*1, CYP3A5*3	CYP3A5	3		Tier 1 VIP	3.75	Metabolism/PK	6	6	sirolimus	Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981203936	
981204372	rs1045642	ABCB1	3		Tier 1 VIP	2.25	Metabolism/PK	8	9	digoxin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204372	
1451241700	CYP3A5*1, CYP3A5*3	CYP3A5	2A		Tier 1 VIP	16.75	Dosage	9	10	tacrolimus	liver transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451241700	Pediatric
981204272	rs1045642	ABCB1	4		Tier 1 VIP	-1.0	Efficacy	4	4	paclitaxel	Breast Neoplasms;Neoplasms	2022-03-22	https://www.pharmgkb.org/clinicalAnnotation/981204272	
981203545	rs6275	DRD2	3		Tier 1 VIP	0.75	Dosage	2	2	methadone	Heroin Dependence	2021-12-08	https://www.pharmgkb.org/clinicalAnnotation/981203545	
981203719	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	1A		Tier 1 VIP	390.75	Dosage	97	107	tacrolimus	heart transplantation;hemopoietic stem cell transplant;Kidney Transplantation;liver transplantation;lung transplantation	2021-10-22	https://www.pharmgkb.org/clinicalAnnotation/981203719	Pediatric
981345350	rs4149056	SLCO1B1	1A		Tier 1 VIP	114.125	Metabolism/PK	13	16	rosuvastatin	Hypercholesterolemia	2022-02-14	https://www.pharmgkb.org/clinicalAnnotation/981345350	Pediatric
1451244800	rs4149056	SLCO1B1	1A		Tier 1 VIP	116.75	Metabolism/PK	17	20	atorvastatin		2022-02-15	https://www.pharmgkb.org/clinicalAnnotation/1451244800	
1451241780	CYP3A5*1, CYP3A5*3	CYP3A5	1B		Tier 1 VIP	37.0	Metabolism/PK	24	25	tacrolimus	liver transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451241780	Pediatric
1451243216	CYP3A5*1, CYP3A5*3	CYP3A5	2A		Tier 1 VIP	8.0	Dosage	9	9	tacrolimus	liver transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451243216	Pediatric
1451254525	rs71647871	CES1	2B		Rare Variant	6.75	Efficacy	2	3	clopidogrel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451254525	
1451261620	rs3788853	XPNPEP2	2B			8.25	Toxicity	3	3	Ace Inhibitors, Plain	Angioedema	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451261620	
1451263877	rs1800559	CACNA1S	1A		Rare Variant; Tier 1 VIP	100.5	Toxicity	3	5	enflurane	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451263877	
1451263966	rs1800559	CACNA1S	1A		Rare Variant; Tier 1 VIP	100.5	Toxicity	4	6	methoxyflurane		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451263966	Pediatric
1451263973	rs1800559	CACNA1S	1A		Rare Variant; Tier 1 VIP	100.5	Toxicity	4	6	sevoflurane	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451263973	Pediatric
1451263980	rs1800559	CACNA1S	1A		Rare Variant; Tier 1 VIP	100.5	Toxicity	4	5	halothane	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451263980	Pediatric
1451263986	rs1800559	CACNA1S	1A		Rare Variant; Tier 1 VIP	100.5	Toxicity	5	7	isoflurane	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451263986	Pediatric
1451264020	rs1800559	CACNA1S	1A		Rare Variant; Tier 1 VIP	100.5	Toxicity	5	7	succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451264020	Pediatric
1451264060	rs772226819	CACNA1S	1A		Rare Variant; Tier 1 VIP	100.25	Toxicity	2	3	enflurane	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451264060	
1451264081	rs772226819	CACNA1S	1A		Rare Variant; Tier 1 VIP	100.25	Toxicity	2	3	halothane	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451264081	
1451264087	rs772226819	CACNA1S	1A		Rare Variant; Tier 1 VIP	100.25	Toxicity	2	3	isoflurane	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451264087	
1451264128	rs772226819	CACNA1S	1A		Rare Variant; Tier 1 VIP	100.25	Toxicity	2	3	succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451264128	
1451264140	rs772226819	CACNA1S	1A		Rare Variant; Tier 1 VIP	100.25	Toxicity	2	3	sevoflurane	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451264140	
1451274200	rs78060119	DPYD	1A		Rare Variant; Tier 1 VIP	100.0	Other	2	3	fluorouracil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451274200	
1451274045	rs67376798	DPYD	1A		Rare Variant; Tier 1 VIP	202.0	Other	11	14	fluorouracil		2021-05-24	https://www.pharmgkb.org/clinicalAnnotation/1451274045	Pediatric
1451274090	rs67376798	DPYD	1A		Rare Variant; Tier 1 VIP	231.25	Toxicity	28	30	capecitabine	Neoplasms	2021-05-24	https://www.pharmgkb.org/clinicalAnnotation/1451274090	
1451274984	rs3918290	DPYD	1A		Rare Variant; Tier 1 VIP	222.25	Toxicity	28	31	capecitabine	Neoplasms	2021-05-24	https://www.pharmgkb.org/clinicalAnnotation/1451274984	
1451275020	rs3918290	DPYD	1A		Rare Variant; Tier 1 VIP	207.0	Other	23	27	fluorouracil		2021-05-24	https://www.pharmgkb.org/clinicalAnnotation/1451275020	Pediatric
1451276160	rs55886062	DPYD	1A		Rare Variant; Tier 1 VIP	201.5	Toxicity	10	12	capecitabine	Neoplasms	2021-05-24	https://www.pharmgkb.org/clinicalAnnotation/1451276160	
1451275220	rs55886062	DPYD	1A		Rare Variant; Tier 1 VIP	201.75	Other	9	11	fluorouracil		2021-05-24	https://www.pharmgkb.org/clinicalAnnotation/1451275220	Pediatric
1451274165	rs75017182	DPYD	1A		Tier 1 VIP	200.0	Toxicity	6	8	capecitabine	Neoplasms	2022-10-27	https://www.pharmgkb.org/clinicalAnnotation/1451274165	
1451428340	CYP2D6*1, CYP2D6*45, CYP2D6*46	CYP2D6	3		Tier 1 VIP	2.0	Metabolism/PK	1	1	metoprolol	Hypertension	2021-04-30	https://www.pharmgkb.org/clinicalAnnotation/1451428340	
981419540	rs6535454	COQ2	3			2.25	Toxicity	1	1	atorvastatin;hmg coa reductase inhibitors;rosuvastatin	Muscular Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981419540	
981238323	rs1695	GSTP1	3		Tier 1 VIP	2.5	Efficacy	5	5	cyclophosphamide	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981238323	
1451428500	CYP2D6*1, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*97, CYP2D6*98	CYP2D6	3		Tier 1 VIP	0.0	Metabolism/PK	1	1	risperidone		2021-04-30	https://www.pharmgkb.org/clinicalAnnotation/1451428500	
1451430540	CYP2D6*1, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*97, CYP2D6*98	CYP2D6	3		Tier 1 VIP	0.0	Metabolism/PK	1	1	venlafaxine		2021-05-03	https://www.pharmgkb.org/clinicalAnnotation/1451430540	
1451592476	rs7858836	ASTN2	3			3.25	Dosage	1	1	fentanyl	Pain, Postoperative	2021-11-22	https://www.pharmgkb.org/clinicalAnnotation/1451592476	
1451431120	HLA-B*15:21	HLA-B	3		Tier 1 VIP	3.75	Toxicity	5	5	carbamazepine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome	2022-01-10	https://www.pharmgkb.org/clinicalAnnotation/1451431120	
1451435940	rs267606619	MT-RNR1	1A		Rare Variant; Tier 1 VIP	101.0	Toxicity	5	6	streptomycin	Ototoxicity	2021-06-15	https://www.pharmgkb.org/clinicalAnnotation/1451435940	
1451592484	rs958804	ASTN2	3			3.25	Dosage	1	1	fentanyl	Pain, Postoperative	2021-11-22	https://www.pharmgkb.org/clinicalAnnotation/1451592484	
1451435945	rs267606619	MT-RNR1	1A		Rare Variant; Tier 1 VIP	101.25	Toxicity	8	9	gentamicin	Ototoxicity	2021-06-15	https://www.pharmgkb.org/clinicalAnnotation/1451435945	Pediatric
1451436100	rs267606619	MT-ND1;MT-RNR1	3		Rare Variant; Tier 1 VIP	0.25	Toxicity	1	1	micronomicin	Ototoxicity	2021-05-12	https://www.pharmgkb.org/clinicalAnnotation/1451436100	
1451436121	rs267606619	MT-RNR1	1A		Rare Variant; Tier 1 VIP	100.25	Toxicity	1	2	tobramycin	Ototoxicity	2021-06-15	https://www.pharmgkb.org/clinicalAnnotation/1451436121	
981238397	rs1695	GSTP1	3		Tier 1 VIP	3.0	Toxicity	1	1	mercaptopurine;methotrexate	Drug Toxicity;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2022-01-04	https://www.pharmgkb.org/clinicalAnnotation/981238397	
1451436133	rs267606618	MT-RNR1	1A		Rare Variant; Tier 1 VIP	101.0	Toxicity	4	5	gentamicin	Ototoxicity	2021-06-15	https://www.pharmgkb.org/clinicalAnnotation/1451436133	Pediatric
1451436138	rs267606618	MT-RNR1	1A		Rare Variant; Tier 1 VIP	100.5	Toxicity	2	3	kanamycin	Ototoxicity	2021-06-15	https://www.pharmgkb.org/clinicalAnnotation/1451436138	
1451436180	rs1556422499	MT-RNR1	3		Tier 1 VIP	0.25	Toxicity	1	1	aminoglycoside antibacterials	Ototoxicity	2021-05-12	https://www.pharmgkb.org/clinicalAnnotation/1451436180	
1451434860	rs267606617	MT-ND1;MT-RNR1	1A		Rare Variant; Tier 1 VIP	108.0	Toxicity	28	29	gentamicin	Ototoxicity	2021-06-15	https://www.pharmgkb.org/clinicalAnnotation/1451434860	Pediatric
1451436226	rs1603218569	MT-ND1;MT-RNR1	3		Tier 1 VIP	0.25	Toxicity	1	1	aminoglycoside antibacterials	Ototoxicity	2021-05-12	https://www.pharmgkb.org/clinicalAnnotation/1451436226	
1451436209	rs28358572		3			0.25	Toxicity	1	1	aminoglycoside antibacterials	Ototoxicity	2021-05-12	https://www.pharmgkb.org/clinicalAnnotation/1451436209	
1451599320	rs2304016	SCN2A	3		Rare Variant	0.5	Efficacy	2	2	carbamazepine	Epilepsy	2021-11-30	https://www.pharmgkb.org/clinicalAnnotation/1451599320	
1449004210	rs2307240	CES1	3			3.5	Efficacy	1	1	clopidogrel	Acute coronary syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449004210	
1449004220	rs28898617	UGT1A10;UGT1A3;UGT1A4;UGT1A5;UGT1A6;UGT1A7;UGT1A8;UGT1A9	3		Rare Variant	2.0	Metabolism/PK	1	1	valproic acid	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449004220	Pediatric
1449004239	rs1829346		3			2.75	Toxicity	1	1	Platinum compounds;radiotherapy	Nasopharyngeal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449004239	
1449004245	rs36080650		3			2.75	Toxicity	1	1	Platinum compounds;radiotherapy	Nasopharyngeal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449004245	
1449004487	rs1059698		3			1.5	Toxicity	1	2	Platinum compounds;radiotherapy	Anemia;Dermatitis;mucositis;Myelosuppression;Nasopharyngeal Neoplasms;Neutropenia;Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449004487	
1449004522	rs73594404		3			1.5	Toxicity	1	2	Platinum compounds;radiotherapy	Anemia;Dermatitis;Leukopenia;mucositis;Myelosuppression;Neutropenia;Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449004522	
1449004528	rs2027701		3			1.0	Toxicity	1	2	Platinum compounds;radiotherapy	Anemia;Dermatitis;Leukopenia;mucositis;Myelosuppression;Neutropenia;Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449004528	
1449004567	rs1045642	ABCB1	3		Tier 1 VIP	4.0	Efficacy;Metabolism/PK	1	2	oxcarbazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449004567	
1449140063	rs3814055	NR1I2	3			3.5	Toxicity;Metabolism/PK	1	2	sirolimus;temsirolimus	adverse events;gastrointestinal toxicity;Myelosuppression;Urinary Bladder Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449140063	
1449140273	rs2075685	TMEM167A;XRCC4	3			3.5	Efficacy	1	1	fluorouracil;Platinum compounds;radiotherapy	Stomach Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449140273	
1449144292	rs324899		3			0.0	Efficacy	1	1	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449144292	
1449144298	rs6942227		3			0.0	Efficacy	1	1	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449144298	
1449144304	rs1611259		3			0.0	Efficacy	1	1	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449144304	
1449004229	rs2298771	SCN1A	4			-4.0	Efficacy	4	5	carbamazepine;clobazam;ethosuximide;lamotrigine;levetiracetam;oxcarbazepine;valproic acid	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449004229	Pediatric
1449144310	rs59724122	EPHX2	3			0.0	Efficacy	1	1	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449144310	
1449144316	rs61123830	GRAMD1B	3			0.0	Efficacy	1	1	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449144316	
1449005066	rs2740574	CYP3A;CYP3A4	3		Tier 1 VIP	3.25	Toxicity	1	1	cyclosporine;tacrolimus	Kidney Transplantation;transplant rejection	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449005066	
1451599327	rs2304016	SCN2A	3		Rare Variant	2.25	Efficacy	1	1	lamotrigine	Epilepsy	2021-11-30	https://www.pharmgkb.org/clinicalAnnotation/1451599327	
1449144322	rs7959663	MYO1H	3			0.0	Efficacy	1	1	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449144322	
1449144328	rs66486766		3			0.0	Efficacy	1	1	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449144328	
1449144334	rs7405404		3			0.0	Efficacy	1	1	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449144334	
1449144340	rs6728642	FAM178B	3			0.0	Efficacy	1	1	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449144340	
1449144346	rs62200793	ZNF804A	3			0.0	Efficacy	1	1	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449144346	
1449144352	rs7588746		3			0.0	Efficacy	1	1	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449144352	
1449564190	rs3734704	HSP90AB1	3			0.0	Toxicity	1	1	bevacizumab	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449564190	
1449564196	rs6929249	HSP90AB1	3			0.0	Toxicity	1	1	bevacizumab	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449564196	
1449564202	rs834576	HSP90AB1	3			0.0	Toxicity	1	1	bevacizumab	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449564202	
1451599340	rs2304016	SCN2A	3		Rare Variant	0.5	Efficacy	2	2	oxcarbazepine	Epilepsy	2021-11-30	https://www.pharmgkb.org/clinicalAnnotation/1451599340	
1451434900	rs267606617	MT-RNR1	1A		Rare Variant; Tier 1 VIP	107.0	Toxicity	34	35	streptomycin	Ototoxicity	2021-06-15	https://www.pharmgkb.org/clinicalAnnotation/1451434900	Pediatric
1449564208	rs9381299	PRKCA	3			0.0	Toxicity	1	1	bevacizumab	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449564208	
1450112801	rs13137622	ABCG2	3		Tier 1 VIP	2.0	Metabolism/PK	1	1	methotrexate	Osteosarcoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450112801	
1451599347	rs2304016	SCN2A	3		Rare Variant	2.25	Efficacy	1	1	phenytoin	Epilepsy	2021-11-30	https://www.pharmgkb.org/clinicalAnnotation/1451599347	
1451599354	rs2304016	SCN2A	3		Rare Variant	2.25	Efficacy	1	1	topiramate	Epilepsy	2021-11-30	https://www.pharmgkb.org/clinicalAnnotation/1451599354	
1449190656	HLA-B*15:02:01	HLA-B	4		Tier 1 VIP	-3.75	Toxicity	6	6	oxcarbazepine	Maculopapular Exanthema	2021-11-30	https://www.pharmgkb.org/clinicalAnnotation/1449190656	
1451436481	rs1556422499	MT-RNR1	3		Tier 1 VIP	0.25	Toxicity	3	3	streptomycin	Ototoxicity	2021-05-13	https://www.pharmgkb.org/clinicalAnnotation/1451436481	
1450932687	rs4680	COMT	3		Tier 1 VIP	0.5	Toxicity	1	2	buprenorphine;fentanyl;tramadol	adverse events;Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450932687	
1451436473	rs1556422499	MT-RNR1	3		Tier 1 VIP	0.25	Toxicity	1	1	dihydrostreptomycin	Ototoxicity	2021-05-12	https://www.pharmgkb.org/clinicalAnnotation/1451436473	
1451434880	rs267606617	MT-RNR1	1A		Rare Variant; Tier 1 VIP	101.75	Toxicity	11	12	kanamycin	Ototoxicity	2021-06-15	https://www.pharmgkb.org/clinicalAnnotation/1451434880	Pediatric
1451434905	rs267606617	MT-ND1;MT-RNR1	3		Rare Variant; Tier 1 VIP	0.25	Toxicity	5	5	neomycin	Ototoxicity	2021-05-13	https://www.pharmgkb.org/clinicalAnnotation/1451434905	
1451434920	rs267606617	MT-RNR1	1A		Rare Variant; Tier 1 VIP	101.25	Toxicity	5	6	amikacin	Ototoxicity	2021-06-15	https://www.pharmgkb.org/clinicalAnnotation/1451434920	Pediatric
1451434930	rs267606617	MT-RNR1	1A		Rare Variant; Tier 1 VIP	100.25	Toxicity	5	7	tobramycin	Ototoxicity	2021-06-15	https://www.pharmgkb.org/clinicalAnnotation/1451434930	Pediatric
1448635968	HLA-DRB3*01:01:02:01	HLA-DRB3	3			3.75	Toxicity	1	1	heparin	heparin-induced thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448635968	
1449163928	rs2069514	CYP1A2	3			0.25	Metabolism/PK	3	3	caffeine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449163928	
1449162866	rs1045642	ABCB1	3		Tier 1 VIP	1.25	Metabolism/PK	2	2	tramadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449162866	
1449162899	rs2032582	ABCB1	3		Tier 1 VIP	0.5	Metabolism/PK	2	2	tramadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449162899	
1449162912	rs1128503	ABCB1	3		Tier 1 VIP	1.0	Metabolism/PK	1	1	tramadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449162912	
1449163252	rs724710	BCL2L11	3			3.0	Toxicity	1	2	corticosteroids	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449163252	Pediatric
1449163306	rs2241843	BCL2L11	3			3.75	Toxicity	1	2	corticosteroids	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449163306	Pediatric
1449164609	rs13058338	RAC2	3			2.5	Efficacy	1	1	idarubicin	Leukemia, Myeloid, Acute	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449164609	
1449164746	rs274558	SLC22A5	3			3.0	Toxicity	1	1	imatinib	Gastrointestinal Stromal Tumors	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449164746	
1449164752	rs683369	SLC22A1	3			2.5	Toxicity	1	1	imatinib	Gastrointestinal Stromal Tumors	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449164752	
1449164863	rs36029	SLC6A2	3			1.0	Other	1	1	3,4-methylenedioxymethamphetamine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449164863	
1449164869	rs1861647	SLC6A2	3			1.0	Other	1	1	3,4-methylenedioxymethamphetamine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449164869	
1449165034	rs2231142	ABCG2	3		Tier 1 VIP	0.75	Toxicity	2	2	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449165034	
1449188737	rs589046	OPRM1	3			2.25	Metabolism/PK	1	1	cotinine;nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449188737	
1449271360	rs7668282	UGT2B7	3			1.0	Metabolism/PK	1	1	morphine	Anemia, Sickle Cell	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449271360	
1449188570	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	1B		Tier 1 VIP	34.0	Toxicity	15	20	acenocoumarol	over-anticoagulation	2021-05-18	https://www.pharmgkb.org/clinicalAnnotation/1449188570	
1449169595	rs5186	AGTR1	3			1.75	Metabolism/PK	1	1	atorvastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449169595	
1449169668	rs2070959	UGT1A6	3			0.0	Efficacy	1	1	aspirin	Colonic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449169668	
1449170060	HLA-A*33:03	HLA-A	3			4.5	Toxicity	2	2	lamotrigine	Maculopapular Exanthema	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449170060	
1449170150	rs2734583		3			3.75	Toxicity	1	1	allopurinol	drug reaction with eosinophilia and systemic symptoms;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449170150	
1449752771	rs2233678	PIN1	3			3.5	Efficacy	1	1	oxaliplatin	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449752771	
1450813825	rs11606194	HTR3B	3			3.0	Toxicity	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450813825	
1450415170	CYP2D6*1, CYP2D6*4	CYP2D6	1A		Tier 1 VIP	103.0	Dosage	2	3	metoprolol	Heart Failure	2021-05-03	https://www.pharmgkb.org/clinicalAnnotation/1450415170	
1450814653	rs2873804	DBH	3			2.75	Efficacy	1	1	bupropion	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450814653	
1450928460	rs6706232	UGT1A10;UGT1A3;UGT1A4;UGT1A5;UGT1A6;UGT1A7;UGT1A8;UGT1A9	3			0.0	Efficacy	1	1	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450928460	
1450928473	rs10012	CYP1B1	3			0.0	Efficacy	1	1	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450928473	
1450928522	rs6280	DRD3	3			0.0	Efficacy	1	1	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450928522	
1450822470	rs2298897	OPRD1	3			3.0	Toxicity	1	1	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450822470	
1449000354	CYP2D6*1, CYP2D6*7, CYP2D6*9, CYP2D6*10, CYP2D6*12, CYP2D6*14, CYP2D6*17, CYP2D6*18, CYP2D6*22, CYP2D6*23, CYP2D6*24, CYP2D6*25, CYP2D6*26, CYP2D6*27, CYP2D6*28, CYP2D6*29, CYP2D6*30, CYP2D6*31, CYP2D6*32, CYP2D6*33, CYP2D6*36, CYP2D6*37, CYP2D6*40, CYP2D6*43, CYP2D6*45, CYP2D6*46, CYP2D6*47, CYP2D6*49, CYP2D6*50, CYP2D6*51, CYP2D6*52, CYP2D6*54, CYP2D6*55, CYP2D6*57, CYP2D6*61, CYP2D6*62, CYP2D6*63, CYP2D6*64, CYP2D6*65, CYP2D6*70, CYP2D6*71, CYP2D6*114	CYP2D6	3		Tier 1 VIP	0.0	Metabolism/PK	1	6	n-desmethyltamoxifen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449000354	
1450822778	rs1799971	OPRM1	3			2.0	Toxicity	1	1	antidepressants;antipsychotics;benzodiazepine derivatives;opioids;Sympathomimetics	Heart Arrest;Overdose;Respiratory Insufficiency	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450822778	
1450822829	rs3852209	HINT1	3			1.25	Other	1	1	nicotine	cessation;Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450822829	
1450823316	rs1051730	CHRNA3	3			2.75	Dosage	1	1	Drugs used in nicotine dependence;nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450823316	
1450823707	rs2514218	DRD2	3		Tier 1 VIP	1.75	Efficacy	1	1	aripiprazole;risperidone	Psychotic Disorders;schizoaffective disorder;Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450823707	Pediatric
1450928608	rs2768759	NTRK1;PEAR1	3			1.5	Efficacy	3	3	aspirin;prasugrel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450928608	
1449000657	CYP2D6*1, CYP2D6*2, CYP2D6*10, CYP2D6*87, CYP2D6*89, CYP2D6*90, CYP2D6*93, CYP2D6*95, CYP2D6*97, CYP2D6*98	CYP2D6	4		Tier 1 VIP	-0.75	Metabolism/PK	2	2	methadone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449000657	
1450812333	rs6277	DRD2	3		Tier 1 VIP	1.0	Efficacy	1	2	nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450812333	
1448636924	rs351855	FGFR4	3			1.75	Efficacy	1	1	everolimus	discontinuation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448636924	
1450812912	rs10055255	CRHBP	3			1.75	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450812912	
1450820979	rs3787140	CHRNA4	3			0.0	Toxicity	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450820979	
1449565072	rs2228130	POLR2A	3			0.25	Toxicity	1	3	gemcitabine	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449565072	
1449748502	rs2032582	ABCB1	3		Tier 1 VIP	2.25	Efficacy	1	1	tacrolimus	Nephrotic Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449748502	
1450810266	rs524731	OPRM1	3			6.25	Toxicity	2	2	heroin;opioids	Heroin Dependence;Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450810266	Pediatric
1450822281	rs1799971	OPRM1	3			0.75	Toxicity	2	2	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450822281	Pediatric
1450823109	rs3778150	OPRM1	3			3.5	Toxicity	1	1	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450823109	
1450823322	rs10485057	OPRM1	3			0.0	Toxicity	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450823322	
1451437666	rs28358569	MT-RNR1	3		Tier 1 VIP	0.25	Toxicity	1	1	streptomycin	Ototoxicity	2021-05-13	https://www.pharmgkb.org/clinicalAnnotation/1451437666	
1451437721	rs28358569	MT-RNR1	3		Tier 1 VIP	0.25	Toxicity	1	1	gentamicin	Ototoxicity	2021-05-13	https://www.pharmgkb.org/clinicalAnnotation/1451437721	
1450814529	rs1800497	DRD2	3		Tier 1 VIP	2.0	Dosage	1	1	ethanol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450814529	Pediatric
1450814671	rs17614642	FKBP5	3			2.25	Efficacy	1	1	bupropion	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450814671	
1450814929	rs17584499	PTPRD	3			2.25	Efficacy	1	1	pioglitazone	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450814929	
1450931522	rs738409	PNPLA3	3			3.5	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450931522	
1450936205	rs1042028	SULT1A1	3			0.0	Metabolism/PK	1	1	desmethylnaproxen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936205	
1449269473	rs7439366	UGT2B7	3			0.5	Efficacy	1	2	oxycodone	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449269473	
1449269910	rs9923231	VKORC1	2A		Tier 1 VIP	12.25	Toxicity	26	26	warfarin	Hemorrhage	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449269910	Pediatric
1145231686	rs2032582	ABCB1	3		Tier 1 VIP	2.375	Efficacy	2	2	pravastatin	Acute coronary syndrome;Hyperlipoproteinemia Type II	2021-12-03	https://www.pharmgkb.org/clinicalAnnotation/1145231686	Pediatric
1451605911	rs11872992	MC4R	3			0.0	Toxicity	1	1	olanzapine	Schizophrenia;Weight gain	2021-12-03	https://www.pharmgkb.org/clinicalAnnotation/1451605911	
1451605946	rs2268639	GLP1R	3			0.0	Toxicity	1	1	olanzapine	Schizophrenia;Weight gain	2021-12-03	https://www.pharmgkb.org/clinicalAnnotation/1451605946	
1450377214	rs1208	NAT2	3		Tier 1 VIP	2.25	Toxicity	1	1	isoniazid;phenytoin	Drug interaction with drug;Drug Toxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450377214	
1451606000	rs1800566	NQO1	3			0.25	Efficacy	1	1	warfarin	Thrombosis	2021-12-03	https://www.pharmgkb.org/clinicalAnnotation/1451606000	
1449271027	rs150688309	PIK3R2	3			0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449271027	
1449271033	rs79430272	PIK3R2	3			0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449271033	
1449271057	rs58695150	PIK3R2	3			0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449271057	
1449271063	rs8110364	PIK3R2	3			0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449271063	
1449271069	rs74743371	CBR3	3			0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449271069	
1451439812	rs267606619	MT-RNR1	1A		Rare Variant; Tier 1 VIP	100.25	Toxicity	1	2	kanamycin	Ototoxicity	2021-06-15	https://www.pharmgkb.org/clinicalAnnotation/1451439812	
1449165230	rs12208357	SLC22A1	3			3.25	Metabolism/PK	5	5	metformin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449165230	
1451436140	rs267606618	MT-RNR1	1A		Rare Variant; Tier 1 VIP	100.75	Toxicity	3	4	streptomycin	Ototoxicity	2021-06-15	https://www.pharmgkb.org/clinicalAnnotation/1451436140	
1449165794	rs237025	SUMO4	3			1.0	Metabolism/PK	1	1	tacrolimus	liver transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449165794	
1448636814	rs9906827	RPTOR	3			5.0	Efficacy;Toxicity	1	2	everolimus	pneumonitis;progression-free survival	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448636814	
1448636842	rs2032582	ABCB1	3		Tier 1 VIP	2.25	Toxicity	1	1	everolimus	Breast Neoplasms;Lymphopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448636842	
1448636848	rs1045642	ABCB1	3		Tier 1 VIP	2.25	Toxicity	1	1	everolimus	Breast Neoplasms;mucositis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448636848	
1450822790	rs1800497	ANKK1;DRD2	3		Tier 1 VIP	0.75	Toxicity	2	2	opioids	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450822790	
1450932989	rs10877012	CYP27B1	3			2.5	Efficacy	1	1	deferasirox	beta-Thalassemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450932989	
1451608148	rs1937840	AKR1C3	3			1.5	Other	1	1	doxorubicin	Breast Neoplasms	2021-12-06	https://www.pharmgkb.org/clinicalAnnotation/1451608148	
1449164352	CYP3A4*1, CYP3A4*22	CYP3A4	3		Tier 1 VIP	1.75	Metabolism/PK	1	1	sildenafil	Heart Failure	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449164352	
1449189236	rs9943291	HMGCS2	3			1.625	Toxicity	1	1	chlorothiazide;hydrochlorothiazide	Hyperglycemia;Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449189236	
1451440020	rs28358571		3			0.25	Toxicity	1	1	streptomycin	Ototoxicity	2021-05-17	https://www.pharmgkb.org/clinicalAnnotation/1451440020	
1451440041	rs28358571		3			0.25	Toxicity	1	1	kanamycin	Ototoxicity	2021-05-17	https://www.pharmgkb.org/clinicalAnnotation/1451440041	
1450374881	rs2032582	ABCB1	3		Tier 1 VIP	2.0	Toxicity	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450374881	Pediatric
1450375024	rs1045642	ABCB1	3		Tier 1 VIP	2.5	Toxicity	1	1	bleomycin;cisplatin;etoposide	Testicular Neoplasms;Vomiting	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450375024	
1450375035	rs2740574	CYP3A;CYP3A4	3		Tier 1 VIP	2.5	Toxicity	1	1	bleomycin;cisplatin;etoposide	Alopecia;Testicular Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450375035	
1449157113	TPMT*1, TPMT*3A, TPMT*3C	TPMT	3		Tier 1 VIP	2.0	Metabolism/PK	1	1	thioguanine	Crohn Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449157113	
1449556772	rs4149056	SLCO1B1	1A		Tier 1 VIP	110.625	Metabolism/PK	9	10	simvastatin;simvastatin acid		2022-02-14	https://www.pharmgkb.org/clinicalAnnotation/1449556772	Pediatric
1449188679	rs6912029	OPRM1	3			2.25	Metabolism/PK	1	1	cotinine;nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449188679	
1449557359	rs11574077	VDR	3			1.75	Metabolism/PK	1	1	irinotecan	Colorectal Neoplasms	2021-12-01	https://www.pharmgkb.org/clinicalAnnotation/1449557359	
1449166824	rs186983396	RYR1	3		Rare Variant; Tier 1 VIP	0.0	Other	1	1	caffeine;chlorocresol	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449166824	
1449270865	rs115457081	IRS1	3		Rare Variant	0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449270865	
1449564951	rs5219	KCNJ11	3			3.25	Efficacy	3	3	sulfonamides, urea derivatives	Diabetes Mellitus	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449564951	
1449270871	rs112242273	GNL3	3			0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449270871	
1449270877	rs299293	HMMR	3			0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449270877	
1449270889	rs299314	HMMR	3			0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449270889	
1449270895	rs3805945	PPP2R5D	3			0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449270895	
1449270901	rs78428806	PERP	3			0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449270901	
1449270907	rs117101815	PERP	3			0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449270907	
1449270925	rs9402944	PERP	3			0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449270925	
1449270931	rs9389568	PERP	3			0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449270931	
1449270937	rs117458836	CYP2C8	3		Tier 1 VIP	0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449270937	
1449270943	rs118088833	TP53AIP1	3		Rare Variant	0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449270943	
1449270949	rs149212925	NOS1	3		Rare Variant	0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449270949	
1449270955	rs144991623	FOXO1	3		Rare Variant	0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449270955	
1449270973	rs181501757	TOP2A	3		Rare Variant	0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449270973	
1449270979	rs142244113	INSR	3			0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449270979	
1449564957	rs757110	ABCC8;KCNJ11	3			0.75	Efficacy	2	2	sulfonamides, urea derivatives	Diabetes Mellitus	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449564957	
1449564963	rs1803274	BCHE	3			0.5	Efficacy	4	4	donepezil	Alzheimer Disease;cognitive dysfunction	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449564963	
1450928454	rs1056827	CYP1B1	3			0.0	Efficacy	1	1	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450928454	
1449003717	rs200707504	CES1	3		Rare Variant	0.125	Metabolism/PK	1	1	oseltamivir		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449003717	
1449003723	rs12459996		3			0.0	Toxicity	1	1	glatiramer acetate		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449003723	
1449003729	rs1056854		3			0.0	Toxicity	1	1	glatiramer acetate		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449003729	
1449003741	rs75041078		3			0.0	Toxicity	1	1	glatiramer acetate		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449003741	
1451553602	rs2231142	ABCG2	4		Tier 1 VIP	-0.875	Metabolism/PK	7	7	methotrexate	Burkitt Lymphoma;Lymphoma, T-Cell;Osteosarcoma;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-12-13	https://www.pharmgkb.org/clinicalAnnotation/1451553602	Pediatric
1450928505	rs4818	COMT	3		Tier 1 VIP	0.0	Efficacy	1	1	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450928505	
1451615421	rs3740065	ABCC2	4			-1.5	Metabolism/PK	4	4	methotrexate	Leukemia, B-Cell, Acute;Osteosarcoma;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-12-13	https://www.pharmgkb.org/clinicalAnnotation/1451615421	Pediatric
1450928534	rs4680	COMT	4		Tier 1 VIP	-1.5	Efficacy	2	2	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450928534	
1450373610	rs9787901	CHST1	3			1.5	Toxicity	1	1	imatinib	Gastrointestinal Stromal Tumors	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450373610	
1450373616	rs10517	NQO1	3			2.0	Efficacy	1	1	imatinib	Gastrointestinal Stromal Tumors	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450373616	
1450377181	rs1041983	NAT2	3		Tier 1 VIP	2.25	Toxicity	1	1	isoniazid;phenytoin	Drug interaction with drug;Drug Toxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450377181	
1450377193	rs1799929	NAT2	3		Tier 1 VIP	2.25	Toxicity	1	1	isoniazid;phenytoin	Drug interaction with drug;Drug Toxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450377193	
1449752982	rs11568626	SLC22A6	4			-1.75	Other	3	3	adefovir dipivoxil;cidofovir;tenofovir		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449752982	
1449753021	rs11568634	SLC22A6	4		Rare Variant	-1.25	Other	2	3	adefovir dipivoxil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449753021	
1450823344	rs10485057	OPRM1	3			0.0	Dosage	1	1	nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450823344	
1450931422	rs10432303	PIP5K1C	3			0.0	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450931422	
1450931428	rs8109485	PIP5K1C	3			0.0	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450931428	
1450931440	rs10405681	PIP5K1C	3			0.0	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450931440	
1450931815	rs1042718	ADRB2	3		Tier 1 VIP	0.125	Other	1	1	fentanyl		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450931815	
1450931828	rs4680	COMT	3		Tier 1 VIP	2.0	Toxicity	1	1	fentanyl	somnolence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450931828	
1450823773	rs1799971	OPRM1	4			-4.0	Toxicity	4	4	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450823773	
1450823785	rs1799971	OPRM1	4			-5.0	Toxicity	4	4	cocaine	Cocaine-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450823785	Pediatric
1449157600	rs367398	NOTCH4	3			2.5	Toxicity	1	1	allopurinol	severe cutaneous adverse reactions	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449157600	
1450377220	rs1799931	NAT2	3		Tier 1 VIP	2.25	Toxicity	1	1	isoniazid;phenytoin	Drug interaction with drug;Drug Toxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450377220	
1450826907	rs1799971	OPRM1	3			2.0	Efficacy	2	2	alfentanil	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450826907	
1450826913	rs1799971	OPRM1	3			1.125	Metabolism/PK	2	2	alfentanil	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450826913	
1450826993	rs1799971	OPRM1	3			2.5	Efficacy	1	1	opioids	Pain, Postoperative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450826993	
1450933062	rs6920220	SH3BP2;TNFAIP3	3			2.5	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Arthritis, Psoriatic;Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450933062	
1450933116	rs1456862	ADGRL3	3			1.75	Toxicity	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450933116	
1451615920	rs2736308		3			5.5	Toxicity	1	2	Bisphosphonates	osteonecrosis of jaw caused by drug	2021-12-13	https://www.pharmgkb.org/clinicalAnnotation/1451615920	
1449140229	rs1128503	ABCB1	3		Tier 1 VIP	1.5	Metabolism/PK	1	1	sirolimus;temsirolimus	Urinary Bladder Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449140229	
1449645366	rs767263838	SULT1A3	3		Rare Variant	0.0	Metabolism/PK	1	1	morphine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645366	
1449645372	rs767263838	SULT1A3	3		Rare Variant	0.0	Metabolism/PK	1	1	tapentadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645372	
1449645378	rs767263838	SULT1A3	3		Rare Variant	0.0	Metabolism/PK	1	1	o-desmethyltramadol;tramadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645378	
1449645386	rs757573592	SULT1A3;SULT1A4	3		Rare Variant	0.0	Metabolism/PK	1	1	acetaminophen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645386	
1449645392	rs757573592	SULT1A3;SULT1A4	3		Rare Variant	0.0	Metabolism/PK	1	1	morphine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645392	
1450813534	rs1709083	CYP2A13	3		Rare Variant	0.0	Toxicity	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450813534	
1450813554	rs28399433	CYP2A6	3		Tier 1 VIP	2.5	Toxicity	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450813554	
1451447387	rs12422149	SLCO2B1	3			1.5	Efficacy	1	1	rosuvastatin		2021-05-20	https://www.pharmgkb.org/clinicalAnnotation/1451447387	
1449168058	rs6700741		3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168058	
1449168065	rs4971678	NRXN1	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168065	
1449168321	rs12094644		3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168321	
1449168628	rs78482393	ANO2	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168628	
1449168635	rs78615940	ANO2	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168635	
1449168642	rs17724494	ANO2	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168642	
1449169490	rs12233719	UGT2B7	3		Rare Variant	1.5	Metabolism/PK	1	2	valproic acid	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449169490	Pediatric
1449271393	rs141084494	RBX1	3		Rare Variant	0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449271393	
1451447440	rs2413739	PACSIN2	3			2.25	Efficacy	1	1	azathioprine	Irritable Bowel Syndrome	2021-05-20	https://www.pharmgkb.org/clinicalAnnotation/1451447440	Pediatric
1449004548	rs7439366	UGT2B7	3			1.0	Efficacy	2	3	oxcarbazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449004548	
1449752787	rs2233678	PIN1	3			2.5	Efficacy	1	1	irinotecan	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449752787	
1449156122	HLA-B*15:24	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156122	
1449155828	HLA-B*39:10:01	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449155828	
1449156084	HLA-B*39:01:01:01	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156084	
1449747881	rs15524	CYP3A5	3		Tier 1 VIP	4.0	Metabolism/PK	2	2	tacrolimus	Kidney Transplantation;liver transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449747881	
1450810387	rs495491	OPRM1	3			6.0	Toxicity	2	2	opioids	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450810387	Pediatric
1449156076	HLA-B*38:02:01	HLA-B	4		Tier 1 VIP	-1.75	Toxicity	2	2	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156076	
1449168086	rs9879065	ZNF385D	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168086	
1449168670	rs10771997		3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168670	
1449168677	rs10771998		3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168677	
1449269868	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	2A		Tier 1 VIP	10.5	Toxicity	11	15	acenocoumarol	Hemorrhage	2021-05-18	https://www.pharmgkb.org/clinicalAnnotation/1449269868	
1451448900	NUDT15*1, NUDT15*4, NUDT15*5, NUDT15*6	NUDT15	3		Tier 1 VIP	2.0	Dosage	2	2	mercaptopurine		2021-05-24	https://www.pharmgkb.org/clinicalAnnotation/1451448900	Pediatric
1450810247	rs524731	OPRM1	3			2.75	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450810247	Pediatric
1450810295	rs3823010	OPRM1	3			6.75	Toxicity	2	2	heroin;opioids	Heroin Dependence;Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450810295	Pediatric
1450810345	rs1381376	OPRM1	3			2.5	Toxicity	1	1	ethanol	Alcoholism	2021-12-03	https://www.pharmgkb.org/clinicalAnnotation/1450810345	
1449169795	rs717620	ABCC2	3			2.5	Efficacy	1	1	atorvastatin	Hypercholesterolemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449169795	
1449170055	HLA-A*02:07:01	HLA-A	3			2.25	Toxicity	1	1	lamotrigine	Maculopapular Exanthema;severe cutaneous adverse reactions;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449170055	
1449170068	HLA-B*44:03:01	HLA-B	3		Tier 1 VIP	2.75	Toxicity	3	3	lamotrigine	Maculopapular Exanthema	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449170068	
1449170133	rs9263726	PSORS1C1	3			3.75	Toxicity	1	1	allopurinol	drug reaction with eosinophilia and systemic symptoms;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449170133	
1448999588	CYP2D6*1, CYP2D6*10, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*97, CYP2D6*98	CYP2D6	3		Tier 1 VIP	0.0	Metabolism/PK	1	2	dapoxetine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448999588	
1449189242	rs61824877		3			3.0	Toxicity	1	1	chlorothiazide;hydrochlorothiazide	Hyperglycemia;Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449189242	
1449577050	rs6151031	ALDH1A1	3		Rare Variant	3.0	Efficacy	1	1	cyclophosphamide;doxorubicin	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449577050	
1449752561	rs1690924	MDM2	3			2.0	Efficacy	1	1	Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449752561	
1449752602	rs1051266	SLC19A1	3		Tier 1 VIP	2.0	Efficacy	1	1	Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449752602	
1450376443	rs28386840	SLC6A2	3			4.875	Efficacy	7	8	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450376443	Pediatric
1451621726	rs1128503	ABCB1	3		Tier 1 VIP	2.5	Toxicity	3	3	methotrexate	Lymphoma;mucositis;Osteosarcoma;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2022-01-04	https://www.pharmgkb.org/clinicalAnnotation/1451621726	Pediatric
1450376745	rs4680	COMT	4		Tier 1 VIP	-6.25	Efficacy	14	14	methylphenidate	Attention Deficit Disorder with Hyperactivity	2022-02-28	https://www.pharmgkb.org/clinicalAnnotation/1450376745	Pediatric
1449157951	rs927650	CYP24A1	3			1.25	Metabolism/PK	1	1	deferasirox	beta-Thalassemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449157951	
1449157957	rs2585428	CYP24A1	3			2.25	Metabolism/PK	1	1	deferasirox	beta-Thalassemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449157957	
1449157963	rs2248359	CYP24A1	3			2.375	Metabolism/PK	2	2	deferasirox	beta-Thalassemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449157963	Pediatric
1449170460	rs3212986	ERCC1	3			3.0	Efficacy	1	1	granisetron;palonosetron	Nausea;Neoplasms;Vomiting	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449170460	
1449270486	rs11940694	KLB	3			0.0	Dosage	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449270486	
1449270883	rs299313	HMMR	3			0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449270883	
1449140263	rs34550074	SLCO2A1	3			2.5	Toxicity	1	1	Thiazides, plain	Hypernatremia;Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449140263	
1449140279	rs10040363	XRCC4	3			3.5	Efficacy	1	1	fluorouracil;Platinum compounds;radiotherapy	Stomach Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449140279	
1449752818	rs201929247	HLA-DRB1	3			3.0	Toxicity	1	1	dapsone	Drug Hypersensitivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449752818	
1450813566	CYP2B6*1, CYP2B6*4	CYP2B6	3		Tier 1 VIP	2.5	Toxicity	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450813566	
1451448820	NUDT15*1, NUDT15*2, NUDT15*3	NUDT15	1A		Tier 1 VIP	208.25	Toxicity	3	5	mercaptopurine	Leukopenia;Neutropenia	2021-05-24	https://www.pharmgkb.org/clinicalAnnotation/1451448820	Pediatric
1451621742	rs1045642	ABCB1	4		Tier 1 VIP	-0.375	Efficacy	7	7	methotrexate	Arthritis, Juvenile Rheumatoid;Arthritis, Rheumatoid	2021-12-16	https://www.pharmgkb.org/clinicalAnnotation/1451621742	Pediatric
1450814813	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15, SLCO1B1*37	SLCO1B1	1A		Tier 1 VIP	106.125	Metabolism/PK	5	6	pitavastatin		2022-02-15	https://www.pharmgkb.org/clinicalAnnotation/1450814813	
1449310234	rs193922764	RYR1	1A		Rare Variant; Tier 1 VIP	100.25	Toxicity	4	5	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449310234	Pediatric
1449310249	rs193922832	RYR1	1A		Rare Variant; Tier 1 VIP	100.0	Toxicity	1	2	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449310249	
1449310265	rs193922843	RYR1	1A		Tier 1 VIP	100.0	Toxicity	1	2	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449310265	
827863843	rs37973	GLCCI1	3			0.0	Efficacy	1	1	budesonide;flunisolide;fluticasone propionate;glucocorticoids;nedocromil;triamcinolone	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827863843	
827864159	rs1024323	GRK4	3			1.75	Efficacy	1	2	metoprolol	Hypertension;Kidney Diseases;Nephrosclerosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827864159	
827864179	rs1801272	CYP2A6	3		Tier 1 VIP	0.25	Other	2	2	coumarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827864179	
827864301	rs11739136	KCNIP1;KCNMB1	3			6.5	Efficacy	3	3	verapamil	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827864301	
1450930548	rs3784921	TXNDC11	3			2.75	Efficacy	1	1	hydrochlorothiazide	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450930548	
1450930554	rs7184292		3			2.25	Efficacy	1	1	atenolol	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450930554	
1450930560	rs7184292		3			2.75	Dosage	1	1	atenolol	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450930560	
1450930827	rs3743075	CHRNA3	3			3.0	Toxicity	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450930827	
1450936741	rs17376019	SRPRB	3			2.0	Metabolism/PK	1	1	ethanol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936741	
1450929786	rs1045642	ABCB1	4		Tier 1 VIP	-1.25	Efficacy	2	2	fentanyl	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450929786	Pediatric
827864250	rs1876828	CRHR1	3			3.5	Efficacy	6	6	corticosteroids	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827864250	Pediatric
827862764	rs12979860	IFNL3;IFNL4	1A			350.5	Efficacy	69	86	peginterferon alfa-2a;peginterferon alfa-2b;ribavirin	Hepatitis C	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827862764	Pediatric
1451634907	rs1805087	MTR	3			0.0	Efficacy	1	1	folic acid;hydroxychloroquine;methotrexate;sulfasalazine	Arthritis, Rheumatoid	2022-01-04	https://www.pharmgkb.org/clinicalAnnotation/1451634907	
1451634914	rs1805087	MTR	3			2.5	Efficacy	1	1	methotrexate	Arthritis, Rheumatoid	2022-01-04	https://www.pharmgkb.org/clinicalAnnotation/1451634914	
1451634940	rs1805087	MTR	3			1.75	Toxicity	1	1	methotrexate	Arthritis, Rheumatoid	2022-01-04	https://www.pharmgkb.org/clinicalAnnotation/1451634940	
1449310001	rs2273359	NELFCD	3			0.0	Efficacy	1	1	diuretics;hydrochlorothiazide;Thiazides, plain	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449310001	
1449310013	rs12046844		3			0.0	Toxicity	1	1	gemcitabine	Leukopenia;Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449310013	
1449716392	rs2032582	ABCB1	3		Tier 1 VIP	0.0	Toxicity	1	2	fentanyl	Neoplasms;Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449716392	
1449716764	rs1128503	ABCB1	3		Tier 1 VIP	3.0	Dosage;Efficacy	3	3	fentanyl	Pain;Pain, Postoperative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449716764	Pediatric
1449748823	rs2229109	ABCB1	3		Tier 1 VIP	3.25	Efficacy	1	1	tacrolimus	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449748823	
1449309975	rs7270101	ITPA	4			-1.25	Toxicity	4	4	azathioprine	Inflammatory Bowel Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449309975	Pediatric
1449309937	rs121918596	RYR1	1A		Rare Variant; Tier 1 VIP	100.5	Toxicity	2	3	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449309937	Pediatric
1451635027	rs9344	CCND1	3			2.5	Efficacy	1	1	methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2022-01-04	https://www.pharmgkb.org/clinicalAnnotation/1451635027	Pediatric
1451635034	rs9344	CCND1	3			0.0	Efficacy	1	1	cisplatin;doxorubicin;methotrexate	Osteosarcoma	2022-01-04	https://www.pharmgkb.org/clinicalAnnotation/1451635034	Pediatric
1450375716	rs10193126	TRIB2	3			0.0	Efficacy	1	1	allopurinol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450375716	
1450375722	rs57449396	TBL1XR1	3			0.0	Efficacy	1	1	allopurinol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450375722	
1450375728	rs2725215	PKD2	3			0.0	Efficacy	1	1	allopurinol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450375728	
1450822476	rs2236855	OPRD1	3			3.0	Toxicity	1	1	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450822476	
1450823115	rs9384169		3			3.5	Toxicity	1	1	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450823115	
1450823333	rs10485057	OPRM1	3			4.0	Dosage	1	1	ethanol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450823333	
1450823350	rs10485057	OPRM1	3			0.0	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450823350	
1450823626	rs9829896	KAT2B	3			2.5	Toxicity	1	1	amphetamine;cannabinoids;cocaine;opioids	Substance-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450823626	
1450823791	rs1799971	OPRM1	3			0.0	Toxicity	1	1	cannabinoids	Marijuana Abuse	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450823791	
1449004876	rs2838958	SLC19A1	3		Tier 1 VIP	2.75	Efficacy	1	1	methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449004876	Pediatric
1449005017	rs41303343	CYP3A5	4		Tier 1 VIP	-1.25	Metabolism/PK	1	2	lumefantrine	Malaria	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449005017	
1449005031	rs10264272	CYP3A5	3		Tier 1 VIP	0.0	Metabolism/PK	1	2	lumefantrine	Malaria	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449005031	
1449005382	rs1000940	RABEP1	3			2.25	Other	1	1	amisulpride;aripiprazole;clozapine;lithium;mirtazapine;olanzapine;paliperidone;quetiapine;risperidone;valproic acid	Bipolar Disorder;Depressive Disorder;Psychotic Disorders;schizoaffective disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449005382	
1449005393	rs1128503	ABCB1	3		Tier 1 VIP	4.0	Efficacy;Toxicity	1	2	remifentanil;sevoflurane	tonsillectomy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449005393	Pediatric
1449004807	rs10841753	SLCO1B1	4		Tier 1 VIP	-1.75	Metabolism/PK	1	3	methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449004807	Pediatric
1449575639	rs1335150891	DPYD	3		Rare Variant; Tier 1 VIP	0.0	Other	1	1	fluorouracil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449575639	
1184000346	G6PD A- 202A_376G, G6PD B (wildtype)	G6PD	3		Tier 1 VIP	0.375	Toxicity	3	3	nitrofurantoin	Anemia, Hemolytic;Hemolysis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184000346	
1184000380	G6PD B (wildtype), G6PD Mediterranean Haplotype	G6PD	3		Tier 1 VIP	0.25	Toxicity	2	2	phenazopyridine	Anemia, Hemolytic;Hemolysis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184000380	
1183702975	rs3745274	CYP2B6	3		Tier 1 VIP	2.75	Dosage	6	6	methadone	Heroin Dependence;Opioid-Related Disorders	2022-02-11	https://www.pharmgkb.org/clinicalAnnotation/1183702975	
1183702959	rs10501087	BDNF-AS	3			3.25	Efficacy	1	1	antipsychotics	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183702959	
1183702964	rs6265	BDNF	3			3.25	Efficacy	1	1	antipsychotics	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183702964	
1183704353	rs6920220	TNFAIP3	3			3.0	Efficacy	1	1	methotrexate		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183704353	
1183945178	CYP1A2*1A, CYP1A2*1F	CYP1A2	3			5.125	Toxicity	3	4	caffeine	Abortion, Spontaneous	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183945178	
1183704339	rs6977820		3			3.0	Toxicity	1	1	antipsychotics	Schizophrenia;tardive dyskinesia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183704339	
1183703010	rs3732218	UGT1A4	3			1.75	Other	1	1	anastrozole		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183703010	
1183704233	rs9394992	SLC29A1	3			1.0	Toxicity	1	2	gemcitabine	Pancreatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183704233	
1183704404	rs6427528	CD84	3			2.0	Efficacy	2	2	etanercept	Arthritis, Rheumatoid;Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183704404	
1184136804	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	3			2.0	Toxicity	2	3	Selective serotonin reuptake inhibitors		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184136804	
1184136899	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	3			2.5	Toxicity	2	3	risperidone	Drug Toxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184136899	
1184169936	rs1801274	FCGR2A	3			4.25	Efficacy	2	3	adalimumab;infliximab	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184169936	
1183704302	rs716274	DYNC2H1	3			0.0	Efficacy	1	1	etoposide;Platinum compounds		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183704302	
1183960795	rs267606723	CFTR	1A		Rare Variant; Tier 1 VIP	202.0	Efficacy	2	4	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183960795	Pediatric
1183682436	rs80338792	SCN4A	3		Rare Variant	0.25	Efficacy	2	3	flecainide;mexiletine	Myotonia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183682436	
1183704272	rs7311358	SLCO1B3	3			2.0	Other	1	2	docetaxel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183704272	
1183704316	rs699947	VEGFA	3			2.25	Efficacy	1	1	sildenafil	Erectile Dysfunction	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183704316	
1184136848	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	3			2.75	Efficacy	6	9	escitalopram	Depression;Depressive Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184136848	
1184136856	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	3			2.25	Efficacy	1	1	ondansetron	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184136856	
1183944118	G6PD A- 202A_376G, G6PD B (wildtype)	G6PD	4		Tier 1 VIP	-0.875	Toxicity	8	8	mefloquine	Malaria	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183944118	Pediatric
1451635167	rs1801394	FASTKD3;MTRR	4			-1.25	Toxicity	2	2	methotrexate	Arthritis, Juvenile Rheumatoid;Arthritis, Rheumatoid	2022-01-04	https://www.pharmgkb.org/clinicalAnnotation/1451635167	Pediatric
1183704311	rs71486745	CYP2C9	3		Tier 1 VIP	2.0	Dosage	1	2	phenytoin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183704311	
1184348731	rs1801280	NAT2	3		Tier 1 VIP	1.75	Toxicity	1	2	cisplatin;cyclophosphamide	Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184348731	
1184472737	rs2234693	ESR1	3			2.75	Toxicity	1	1	anastrozole;letrozole	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184472737	
1184472746	rs9340799	ESR1	3			2.75	Toxicity	1	1	anastrozole;letrozole	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184472746	
1184516188	G6PD B (wildtype), G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham	G6PD	3		Tier 1 VIP	0.0	Toxicity	1	1	sulfadoxine	Hemolysis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184516188	
1183702981	rs2279343	CYP2B6	3		Tier 1 VIP	1.0	Dosage	4	4	methadone	Heroin Dependence	2022-01-10	https://www.pharmgkb.org/clinicalAnnotation/1183702981	
1184472649	CYP2A6*1, CYP2A6*15, CYP2A6*21, CYP2A6*22	CYP2A6	3		Tier 1 VIP	0.0	Metabolism/PK	1	1	methoxsalen		2022-09-29	https://www.pharmgkb.org/clinicalAnnotation/1184472649	
1184661207	rs2108622	CYP4F2	3		Tier 1 VIP	4.75	Dosage	4	4	phenprocoumon		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184661207	
1183705788	rs118192170	RYR1	1A		Tier 1 VIP	100.25	Toxicity	3	4	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705788	
1183960800	rs74503330	CFTR	1A		Rare Variant; Tier 1 VIP	202.0	Efficacy	3	5	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183960800	Pediatric
1183960766	rs121908757	CFTR	1A		Rare Variant; Tier 1 VIP	204.75	Efficacy	4	6	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183960766	Pediatric
1183960775	rs121909005	CFTR	1A		Rare Variant; Tier 1 VIP	202.25	Efficacy	3	5	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183960775	Pediatric
1183960785	rs121909041	CFTR	1A		Rare Variant; Tier 1 VIP	202.0	Efficacy	2	4	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183960785	Pediatric
1184136380	rs11322783	IFNL4	1B			65.25	Efficacy	23	29	peginterferon alfa-2a;peginterferon alfa-2b;ribavirin	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184136380	
1183704321	rs699947	VEGFA	3			2.0	Toxicity	1	1	sunitinib		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183704321	
1183704372	rs6749447	STK39	3			3.0	Efficacy	1	1	losartan		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183704372	
1184233161	rs5522	NR3C2	3			2.75	Efficacy	1	1	enalapril	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184233161	
1184233180	rs1799752	ACE	3		Tier 1 VIP	1.25	Other	1	3	antidepressants;antiepileptics;Beta Blocking Agents;calcium channel blockers	Headache Disorders;Migraine with Aura;Migraine without Aura	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184233180	
1184348713	rs698	ADH1C	3			2.25	Efficacy	1	1	cisplatin;cyclophosphamide	Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184348713	
1184348718	rs1142345	TPMT	3		Tier 1 VIP	2.25	Efficacy	1	1	cisplatin;cyclophosphamide	Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184348718	
1184514202	rs10497203	TANC1	3			1.75	Toxicity	1	1	radiotherapy	Prostatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184514202	
1183888959	rs8099917	IFNL3	2A			15.5	Efficacy	6	6	peginterferon alfa-2a;peginterferon alfa-2b;ribavirin;telaprevir	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183888959	
1183960805	rs80282562	CFTR	1A		Rare Variant; Tier 1 VIP	202.0	Efficacy	2	4	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183960805	Pediatric
1184348872	rs2268639	GLP1R	3			0.0	Toxicity	1	1	clozapine	Schizophrenia;Weight gain	2021-12-03	https://www.pharmgkb.org/clinicalAnnotation/1184348872	
1183704297	rs717620	ABCC2	3			3.0	Dosage	1	1	atorvastatin;simvastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183704297	
1184348774	rs1052536	LIG3	3			1.875	Toxicity	1	2	cisplatin;cyclophosphamide	Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184348774	
1184348859	rs13429709	GCG	3			2.0	Other	1	2	clozapine;olanzapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184348859	
1184473019	UGT1A6*1a, UGT1A6*2a, UGT1A6*3a, UGT1A6*4a, UGT1A6*8	UGT1A6	3			4.5	Dosage	1	2	valproic acid	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184473019	Pediatric
1184511154	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	3		Tier 1 VIP	3.5	Other	2	4	donepezil	Alzheimer Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184511154	
1184512128	rs3824662	GATA3	3			6.0	Efficacy	1	2	asparaginase;cyclophosphamide;cytarabine;daunorubicin;dexamethasone;doxorubicin;leucovorin;mercaptopurine;methotrexate;pegaspargase;prednisone;thioguanine;vincristine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184512128	Pediatric
1183704277	rs729147	ADH7	4			-1.25	Toxicity	2	2	anthracyclines and related substances		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183704277	Pediatric
1183704367	rs6759892	UGT1A6	4			-1.25	Toxicity	2	2	anthracyclines and related substances		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183704367	Pediatric
1183960318	rs121908755	CFTR	1A		Rare Variant; Tier 1 VIP	202.5	Efficacy	5	7	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183960318	Pediatric
1184642788	G6PD A- 202A_376G, G6PD B (wildtype)	G6PD	3		Tier 1 VIP	0.125	Toxicity	1	1	sulfasalazine	Hemolysis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184642788	
1183703005	rs3732219	UGT1A4	3			0.0	Other	1	1	anastrozole		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183703005	
1183704399	rs658903	KCNJ1	3			3.25	Toxicity	1	1	hydrochlorothiazide	Diabetes Mellitus;Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183704399	
1183704414	rs6151031	ALDH1A1	3		Rare Variant	2.5	Toxicity	1	1	carboplatin;cyclophosphamide;thiotepa		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183704414	
1183704419	rs6072262	TOP1	3			2.0	Toxicity	1	1	irinotecan		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183704419	
1184348703	rs3219484	MUTYH	3			3.0	Toxicity	1	1	cisplatin;cyclophosphamide	Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184348703	
1184348708	rs1051740	EPHX1	3			1.5	Toxicity	1	2	cisplatin;cyclophosphamide	Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184348708	
1183704267	rs7319981	SLC10A2	4			-1.25	Toxicity	2	2	anthracyclines and related substances	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183704267	Pediatric
1183888969	rs12979860	IFNL3;IFNL4	1A			219.0	Efficacy	9	11	peginterferon alfa-2a;peginterferon alfa-2b;ribavirin;telaprevir	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183888969	
1184134160	rs11211524	CMPK1	3			0.75	Efficacy	2	2	gemcitabine	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184134160	
1184134170	rs4694362	DCK	3			2.5	Toxicity	1	1	gemcitabine	Pancreatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184134170	
1184514449	rs274618	GRM3	3			2.5	Other	1	1	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184514449	
1184514458	rs1990040	GRM3	3			2.5	Other	1	1	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184514458	
1184514464	rs13242038	GRM3	3			2.5	Other	1	1	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184514464	
1184514469	rs724226	GRM3	3			2.5	Other	1	1	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184514469	
1184514474	rs2189814	GRM3	3			2.5	Other	1	1	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184514474	
1184514253	rs264588	TANC1	3			1.75	Toxicity	1	1	radiotherapy	Prostatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184514253	
1184514260	rs264631	TANC1	3			1.75	Toxicity	1	1	radiotherapy	Prostatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184514260	
1184563800	G6PD B (wildtype), G6PD Canton, Taiwan-Hakka, Gifu-like, Agrigento-like	G6PD	4		Tier 1 VIP	-0.375	Toxicity	10	10	sulfamethoxazole / trimethoprim	Anemia, Hemolytic;Hemolysis	2021-09-15	https://www.pharmgkb.org/clinicalAnnotation/1184563800	Pediatric
1184473080	rs717620	ABCC2	4			-1.75	Metabolism/PK	6	6	methotrexate	Leukemia, Lymphoid;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-12-13	https://www.pharmgkb.org/clinicalAnnotation/1184473080	Pediatric
1184473109	rs717620	ABCC2	3			2.75	Toxicity	4	5	methotrexate	Leukemia;Lymphoma;Osteosarcoma;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2022-01-04	https://www.pharmgkb.org/clinicalAnnotation/1184473109	Pediatric
1184472550	rs1045642	ABCB1	3		Tier 1 VIP	0.75	Other	1	1	hmg coa reductase inhibitors		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184472550	
1183960780	rs121909013	CFTR	1A		Rare Variant; Tier 1 VIP	202.0	Efficacy	2	4	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183960780	Pediatric
1184472555	rs1128503	ABCB1	3		Tier 1 VIP	1.75	Other	1	1	hmg coa reductase inhibitors		2021-06-10	https://www.pharmgkb.org/clinicalAnnotation/1184472555	
1451635460	rs678849	OPRD1	3			2.25	Efficacy	1	1	disulfiram	Cocaine-Related Disorders	2022-01-04	https://www.pharmgkb.org/clinicalAnnotation/1451635460	
1183702969	rs11030104	BDNF	3			3.25	Efficacy	1	1	antipsychotics	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183702969	
1183848120	rs56040400	C5	3		Rare Variant	0.25	Efficacy	1	1	eculizumab		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183848120	
1183703760	rs2232228	HAS3	3			3.5	Toxicity	1	1	anthracyclines and related substances	Cardiomyopathies	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183703760	Pediatric
1183704248	rs7779029	SEMA3C	3			0.0	Toxicity	1	1	irinotecan	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183704248	
1183689217	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	1A		Tier 1 VIP	268.5625	Metabolism/PK	47	77	voriconazole		2021-04-26	https://www.pharmgkb.org/clinicalAnnotation/1183689217	Pediatric
1183863775	rs934635		3			6.5	Toxicity	1	2	exemestane	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183863775	
1183863780	rs16964189		3			2.5	Toxicity	1	1	exemestane	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183863780	
1184472751	rs1048977	CDA	3			2.5	Other	5	5	gemcitabine	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184472751	
1184472841	rs2108622	CYP4F2	3		Tier 1 VIP	0.0	Metabolism/PK	4	5	vitamin e		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184472841	Pediatric
1184472890	rs2306744	DCK	3			2.5	Efficacy	1	2	cytarabine;idarubicin	Leukemia, Myeloid, Acute	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184472890	
1183704243	rs7851395	SLC31A1	3			2.25	Efficacy	1	1	carboplatin;cisplatin	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183704243	
1183848125	rs3785161	CES1P1	3			2.0	Efficacy	1	1	clopidogrel	Coronary Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183848125	
1183960790	rs193922525	CFTR	1A		Rare Variant; Tier 1 VIP	202.0	Efficacy	2	4	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183960790	Pediatric
1184233166	NAT2*4, NAT2*5D, NAT2*6B, NAT2*7A, NAT2*12A, NAT2*13A, NAT2*14A	NAT2	3		Tier 1 VIP	4.5	Efficacy	5	7	hydralazine	Hypertension	2022-07-19	https://www.pharmgkb.org/clinicalAnnotation/1184233166	
1183680699	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C	TPMT	3		Tier 1 VIP	5.0	Toxicity	1	2	azathioprine	Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183680699	
1184513736	rs41271330	BMP5	3			5.75	Efficacy	1	2	escitalopram	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184513736	
1184654253	HLA-DRB1*14:01:01	HLA-DRB1	3			2.75	Toxicity	1	1	allopurinol	Drug Hypersensitivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184654253	
1184648909	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C, TPMT*4, TPMT*6, TPMT*9, TPMT*12	TPMT	1A		Tier 1 VIP	225.625	Toxicity	30	44	mercaptopurine		2022-04-13	https://www.pharmgkb.org/clinicalAnnotation/1184648909	Pediatric
1184746746	TPMT*1, TPMT*19, TPMT*20, TPMT*21, TPMT*22, TPMT*30, TPMT*32, TPMT*33, TPMT*34	TPMT	3		Tier 1 VIP	0.0	Metabolism/PK	5	5	thioguanine		2022-04-14	https://www.pharmgkb.org/clinicalAnnotation/1184746746	Pediatric
1184653758	TPMT*1, TPMT*21, TPMT*24, TPMT*25, TPMT*32, TPMT*33, TPMT*34, TPMT*37	TPMT	3		Tier 1 VIP	0.0	Metabolism/PK	6	7	mercaptopurine	Lupus Erythematosus, Systemic;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2022-04-14	https://www.pharmgkb.org/clinicalAnnotation/1184653758	Pediatric
1183704287	rs723685	SLC22A16	3			2.0	Dosage	1	1	cyclophosphamide;doxorubicin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183704287	
1184472708	rs747199	SLC29A1	3			0.0	Efficacy	1	1	gemcitabine;paclitaxel	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184472708	
1184513893	rs28933389	BCHE	3		Rare Variant	0.0	Toxicity	2	2	succinylcholine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184513893	
1184516153	G6PD B (wildtype), G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham	G6PD	3		Tier 1 VIP	0.25	Toxicity	2	2	aspirin	Hemolysis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184516153	Pediatric
1184513880	rs1803274	BCHE	3			2.5	Toxicity	8	8	succinylcholine	postanesthesia apnea	2021-04-21	https://www.pharmgkb.org/clinicalAnnotation/1184513880	Pediatric
1184513863	rs1799807	BCHE	3			2.5	Toxicity	10	10	succinylcholine	postanesthesia apnea	2021-04-21	https://www.pharmgkb.org/clinicalAnnotation/1184513863	Pediatric
1183863785	rs7176005	CYP19A1	3			3.0	Toxicity	2	2	exemestane	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183863785	
1183863989	rs9936750		3			2.75	Toxicity	1	1	capecitabine	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183863989	
1184472900	rs80143932	DCK	3			2.5	Efficacy	1	2	cytarabine;idarubicin	Leukemia, Myeloid, Acute	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184472900	
1184514240	rs264663	TANC1	3			0.0	Toxicity	1	1	radiotherapy	Prostatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184514240	
1450821418	rs1799971	OPRM1	3			4.5	Dosage	14	15	ethanol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450821418	Pediatric
1184514209	rs7582141	TANC1	3			1.75	Toxicity	1	1	radiotherapy	Prostatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184514209	
1184514217	rs6432512	TANC1	3			1.75	Toxicity	1	1	radiotherapy	Prostatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184514217	
1184514248	rs264651	TANC1	3			0.0	Toxicity	1	1	radiotherapy	Prostatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184514248	
1184514050	rs116855232	NUDT15	1A		Tier 1 VIP	140.25	Toxicity	17	20	azathioprine	Inflammatory Bowel Diseases;Myelosuppression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184514050	Pediatric
1451636580	rs11045879	SLCO1B1	3		Tier 1 VIP	2.5	Toxicity	1	1	mercaptopurine	gastrointestinal toxicity;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2022-01-05	https://www.pharmgkb.org/clinicalAnnotation/1451636580	Pediatric
1184136773	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	3			1.5	Toxicity	1	1	clomipramine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184136773	
1183704330	rs699	AGT	3			2.25	Toxicity	1	1	Antiinflammatory agents, non-steroids		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183704330	
1184472764	rs11598702	NT5C2	3			2.0	Metabolism/PK	2	2	gemcitabine	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184472764	
1184568404	G6PD B (wildtype), G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham	G6PD	4		Tier 1 VIP	-0.625	Toxicity	2	2	sulfametopyrazine	Hemolysis	2021-09-15	https://www.pharmgkb.org/clinicalAnnotation/1184568404	
1184513898	rs28933390	BCHE	3		Rare Variant	0.25	Toxicity	3	3	succinylcholine		2021-09-27	https://www.pharmgkb.org/clinicalAnnotation/1184513898	
1451637000	rs115346678		3			0.0	Toxicity	1	1	aspirin	adverse events	2022-01-05	https://www.pharmgkb.org/clinicalAnnotation/1451637000	
1183704262	rs7325568		3			0.0	Toxicity	1	1	fluorouracil;oxaliplatin	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183704262	
1184233711	rs1045642	ABCB1	3		Tier 1 VIP	0.5	Other	10	11	efavirenz	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184233711	Pediatric
1184133889	rs3842	ABCB1	3		Tier 1 VIP	4.125	Other	6	6	efavirenz	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184133889	Pediatric
1184134274	rs1045642	ABCB1	3		Tier 1 VIP	2.5	Efficacy	1	1	morphine	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184134274	
1184348745	rs17655	ERCC5	3			3.75	Efficacy	1	2	platinum	Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184348745	
1184349177	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	3			3.25	Efficacy	18	26	paroxetine	Depressive Disorder, Major;Mood Disorders;Panic Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184349177	
1184472721	rs760370	SLC29A1	3			0.0	Efficacy	2	2	gemcitabine	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184472721	
1184472796	rs7867504	SLC28A3	3			0.0	Other	1	1	gemcitabine	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184472796	
1450826545	rs28363170	SLC6A3	3			2.5	Other	1	1	ethanol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450826545	
1184348736	rs11226	RAD52	4			-0.25	Toxicity	1	2	cisplatin;cyclophosphamide	Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184348736	
1184661194	rs2108622	CYP4F2	2A		Tier 1 VIP	11.75	Dosage	14	15	acenocoumarol	Atrial Fibrillation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184661194	
1450826763	rs1799971	OPRM1	4			-2.25	Dosage	2	4	nicotine		2021-12-06	https://www.pharmgkb.org/clinicalAnnotation/1450826763	
1450826857	rs1799971	OPRM1	3			0.25	Toxicity	6	8	morphine	adverse events;Constipation;Delirium;Dizziness;Nausea;Pain, Postoperative;Postoperative Nausea and Vomiting;Pruritus;Respiratory Insufficiency;somnolence;Urinary Retention;Vomiting	2022-02-10	https://www.pharmgkb.org/clinicalAnnotation/1450826857	Pediatric
1183705764	rs121918592	RYR1	1A		Rare Variant; Tier 1 VIP	104.75	Toxicity	27	30	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705764	Pediatric
1183705773	rs118192162	RYR1	1A		Rare Variant; Tier 1 VIP	102.5	Toxicity	4	5	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705773	
1183705817	rs28933397	RYR1	1A		Rare Variant; Tier 1 VIP	102.75	Toxicity	10	11	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705817	Pediatric
1183705822	rs121918595	RYR1	1A		Rare Variant; Tier 1 VIP	100.75	Toxicity	6	7	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705822	Pediatric
1183705827	rs121918594	RYR1	1A		Rare Variant; Tier 1 VIP	101.25	Toxicity	7	9	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705827	
1183704257	rs7740004	TBC1D32	3			0.0	Toxicity	1	1	Bisphosphonates	Osteonecrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183704257	
1183704282	rs726501	MAP3K1	3			3.0	Efficacy	1	1	carboplatin;cisplatin;docetaxel;erlotinib;gefitinib;paclitaxel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183704282	
1183704292	rs7186128		3			0.0	Efficacy	1	1	cisplatin;irinotecan		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183704292	
1183704390	rs6702335	EPB41	3			3.25	Efficacy	1	1	bupropion;nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183704390	
1183705010	rs2279345	CYP2B6	3		Tier 1 VIP	7.75	Metabolism/PK	5	6	efavirenz	HIV Infections;Tuberculosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705010	
1183705354	G6PD A- 202A_376G, G6PD B (wildtype)	G6PD	3		Tier 1 VIP	0.25	Toxicity	1	1	dimercaprol	Hemolysis;Lead Poisoning, Nervous System, Childhood	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705354	Pediatric
1450826788	rs6088638	ACSS2	3			2.25	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450826788	
1450931434	rs4432372	PIP5K1C	3			0.0	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450931434	
1450931453	rs10419980	PIP5K1C	3			0.0	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450931453	
1450931583	rs6311	HTR2A	3			2.25	Toxicity	1	1	citalopram	Depressive Disorder, Major;Nausea;Vomiting	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450931583	
1450929804	rs1045642	ABCB1	4		Tier 1 VIP	-1.25	Dosage	5	5	morphine	Pain;Pain, Postoperative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450929804	
1183863836	rs887829	UGT1A1	3		Tier 1 VIP	6.25	Other	3	4	atazanavir	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183863836	
1450823887	rs1799971	OPRM1	3			1.25	Other	2	3	nicotine		2021-12-07	https://www.pharmgkb.org/clinicalAnnotation/1450823887	Pediatric
1183705307	G6PD B (wildtype), G6PD Mediterranean Haplotype, G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham	G6PD	3		Tier 1 VIP	0.25	Toxicity	1	1	ciprofloxacin	Anemia, Hemolytic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705307	
1450822836	rs3852209	HINT1	3			2.75	Efficacy	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450822836	
1450823583	rs16969968	CHRNA3;CHRNA5	3			4.75	Dosage;Efficacy	3	3	nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450823583	
1450934702	rs398123226	GLA	3			0.0	Efficacy	1	2	migalastat	Fabry Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450934702	
1450934767	rs116855232	NUDT15	3		Tier 1 VIP	3.0	Toxicity	3	3	azathioprine;mercaptopurine	Pancytopenia;Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450934767	
1183704238	rs7853758	SLC28A3	3			2.0	Toxicity	2	2	anthracyclines and related substances	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183704238	Pediatric
1450935288	CYP2C8*1, CYP2C8*3	CYP2C8	3		Tier 1 VIP	2.75	Dosage	1	1	ibuprofen		2021-05-18	https://www.pharmgkb.org/clinicalAnnotation/1450935288	
1449157419	rs1800497	DRD2	3		Tier 1 VIP	2.75	Toxicity	1	1	ethanol	Alcoholism;Death	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449157419	
1449157547	rs3099844	CYCSP5	3			6.75	Toxicity	2	2	allopurinol	drug reaction with eosinophilia and systemic symptoms;severe cutaneous adverse reactions;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449157547	
1451637008	rs34545984		3			0.0	Toxicity	1	1	cephalexin	adverse events	2022-01-05	https://www.pharmgkb.org/clinicalAnnotation/1451637008	
1451434925	rs267606617	MT-ND1;MT-RNR1	3		Rare Variant; Tier 1 VIP	0.25	Toxicity	1	1	isepamicin	Ototoxicity	2021-05-10	https://www.pharmgkb.org/clinicalAnnotation/1451434925	
1451475700	rs2236225	MTHFD1	3			2.0	Efficacy	1	1	cisplatin;doxorubicin;methotrexate	Osteosarcoma	2021-07-28	https://www.pharmgkb.org/clinicalAnnotation/1451475700	Pediatric
1183703019	rs1800544	ADRA2A	4			-2.875	Efficacy	11	14	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183703019	Pediatric
1183705698	rs118192172	RYR1	1A		Rare Variant; Tier 1 VIP	106.75	Toxicity	51	55	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705698	Pediatric
1183705759	rs118192161	RYR1	1A		Rare Variant; Tier 1 VIP	107.0	Toxicity	26	27	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705759	
1183705807	rs118192177	RYR1	1A		Rare Variant; Tier 1 VIP	103.25	Toxicity	22	25	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705807	Pediatric
1183705812	rs121918593	RYR1	1A		Rare Variant; Tier 1 VIP	105.5	Toxicity	35	36	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705812	Pediatric
1451475720	rs717620	ABCC2	3			2.0	Efficacy	1	1	cisplatin;doxorubicin;methotrexate	Osteosarcoma	2021-07-28	https://www.pharmgkb.org/clinicalAnnotation/1451475720	Pediatric
1451637100	rs9620007	WBP2NL	3			0.0	Toxicity	1	1	codeine	adverse events	2022-01-05	https://www.pharmgkb.org/clinicalAnnotation/1451637100	
1450936169	rs765399160	SULT1A1	3		Rare Variant	0.0	Metabolism/PK	1	1	acetaminophen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936169	
1450936177	rs28374453	NPIPB8;SULT1A1	3			0.0	Metabolism/PK	1	1	tapentadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936177	
1450936189	rs28374453	NPIPB8;SULT1A1	3			0.0	Metabolism/PK	1	1	acetaminophen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936189	
1450936217	rs72547527	SULT1A1	3		Rare Variant	0.0	Metabolism/PK	1	1	acetaminophen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936217	
1450936272	rs758145522	SULT1A1	3		Rare Variant	0.0	Metabolism/PK	1	1	desmethylnaproxen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936272	
1450936302	rs544820732	SULT1A1	3		Rare Variant	0.0	Metabolism/PK	1	1	tapentadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936302	
1450936308	rs552524124	SULT1A1	3		Rare Variant	0.0	Metabolism/PK	1	1	tapentadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936308	
1183705226	G6PD A- 202A_376G, G6PD B (wildtype), G6PD Mediterranean Haplotype, G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham	G6PD	4		Tier 1 VIP	-1.25	Toxicity	6	6	chloroquine	Anemia, Hemolytic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705226	Pediatric
1451637140	rs62436463	OPRM1	3			0.0	Toxicity	1	1	hydrocodone	adverse events	2022-01-05	https://www.pharmgkb.org/clinicalAnnotation/1451637140	
1183705783	rs118192167	RYR1	1A		Rare Variant; Tier 1 VIP	100.0	Toxicity	1	2	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705783	
1183704358	rs6907567	SLC22A16	3			4.25	Efficacy;Toxicity	2	2	cyclophosphamide;doxorubicin;fluorouracil	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183704358	
1183705086	G6PD A- 202A_376G, G6PD B (wildtype)	G6PD	3		Tier 1 VIP	0.875	Toxicity	5	5	chloramphenicol	Anemia, Hemolytic;Hemolysis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705086	Pediatric
1184233486	rs6269	COMT	3		Tier 1 VIP	2.0	Other	1	1	opioids	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184233486	Pediatric
1184233504	rs4633	COMT	3		Tier 1 VIP	2.0	Other	1	1	opioids	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184233504	Pediatric
1184233517	rs4818	COMT	3		Tier 1 VIP	2.0	Other	1	1	opioids	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184233517	Pediatric
1451637147	rs62436463	OPRM1	3			0.0	Toxicity	1	1	oxycodone	adverse events	2022-01-05	https://www.pharmgkb.org/clinicalAnnotation/1451637147	
1184233524	rs4680	COMT	3		Tier 1 VIP	1.5	Other	1	1	opioids	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184233524	Pediatric
1451475800	rs1695	GSTP1	3		Tier 1 VIP	2.0	Efficacy	1	2	cisplatin;doxorubicin;methotrexate	Osteosarcoma	2021-07-28	https://www.pharmgkb.org/clinicalAnnotation/1451475800	Pediatric
1183703748	rs61742245	VKORC1	2A		Rare Variant; Tier 1 VIP	7.25	Dosage	6	6	warfarin		2021-11-18	https://www.pharmgkb.org/clinicalAnnotation/1183703748	
1451475820	GSTT1 non-null, GSTT1 null	GSTT1	3			0.0	Efficacy	1	1	cisplatin;doxorubicin;methotrexate	Osteosarcoma	2021-07-28	https://www.pharmgkb.org/clinicalAnnotation/1451475820	Pediatric
1449162249	rs2562456		3			2.5	Efficacy	1	1	ketorolac		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449162249	
1449164763	rs10258429	EGFR	3			3.0	Toxicity	1	1	imatinib	Gastrointestinal Stromal Tumors	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449164763	
1449164769	rs2235040	ABCB1	3		Tier 1 VIP	2.5	Toxicity	1	1	imatinib	Gastrointestinal Stromal Tumors	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449164769	
1449192406	rs121909011	CFTR	3		Rare Variant; Tier 1 VIP	0.25	Efficacy	1	1	ivacaftor / lumacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449192406	
1449182358	rs1051660	OPRK1	3			2.5	Dosage	1	1	morphine	Neoplasms;Pain	2021-04-09	https://www.pharmgkb.org/clinicalAnnotation/1449182358	
1449191373	rs397508256	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191373	
1451463900	rs4948496	ARID5B	3			1.5	Toxicity	1	1	methotrexate	Leukopenia;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-06-22	https://www.pharmgkb.org/clinicalAnnotation/1451463900	Pediatric
1451637160	rs62436463	OPRM1	3			0.0	Toxicity	1	1	tramadol	adverse events	2022-01-05	https://www.pharmgkb.org/clinicalAnnotation/1451637160	
1451637200	rs739296	SEPTIN3;WBP2NL	3			0.0	Toxicity	1	1	hydrocodone	adverse events	2022-01-05	https://www.pharmgkb.org/clinicalAnnotation/1451637200	
1451476060	rs9344	CCND1	3			0.0	Efficacy	1	1	cisplatin;doxorubicin;methotrexate	Osteosarcoma	2021-07-29	https://www.pharmgkb.org/clinicalAnnotation/1451476060	Pediatric
1183705778	rs118192163	RYR1	1A		Rare Variant; Tier 1 VIP	101.5	Toxicity	12	13	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705778	Pediatric
1183702417	rs8103142	IFNL3	3			3.5	Efficacy	1	1	peginterferon alfa-2a;peginterferon alfa-2b;ribavirin	Hepatitis C	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183702417	
1183704409	rs6311	HTR2A	3			0.0	Efficacy	1	1	antipsychotics	tardive dyskinesia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183704409	
1183705797	rs118192175	RYR1	1A		Rare Variant; Tier 1 VIP	100.0	Toxicity	3	5	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705797	
1183705802	rs118192176	RYR1	1A		Rare Variant; Tier 1 VIP	103.75	Toxicity	21	23	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705802	Pediatric
1451464245	rs1801131	MTHFR	4		Tier 1 VIP	-0.25	Dosage	2	2	methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-06-23	https://www.pharmgkb.org/clinicalAnnotation/1451464245	Pediatric
1183703000	rs2010963	VEGFA	3			2.0	Efficacy	1	1	cyclophosphamide	Prostatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183703000	
1184654143	CYP2C19*1, CYP2C19*5, CYP2C19*6, CYP2C19*8, CYP2C19*9, CYP2C19*10, CYP2C19*11, CYP2C19*13, CYP2C19*14, CYP2C19*15, CYP2C19*16, CYP2C19*18, CYP2C19*19, CYP2C19*22, CYP2C19*23, CYP2C19*24, CYP2C19*25, CYP2C19*26	CYP2C19	3		Tier 1 VIP	3.0	Metabolism/PK	9	34	mephenytoin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184654143	
1184654214	HLA-C*08:01	HLA-C	3			3.25	Toxicity	3	3	allopurinol	Drug Hypersensitivity;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184654214	
1184654247	HLA-DRB1*09:01:02	HLA-DRB1	3			2.75	Toxicity	1	1	allopurinol	Drug Hypersensitivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184654247	
1183703784	rs115232898	DPYD	1A		Rare Variant; Tier 1 VIP	100.5	Toxicity	2	3	fluorouracil	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183703784	
1184654139	HLA-C*03:02	HLA-C	2B			19.5	Toxicity	5	6	allopurinol	Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184654139	
1451637155	rs113100019	FIP1L1	3		Rare Variant	0.0	Toxicity	1	1	meperidine	adverse events	2022-01-05	https://www.pharmgkb.org/clinicalAnnotation/1451637155	
1184755902	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*13, CYP2D6*31, CYP2D6*69, CYP2D6*100, CYP2D6*101	CYP2D6	3		Tier 1 VIP	0.625	Other	4	5	dextromethorphan		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184755902	
1444668236	rs10747673		3			4.0	Efficacy	1	2	metformin	Diabetes Mellitus	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444668236	
1444673084	rs2631367	SLC22A5	3			2.75	Efficacy	1	1	imatinib	Gastrointestinal Stromal Tumors	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444673084	
1444673142	rs2274567	CR1	3			2.75	Efficacy	1	1	eculizumab	paroxysmal nocturnal hemoglobinuria	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444673142	
1444673156	rs396991	FCGR3A	3			3.25	Efficacy	2	3	adalimumab;etanercept;infliximab	Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444673156	
1444695653	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*5, CYP2C19*6, CYP2C19*7, CYP2C19*8	CYP2C19	3		Tier 1 VIP	5.5	Metabolism/PK	8	19	mephenytoin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444695653	
1444700509	rs2231142	ABCG2	3		Tier 1 VIP	1.0	Metabolism/PK	2	2	imatinib		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700509	
1444700522	rs2231137	ABCG2	3		Tier 1 VIP	0.0	Other	1	1	dasatinib;imatinib;nilotinib		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700522	
1444700796	rs12768009	CYP2C19	3		Tier 1 VIP	0.0	Metabolism/PK	1	1	nevirapine	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700796	
1444700881	rs16947		3			2.0	Toxicity	1	1	timolol	Bradycardia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700881	
1444703123	rs1799752	ACE	3		Tier 1 VIP	5.75	Toxicity	2	2	Ace Inhibitors, Plain		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703123	
1444703131	rs1799978	DRD2	3		Tier 1 VIP	2.25	Efficacy	1	1	olanzapine;risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703131	
1444703146	rs1800469	TGFB1	3			2.5	Toxicity	1	1	aspirin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703146	
1444703154	rs1800477	BCL2	3		Rare Variant	2.0	Efficacy	1	1	interferons;ribavirin	Hepatitis C	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703154	
1445401118	rs11942466	AREG	3			2.25	Efficacy	1	1	capecitabine;radiotherapy	Rectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401118	
1445401125	rs11615	ERCC1	3			1.75	Efficacy	1	1	capecitabine;radiotherapy	Rectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401125	
1445401897	rs2242480	CYP3A4	3		Tier 1 VIP	1.5	Metabolism/PK	2	2	carbamazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401897	
1444673149	rs1801274	FCGR2A	4			-0.75	Efficacy	2	3	adalimumab;etanercept;infliximab	Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444673149	
1444703571	rs4982133		4			-1.0	Efficacy	2	2	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703571	
1451476200	rs2236225	MTHFD1	3			3.0	Toxicity	4	4	methotrexate	Anemia;Leukopenia;Lymphoma, Non-Hodgkin;mucositis;Osteosarcoma;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Thrombocytopenia;Toxic liver disease	2022-01-04	https://www.pharmgkb.org/clinicalAnnotation/1451476200	Pediatric
1451493592	rs4762	AGT	3			1.0	Efficacy	2	2	irbesartan	Hypertension;Hypertrophy, Left Ventricular	2021-09-09	https://www.pharmgkb.org/clinicalAnnotation/1451493592	
1445401317	rs2295632	FAAH	3			0.0	Toxicity	3	3	opioids		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401317	Pediatric
1445737062	rs1799983	NOS3	3			3.25	Efficacy	2	3	anthracyclines and related substances;cyclophosphamide;doxorubicin;epirubicin;fluorouracil;methotrexate;oxaliplatin;Platinum compounds	Neoplasms;Ovarian Neoplasms;Stomach Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445737062	
1446898857	rs806378	CNR1	3			2.0	Toxicity	2	2	clozapine;olanzapine;risperidone	Autism Spectrum Disorder;Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446898857	Pediatric
1446899151	rs699664	GGCX	4			-9.5	Dosage	14	15	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446899151	Pediatric
1185000205	rs776746	CYP3A5	4		Tier 1 VIP	-1.125	Toxicity	3	3	tacrolimus	Neurotoxicity Syndromes	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1185000205	
1444666950	HLA-B*51:01:01	HLA-B	3		Tier 1 VIP	1.25	Toxicity	4	5	carbamazepine	Drug Hypersensitivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666950	
1444673025	rs2230345	GRK5	3			1.5	Efficacy	2	2	Antihypertensives;Beta Blocking Agents	Heart Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444673025	
1444673072	rs20575	TNFRSF10A	3			4.75	Efficacy	1	4	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Arthritis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444673072	
1444700822	rs13064411	CFAP44	3			2.5	Efficacy	1	1	hmg coa reductase inhibitors		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700822	
1444700830	rs1353411	PTGER2	3			1.5	Toxicity	1	1	aspirin	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700830	
1444703178	rs1800795	IL6	3			2.25	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703178	
1444703187	rs1801252	ADRB1	3		Tier 1 VIP	1.0	Efficacy	1	1	timolol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703187	
1444703195	rs342293		3			0.0	Efficacy	1	1	clopidogrel	Coronary Artery Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703195	
1444703840	rs307826	FLT4	3			2.75	Efficacy	1	1	sunitinib	Carcinoma, Renal Cell	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703840	
1444703848	rs307821	FLT4	3			2.25	Efficacy	1	1	sunitinib	Carcinoma, Renal Cell	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703848	
1444704055	rs3212198	HNF4A	3			0.0	Dosage	1	1	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704055	
1444704067	rs2472297	CYP1A1	3			2.25	Metabolism/PK	1	1	olanzapine	Psychotic Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704067	
1444704074	rs4410790	AHR	3			2.25	Metabolism/PK	1	1	olanzapine	Psychotic Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704074	
1444704134	rs4132670	TCF7L2	3			2.5	Toxicity	1	1	hydrochlorothiazide	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704134	
1444704141	rs4133101	PTGER4	3			2.5	Toxicity	1	1	celecoxib	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704141	
1444930850	rs12979860	IFNL3;IFNL4	3			2.0	Efficacy	3	3	peginterferon alfa-2a;peginterferon alfa-2b;ribavirin;simeprevir	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444930850	
1445401179	rs1570360	VEGFA	3			2.0	Efficacy	1	1	cyclophosphamide;docetaxel	Prostatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401179	
1445401310	rs2291767	OTOS	3			0.0	Toxicity	2	2	cisplatin	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401310	Pediatric
1445117525	rs193922876	RYR1	1A		Tier 1 VIP	100.25	Toxicity	1	2	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445117525	Pediatric
1445401008	rs1800559	CACNA1S	1A		Rare Variant; Tier 1 VIP	100.5	Toxicity	3	5	desflurane	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401008	
1451637183	rs739296	SEPTIN3;WBP2NL	3			0.0	Toxicity	1	1	codeine	adverse events	2022-01-05	https://www.pharmgkb.org/clinicalAnnotation/1451637183	
1444666938	HLA-A*02:01	HLA-A	4			-2.75	Toxicity	5	5	carbamazepine	Drug Hypersensitivity;drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Maculopapular Exanthema;severe cutaneous adverse reactions;Stevens-Johnson Syndrome	2022-10-19	https://www.pharmgkb.org/clinicalAnnotation/1444666938	
1184986744	rs2236861	OPRD1	3			1.75	Other	1	1	opioids	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184986744	
1184986770	rs948854	GAL	3			2.25	Other	1	1	opioids	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184986770	
1445722592	rs662	PON1	3			2.0	Efficacy	1	1	epirubicin;fluorouracil;oxaliplatin	Neoplasms;Stomach Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445722592	
1450371701	rs396991	FCGR3A	3			2.25	Efficacy	1	1	tocilizumab	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450371701	
1450375740	rs76979899	ABCG2	3		Tier 1 VIP	0.0	Efficacy	1	1	allopurinol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450375740	
1450375758	rs9366772	HLA-C	3			0.0	Efficacy	1	1	allopurinol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450375758	
1450375752	rs10011796	ABCG2	4		Tier 1 VIP	-1.5	Efficacy	2	2	allopurinol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450375752	
1451637220	rs739296	SEPTIN3;WBP2NL	3			0.0	Toxicity	1	1	oxycodone	adverse events	2022-01-05	https://www.pharmgkb.org/clinicalAnnotation/1451637220	
1444667234	rs2291078	UMPS	3			0.0	Efficacy	1	1	capecitabine;fluorouracil	Neoplasm Metastasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444667234	
1444667256	rs3772809	UMPS	3			0.0	Efficacy	1	1	capecitabine;fluorouracil	Neoplasm Metastasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444667256	
1444667263	rs3772810	UMPS	3			0.0	Efficacy	1	1	capecitabine;fluorouracil	Neoplasm Metastasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444667263	
1444700354	rs1042713	ADRB2	3		Tier 1 VIP	1.0	Other	1	1	isoproterenol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700354	
1444700362	rs10465180	NTRK2	3			3.5	Efficacy	1	1	clozapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700362	
1444700371	rs1778929	NTRK2	3			0.0	Efficacy	1	1	clozapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700371	
1444700382	rs1360780	FKBP5	3			0.0	Efficacy	1	1	clozapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700382	
1444700597	rs11030918	RRM1	3			3.0	Toxicity	1	1	gemcitabine;Platinum compounds	Mesothelioma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700597	
1444700605	rs11078659	ALOX12	3			2.5	Efficacy;Toxicity	1	1	celecoxib	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700605	
1444700838	rs376817657	CYP2A6	3		Rare Variant; Tier 1 VIP	2.5	Metabolism/PK	1	1	nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700838	
1444700845	rs140471703	CYP2A6	3		Rare Variant; Tier 1 VIP	2.5	Metabolism/PK	1	1	nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700845	
1444700853	rs143690364	CYP2A6	3		Rare Variant; Tier 1 VIP	2.5	Metabolism/PK	1	1	nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700853	
1444701017	rs1886629	KCNT2	3			0.0	Toxicity	1	1	Bisphosphonates	Osteonecrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444701017	
1444701024	rs2070744	NOS3	3			2.25	Efficacy	1	1	sildenafil	Erectile Dysfunction	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444701024	
1444705158	rs5182	AGTR1	3			0.0	Toxicity	1	1	Ace Inhibitors, Plain	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444705158	
1444705166	rs809736	RORA	3			0.0	Efficacy	1	1	citalopram	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444705166	
1445400945	rs1799983	NOS3	3			2.5	Efficacy	1	1	salvianolic acid b	Coronary Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445400945	
1445401205	rs1128503	ABCB1	3		Tier 1 VIP	2.5	Efficacy	3	3	imatinib	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401205	
1445401218	rs11280056	TYMS	3		Tier 1 VIP	2.25	Efficacy	1	1	pemetrexed	Mesothelioma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401218	
1445401247	rs1128503	ABCB1	3		Tier 1 VIP	2.0	Efficacy	1	1	rocuronium		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401247	
1445402144	rs2229109	ABCB1	3		Tier 1 VIP	3.0	Efficacy	1	1	doxorubicin;methotrexate;prednisolone;vincristine	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445402144	Pediatric
1445402163	rs846908	HSD11B1	3			1.75	Metabolism/PK	1	1	tacrolimus	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445402163	
1445402175	rs4844880	HSD11B1	3			2.25	Metabolism/PK	1	1	tacrolimus	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445402175	
1445402182	rs846910	HSD11B1	3			1.75	Metabolism/PK	1	1	tacrolimus	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445402182	
1445585748	rs7294	VKORC1	3		Tier 1 VIP	2.0	Dosage	1	1	acenocoumarol;phenprocoumon		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445585748	
1451476309	rs17222723	ABCC2	3			2.0	Toxicity	1	1	methotrexate	Leukopenia;Osteosarcoma	2021-07-29	https://www.pharmgkb.org/clinicalAnnotation/1451476309	Pediatric
1451637280	rs739296	SEPTIN3;WBP2NL	3			0.0	Toxicity	1	1	tramadol	adverse events	2022-01-05	https://www.pharmgkb.org/clinicalAnnotation/1451637280	
1184754040	CYP2C19*1, CYP2C19*23, CYP2C19*29, CYP2C19*30, CYP2C19*31, CYP2C19*33	CYP2C19	3		Tier 1 VIP	0.0	Metabolism/PK	2	2	omeprazole		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184754040	
1184987460	rs1799971	OPRM1	3			2.0	Other	1	1	Analgesics;Antiinflammatory agents, non-steroids;Ergot alkaloids;opioids;sumatriptan	Substance Withdrawal Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184987460	
1444608441	rs6280	DRD3	3			1.75	Efficacy	1	1	methylphenidate	Autism Spectrum Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444608441	Pediatric
1444700740	rs11628713	PAPLN	3			0.0	Toxicity	1	1	citalopram	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700740	
1444700748	rs11719165		3			0.0	Toxicity	1	1	gemcitabine	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700748	
1444703339	rs2075797	PTGER2	3			1.0	Toxicity	1	1	aspirin	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703339	
1444703346	rs2108622	CYP4F2	3		Tier 1 VIP	3.5	Other	2	2	aspirin;clopidogrel	Acute coronary syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703346	
1444703380	rs2189784	CYP4F2	3		Tier 1 VIP	2.75	Dosage	4	5	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703380	
1444703393	rs2216711	GDNF	3			2.0	Efficacy	1	1	paroxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703393	
1444703784	rs578427		3			1.25	Metabolism/PK	1	3	metformin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703784	
1444703791	rs34834489	SLC47A2	3			0.125	Metabolism/PK	1	3	metformin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703791	
1444703869	rs4149081	SLCO1B1	3		Tier 1 VIP	4.0	Efficacy	1	2	simvastatin	Coronary Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703869	
1444703884	rs4984241	CA12	3			0.0	Other	1	1	topiramate;zonisamide		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703884	
1444703906	rs3836790	SLC6A3	3			4.25	Efficacy	1	2	levodopa	Parkinson Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703906	
1444703250	rs2071197	HNF4A	4			-0.5	Metabolism/PK	2	4	carbamazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703250	
1444703578	rs2650972		4			-1.25	Efficacy	2	2	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703578	
1451476360	rs11615	ERCC1	3			2.0	Toxicity	1	1	cisplatin;doxorubicin	mucositis;Osteosarcoma	2021-07-29	https://www.pharmgkb.org/clinicalAnnotation/1451476360	Pediatric
1444703619	rs3740065	ABCC2	3			2.5	Toxicity	1	1	methotrexate	Carcinoma, Non-Small-Cell Lung;Drug Toxicity;Leukemia, B-Cell, Acute	2021-12-13	https://www.pharmgkb.org/clinicalAnnotation/1444703619	Pediatric
1296666989	rs2003569	UGT1A9	3			3.0	Efficacy	1	1	simvastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1296666989	
1445400792	rs11264359	FDPS	3			4.25	Efficacy	2	2	atorvastatin;Bisphosphonates	Coronary Disease;Osteoporosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445400792	
1445400917	rs1611115	DBH	3			2.25	Efficacy	1	1	naltrexone	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445400917	
1445594343	rs113095083	ILKAP	3			0.0	Efficacy	1	1	hydrochlorothiazide	Essential hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445594343	
1445594352	rs12505746	TET2	3			0.0	Efficacy	1	1	hydrochlorothiazide	Essential hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445594352	
1445594359	rs7706429	FBXL17	3			0.0	Efficacy	1	1	hydrochlorothiazide	Essential hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445594359	
1446902898	rs12346562		3			2.5	Efficacy	1	2	atenolol;bisoprolol	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446902898	
1446902905	rs12346562		3			2.5	Efficacy	1	1	hydrochlorothiazide	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446902905	
1446902912	rs1104514		3			2.5	Efficacy	1	1	atenolol	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446902912	
1446902920	rs10739150		3			2.5	Efficacy	1	1	atenolol	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446902920	
1446902927	rs4742610	PTPRD	3			1.75	Efficacy	1	1	trandolapril;verapamil	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446902927	
1446905759	rs2297480	FDPS	3			1.75	Other	1	1	atorvastatin	Coronary Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446905759	
1446906439	rs2032582	ABCB1	3		Tier 1 VIP	1.75	Toxicity	1	1	capecitabine	Colorectal Neoplasms;hand-foot syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446906439	
1446906446	rs1800896	IL10	3			2.25	Toxicity	1	1	efavirenz	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446906446	
1451493693	rs5186	AGTR1	3			2.75	Efficacy	3	3	irbesartan	Hypertension;Hypertrophy, Left Ventricular	2021-09-09	https://www.pharmgkb.org/clinicalAnnotation/1451493693	
1445400910	rs193922747	RYR1	1A		Rare Variant; Tier 1 VIP	100.75	Toxicity	6	7	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445400910	
1446905691	rs1127354	ITPA	2B			24.0	Toxicity	14	14	peginterferon alfa-2b;ribavirin	Anemia;Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446905691	
1446905703	rs7270101	ITPA	2B			8.0	Toxicity	6	6	peginterferon alfa-2b;ribavirin	Anemia;Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446905703	
1445400880	rs4240803	SLC7A5	3			3.0	Toxicity	1	1	melphalan	Multiple Myeloma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445400880	
1445401156	rs1056515	RGS5	3			2.0	Efficacy	1	1	bevacizumab;fluorouracil;irinotecan;leucovorin	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401156	
1445402111	rs4680	COMT	3		Tier 1 VIP	2.5	Efficacy	1	1	clozapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445402111	
1445400887	rs112563513	RYR1	1A		Rare Variant; Tier 1 VIP	102.25	Toxicity	7	9	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445400887	Pediatric
1444694385	rs5030952	CAPN10	3			2.5	Toxicity	1	1	tacrolimus	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444694385	
1444694562	rs1800872	IL10	3			0.0	Dosage	1	1	tacrolimus	liver transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444694562	
1444694574	rs1800871	IL10	3			0.0	Dosage	1	1	tacrolimus	liver transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444694574	
1445296897	CYP2C9*1, CYP2C9*59	CYP2C9	3		Tier 1 VIP	0.25	Dosage	1	1	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445296897	
1445400873	rs1799983	NOS3	3			2.0	Efficacy	1	1	daunorubicin	Leukemia, Myeloid, Acute	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445400873	
1449753224	rs10929302	UGT1A1	3		Tier 1 VIP	1.75	Toxicity	1	1	risperidone	Hyperprolactinemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449753224	Pediatric
1450375053	rs13181	ERCC2	3			3.0	Toxicity	1	1	bleomycin;cisplatin;etoposide	Alopecia;Testicular Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450375053	
1445400894	rs28933396	RYR1	1A		Rare Variant; Tier 1 VIP	102.25	Toxicity	16	17	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445400894	
1445401168	rs6313	HTR2A	4			-2.0	Efficacy	3	4	antidepressants	Bipolar Disorder;Depression;Depressive Disorder, Major	2021-04-21	https://www.pharmgkb.org/clinicalAnnotation/1445401168	
1449747575	rs144336148	RYR1	3		Rare Variant; Tier 1 VIP	0.0	Toxicity	1	1	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-10-27	https://www.pharmgkb.org/clinicalAnnotation/1449747575	
1451476500	rs2231142	ABCG2	4		Tier 1 VIP	-2.25	Toxicity	4	4	methotrexate	Burkitt Lymphoma;Drug Toxicity;Lymphoma, T-Cell;Osteosarcoma;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2022-01-04	https://www.pharmgkb.org/clinicalAnnotation/1451476500	Pediatric
1451637320	rs185462714	SERINC5	3		Rare Variant	0.0	Toxicity	1	1	meperidine	adverse events	2022-01-05	https://www.pharmgkb.org/clinicalAnnotation/1451637320	
1445400156	rs193922803	RYR1	1A		Rare Variant; Tier 1 VIP	100.25	Toxicity	6	7	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445400156	
1444673177	rs144854329	VEGFA	3			2.25	Efficacy	1	1	docetaxel	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444673177	
1444679942	rs529520	OPRD1	3			1.5	Efficacy	2	3	buprenorphine	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444679942	
1444680131	rs4704559	HOMER1	3			4.5	Toxicity	1	2	levodopa	Parkinson Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444680131	
1444680138	rs2592551	GGCX	3			3.25	Dosage	1	1	warfarin	Atrial Fibrillation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444680138	
1444703768	rs5443	GNB3	3			2.75	Efficacy	1	2	nortriptyline	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703768	
1444703777	rs6051702	ITPA	3			3.0	Toxicity	1	1	peginterferon alfa-2a;ribavirin	Hepatitis C	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703777	
1444704025	rs2279343	CYP2B6	3		Tier 1 VIP	2.5	Metabolism/PK	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704025	
1444704032	rs2302821	PTGES	3			2.5	Toxicity	1	1	celecoxib	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704032	
1444704040	rs2306168	SLCO2B1	3			1.0	Metabolism/PK	1	1	fexofenadine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704040	
1444704048	rs2973049	GDNF	3			2.75	Efficacy	1	1	paroxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704048	
1446766000	rs11959113		3			2.25	Dosage	1	1	fentanyl	Pain, Postoperative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446766000	
1446899476	rs71647871	CES1	3		Rare Variant	1.5	Metabolism/PK	1	1	enalapril		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446899476	
1444673170	rs699947	VEGFA	4			-0.75	Efficacy	2	2	docetaxel	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444673170	
1444680101	rs581111	OPRD1	4			-0.75	Efficacy	2	3	buprenorphine	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444680101	
1451648366	rs62368105		3			0.0	Efficacy	1	1	buprenorphine	Opioid-Related Disorders	2022-01-14	https://www.pharmgkb.org/clinicalAnnotation/1451648366	
1451648374	rs6973474		3			0.0	Efficacy	1	1	buprenorphine	Opioid-Related Disorders	2022-01-14	https://www.pharmgkb.org/clinicalAnnotation/1451648374	
1445400172	rs118192124	RYR1	1A		Rare Variant; Tier 1 VIP	100.5	Toxicity	6	7	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445400172	Pediatric
1451716760	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	4		Tier 1 VIP	-0.625	Efficacy	6	8	citalopram	Depressive Disorder, Major;Obsessive-Compulsive Disorder	2022-03-11	https://www.pharmgkb.org/clinicalAnnotation/1451716760	
1451476520	rs4673	CYBA	3			2.5	Toxicity	1	1	cisplatin;doxorubicin	Anemia;mucositis;Osteosarcoma	2021-07-29	https://www.pharmgkb.org/clinicalAnnotation/1451476520	Pediatric
1447676595	HLA-B*15:02:01	HLA-B	1A		Tier 1 VIP	107.5	Toxicity	9	11	lamotrigine	Epidermal Necrolysis, Toxic;Epilepsy;severe cutaneous adverse reactions;Stevens-Johnson Syndrome	2022-03-01	https://www.pharmgkb.org/clinicalAnnotation/1447676595	
1451637387	rs76103438		3			0.0	Toxicity	1	1	simvastatin	adverse events	2022-01-05	https://www.pharmgkb.org/clinicalAnnotation/1451637387	
1447521350	HLA-B*38:02:01	HLA-B	3		Tier 1 VIP	6.25	Toxicity	2	2	carbimazole;methimazole	Graves Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447521350	
1451648382	rs13169373		3			0.0	Efficacy	1	1	buprenorphine	Opioid-Related Disorders	2022-01-14	https://www.pharmgkb.org/clinicalAnnotation/1451648382	
1451648420	rs7205113		3			0.0	Efficacy	1	1	buprenorphine	Opioid-Related Disorders	2022-01-14	https://www.pharmgkb.org/clinicalAnnotation/1451648420	
1451678080	rs1799971	OPRM1	4			-2.0	Toxicity	3	4	oxycodone	adverse events;Constipation;Delirium;Nausea;Pruritus;somnolence;Urinary Retention	2022-02-10	https://www.pharmgkb.org/clinicalAnnotation/1451678080	
1446896644	rs6265	BDNF	3			2.5	Efficacy	1	1	olanzapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446896644	
1446897502	rs1364805		3			0.0	Efficacy	1	1	montelukast	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446897502	Pediatric
1446897509	rs7794356	GALNT17	3			0.0	Efficacy	1	1	montelukast	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446897509	Pediatric
1446897520	rs6475448	MLLT3	3			0.0	Efficacy	1	1	montelukast	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446897520	Pediatric
1446897526	rs953977		3			0.0	Efficacy	1	1	montelukast	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446897526	Pediatric
1446897533	rs2073618	TNFRSF11B	3			4.25	Toxicity	1	2	anastrozole;letrozole	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446897533	
1446897540	rs7984870	TNFSF11	3			4.25	Efficacy	1	2	anastrozole;letrozole	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446897540	
1446897675	rs1128503	ABCB1	3		Tier 1 VIP	3.75	Toxicity	2	3	sunitinib	Carcinoma, Renal Cell	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446897675	
1446897710	rs2032582	ABCB1	3		Tier 1 VIP	5.0	Efficacy	2	2	sunitinib	Carcinoma, Renal Cell	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446897710	
1183632200	rs2032582	ABCB1	3		Tier 1 VIP	4.5	Efficacy	2	2	ondansetron	Postoperative Nausea and Vomiting;Vomiting	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183632200	
1451476540	rs1695	GSTP1	3		Tier 1 VIP	3.0	Toxicity	1	1	cisplatin;doxorubicin;methotrexate	cardiotoxicity;Osteosarcoma	2021-07-29	https://www.pharmgkb.org/clinicalAnnotation/1451476540	Pediatric
1451648440	rs756770	ADAMTSL2	3			0.0	Efficacy	1	1	buprenorphine	Opioid-Related Disorders	2022-01-14	https://www.pharmgkb.org/clinicalAnnotation/1451648440	
1446899209	CYP2D6*1, CYP2D6*4	CYP2D6	3		Tier 1 VIP	6.0	Dosage;Toxicity	1	2	maprotiline;opipramol	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446899209	
1446899303	CYP2B6*1, CYP2B6*6	CYP2B6	3		Tier 1 VIP	2.0	Metabolism/PK	1	1	ketamine	Neoplasms;Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446899303	
1446899616	rs776746	CYP3A5	3		Tier 1 VIP	4.75	Dosage;Metabolism/PK	2	3	cyclosporine	liver transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446899616	
1446899680	rs17885382	HLA-DRB1	3			3.0	Toxicity	1	1	asparaginase	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446899680	Pediatric
1446899688	rs6021191	NFATC2	3			3.0	Toxicity	1	2	asparaginase	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446899688	Pediatric
1446899949	rs1061472	ATP7B	3			3.0	Toxicity	1	1	carboplatin;taxanes	Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446899949	
1451476581	rs13181	ERCC2	3			1.5	Toxicity	1	1	cisplatin;doxorubicin;methotrexate	nephrotoxicity;Osteosarcoma	2021-07-29	https://www.pharmgkb.org/clinicalAnnotation/1451476581	Pediatric
1451504280	rs774072493	BCHE	3		Rare Variant	0.25	Toxicity	1	1	succinylcholine	Apnea	2021-09-27	https://www.pharmgkb.org/clinicalAnnotation/1451504280	
1444704928	rs3758785	GPR83	3			0.0	Efficacy	1	1	hydrochlorothiazide	Essential hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704928	
1444608250	CYP1A2*1A, CYP1A2*1C, CYP1A2*1F	CYP1A2	3			2.75	Toxicity	2	2	clozapine	Confusion;Drug Toxicity;Headache;Muscle Rigidity;Schizophrenia;sedation;Seizures;Tachycardia	2022-03-18	https://www.pharmgkb.org/clinicalAnnotation/1444608250	
1444607408	rs1045642	ABCB1	3		Tier 1 VIP	2.5	Efficacy	5	7	imatinib	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607408	
1444607420	rs889895	CREB1	3			0.5	Efficacy	1	2	antidepressants	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607420	
1444607466	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*6	CYP2C9	3		Tier 1 VIP	2.25	Toxicity	1	1	olanzapine	Hypotension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607466	
1444607666	rs12721646	CYP2B6	3		Tier 1 VIP	0.0	Other	2	2	nevirapine	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607666	
1444608238	rs4532	DRD1	3			4.5	Toxicity	1	3	dextroamphetamine;methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444608238	Pediatric
1444666615	rs3213239	APLF	3			3.0	Efficacy	1	1	Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666615	
1444666622	rs13181	ERCC2	3			2.5	Toxicity	1	1	Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666622	
1444666629	rs1799793	ERCC2	3			4.5	Toxicity	2	2	Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666629	
1444668457	rs2900478	SLCO1B1	3		Tier 1 VIP	1.25	Efficacy	1	1	hmg coa reductase inhibitors		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444668457	
1444668468	rs445925		3			1.25	Efficacy	1	1	hmg coa reductase inhibitors		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444668468	
1444673108	rs11692021	UGT1A9	3			2.5	Toxicity	2	2	irinotecan	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444673108	
1444673115	rs2070959	UGT1A6	3			2.5	Toxicity	1	1	irinotecan	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444673115	
1444686816	rs11265572		3			1.75	Metabolism/PK	1	1	tacrolimus	liver transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444686816	
1444686824	rs2231142	ABCG2	3		Tier 1 VIP	2.5	Efficacy	1	1	sulfasalazine	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444686824	
1444686836	rs1800871	IL10	3			2.0	Dosage;Efficacy	1	1	tacrolimus	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444686836	
1444700688	rs1160351	MDGA2	3			0.0	Toxicity	1	1	fluvoxamine;milnacipran;paroxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700688	
1444704921	rs3740066	ABCC2	3			1.5	Metabolism/PK	1	1	carbamazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704921	
1444704936	rs3758785	GPR83	3			0.0	Efficacy	1	1	candesartan	Essential hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704936	
1444704943	rs3764043	SLCO1A2	3			2.0	Metabolism/PK	1	1	imatinib	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704943	
1444843382	rs11231809	SLC22A11	3			2.5	Efficacy	1	1	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444843382	
1444843389	rs246240	ABCC1	3			3.0	Efficacy	1	1	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444843389	
1444843402	rs3784864	ABCC1	3			2.5	Efficacy	1	1	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444843402	
1447673027	rs9934438	VKORC1	3		Tier 1 VIP	4.75	Efficacy	2	2	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447673027	
1447681808	rs10046	CYP19A1	3			2.75	Other	1	2	hdl cholesterol;letrozole;triglycerides	Breast Neoplasms;Menopause	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447681808	
1444686803	rs2231142	ABCG2	4		Tier 1 VIP	-0.25	Efficacy	2	2	capecitabine;fluorouracil;leucovorin;oxaliplatin	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444686803	
1444668444	rs10455872	LPA	3			6.75	Efficacy	3	4	hmg coa reductase inhibitors	Coronary Artery Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444668444	
1447673659	rs111888148	RYR1	3		Rare Variant; Tier 1 VIP	0.25	Toxicity	3	3	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-10-27	https://www.pharmgkb.org/clinicalAnnotation/1447673659	
1444930642	rs12979860	IFNL3;IFNL4	3			5.75	Efficacy	2	2	ledipasvir;sofosbuvir	Hepatitis C, Chronic	2021-12-01	https://www.pharmgkb.org/clinicalAnnotation/1444930642	
1451678101	rs4680	COMT	4		Tier 1 VIP	-0.25	Toxicity	2	3	oxycodone	adverse events;Constipation;Delirium;Nausea;Pruritus;somnolence;Urinary Retention	2022-02-10	https://www.pharmgkb.org/clinicalAnnotation/1451678101	
1447672998	rs9923231	VKORC1	2A		Tier 1 VIP	17.75	Efficacy	11	12	warfarin	time to therapeutic inr	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447672998	Pediatric
1447673015	rs9923231	VKORC1	2A		Tier 1 VIP	9.0	Efficacy	9	9	warfarin	time in therapeutic range	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447673015	Pediatric
1447673669	rs193922809	RYR1	1A		Rare Variant; Tier 1 VIP	100.25	Toxicity	2	3	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447673669	
1451476547	rs1695	GSTP1	3		Tier 1 VIP	2.0	Toxicity	1	1	doxorubicin	Leukopenia;Osteosarcoma	2021-07-29	https://www.pharmgkb.org/clinicalAnnotation/1451476547	Pediatric
1451465324	rs4149056	SLCO1B1	1A		Tier 1 VIP	103.5	Toxicity	1	2	lovastatin	statin-related myopathy	2022-02-15	https://www.pharmgkb.org/clinicalAnnotation/1451465324	
1451718264	rs13210472		3			3.0	Toxicity	1	1	hmg coa reductase inhibitors	Neoplasms	2022-03-11	https://www.pharmgkb.org/clinicalAnnotation/1451718264	
1444607730	rs9852	TBC1D1	3			2.0	Toxicity	1	1	clozapine;olanzapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607730	
1444667334	rs17431184	PTEN	3			0.0	Efficacy	1	1	capecitabine;fluorouracil	Neoplasm Metastasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444667334	
1444667346	rs2236722	CYP19A1	3		Rare Variant	0.0	Efficacy	1	1	capecitabine;fluorouracil	Neoplasm Metastasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444667346	
1444700474	rs45605536	ABCG2	3		Rare Variant; Tier 1 VIP	0.0	Other	1	1	dasatinib;imatinib		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700474	
1444700488	rs58818712	ABCG2	3		Rare Variant; Tier 1 VIP	0.0	Other	1	1	dasatinib;imatinib		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700488	
1444700495	rs41282401	ABCG2	3		Rare Variant; Tier 1 VIP	0.0	Other	1	1	dasatinib;imatinib;nilotinib		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700495	
1444700502	rs1061018	ABCG2	3		Rare Variant; Tier 1 VIP	0.0	Other	1	1	dasatinib;imatinib;nilotinib		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700502	
1444703936	rs3750117	NT5C3A	3			3.0	Efficacy	1	1	cytarabine;idarubicin	Leukemia, Myeloid, Acute	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703936	
1444703951	rs495828		3			5.5	Toxicity	1	2	enalapril	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703951	
1444703976	rs2306719	CA12	3			0.0	Other	1	1	topiramate;zonisamide		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703976	
1444704795	rs10279545	COL26A1	3			0.0	Toxicity	1	1	aspirin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704795	
1444704810	rs1045280	ARRB2	3			1.5	Other	1	1	methamphetamine	Substance-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704810	
1444706854	rs11677416	IL1A	3			0.0	Efficacy	1	1	olanzapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444706854	
1444706861	rs1880676	CHAT	3			0.0	Efficacy	1	1	olanzapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444706861	
1444706876	rs2734842	DRD2	3		Tier 1 VIP	1.75	Toxicity	1	1	olanzapine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444706876	
1444706883	rs3810950	CHAT	3			0.0	Efficacy	1	1	olanzapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444706883	
1444706890	rs4436578	DRD2	3		Tier 1 VIP	3.25	Toxicity	1	1	clozapine;olanzapine;risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444706890	
1445400939	rs1801131	MTHFR	3		Tier 1 VIP	1.5	Toxicity	1	1	clozapine;olanzapine	schizoaffective disorder;Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445400939	
1445401413	rs11563250	UGT1A	3			2.0	Metabolism/PK	1	1	bilirubin	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401413	
1445401420	rs11563250	UGT1A	3			3.75	Toxicity	1	1	irinotecan	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401420	
1445401439	rs1934969	CYP2C9	3		Tier 1 VIP	1.25	Metabolism/PK	1	1	phenytoin	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401439	
1447678472	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*10, CYP2D6*14	CYP2D6	3		Tier 1 VIP	0.75	Toxicity	12	15	antipsychotics	Dystonia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447678472	
1447678614	rs9346455		3			0.0	Toxicity	1	1	antipsychotics	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447678614	
1447679509	GSTM1 non-null, GSTM1 null	GSTM1	3			2.25	Efficacy	6	7	cisplatin;oxaliplatin;Platinum compounds	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447679509	
1444703702	rs6313	HTR2A	4			-1.75	Efficacy	1	2	fluvoxamine;paroxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703702	
1444703739	rs6313	HTR2A	4			-1.75	Efficacy	1	2	fluvoxamine;paroxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703739	
1445400924	rs63749869	RYR1	1A		Rare Variant; Tier 1 VIP	100.25	Toxicity	5	6	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445400924	
1451476564	rs1801133	CLCN6;MTHFR	3		Tier 1 VIP	0.0	Toxicity	1	1	cisplatin;doxorubicin;methotrexate	nephrotoxicity;Osteosarcoma	2021-07-29	https://www.pharmgkb.org/clinicalAnnotation/1451476564	Pediatric
1451504300	rs568724445	BCHE	3		Rare Variant	0.25	Toxicity	1	1	succinylcholine	Apnea	2021-09-27	https://www.pharmgkb.org/clinicalAnnotation/1451504300	
1444704784	rs1024323	GRK4	3			0.0	Toxicity	1	1	atenolol;verapamil	Coronary Artery Disease;Hypertension	2022-09-23	https://www.pharmgkb.org/clinicalAnnotation/1444704784	
1446904283	rs56061981	CXCL10	3			2.75	Efficacy	1	1	peginterferon alfa-2a;peginterferon alfa-2b	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446904283	
1446904972	rs717620	ABCC2	3			0.25	Toxicity	1	1	deferasirox	beta-Thalassemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446904972	Pediatric
1446905018	rs8187710	ABCC2	3			0.25	Toxicity	1	1	deferasirox	beta-Thalassemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446905018	Pediatric
1446906399	rs889299	SCNN1B	3			2.25	Toxicity	1	1	Farglitazar;glyburide	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446906399	
1446906412	rs2429427	TANC2	3			2.25	Efficacy	1	1	calcium channel blockers	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446906412	
1446906421	rs2242480	CYP3A4	3		Tier 1 VIP	4.5	Toxicity	1	2	methadone	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446906421	
1446907957	rs7254579	CYP2B6	3		Tier 1 VIP	2.0	Metabolism/PK	1	1	cyclophosphamide	Lupus erythematosus	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446907957	
1446908002	rs4802101	CYP2B6	3		Tier 1 VIP	5.5	Toxicity;Metabolism/PK	1	2	cyclophosphamide	Lupus erythematosus	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446908002	
1447680028	rs371194629	HLA-G	3			3.25	Efficacy	1	1	capecitabine;fluorouracil	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447680028	
1447680035	rs9380142	HLA-G	3			3.25	Efficacy	1	1	capecitabine;fluorouracil	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447680035	
1447680045	rs17179108	HLA-G	3			2.25	Efficacy	1	1	capecitabine;fluorouracil	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447680045	
1447680068	rs4646	CYP19A1	3			1.5	Other	1	1	letrozole	Breast Neoplasms;Menopause	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447680068	
1447681831	rs2289105	CYP19A1	3			2.75	Other	1	2	hdl cholesterol;letrozole;triglycerides	Breast Neoplasms;Menopause	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447681831	
1447682293	rs700518	CYP19A1	3			1.5	Other	1	1	letrozole	Breast Neoplasms;Menopause	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447682293	
1446905231	rs4803419	CYP2B6	3		Tier 1 VIP	1.375	Metabolism/PK	5	5	efavirenz	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446905231	Pediatric
1451496100	G6PD B (wildtype), G6PD Canton, Taiwan-Hakka, Gifu-like, Agrigento-like	G6PD	3		Tier 1 VIP	0.5	Toxicity	3	3	sulfamethoxazole	Hemolysis	2021-09-15	https://www.pharmgkb.org/clinicalAnnotation/1451496100	
1451743169	rs17064642	MYOM2	3			4.0	Efficacy	1	1	aspirin;clopidogrel	Acute coronary syndrome;major adverse cardiac events (mace)	2022-04-06	https://www.pharmgkb.org/clinicalAnnotation/1451743169	
1451504307	rs764841347	BCHE	3		Rare Variant	0.25	Toxicity	1	1	succinylcholine	Apnea	2021-09-27	https://www.pharmgkb.org/clinicalAnnotation/1451504307	
1451723589	CYP3A4*1, CYP3A4*3	CYP3A4	3		Tier 1 VIP	0.0	Metabolism/PK	1	1	quetiapine		2022-03-18	https://www.pharmgkb.org/clinicalAnnotation/1451723589	
1444666110	rs2231142	ABCG2	3		Tier 1 VIP	5.25	Toxicity	3	4	sunitinib	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666110	
1444666589	rs3738948	ERCC3	3			2.25	Efficacy	1	1	Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666589	
1444666601	rs1800975	XPA	3			2.25	Efficacy	1	1	Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666601	
1444666608	rs1799801	ERCC4	3			2.25	Efficacy	1	1	Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666608	
1444666667	rs4413407	CXXC4	3			3.0	Efficacy	1	1	Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666667	
1444673184	rs35864111	VEGFA	3			2.25	Efficacy	1	1	docetaxel	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444673184	
1444700625	rs112561475	UGT2B10	3			1.5	Metabolism/PK	1	1	nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700625	
1444700639	rs1126510	PTGIR	3			1.5	Toxicity	1	1	aspirin	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700639	
1444700647	rs113165732	OCRL	3			0.25	Other	1	1	tenofovir	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700647	
1444704081	rs4570625	TPH2	3			0.0	Efficacy	1	1	citalopram	Depressive Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704081	Pediatric
1445402209	rs12044852	CD58	3			2.0	Efficacy	1	1	interferon beta-1a;interferon beta-1b	Multiple Sclerosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445402209	
1446897159	rs1143634	IL1B	3			3.0	Toxicity	1	1	antipsychotics	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446897159	
1451504376	rs201820739	BCHE	3		Rare Variant	0.25	Toxicity	1	1	succinylcholine	Apnea	2021-09-27	https://www.pharmgkb.org/clinicalAnnotation/1451504376	
1446906343	rs5443	GNB3	3			3.5	Other	1	2	Beta Blocking Agents		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446906343	
1446906350	rs6166	FSHR	3			1.375	Efficacy	1	1	follitropin beta;thyrotropin alfa;urofollitropin	Infertility, Female;Ovarian hyperstimulation syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446906350	
1444607641	rs2269577	XBP1	3			2.0	Efficacy;Toxicity	1	4	Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607641	
1444666543	rs887829		3			1.25	Metabolism/PK	2	2	deferasirox	beta-Thalassemia	2018-06-21	https://www.pharmgkb.org/clinicalAnnotation/1444666543	Pediatric
1444607648	rs58425034	CYP2B6	3		Tier 1 VIP	0.0	Other	2	2	nevirapine	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607648	
1444608053	rs3957357	GSTA1	3			1.5	Efficacy	1	1	doxorubicin	Sarcoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444608053	
1444666550	rs2273697	ABCC2	3			1.25	Metabolism/PK	1	1	deferasirox	beta-Thalassemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666550	
1444667461	rs1047626	SLC30A9	3			3.0	Toxicity	1	1	aspirin	aspirin-induced asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444667461	Pediatric
1444700815	rs1495741		3			6.5	Toxicity	2	2	Drugs For Treatment Of Tuberculosis	Tuberculosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700815	
1444706209	rs4149036	SLCO1B1	3		Tier 1 VIP	3.0	Efficacy	1	1	atorvastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444706209	
1444706830	rs3087879	SLC1A1	3			3.5	Efficacy	1	1	Selective serotonin reuptake inhibitors	Obsessive-Compulsive Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444706830	
1444930908	rs12979860	IFNL3;IFNL4	3			0.0	Efficacy	1	1	daclatasvir;peginterferon alfa-2a;peginterferon alfa-2b;ribavirin	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444930908	
1445401260	rs2306283	SLCO1B1	3		Tier 1 VIP	2.0	Efficacy	1	1	rocuronium		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401260	
1445401267	rs9282564	ABCB1	3		Tier 1 VIP	2.75	Toxicity	1	1	morphine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401267	Pediatric
1446906328	rs4688040	NR1I2	3		Rare Variant	1.25	Metabolism/PK	1	1	carbamazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446906328	
1446906335	rs4825476	GRIA3	3			3.0	Toxicity	1	1	citalopram	Depression;suicide	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446906335	
1446906363	rs6277	DRD2	3		Tier 1 VIP	2.0	Efficacy	1	1	aripiprazole	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446906363	
1446906370	rs8192709	CYP2B6	3		Tier 1 VIP	0.25	Metabolism/PK	2	2	efavirenz		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446906370	
1446906391	rs944050	ESR2	3			2.25	Efficacy	1	1	gemcitabine	Pancreatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446906391	
1447813539	rs1059751	ABCC4	3			2.25	Toxicity	1	1	tenofovir	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447813539	
1447813554	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	3		Tier 1 VIP	2.5	Efficacy;Metabolism/PK	8	10	tamoxifen	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447813554	
1447813708	rs78015114		3			1.25	Efficacy	1	1	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447813708	
1447813720	rs75222709		3			1.25	Efficacy	1	1	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447813720	
1447813855	rs10140457	ESR2	3			2.5	Toxicity	1	1	letrozole	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447813855	
1447813873	rs4870061	ESR1	3			5.0	Toxicity	1	2	letrozole	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447813873	
1447813969	rs1801133	MTHFR	3		Tier 1 VIP	7.25	Efficacy	3	3	fluorouracil;leucovorin;oxaliplatin	Colonic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447813969	
1447814178	rs2010963	VEGFA	3			2.75	Toxicity	1	1	sorafenib	Carcinoma, Renal Cell;hand-foot syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447814178	
1447814397	rs9322335	ESR1	3			5.0	Toxicity	1	2	exemestane;letrozole	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447814397	
1447814403	rs717620	ABCC2	3			0.0	Metabolism/PK	1	1	efavirenz	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447814403	
1447814424	rs3793790	CHAT	3			2.0	Efficacy	1	1	donepezil;galantamine;rivastigmine	Alzheimer Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447814424	
1447814450	rs3917412	SELE	3			2.25	Efficacy	1	1	capecitabine;fluorouracil;leucovorin;oxaliplatin	Colonic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447814450	
1444607611	rs1065852	CYP2D6	3		Tier 1 VIP	1.75	Efficacy	1	1	escitalopram	Depressive Disorder, Major	2021-04-22	https://www.pharmgkb.org/clinicalAnnotation/1444607611	
1451504360	rs1560022535	BCHE	3		Rare Variant	0.25	Toxicity	1	1	succinylcholine	Apnea	2021-09-27	https://www.pharmgkb.org/clinicalAnnotation/1451504360	Pediatric
1451504368	rs531738678	BCHE	3		Rare Variant	0.25	Toxicity	1	1	succinylcholine	Apnea	2021-09-27	https://www.pharmgkb.org/clinicalAnnotation/1451504368	
1444666533	CYP3A4*1, CYP3A4*8, CYP3A4*20, CYP3A4*22	CYP3A4	3		Tier 1 VIP	3.0	Toxicity	2	2	paclitaxel	Breast Neoplasms;Ovarian Neoplasms	2022-03-22	https://www.pharmgkb.org/clinicalAnnotation/1444666533	
1447943620	rs11313667	LRRC15	3			0.0	Efficacy	1	1	hydrochlorothiazide	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447943620	
1447943626	rs11313667	LRRC15	3			0.0	Efficacy	1	1	metoprolol	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447943626	
1444686850	rs683369	SLC22A1	3			5.75	Efficacy;Metabolism/PK	1	3	imatinib	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444686850	
1444686857	rs3806598	UGT1A9	3			0.0	Metabolism/PK	1	1	SN-38		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444686857	
1444686868	rs34231037	KDR	3			2.5	Efficacy;Metabolism/PK	1	2	pazopanib	Kidney Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444686868	
1444686880	rs2741049	UGT1A9	3			0.0	Metabolism/PK	1	3	SN-38		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444686880	
1444687039	rs4149570	TNFRSF1A	3			3.5	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Crohn Disease;Inflammatory Bowel Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444687039	
1444700788	CYP2C19*1, CYP2C19*17	CYP2C19	3		Tier 1 VIP	2.5	Toxicity	1	1	prasugrel	Acute coronary syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700788	
1447813701	rs79663003		3			1.25	Efficacy	1	1	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447813701	
1447814153	rs2239702	KDR	3			4.0	Efficacy	1	2	sorafenib	Carcinoma, Renal Cell	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447814153	
1447814165	rs1570360	VEGFA	3			1.75	Efficacy	1	1	sorafenib	Carcinoma, Renal Cell	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447814165	
1447814185	rs1045642	ABCB1	3		Tier 1 VIP	2.25	Toxicity	1	1	sorafenib	Carcinoma, Renal Cell;Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447814185	
1447814385	rs1967309	ADCY9	3			3.0	Efficacy;Toxicity	2	2	dalcetrapib	Acute coronary syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447814385	
1447943597	rs1045642	ABCB1	3		Tier 1 VIP	0.5	Efficacy	2	2	venlafaxine	Depressive Disorder;Narcolepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447943597	
1447943608	rs1045642	ABCB1	3		Tier 1 VIP	1.75	Efficacy	1	1	Selective serotonin reuptake inhibitors	Depressive Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447943608	
1447943614	rs11313667	LRRC15	3			0.0	Efficacy	1	1	atenolol	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447943614	
1447943700	rs1045642	ABCB1	3		Tier 1 VIP	2.0	Efficacy	1	1	modafinil	Narcolepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447943700	
1447943721	rs1076560	DRD2	3		Tier 1 VIP	1.75	Efficacy	1	1	olanzapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447943721	
1447943760	rs13250975	NRG1	3			1.625	Efficacy	1	1	antipsychotics	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447943760	
1447943772	rs1367094	ZMAT4	3			0.0	Efficacy	1	1	atenolol	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447943772	
1447944813	rs138337	ST13	3			1.5	Efficacy	1	1	corticosteroids	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447944813	Pediatric
1444686843	rs4646437	CYP3A4	2A		Tier 1 VIP	10.5	Metabolism/PK	6	6	tacrolimus	Kidney Transplantation;liver transplantation;Proteinuria	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444686843	Pediatric
1447749024	rs1800566	NQO1	4			-3.25	Dosage	4	5	warfarin		2021-12-03	https://www.pharmgkb.org/clinicalAnnotation/1447749024	
1449157278	rs678849	OPRD1	3			5.75	Efficacy	3	5	buprenorphine	Opioid-Related Disorders	2022-02-09	https://www.pharmgkb.org/clinicalAnnotation/1449157278	
1447672622	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	4		Tier 1 VIP	-3.25	Efficacy	14	15	warfarin		2021-05-19	https://www.pharmgkb.org/clinicalAnnotation/1447672622	Pediatric
1445594491	rs4431329	FBXL17	3			0.0	Efficacy	1	1	hydrochlorothiazide	Essential hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445594491	
1445594498	rs9285669		3			0.0	Efficacy	1	1	hydrochlorothiazide	Essential hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445594498	
1445594505	rs11993031	CSMD1	3			0.0	Efficacy	1	1	hydrochlorothiazide	Essential hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445594505	
1446897166	rs16944	IL1B	3			3.0	Toxicity	1	1	antipsychotics	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446897166	
1446897184	rs4849127	IL1B	3			3.0	Toxicity	1	1	antipsychotics	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446897184	
1446899372	rs2231142	ABCG2	3		Tier 1 VIP	1.5	Metabolism/PK	3	3	sulfasalazine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446899372	
1447672600	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*13, CYP2C9*14	CYP2C9	2A		Tier 1 VIP	10.5	Efficacy	10	15	warfarin	Atrial Fibrillation;heart valve replacement	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447672600	Pediatric
1447673759	rs118192178	RYR1	1A		Rare Variant; Tier 1 VIP	101.75	Toxicity	5	8	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447673759	Pediatric
1447673778	rs193922818	RYR1	1A		Rare Variant; Tier 1 VIP	101.0	Toxicity	7	9	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447673778	Pediatric
1447673787	rs193922878	RYR1	1A		Tier 1 VIP	101.0	Toxicity	5	6	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447673787	
1447675871	rs193922753	RYR1	1A		Rare Variant; Tier 1 VIP	100.75	Toxicity	3	4	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447675871	
1447676001	rs118192116	RYR1	1A		Rare Variant; Tier 1 VIP	100.0	Toxicity	1	2	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447676001	
1447676077	rs193922807	RYR1	1A		Tier 1 VIP	100.0	Toxicity	2	3	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447676077	Pediatric
1447672640	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	4		Tier 1 VIP	-3.5	Efficacy	8	8	warfarin		2021-05-19	https://www.pharmgkb.org/clinicalAnnotation/1447672640	Pediatric
1451725560	CYP3A4*1, CYP3A4*22	CYP3A4	3		Tier 1 VIP	1.25	Toxicity	1	2	alprazolam	adverse events;Alcoholism;Anxiety Disorders	2022-03-21	https://www.pharmgkb.org/clinicalAnnotation/1451725560	
1444666290	rs1042713	ADRB2	3		Tier 1 VIP	2.25	Efficacy	1	1	tiotropium	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666290	
1444667758	rs1946518	IL18	3			3.25	Metabolism/PK	2	3	tacrolimus	Kidney Transplantation;lung transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444667758	
1444686760	rs1799853	CYP2C9	3		Tier 1 VIP	3.0	Metabolism/PK	1	2	busulfan	hemopoietic stem cell transplant	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444686760	Pediatric
1444686789	rs3745274	CYP2B6	3		Tier 1 VIP	6.5	Efficacy;Toxicity	1	3	imatinib	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444686789	
1444703803	rs36056065	SLC22A1	3			3.0	Toxicity	1	1	metformin	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703803	
1444706869	rs2734841	DRD2	3		Tier 1 VIP	1.75	Toxicity	1	1	olanzapine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444706869	
1447676781	rs8099917	IFNL3	3			2.5	Efficacy	1	1	peginterferon alfa-2a;peginterferon alfa-2b;ribavirin;simeprevir	Hepatitis C	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447676781	
1447681869	rs3759811	CYP19A1	3			1.5	Other	1	1	letrozole	Breast Neoplasms;Menopause	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447681869	
1447681876	rs4775936	CYP19A1	3			1.5	Other	1	1	letrozole	Breast Neoplasms;Menopause	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447681876	
1447681883	rs1008805	CYP19A1	3			1.25	Other	1	1	hmg coa reductase inhibitors;letrozole	Breast Neoplasms;Menopause	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447681883	
1451649020	rs671	ALDH2	3		Rare Variant	2.5	Efficacy	1	1	naltrexone	Alcoholism	2022-01-14	https://www.pharmgkb.org/clinicalAnnotation/1451649020	
1447945787	CYP2B6*1, CYP2B6*6	CYP2B6	3		Tier 1 VIP	2.0	Metabolism/PK	1	1	cyclophosphamide	Lymphoma, B-Cell	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447945787	Pediatric
1447945800	rs1056836	CYP1B1	3			2.5	Toxicity	1	1	cyclophosphamide;epirubicin;paclitaxel	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447945800	
1447945850	rs2229109	ABCB1	3		Tier 1 VIP	3.5	Toxicity	1	1	bleomycin;cyclophosphamide;doxorubicin;prednisone;rituximab;vincristine;vindesine	Lymphoma, Non-Hodgkin	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447945850	
1447945887	rs396991	FCGR3A	3			0.5	Efficacy	2	2	infliximab	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447945887	
1447945958	rs12817819	ATP2B1	3			1.75	Efficacy	1	2	Antihypertensives	Coronary Artery Disease;Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447945958	
1447945967	rs6465084	GRM3	3			5.25	Efficacy	2	2	antipsychotics	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447945967	
1447945978	rs1468412	GRM3	3			2.25	Toxicity	1	1	antipsychotics	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447945978	
1447945985	rs12467557	NRXN1	3			1.75	Efficacy	1	1	antipsychotics	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447945985	
1447945992	rs10490162	NRXN1	3			1.75	Efficacy	1	1	antipsychotics	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447945992	
1447945999	rs17671591	HMGCR	3			5.5	Efficacy	2	2	atorvastatin	Hypercholesterolemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447945999	
1447946011	rs10490924	ARMS2	3			4.25	Efficacy	2	2	bevacizumab	Macular Degeneration	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447946011	
1447946061	CYP2E1*1A, CYP2E1*5B	CYP2E1	3			3.75	Toxicity	5	5	Drugs For Treatment Of Tuberculosis	Tuberculosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447946061	Pediatric
1447946088	rs1001179	CAT	3			2.75	Other	1	2	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447946088	
1447946098	rs1295686	IL13	3			2.25	Efficacy	1	1	Hepatitis vaccines		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447946098	
1447946107	rs1805015	IL4R	3			2.25	Efficacy	1	1	Hepatitis vaccines		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447946107	
1449156223	HLA-DRB1*01:02:01	HLA-DRB1	3			2.0	Toxicity	2	2	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156223	
1449192991	rs1800497	DRD2	3		Tier 1 VIP	3.0	Toxicity	1	1	ethanol	Alcoholism;Substance-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449192991	
1444667668	rs3753380	PTGFR	3			1.75	Efficacy	2	2	latanoprost	Glaucoma, Open-Angle	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444667668	
1451648980	rs698	ADH1C	3			2.5	Efficacy	1	1	naltrexone	Alcoholism	2022-01-14	https://www.pharmgkb.org/clinicalAnnotation/1451648980	
1451726525	rs1045642	ABCB1	4		Tier 1 VIP	-1.25	Efficacy	2	2	docetaxel	Breast Neoplasms;Neoplasms	2022-03-22	https://www.pharmgkb.org/clinicalAnnotation/1451726525	
1444667680	rs3766355	PTGFR	3			1.75	Efficacy	2	2	latanoprost	Glaucoma, Open-Angle	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444667680	
1444667704	rs10306114	PTGS1	3			0.0	Efficacy	1	1	latanoprost	Glaucoma, Open-Angle	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444667704	
1444667733	rs11568658	ABCC4	3			2.75	Efficacy	1	1	latanoprost	Glaucoma, Open-Angle	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444667733	
1444686893	rs6494223	CHRNA7	3			2.0	Efficacy	1	1	donepezil;galantamine;rivastigmine	Alzheimer Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444686893	
1445400992	rs1563828	MDM4	3			2.5	Efficacy	1	1	docetaxel;epirubicin	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445400992	
1445401001	rs1056836	CYP1B1	3			2.0	Efficacy	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401001	
1447681902	rs749292	CYP19A1	3			1.5	Other	1	1	letrozole	Breast Neoplasms;Menopause	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447681902	
1447682300	rs1062033	CYP19A1	3			1.25	Other	1	1	hmg coa reductase inhibitors;letrozole	Breast Neoplasms;Menopause	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447682300	
1447943640	rs2177370	CHAT	3			2.0	Efficacy	1	1	donepezil	Alzheimer Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447943640	
1447943653	rs2177370	CHAT	3			2.0	Efficacy	1	1	rivastigmine	Alzheimer Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447943653	
1447943673	rs5443	GNB3	3			2.25	Efficacy	1	1	hydralazine / isosorbide dinitrate	Heart Failure	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447943673	
1447943685	rs5443	GNB3	3			2.0	Efficacy	1	1	telmisartan	Essential hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447943685	
1447943693	rs6280	DRD3	3			1.25	Metabolism/PK	1	1	quetiapine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447943693	
1447943713	rs1045642	ABCB1	3		Tier 1 VIP	1.5	Metabolism/PK	1	1	silibinin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447943713	
1447943753	rs1128503	ABCB1	3		Tier 1 VIP	2.0	Efficacy	1	1	modafinil	Narcolepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447943753	
1447944755	rs1079597	DRD2	3		Tier 1 VIP	2.0	Efficacy	1	1	amisulpride	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447944755	
1447944806	rs138335	ST13	3			1.5	Efficacy	1	1	corticosteroids	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447944806	Pediatric
1447944819	rs1449683	FGF2	3			1.5	Efficacy	1	1	fluvoxamine	Depressive Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447944819	
1447944855	rs1544938	ADCY2	3			1.625	Efficacy	1	1	antipsychotics	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447944855	
1447943739	rs1128503	ABCB1	4		Tier 1 VIP	-0.625	Metabolism/PK	3	3	efavirenz	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447943739	
1444686796	rs1741981	HDAC1	3			3.25	Efficacy	1	2	corticosteroids	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444686796	Pediatric
1444704267	rs4702484	ADCY2	4			-1.75	Efficacy	1	2	capecitabine	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704267	
1444704373	rs446112		3			1.0	Efficacy	1	1	etoposide		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704373	
1444704385	rs4506565	TCF7L2	3			2.5	Toxicity	1	1	hydrochlorothiazide	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704385	
1444704392	rs4654327	OPRD1	3			1.5	Efficacy	1	1	naltrexone	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704392	
1444704400	rs4680	COMT	3		Tier 1 VIP	1.5	Efficacy	1	1	entacapone	Parkinson Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704400	
1447944882	rs17716295	NRG1	3			1.375	Efficacy	1	1	antipsychotics	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447944882	
1444704366	rs4329505	IL6R	4			-0.5	Efficacy	2	2	tocilizumab	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704366	
1451648958	rs2066702	ADH1B	3			2.5	Efficacy	1	1	naltrexone	Alcoholism	2022-01-14	https://www.pharmgkb.org/clinicalAnnotation/1451648958	
1185000052	rs776746	CYP3A5	3		Tier 1 VIP	1.0	Toxicity	2	2	tacrolimus	Kidney Failure	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1185000052	
1444667661	rs3792269	CAPN10	3			3.0	Efficacy	1	1	metformin	Diabetes Mellitus	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444667661	
1444686907	rs4646437	CYP3A4	3		Tier 1 VIP	2.5	Efficacy;Metabolism/PK	1	2	cyclosporine	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444686907	
1444686914	rs2276707	NR1I2	3			1.25	Metabolism/PK	2	2	tacrolimus	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444686914	
1444686921	rs4848306	IL1B	3			3.0	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Colitis, Ulcerative;Inflammatory Bowel Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444686921	
1444686927	rs4251961	IL1RN	3			2.75	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Colitis, Ulcerative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444686927	
1445401274	rs7438135	UGT2B7	3			0.875	Metabolism/PK	2	2	morphine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401274	Pediatric
1184999911	CYP3A5*1, CYP3A5*3	CYP3A5	1B		Tier 1 VIP	30.375	Metabolism/PK	26	30	tacrolimus	liver transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184999911	Pediatric
1444700589	rs11023197	RRAS2	3			1.75	Efficacy	1	1	tamoxifen	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700589	
1445401281	rs7317112	ABCC4	3			2.5	Toxicity	1	1	methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401281	Pediatric
1448573506	rs3745274	CYP2B6	3		Tier 1 VIP	0.75	Metabolism/PK	1	1	3,4-methylenedioxymethamphetamine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448573506	
1448602689	rs2669429	DPYS	3			3.0	Toxicity	1	1	atenolol	Hyperglycemia;Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448602689	
1448602859	rs3217164	CES1	3			3.0	Toxicity	1	1	capecitabine	Drug Toxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448602859	
1448602865	rs2244614	CES1	3			3.0	Toxicity	1	1	capecitabine	Drug Toxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448602865	
1448602871	rs2244613	CES1	3			2.5	Toxicity	1	1	capecitabine	Drug Toxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448602871	
1448602877	rs11861118	CES1P1	3			2.5	Toxicity	1	1	capecitabine	Drug Toxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448602877	
1448602883	rs7187684	CES1P1	3			2.5	Toxicity	1	1	capecitabine	Drug Toxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448602883	
1444687046	rs2430561	IFNG	3			2.75	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Crohn Disease;Inflammatory Bowel Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444687046	
1445401142	rs4680	COMT	3		Tier 1 VIP	2.0	Toxicity	1	1	antipsychotics		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401142	Pediatric
1445401149	rs4680	COMT	3		Tier 1 VIP	2.0	Toxicity	1	1	antipsychotics		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401149	Pediatric
1445585156	rs1045642	ABCB1	3		Tier 1 VIP	2.5	Metabolism/PK	1	2	daptomycin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445585156	
1451678087	rs4680	COMT	4		Tier 1 VIP	-0.25	Toxicity	2	3	morphine	adverse events;Constipation;Delirium;Nausea;Pruritus;somnolence;Urinary Retention	2022-02-10	https://www.pharmgkb.org/clinicalAnnotation/1451678087	
1451638880	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	3		Tier 1 VIP	3.0	Efficacy	1	1	ketorolac	Pain, Postoperative	2022-01-06	https://www.pharmgkb.org/clinicalAnnotation/1451638880	
1451649200	rs3829125	AKR1C4	3			0.0	Metabolism/PK	1	1	naltrexone		2022-01-14	https://www.pharmgkb.org/clinicalAnnotation/1451649200	
1451649186	rs17134592	AKR1C4	3			0.0	Metabolism/PK	1	1	naltrexone		2022-01-14	https://www.pharmgkb.org/clinicalAnnotation/1451649186	
1451679740	rs55944529	DAO	3			2.25	Metabolism/PK	1	1	methadone	Heroin Dependence	2022-02-11	https://www.pharmgkb.org/clinicalAnnotation/1451679740	
1451504901	rs1801133	MTHFR	3		Tier 1 VIP	7.75	Metabolism/PK	13	13	methotrexate	Burkitt Lymphoma;Leukemia;Lymphoma;Lymphoma, T-Cell;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2022-02-25	https://www.pharmgkb.org/clinicalAnnotation/1451504901	Pediatric
1444668597	rs9939609	FTO	3			2.0	Efficacy	1	1	interferon alfa-2a, recombinant;interferon alfa-2b, recombinant;ribavirin	Hepatitis C, Chronic;HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444668597	
1444694373	rs7903146	TCF7L2	3			0.0	Toxicity	3	3	cyclosporine;sirolimus;tacrolimus	Kidney Transplantation;liver transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444694373	
1444695339	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	3		Tier 1 VIP	6.75	Metabolism/PK	8	8	clobazam	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444695339	Pediatric
1446897191	rs6265	BDNF	3			5.0	Toxicity	2	2	antipsychotics	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446897191	
1446903007	rs7439366	UGT2B7	3			2.25	Dosage	1	1	codeine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446903007	
1451720996	rs7317112	ABCC4	3			1.75	Toxicity	1	1	Glucarpidase	nephrotoxicity	2022-09-22	https://www.pharmgkb.org/clinicalAnnotation/1451720996	Pediatric
1448601910	rs2242446	SLC6A2	3			2.75	Efficacy	1	1	venlafaxine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448601910	
1448602210	rs9361233	HTR1B	3			2.25	Efficacy	1	1	fluoxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448602210	Pediatric
1451649500	rs997917	OPRK1	3			0.0	Toxicity	1	1	cocaine	Cocaine-Related Disorders	2022-01-14	https://www.pharmgkb.org/clinicalAnnotation/1451649500	
1451649540	rs997917	OPRK1	3			0.0	Toxicity	1	1	opioids	Opioid-Related Disorders	2022-01-14	https://www.pharmgkb.org/clinicalAnnotation/1451649540	
1448603309	rs324420	FAAH	3			2.5	Toxicity	3	4	morphine	Constipation;Delirium;Lung Neoplasms;Nausea;Pain;Postoperative Nausea and Vomiting;Pruritus;Respiratory Insufficiency;somnolence;Urinary Retention	2022-02-10	https://www.pharmgkb.org/clinicalAnnotation/1448603309	Pediatric
1451679780	rs55944529	DAO	3			2.75	Dosage	1	1	methadone	Heroin Dependence	2022-02-11	https://www.pharmgkb.org/clinicalAnnotation/1451679780	
1451721004	rs9345389		3			0.0	Toxicity	1	1	Glucarpidase	nephrotoxicity	2022-03-15	https://www.pharmgkb.org/clinicalAnnotation/1451721004	Pediatric
1451721021	rs3824662	GATA3	3			0.0	Toxicity	1	1	Glucarpidase	nephrotoxicity	2022-03-15	https://www.pharmgkb.org/clinicalAnnotation/1451721021	Pediatric
1451737460	rs11640115	JMJD8;WDR24	3			3.5	Efficacy	1	1	aspirin;clopidogrel	Acute coronary syndrome;major adverse cardiac events (mace)	2022-03-31	https://www.pharmgkb.org/clinicalAnnotation/1451737460	
1444668402	rs646776	CELSR2	3			1.25	Efficacy	1	1	hmg coa reductase inhibitors		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444668402	
1444700896	rs776746	CYP3A5	3		Tier 1 VIP	1.5	Metabolism/PK	1	1	quetiapine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700896	
1451721013	rs4149056	SLCO1B1	3		Tier 1 VIP	0.0	Toxicity	1	1	Glucarpidase	nephrotoxicity	2022-09-22	https://www.pharmgkb.org/clinicalAnnotation/1451721013	Pediatric
1446897696	rs2032582	ABCB1	3		Tier 1 VIP	5.0	Toxicity	2	2	sunitinib	Carcinoma, Renal Cell;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446897696	
1451638961	rs1128503	ABCB1	3		Tier 1 VIP	2.25	Toxicity	2	2	paclitaxel	Breast Neoplasms;Peripheral Nervous System Diseases	2022-01-06	https://www.pharmgkb.org/clinicalAnnotation/1451638961	
1451720980	rs10908521	INSRR;NTRK1	3			0.0	Toxicity	1	1	Glucarpidase	nephrotoxicity	2022-03-15	https://www.pharmgkb.org/clinicalAnnotation/1451720980	Pediatric
1451748166	rs2952768		3			2.75	Dosage	1	1	fentanyl	Pain, Postoperative	2022-04-11	https://www.pharmgkb.org/clinicalAnnotation/1451748166	
1184987404	rs10485828	TUBB1	3			0.0	Other	1	1	anastrozole;exemestane	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184987404	
1184988860	rs2058878	GRIN2B	3			2.0	Efficacy	1	1	acamprosate	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184988860	
1184997066	HLA-B*38:01:01	HLA-B	3		Tier 1 VIP	3.0	Efficacy	1	1	peginterferon alfa-2a;peginterferon alfa-2b;ribavirin	Hepatitis C	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184997066	
1184997072	HLA-B*38:02:01	HLA-B	3		Tier 1 VIP	3.0	Toxicity	1	1	oxcarbazepine	Maculopapular Exanthema	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184997072	
1451748840	TPMT*1, TPMT*21, TPMT*33, TPMT*34	TPMT	3		Tier 1 VIP	3.5	Toxicity	1	1	mercaptopurine	Neutropenia;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Thrombocytopenia	2022-04-12	https://www.pharmgkb.org/clinicalAnnotation/1451748840	Pediatric
1184998947	rs1045642	ABCB1	3		Tier 1 VIP	0.0	Other	1	1	morphine	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184998947	Pediatric
1184998975	rs4793665	ABCC3	3			3.75	Other	2	2	morphine	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184998975	Pediatric
1184997092	HLA-B*44:02:01:01	HLA-B	3		Tier 1 VIP	2.5	Efficacy	1	1	interferon alfa-2a, recombinant;ribavirin	Hepatitis C	2022-02-28	https://www.pharmgkb.org/clinicalAnnotation/1184997092	
1451720988	rs1353327		3			0.0	Toxicity	1	1	Glucarpidase	nephrotoxicity	2022-03-15	https://www.pharmgkb.org/clinicalAnnotation/1451720988	Pediatric
1451726789	CYP2C8*1, CYP2C8*2, CYP2C8*3, CYP2C8*4	CYP2C8	4		Tier 1 VIP	-1.0	Toxicity	7	8	paclitaxel	Drug Toxicity;Neutropenia;Peripheral Nervous System Diseases;Toxic liver disease	2022-03-22	https://www.pharmgkb.org/clinicalAnnotation/1451726789	
1451737500	rs4736529	EFR3A	3			3.5	Efficacy	1	1	aspirin;clopidogrel	Acute coronary syndrome;major adverse cardiac events (mace)	2022-03-31	https://www.pharmgkb.org/clinicalAnnotation/1451737500	
1296598910	rs4253728	PPARA	3			2.0	Dosage	1	1	phenprocoumon		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1296598910	
1451721028	rs10821936	ARID5B	3		Rare Variant	0.0	Toxicity	1	1	Glucarpidase	nephrotoxicity	2022-03-15	https://www.pharmgkb.org/clinicalAnnotation/1451721028	Pediatric
1444666308	rs2832407	GRIK1	3			2.5	Efficacy;Metabolism/PK	1	2	topiramate	Alcohol-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666308	
1444673163	rs1057868	POR	3			2.75	Metabolism/PK	3	3	cyclosporine	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444673163	Pediatric
1444686935	rs352139	TLR9	3			3.5	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Crohn Disease;Inflammatory Bowel Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444686935	
1444686942	rs4696480	TLR2	3			2.75	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Colitis, Ulcerative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444686942	
1444686958	rs1816702	TLR2	3			2.75	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Crohn Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444686958	
1444694504	rs2237895	KCNQ1	3			2.0	Toxicity	1	1	tacrolimus	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444694504	
1444694544	rs1800896	IL10	3			2.25	Dosage	1	1	tacrolimus	liver transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444694544	
1444703639	rs3763980	SLC16A7	3			1.5	Efficacy	1	1	methotrexate	Arthritis, Juvenile Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703639	Pediatric
1444703668	rs642990		3			2.5	Toxicity	1	1	gemcitabine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703668	
1444713220	HLA-DRB3*02:02:01:01	HLA-DRB3	3			2.0	Toxicity	1	1	clozapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444713220	
1444713245	HLA-B*44:03:01	HLA-B	3		Tier 1 VIP	3.25	Toxicity	1	1	ticlopidine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444713245	
1444828083	G6PD A- 202A_376G	G6PD	3		Tier 1 VIP	0.375	Toxicity	2	2	pegloticase	Hemolysis;Methemoglobinemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444828083	
1445616165	rs77876672	DIAPH3	3			0.0	Efficacy	1	1	hydrochlorothiazide	Essential hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445616165	
1445619121	rs9590353	UGGT2	3			0.0	Efficacy	1	1	hydrochlorothiazide	Essential hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445619121	
1445619585	rs9915451	ANKFN1	3			0.0	Efficacy	1	1	hydrochlorothiazide	Essential hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445619585	
1448573300	rs4889606	STX1B	3			3.25	Efficacy	1	1	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448573300	
1444694511	rs2032582	ABCB1	4		Tier 1 VIP	-7.375	Dosage;Metabolism/PK	21	25	tacrolimus	Kidney Transplantation;liver transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444694511	Pediatric
1444703649	rs6064463		4			-1.0	Efficacy	2	2	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703649	
1444666386	rs28399499	CYP2B6	2A		Tier 1 VIP	9.5	Toxicity	4	4	nevirapine	Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666386	
1296599132	rs1045642	ABCB1	3		Tier 1 VIP	4.75	Toxicity	9	12	methotrexate	Burkitt Lymphoma;Drug Toxicity;Lymphoma, T-Cell;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2022-01-04	https://www.pharmgkb.org/clinicalAnnotation/1296599132	Pediatric
1451748940	TPMT*1, TPMT*21, TPMT*33, TPMT*34	TPMT	3		Tier 1 VIP	7.0	Toxicity	1	2	thioguanine	Neutropenia;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Thrombocytopenia	2022-04-12	https://www.pharmgkb.org/clinicalAnnotation/1451748940	Pediatric
1448573615	rs1128503	ABCB1	3		Tier 1 VIP	1.0	Efficacy	2	2	tacrolimus	Colitis, Ulcerative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448573615	Pediatric
1448601692	rs3732759	P2RY12	3			2.0	Efficacy	1	1	clopidogrel	Coronary Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448601692	
1448603297	rs4141964	FAAH	3			3.0	Toxicity	1	1	morphine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448603297	Pediatric
1448603303	rs3766246	FAAH	3			3.0	Toxicity	1	1	morphine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448603303	Pediatric
1448604082	rs113993960	CFTR	3		Rare Variant; Tier 1 VIP	0.75	Efficacy	1	2	cavosonstat	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448604082	Pediatric
1448604316	rs2277984	C3	3			0.0	Toxicity	1	1	clozapine	Metabolic Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448604316	
1448594289	rs2279343	CYP2B6	4		Tier 1 VIP	-1.25	Metabolism/PK	2	4	propofol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448594289	
1451737520	rs74569896	NECAB1	3			3.5	Efficacy	1	1	aspirin;clopidogrel	Acute coronary syndrome;major adverse cardiac events (mace)	2022-03-31	https://www.pharmgkb.org/clinicalAnnotation/1451737520	
1451748948	TPMT*1, TPMT*21, TPMT*33, TPMT*34	TPMT	3		Tier 1 VIP	3.5	Dosage	1	1	mercaptopurine	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2022-04-12	https://www.pharmgkb.org/clinicalAnnotation/1451748948	Pediatric
1184989970	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	4			-3.5	Efficacy	8	8	sertraline	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184989970	
1444607496	CYP3A5*1, CYP3A5*3	CYP3A5	4		Tier 1 VIP	-0.75	Metabolism/PK	3	3	olanzapine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607496	
1184755574	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*38	CYP2D6	3		Tier 1 VIP	0.125	Other	3	4	debrisoquine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184755574	
1184756108	CYP2D6*1, CYP2D6*4, CYP2D6*15	CYP2D6	3		Tier 1 VIP	0.125	Other	1	1	debrisoquine;dextromethorphan		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184756108	
1184986481	rs35599367	CYP3A4	3		Tier 1 VIP	5.875	Other	7	9	cyclosporine	Organ Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184986481	Pediatric
1184986491	rs4823613	PPARA	3			1.5	Other	1	1	tacrolimus	Organ Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184986491	
1184989950	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	3			0.5	Efficacy	8	11	fluoxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184989950	
1184989960	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	3			3.5	Toxicity	1	2	fluoxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184989960	
1184990000	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	3			2.0	Toxicity	1	1	mirtazapine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184990000	
1296598634	HLA-B*39:01:01:01	HLA-B	3		Tier 1 VIP	2.5	Toxicity	1	1	sulfasalazine	drug reaction with eosinophilia and systemic symptoms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1296598634	
1296598640	HLA-B*13:01:01	HLA-B	3		Tier 1 VIP	3.0	Toxicity	1	1	sulfasalazine	drug reaction with eosinophilia and systemic symptoms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1296598640	
1296598646	HLA-B*15:05:01	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	sulfasalazine	drug reaction with eosinophilia and systemic symptoms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1296598646	
1444607348	rs478437		3			0.0	Efficacy	1	1	tamoxifen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607348	
1444607366	rs310786	E2F7	3			0.0	Efficacy	1	1	tamoxifen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607366	
1444607373	rs310786	E2F7	3			2.0	Toxicity	1	1	tamoxifen	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607373	
1444607379	rs57098334	SLC6A4	3			1.25	Efficacy	2	2	sertraline	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607379	
1444607507	TPMT*1, TPMT*3A, TPMT*3C	TPMT	3		Tier 1 VIP	2.25	Toxicity	1	1	olanzapine	Fatigue	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607507	
1444607526	UGT1A1*1, UGT1A1*28	UGT1A1	3		Tier 1 VIP	2.75	Toxicity	1	1	olanzapine	Fatigue	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607526	
1444607634	rs628031	SLC22A1	3			4.5	Efficacy	2	2	metformin	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607634	
1444607674	rs6295	HTR1A	3			1.25	Efficacy	2	2	fluoxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607674	
1444607851	rs4073	CXCL8	3			1.75	Efficacy	1	1	bevacizumab	Macular Degeneration	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607851	
1444607863	rs11572076	CYP2C8	3		Tier 1 VIP	3.0	Toxicity	1	1	mycophenolate mofetil	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607863	
1444672766	rs1799963	F2	3		Rare Variant	3.5	Toxicity	4	4	hormonal contraceptives for systemic use	Stroke;Venous Thrombosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444672766	
1444672774	rs5443	GNB3	3			5.0	Efficacy	2	3	clonidine	Liver Cirrhosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444672774	
1451649631	rs12678747	EYA1	3			3.0	Toxicity	1	1	aspirin	Peptic Ulcer	2022-01-14	https://www.pharmgkb.org/clinicalAnnotation/1451649631	
1451737560	rs75750968	AGAP3	3			3.5	Efficacy	1	1	aspirin;clopidogrel	Acute coronary syndrome;major adverse cardiac events (mace)	2022-03-31	https://www.pharmgkb.org/clinicalAnnotation/1451737560	
1451749040	TPMT*1, TPMT*21, TPMT*33, TPMT*34	TPMT	3		Tier 1 VIP	3.5	Dosage	1	1	thioguanine	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2022-04-12	https://www.pharmgkb.org/clinicalAnnotation/1451749040	Pediatric
1184753786	SLCO1B1*15, SLCO1B1*37	SLCO1B1	3		Tier 1 VIP	1.0	Metabolism/PK	1	1	olmesartan		2021-10-12	https://www.pharmgkb.org/clinicalAnnotation/1184753786	
1184754281	CYP2C19*1, CYP2C19*2, CYP2C19*16	CYP2C19	3		Tier 1 VIP	0.125	Metabolism/PK	1	1	methylphenobarbital		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184754281	
1184986321	rs724710	BCL2L11	3			1.75	Efficacy	1	2	imatinib	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184986321	
1184986585	rs9535828	ATP7B	3			2.5	Efficacy	1	1	Platinum compounds	Lung Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184986585	
1184986763	rs1045642	ABCB1	3		Tier 1 VIP	4.75	Other	2	2	opioids	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184986763	
1184987048	rs10267099	ABCB1	3		Tier 1 VIP	1.5	Toxicity	1	1	atenolol	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184987048	
1184989940	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	3			4.75	Efficacy	6	10	citalopram	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184989940	Pediatric
1444700423	rs316019	SLC22A2	3			1.0	Toxicity	4	4	cisplatin	Ototoxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700423	Pediatric
1444700445	rs76228616	TRAF3IP2	3			2.5	Toxicity	1	1	nevirapine	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700445	
1444700767	rs12083537	IL6R	3			4.5	Efficacy	2	2	tocilizumab	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700767	
1444700888	rs9516519	ABCC4	3			4.0	Toxicity	1	2	methotrexate	Leukemia, B-Cell, Acute	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700888	Pediatric
1444703107	rs1705772	ALG10	3			2.0	Toxicity	1	1	gemcitabine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703107	
1444706112	rs5744247	IL18	3			2.25	Metabolism/PK	2	3	tacrolimus	Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444706112	
1444706787	rs4680	COMT	3		Tier 1 VIP	2.25	Efficacy	1	1	paroxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444706787	
1444706794	rs4675690		3			3.0	Toxicity	1	1	citalopram	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444706794	
1444706810	rs301434	SLC1A1	3			0.0	Efficacy	1	1	Selective serotonin reuptake inhibitors	Obsessive-Compulsive Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444706810	
1444706818	rs301435	SLC1A1	3			0.0	Efficacy	1	1	Selective serotonin reuptake inhibitors	Obsessive-Compulsive Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444706818	
1444703100	rs1703794		4			-1.0	Efficacy	2	2	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703100	
1444709147	rs1387923	NTRK2	4			-1.75	Efficacy	2	2	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444709147	
1451737600	rs140410716	ECHS1	3	Yes: Association only supported by one publication.	Rare Variant	3.5	Efficacy	1	1	aspirin;clopidogrel	Acute coronary syndrome;major adverse cardiac events (mace)	2022-03-31	https://www.pharmgkb.org/clinicalAnnotation/1451737600	
1184986174	rs75017182	DPYD	1A		Tier 1 VIP	199.5	Toxicity	9	11	fluorouracil	Neoplasms	2022-10-27	https://www.pharmgkb.org/clinicalAnnotation/1184986174	
1185000238	rs776746	CYP3A5	3		Tier 1 VIP	0.5	Efficacy	3	3	tacrolimus	Colitis, Ulcerative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1185000238	
1444607295	rs806368	CNR1	3			1.0	Other	1	2	cocaine	Cocaine-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607295	
1444607302	rs6454674	CNR1	3			2.5	Other	1	2	cocaine	Cocaine-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607302	
1444607737	rs1229984	ADH1B	3			1.5	Metabolism/PK	1	1	ethanol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607737	
1444607744	rs72552763	SLC22A1	3			1.75	Metabolism/PK	1	1	metformin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607744	
1444607751	rs1799782	XRCC1	3			0.0	Efficacy	6	7	Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607751	
1444607979	rs1042927	RRM1	3			1.25	Efficacy	3	3	gemcitabine;Platinum compounds	Mesothelioma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607979	
1444608491	rs1353295	AREG	3			1.75	Efficacy	1	1	cetuximab;irinotecan;panitumumab	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444608491	
1444665939	rs13104811	AREG	3			2.25	Efficacy	1	1	cetuximab;irinotecan;panitumumab	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444665939	
1444667912	rs4880	SOD2	3			1.5	Toxicity	1	1	valproic acid	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444667912	Pediatric
1444686969	rs11938228	TLR2	3			6.5	Efficacy	2	2	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Inflammatory Bowel Diseases;Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444686969	
1444686976	rs3804099	TLR2	3			3.5	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Inflammatory Bowel Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444686976	
1444686983	rs2569190	CD14	3			2.25	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Colitis, Ulcerative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444686983	
1444686990	rs2275913	IL17A	3			3.0	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Colitis, Ulcerative;Inflammatory Bowel Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444686990	
1444686997	rs6927172	TNFAIP3	3			3.0	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Colitis, Ulcerative;Inflammatory Bowel Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444686997	
1444687004	rs10499563	IL6	3			4.0	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Colitis, Ulcerative;Inflammatory Bowel Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444687004	
1444687025	rs5030728	TLR4	3			3.75	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Inflammatory Bowel Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444687025	
1444687032	rs1554973	CNPY4	3			2.5	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Inflammatory Bowel Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444687032	
1444700760	rs12054895		4			-1.5	Efficacy	1	2	citalopram;escitalopram	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700760	
1444700999	rs1799722	BDKRB2	3			2.0	Efficacy	1	1	enalapril		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700999	
1444701007	rs1799722	BDKRB2	3			3.0	Toxicity	1	1	enalapril;imidapril;lisinopril	Cough;Essential hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444701007	
1444704818	rs1045642	ABCB1	3		Tier 1 VIP	2.5	Toxicity	1	1	codeine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704818	
1444705191	rs10848635	CACNA1C	3			0.0	Toxicity	1	1	citalopram	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444705191	
1444705198	rs10975641	GLDC	3			3.5	Efficacy	1	1	citalopram;escitalopram	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444705198	
1444705206	rs2270007	CRHR2	3			3.0	Efficacy	1	1	citalopram	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444705206	
1444705222	rs585719		3			2.0	Efficacy	1	1	citalopram	Depressive Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444705222	
1444705229	rs6127921		3			0.0	Efficacy	1	1	citalopram	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444705229	
1444706124	rs11045872	SLCO1B1	3		Tier 1 VIP	0.0	Metabolism/PK	1	1	methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444706124	Pediatric
1445556297	rs3211371	CYP2B6	3		Tier 1 VIP	4.0	Efficacy	2	3	bupropion	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445556297	
1184999957	rs776746	CYP3A5	4		Tier 1 VIP	-3.25	Efficacy	5	5	tacrolimus	transplant rejection	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184999957	Pediatric
1444705214	rs25531	SLC6A4	4			-2.0	Toxicity	3	3	citalopram		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444705214	
1444672826	rs1045642	ABCB1	4		Tier 1 VIP	-2.25	Efficacy	4	4	pantoprazole	Helicobacter Infections	2021-04-20	https://www.pharmgkb.org/clinicalAnnotation/1444672826	
1444704833	rs1045642	ABCB1	3		Tier 1 VIP	2.75	Dosage	6	6	opioids	Pain;Pain, Postoperative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704833	
1445421156	CYP2B6*1, CYP2B6*2, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*18, CYP2B6*22, CYP2B6*30	CYP2B6	2A		Tier 1 VIP	18.125	Metabolism/PK	12	16	bupropion		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445421156	
1444608367	rs267606617	MT-RNR1	1A		Rare Variant; Tier 1 VIP	108.5	Toxicity	31	32	aminoglycoside antibacterials	Ototoxicity	2021-06-15	https://www.pharmgkb.org/clinicalAnnotation/1444608367	Pediatric
1444706154	rs11045821	SLCO1B1	3		Tier 1 VIP	1.5	Metabolism/PK	1	1	methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444706154	Pediatric
1444668808	rs1799752	ACE	3		Tier 1 VIP	0.75	Efficacy	2	2	irbesartan	Hypertension;Hypertrophy, Left Ventricular	2021-09-09	https://www.pharmgkb.org/clinicalAnnotation/1444668808	
1184749280	rs1135989	ACTG1	3			3.0	Toxicity	1	1	vincristine	Neurotoxicity Syndromes	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184749280	Pediatric
1184764189	rs2844665		3			0.0	Toxicity	1	2	allopurinol	Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184764189	
1184986454	rs3099844	CYCSP5	3			1.5	Toxicity	2	2	nevirapine	Acquired Immunodeficiency Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184986454	
1184986756	rs9479757	OPRM1	3			1.75	Other	1	1	opioids	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184986756	
1184987411	CYP2C19*1, CYP2C19*2	CYP2C19	3		Tier 1 VIP	0.875	Other	1	2	bupropion		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184987411	
1444666705	rs3768142	MTR	3			2.75	Toxicity	1	1	methotrexate	Agranulocytosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666705	Pediatric
1444666731	rs28364032	CRHR1	3			3.25	Efficacy	1	1	antidepressants	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666731	
1444666738	rs520210	NEDD4L	3			2.5	Efficacy	1	1	citalopram	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666738	
1444667578	rs1074373		3			3.0	Toxicity	1	1	aspirin	aspirin-induced asthma;Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444667578	Pediatric
1184997925	rs2501873	NR1I3	4			-2.0	Dosage	2	2	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184997925	
1444666717	rs4948496	ARID5B	3			1.125	Metabolism/PK	2	2	methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-06-22	https://www.pharmgkb.org/clinicalAnnotation/1444666717	Pediatric
1184749370	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15, SLCO1B1*37	SLCO1B1	3		Tier 1 VIP	2.0	Metabolism/PK	1	2	repaglinide		2021-10-12	https://www.pharmgkb.org/clinicalAnnotation/1184749370	
1184749160	rs3770102	CAPG	3			3.0	Toxicity	1	1	vincristine	Drug Toxicity;Neurotoxicity Syndromes	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184749160	Pediatric
1444704914	rs1045642	ABCB1	3		Tier 1 VIP	2.0	Metabolism/PK	1	1	etoposide	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704914	
1444710680	HLA-DQB1*06:02:01	HLA-DQB1	3			0.5	Toxicity	4	4	Influenza vaccines	Narcolepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444710680	Pediatric
1183697617	rs45445694	TYMS	3		Tier 1 VIP	7.5	Toxicity	7	7	methotrexate	Lymphoma, Non-Hodgkin;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-10-21	https://www.pharmgkb.org/clinicalAnnotation/1183697617	Pediatric
1451640205	rs12749274		3			0.0	Efficacy	1	1	naltrexone	Alcoholism	2022-01-07	https://www.pharmgkb.org/clinicalAnnotation/1451640205	
1184756886	HLA-DQB1*02:02	HLA-DQB1	3			0.0	Toxicity	1	1	acetaminophen	severe cutaneous adverse reactions	2022-04-07	https://www.pharmgkb.org/clinicalAnnotation/1184756886	
1184747857	rs9370867	MYLIP	3			2.5	Efficacy	1	1	atorvastatin	Hypercholesterolemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184747857	
1184986985	rs4648287	PTGS2	3			1.5	Toxicity	1	1	atenolol	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184986985	
1184986992	rs10157410	PLA2G4A	3			1.5	Toxicity	1	1	atenolol	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184986992	
1184987008	rs2144297	GALNT2	3			1.0	Toxicity	1	1	atenolol	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184987008	
1184987030	rs2144300	GALNT2	3			2.0	Other	1	1	atenolol	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184987030	
1184987041	rs3213619	ABCB1	3		Tier 1 VIP	1.5	Toxicity	1	1	atenolol	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184987041	
1185000225	rs776746	CYP3A5	3		Tier 1 VIP	4.25	Toxicity	6	6	tacrolimus	Infection	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1185000225	Pediatric
1444608377	rs1126757	IL11	3			1.5	Efficacy	1	1	escitalopram	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444608377	
1444665984	rs712829	EGFR	3		Rare Variant	2.25	Efficacy	1	1	cetuximab;irinotecan;panitumumab	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444665984	
1444666032	UGT1A7*3	UGT1A7	3			1.5	Toxicity	1	1	irinotecan;oxaliplatin;tegafur / gimeracil / oteracil	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666032	
1444666038	UGT1A6*2a	UGT1A6	3			1.5	Toxicity	1	1	irinotecan;oxaliplatin;tegafur / gimeracil / oteracil	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666038	
1444667902	rs2241766	ADIPOQ	3			2.75	Efficacy	1	1	pioglitazone	Diabetes Mellitus	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444667902	
1444703473	rs776746	CYP3A5	3		Tier 1 VIP	1.0	Metabolism/PK	1	1	vardenafil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703473	
1444703502	rs4291	ACE	3		Tier 1 VIP	2.75	Toxicity	1	1	aspirin	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703502	
1444703509	rs3775291	TLR3	3			2.25	Toxicity	1	1	aspirin	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703509	
1444703985	rs2734833	DRD2	3		Tier 1 VIP	0.0	Efficacy	1	1	Selective serotonin reuptake inhibitors	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703985	
1444704005	rs2433320		3			2.0	Efficacy	1	1	fluoxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704005	
1444704012	rs2279238	NR1H3	3			2.25	Toxicity	1	1	verapamil	Coronary Artery Disease;Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704012	
1444704419	rs2289669	SLC47A1	3			4.0	Efficacy	5	5	metformin	Diabetes Mellitus, Type 2;Polycystic Ovary Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704419	
1444705236	rs6313	HTR2A	3			2.5	Toxicity	1	1	citalopram	Depressive Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444705236	
1444705243	rs6966038		3			0.0	Efficacy	1	1	citalopram	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444705243	
1445556405	rs3087374	POLG	3			4.0	Toxicity	1	1	valproic acid	Toxic liver disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445556405	
1444704426	rs2290271	SLC28A1	4			-1.5	Toxicity	2	2	anthracyclines and related substances		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704426	Pediatric
1185003565	rs396991	FCGR3A	3			4.25	Efficacy	2	3	trastuzumab	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1185003565	
1451683665	rs523349	SRD5A2	3			2.25	Efficacy	1	1	abiraterone	Prostatic Neoplasms	2022-02-15	https://www.pharmgkb.org/clinicalAnnotation/1451683665	
1184986201	rs11479	TYMP	3			5.5	Toxicity	1	2	capecitabine;fluorouracil	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184986201	
1184986298	rs9351963	KCNQ5	3			0.0	Toxicity	1	1	irinotecan	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184986298	
1184986567	rs1927907	TLR4	3			2.25	Other	1	1	tacrolimus	Organ Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184986567	
1184986578	rs9535826	ATP7B	3			3.0	Efficacy	1	1	Platinum compounds	Lung Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184986578	
1184986654	rs3814058	NR1I2	3			1.5	Other	1	1	repaglinide		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184986654	
1184997025	HLA-B*27:09	HLA-B	3		Tier 1 VIP	3.0	Toxicity	1	1	oxcarbazepine	Maculopapular Exanthema	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184997025	
1184997034	HLA-B*35:01:01:01	HLA-B	3		Tier 1 VIP	5.75	Toxicity	3	3	nevirapine	Drug Hypersensitivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184997034	
1184997043	HLA-B*35:05:01	HLA-B	3		Tier 1 VIP	6.75	Toxicity	2	2	nevirapine	Exanthema	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184997043	
1185000097	rs2273697	ABCC2	3			3.0	Toxicity	1	1	carbamazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1185000097	
1444706911	rs472660	CYP3A43	3			0.25	Metabolism/PK	2	3	olanzapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444706911	
1184986386	rs7196161	VKORC1	3		Tier 1 VIP	3.5	Dosage	5	5	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184986386	
1444699749	HLA-DRB1*01:01:01	HLA-DRB1	2B			11.5	Toxicity	6	7	nevirapine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444699749	
1451640212	rs77583603		3			0.0	Efficacy	1	1	acamprosate	Alcoholism	2022-01-07	https://www.pharmgkb.org/clinicalAnnotation/1451640212	
1184986540	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	3		Tier 1 VIP	1.5	Toxicity	1	1	sulfonamides, urea derivatives	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184986540	
1184997106	HLA-B*48:04	HLA-B	3		Tier 1 VIP	3.0	Toxicity	1	1	oxcarbazepine	Maculopapular Exanthema	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184997106	
1184997213	HLA-B*15:18:01, HLA-B*40:01:01	HLA-B	3		Tier 1 VIP	0.5	Toxicity	2	2	oxcarbazepine	Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184997213	Pediatric
1444607697	rs12762549	ABCC2	3			1.0	Toxicity;Metabolism/PK	2	3	docetaxel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607697	
1444607704	rs6759892	UGT1A6	3			7.0	Efficacy;Toxicity	1	4	deferiprone	beta-Thalassemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607704	
1444607716	rs2032582	ABCB1	3		Tier 1 VIP	2.0	Metabolism/PK	2	2	ritonavir	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607716	
1444607723	rs1799971	OPRM1	3			8.0	Toxicity	1	4	hydrocodone	Constipation;dry mouth;Respiratory Insufficiency	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607723	
1444607768	rs6311	HTR2A	3			4.0	Efficacy;Toxicity	2	3	fluvoxamine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607768	
1444607775	rs442767	DHFR	3			2.25	Toxicity	1	1	pemetrexed	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607775	
1444607782	rs4149056	SLCO1B1	3		Tier 1 VIP	2.0	Toxicity	2	4	mycophenolate mofetil	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607782	
1444607870	GSTM1 non-null, GSTM1 null	GSTM1	3			4.5	Efficacy;Toxicity	1	2	bleomycin;dacarbazine;doxorubicin;vinblastine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607870	
1444607960	rs6822844	IL2	3			4.75	Efficacy	1	2	rituximab	Lupus Erythematosus, Systemic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607960	
1444607966	rs11141915	DAPK1	3			0.0	Toxicity	1	1	gemcitabine	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607966	
1444665946	rs9996584	AREG	3			4.5	Efficacy	1	2	cetuximab;irinotecan;panitumumab	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444665946	
1444665964	rs11942466	AREG	3			5.5	Efficacy	1	2	cetuximab;irinotecan;panitumumab	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444665964	
1444666756	rs6467136	PAX4	3			5.25	Efficacy	1	2	rosiglitazone	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666756	
1444666763	rs1801133	MTHFR	3		Tier 1 VIP	4.0	Efficacy	2	2	pemetrexed	Carcinoma, Non-Small-Cell Lung;Mesothelioma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666763	
1444666770	rs1650697	DHFR	3			2.5	Toxicity	1	1	pemetrexed	Carcinoma, Non-Small-Cell Lung;Mesothelioma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666770	
1444666777	rs11545078	GGH	3			3.0	Toxicity	1	1	pemetrexed	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666777	
1444666789	rs61734430	FOLR3	3			2.5	Efficacy	1	1	pemetrexed	Carcinoma, Non-Small-Cell Lung;Mesothelioma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666789	
1444666796	rs1051298	SLC19A1	3		Tier 1 VIP	4.0	Efficacy	2	2	pemetrexed	Carcinoma, Non-Small-Cell Lung;Mesothelioma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666796	
1444666803	rs3788189	SLC19A1	3		Tier 1 VIP	2.0	Efficacy	1	1	pemetrexed	Carcinoma, Non-Small-Cell Lung;Mesothelioma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666803	
1444666818	rs914232	SLC19A1	3		Tier 1 VIP	2.5	Efficacy	1	1	pemetrexed	Carcinoma, Non-Small-Cell Lung;Mesothelioma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666818	
1444703086	rs12708954	SLC6A2	3			3.0	Efficacy	1	1	atomoxetine	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703086	Pediatric
1444703230	rs2032582	ABCB1	3		Tier 1 VIP	0.0	Efficacy	1	2	fluoxetine	Depressive Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703230	Pediatric
1444712823	HLA-DQA1*02:01	HLA-DQA1	3			6.5	Toxicity	2	2	lapatinib	Toxic liver disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444712823	
1444712832	HLA-DRB1*07:01:01:01	HLA-DRB1	3			7.5	Toxicity	3	3	lapatinib	Toxic liver disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444712832	
1445624605	rs2076828	SLC22A3	3			1.75	Efficacy	1	2	metformin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445624605	
1184986623	rs2011425	UGT1A4	3			2.25	Metabolism/PK	5	5	lamotrigine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184986623	Pediatric
1444708021	HLA-B*46:01:01	HLA-B	3		Tier 1 VIP	0.75	Toxicity	2	2	carbamazepine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome	2022-01-10	https://www.pharmgkb.org/clinicalAnnotation/1444708021	
1184755459	CYP2D6*1, CYP2D6*5, CYP2D6*8	CYP2D6	3		Tier 1 VIP	0.125	Other	1	1	debrisoquine;sparteine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184755459	
1184986643	rs2276706	NR1I2	3			1.5	Other	1	1	repaglinide		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184986643	
1184988834	rs1063320	HLA-G	3			1.25	Efficacy	1	3	hmg coa reductase inhibitors	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184988834	
1445594176	rs1142345	TPMT	3		Tier 1 VIP	5.75	Dosage;Toxicity	6	8	mercaptopurine	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445594176	Pediatric
1445594556	rs7387065	CSMD1	3			0.0	Efficacy	1	1	hydrochlorothiazide	Essential hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445594556	
1445601678	rs11189015	SLIT1	3			0.0	Efficacy	1	1	hydrochlorothiazide	Essential hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445601678	
1449003811	rs8176719	ABO	3			3.0	Toxicity	1	1	hormonal contraceptives for systemic use		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449003811	
1449003817	rs1799853	CYP2C9	3		Tier 1 VIP	3.0	Toxicity	1	1	hormonal contraceptives for systemic use		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449003817	
1449003823	rs6350	SLC6A3	3			3.0	Toxicity	1	1	ethanol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449003823	
1449003829	rs1128503	ABCB1	3		Tier 1 VIP	2.0	Efficacy	1	1	clopidogrel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449003829	
1449003839	rs8094439	CDH2	3			2.25	Efficacy	1	1	methadone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449003839	
1449003845	rs17446819	CDH2	3			2.25	Efficacy	1	1	methadone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449003845	
1449003851	HLA-C*01:02:01, HLA-C*02:02:01, HLA-C*03:02, HLA-C*04:01:01:01, HLA-C*05:01:01:01, HLA-C*06:02:01:01, HLA-C*07:01:01, HLA-C*08:01, HLA-C*12:02:01, HLA-C*14:02:01, HLA-C*15:02:01, HLA-C*16:01:01, HLA-C*17:01:01:01	HLA-C	3			0.0	Efficacy	1	1	peginterferon alfa-2b;ribavirin	Hepatitis C	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449003851	
1449003869	rs7574865	STAT4	3			2.5	Efficacy	1	1	etanercept	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449003869	
1444703243	rs2032582	ABCB1	4		Tier 1 VIP	-4.0	Efficacy	3	5	carbamazepine;phenytoin;valproic acid	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703243	
1444666130	HLA-DPB1*03:01:01	HLA-DPB1	2B			11.0	Toxicity	3	3	aspirin	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666130	
1444706709	HLA-C*01:02:01	HLA-C	2B			8.0	Toxicity	3	3	methazolamide	Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444706709	
1444666137	HLA-DPB1*04:01:01:01	HLA-DPB1	3			2.5	Toxicity	1	1	aspirin	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666137	
1444666145	HLA-DRB1*11:01:01	HLA-DRB1	3			3.0	Toxicity	1	1	Antiinflammatory agents, non-steroids	anaphylactoid reaction	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666145	
1444666342	rs2250242	ORM2	3			1.0	Metabolism/PK	1	1	docetaxel	Prostatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666342	
1444666376	rs5051	AGT	3			2.5	Efficacy	1	1	benazepril;imidapril	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666376	
1444666557	rs2606345	CYP1A1	3			1.25	Metabolism/PK	2	2	deferasirox	beta-Thalassemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666557	
1444666564	rs762551	CYP1A2	3			0.75	Metabolism/PK	2	2	deferasirox	beta-Thalassemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666564	
1444666571	rs2470890	CYP1A2	3			1.75	Metabolism/PK	2	2	deferasirox	beta-Thalassemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666571	
1444667537	rs1042151	HLA-DPB1	3			0.0	Toxicity	1	1	aspirin	aspirin-induced asthma;Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444667537	Pediatric
1444667549	rs3129294	HLA-DPB2	3			0.0	Toxicity	1	1	aspirin	aspirin-induced asthma;Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444667549	Pediatric
1444667566	rs3130100	ZBTB22	3			3.0	Toxicity	1	1	aspirin	aspirin-induced asthma;Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444667566	Pediatric
1444702822	rs1045642	ABCB1	3		Tier 1 VIP	2.5	Efficacy	1	1	phenobarbital	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444702822	
1444703408	rs8187707	ABCC2	3			0.25	Toxicity	1	1	tenofovir	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703408	
1444703422	rs7917983	TCF7L2	3			2.5	Toxicity	1	1	hydrochlorothiazide	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703422	
1444703521	rs5050	AGT	3			2.75	Toxicity	1	1	aspirin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703521	
1444703529	rs2412459	EIF2AK4	3			0.0	Efficacy	1	1	olanzapine;quetiapine;risperidone;ziprasidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703529	
1444703537	rs2412459	EIF2AK4	3			0.0	Efficacy	1	1	haloperidol	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703537	
1444703544	rs7518660	IL23R	3			2.5	Toxicity	1	1	celecoxib	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703544	
1444703552	rs7438135	UGT2B7	3			3.0	Toxicity	1	1	mycophenolate mofetil	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703552	
1444703560	rs6506569	PTPRM	4			-1.0	Efficacy	2	2	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703560	
1444703401	rs924607	CEP72	3			4.5	Toxicity	2	2	vincristine	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703401	Pediatric
1444665904	CYP2D6*1, CYP2D6*4, CYP2D6*10	CYP2D6	3		Tier 1 VIP	2.75	Metabolism/PK	2	2	vortioxetine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444665904	
1184748865	rs1476413	MTHFR	3		Tier 1 VIP	0.0	Efficacy	1	1	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184748865	
1184748874	rs17421511	MTHFR	3		Tier 1 VIP	0.0	Efficacy	1	1	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184748874	
1184748879	rs16853826	ATIC	3			2.0	Toxicity	1	1	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184748879	
1184748884	rs10197559	ATIC	3			0.0	Toxicity	1	1	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184748884	
1184748889	rs1643650	DHFR	3			0.0	Efficacy	1	1	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184748889	
1184997142	HLA-B*58:01	HLA-B	3		Tier 1 VIP	4.25	Toxicity	3	3	lamotrigine	severe cutaneous adverse reactions	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184997142	
1184997195	HLA-B*59:01:01:01	HLA-B	3		Tier 1 VIP	0.25	Toxicity	1	1	acetazolamide	Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184997195	
1444608396	rs2293347	EGFR	3			3.0	Efficacy	1	1	fluorouracil	Stomach Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444608396	
1444667175	rs28360521	CYP2D6	3		Tier 1 VIP	0.0	Toxicity	1	1	aspirin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444667175	
1444667499	rs3097671	HLA-DPB1	3			0.0	Toxicity	1	1	aspirin	aspirin-induced asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444667499	Pediatric
1444667512	rs1042136	HLA-DPB1	3			3.0	Toxicity	1	1	aspirin	aspirin-induced asthma;Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444667512	Pediatric
1444700536	rs10792367		3			3.25	Efficacy	1	1	hydrochlorothiazide	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700536	
1446896596	rs2472304	CYP1A2	3			1.0	Metabolism/PK	1	1	erlotinib		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446896596	
1444700391	rs1051730	CHRNA3	3			2.5	Toxicity	3	3	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700391	
1444608384	rs396991	FCGR3A	2B			8.0	Efficacy	3	3	rituximab	Arthritis, Rheumatoid;Neuromyelitis Optica	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444608384	
1444665995	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*8, CYP2C9*13, CYP2C9*36, CYP2C9*37, CYP2C9*38, CYP2C9*39, CYP2C9*40, CYP2C9*42, CYP2C9*43, CYP2C9*44, CYP2C9*45, CYP2C9*46, CYP2C9*47, CYP2C9*48, CYP2C9*50, CYP2C9*52, CYP2C9*53, CYP2C9*54, CYP2C9*55, CYP2C9*59, CYP2C9*60, CYP2C9*62	CYP2C9	3		Tier 1 VIP	2.0	Metabolism/PK	6	29	diclofenac		2022-04-04	https://www.pharmgkb.org/clinicalAnnotation/1444665995	
1444700667	rs11568817	HTR1B	3			2.5	Toxicity	1	1	escitalopram	Anxiety Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700667	
1444700675	rs6311	HTR2A	3			2.5	Toxicity	1	1	escitalopram	Anxiety Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700675	
1184756841	HLA-C*03:02	HLA-C	3			3.25	Toxicity	1	1	allopurinol	Exanthema	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184756841	
1184756979	CYP2D6*1, CYP2D6*29	CYP2D6	3		Tier 1 VIP	3.375	Other	2	7	debrisoquine;dextromethorphan		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184756979	
1184764194	rs3094188	PSORS1C3	3			0.0	Toxicity	1	2	allopurinol	Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184764194	
1184764199	rs3130501	POU5F1	3			0.0	Toxicity	1	1	allopurinol	Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184764199	
1184764204	rs3130931	POU5F1	3			0.0	Toxicity	1	2	allopurinol	Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184764204	
1184997007	HLA-B*15:18:01	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	carbamazepine	Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184997007	
1184997013	HLA-B*15:19	HLA-B	3		Tier 1 VIP	3.0	Toxicity	1	1	oxcarbazepine	Maculopapular Exanthema	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184997013	
1184997019	HLA-B*15:27:01	HLA-B	3		Tier 1 VIP	3.25	Toxicity	1	1	oxcarbazepine	Maculopapular Exanthema	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184997019	
1444703032	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	3		Tier 1 VIP	4.0	Metabolism/PK	3	3	mianserin	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703032	
1184997201	HLA-B*59:01:01:01	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	carbamazepine	Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184997201	
1444700660	rs1155463		3			2.5	Toxicity	1	1	gemcitabine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700660	
1444703063	rs4244285	CYP2C19	3		Tier 1 VIP	0.25	Toxicity	1	1	venlafaxine	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703063	
1444703115	rs1736557	FMO3	3			2.75	Efficacy	1	1	rosuvastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703115	
1444703207	rs1877724	EPHX1	3			2.25	Dosage	1	1	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703207	
1444703215	rs1901440		3			0.0	Toxicity	1	1	gemcitabine	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703215	
1444704321	rs1061622	TNFRSF1B	3			5.75	Efficacy	4	4	infliximab;Tumor necrosis factor alpha (TNF-alpha) inhibitors	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704321	
1444704328	rs3397	TNFRSF1B	3			5.5	Efficacy	1	2	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704328	
1444704335	rs1061631	TNFRSF1B	3			0.0	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704335	
1444704763	rs1006737	CACNA1C	3			0.0	Toxicity	1	1	citalopram	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704763	
1444704775	rs10121600	GRIN3A	3			1.5	Other	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704775	
1444704861	rs11849538		3			0.0	Other	1	5	estradiol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704861	
1444704869	rs1044397	CHRNA4	3			2.75	Other	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704869	
1444704881	rs1045642	ABCB1	3		Tier 1 VIP	2.0	Toxicity	1	1	methylprednisolone;prednisolone	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704881	
1450826374	rs1902023	UGT2B15	3			1.0	Metabolism/PK	1	2	lorazepam		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450826374	
1444703223	rs1901633		4			-1.0	Efficacy	2	2	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703223	
1184997207	HLA-B*59:01:01:01	HLA-B	2A		Tier 1 VIP	8.75	Toxicity	6	6	methazolamide	Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184997207	
1184997120	HLA-B*56:02	HLA-B	3		Tier 1 VIP	3.0	Toxicity	3	3	phenytoin	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome	2021-05-07	https://www.pharmgkb.org/clinicalAnnotation/1184997120	
1184754547	SLCO1B1*1, SLCO1B1*12, SLCO1B1*13	SLCO1B1	3		Tier 1 VIP	0.0	Metabolism/PK	1	2	conjugated estrogens		2021-10-12	https://www.pharmgkb.org/clinicalAnnotation/1184754547	
1184753824	SLCO1B1*1, SLCO1B1*5, SLCO1B1*9, SLCO1B1*14, SLCO1B1*15, SLCO1B1*37	SLCO1B1	3		Tier 1 VIP	1.0	Metabolism/PK	1	5	atrasentan		2021-10-13	https://www.pharmgkb.org/clinicalAnnotation/1184753824	
1184997136	HLA-B*58:01	HLA-B	4		Tier 1 VIP	-0.75	Toxicity	3	3	carbamazepine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Maculopapular Exanthema;severe cutaneous adverse reactions;Stevens-Johnson Syndrome	2022-01-10	https://www.pharmgkb.org/clinicalAnnotation/1184997136	
1446899836	rs9825762	SCN10A	3			3.0	Toxicity	1	1	carboplatin;taxanes	Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446899836	
1444607318	rs7643645	NR1I2	3			3.875	Metabolism/PK	1	3	risperidone	Psychotic Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607318	
1444607325	rs1061170	CFH	3			1.75	Dosage	1	1	bevacizumab	Macular Degeneration	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607325	
1444607427	rs1799735	GSTM3	3			2.5	Metabolism/PK	1	2	olanzapine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607427	
1444607459	rs1800497	ANKK1	3			0.75	Metabolism/PK	1	1	olanzapine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607459	
1444607565	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*41	CYP2D6	3		Tier 1 VIP	2.375	Metabolism/PK	1	3	galantamine	Dementia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607565	
1444607796	rs3785143	SLC6A2	3			3.0	Efficacy	1	1	atomoxetine	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607796	Pediatric
1444607803	rs1045642	ABCB1	3		Tier 1 VIP	3.5	Other	2	2	olanzapine	Psychotic Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607803	
1444607827	rs2252281	SLC47A1	3			4.0	Efficacy	3	4	metformin	Diabetes Mellitus, Type 2;Polycystic Ovary Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607827	
1444607986	CYP2B6*1, CYP2B6*6	CYP2B6	3		Tier 1 VIP	2.5	Efficacy;Toxicity	1	4	cyclophosphamide	Leukemia, Lymphocytic, Chronic, B-Cell	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607986	
1444608027	rs7124442	BDNF	3			1.25	Efficacy	2	2	citalopram	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444608027	
1444608182	rs12022243	DPYD	3		Tier 1 VIP	3.0	Toxicity	1	3	capecitabine	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444608182	
1444608189	rs2612091	ENOSF1	3			2.5	Toxicity	2	4	capecitabine	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444608189	
1444608201	rs2741171	ENOSF1	3			4.0	Toxicity	1	3	capecitabine	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444608201	
1444608224	rs12132152	DPYD	3		Tier 1 VIP	5.0	Toxicity	1	3	capecitabine	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444608224	
1444608231	rs1126442	GRIN1	3			2.25	Toxicity	1	1	methamphetamine	Psychotic Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444608231	
1444608284	rs1786929		3			2.25	Efficacy	1	1	fluticasone propionate;montelukast	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444608284	Pediatric
1444608291	rs967676	CA10	3			2.0	Efficacy	1	1	fluticasone propionate;montelukast	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444608291	Pediatric
1444667222	rs1047840	EXO1	3			0.0	Efficacy	1	1	capecitabine;fluorouracil	Neoplasm Metastasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444667222	
1444667432	rs3818822	CHIA	3			3.0	Toxicity	1	1	aspirin	aspirin-induced asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444667432	Pediatric
1444667585	rs7862221	TSC1	3			3.0	Toxicity	1	1	aspirin	aspirin-induced asthma;Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444667585	Pediatric
1444667592	rs11819745	THRA	3			3.0	Toxicity	1	1	aspirin	aspirin-induced asthma;Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444667592	Pediatric
1444702771	rs2760118	ALDH5A1	3			3.0	Efficacy	1	1	methadone	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444702771	
1444843493	rs3828913	MICB	3		Rare Variant	3.0	Efficacy	1	1	peginterferon alfa-2a;peginterferon alfa-2b;ribavirin	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444843493	
1451760600	rs6311	HTR2A	3			1.0	Toxicity	1	3	Selective serotonin reuptake inhibitors	ability to concentrate;Depressive Disorder, Major;Diarrhea;Dizziness;Tremor	2022-04-22	https://www.pharmgkb.org/clinicalAnnotation/1451760600	
1446899176	rs10517	NQO1	3			5.25	Dosage	2	2	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446899176	
1446899708	rs6838116	KCNIP4	3			0.0	Toxicity	1	1	Ace Inhibitors, Plain		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446899708	
1446899722	rs16870989	KCNIP4	4			-2.0	Toxicity	2	2	Ace Inhibitors, Plain		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446899722	
1446899729	rs145489027	KCNIP4	3			0.0	Toxicity	2	2	Ace Inhibitors, Plain		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446899729	
1446899736	rs1495509	KCNIP4	3			0.5	Toxicity	2	2	Ace Inhibitors, Plain		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446899736	
1446899749	CYP3A4*1, CYP3A4*22	CYP3A4	3		Tier 1 VIP	4.75	Metabolism/PK	4	5	simvastatin	Hypercholesterolemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446899749	
1446899843	rs6900017	VEGFA	3			3.0	Toxicity	1	1	carboplatin;taxanes	Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446899843	
1446899860	rs9369421	VEGFA	3			3.0	Toxicity	1	1	carboplatin;taxanes		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446899860	
1446899866	rs9369421	VEGFA	3			2.5	Efficacy	1	1	carboplatin;taxanes	Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446899866	
1446899883	rs879825	VEGFA	3			3.5	Toxicity	1	1	carboplatin;taxanes	Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446899883	
1446899890	rs3594	GSR	3			3.5	Toxicity	1	1	carboplatin;taxanes	Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446899890	
1446899905	rs1801249	ATP7B	3			3.0	Toxicity	1	1	carboplatin;taxanes	Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446899905	
1446903240	rs6785049	NR1I2	3			2.75	Toxicity	1	1	sunitinib	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446903240	
1446903310	rs17109924	LGR5	3			3.25	Efficacy	1	1	fluorouracil	Colonic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446903310	
1185000522	rs1045642	ABCB1	4		Tier 1 VIP	-7.375	Other	11	14	atazanavir;ritonavir	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1185000522	Pediatric
1444607789	rs1176744	HTR3B	4			-0.25	Toxicity	2	3	paroxetine	Mental Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444607789	
1444608040	rs7103411	BDNF	4			-0.5	Efficacy	3	3	citalopram	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444608040	
1446899715	rs7675300	KCNIP4	4			-0.75	Toxicity	2	2	Ace Inhibitors, Plain		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446899715	
1446898992	rs489693	MC4R	3			4.875	Toxicity	4	5	antipsychotics	Weight gain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446898992	Pediatric
1184987378	rs4550690	MAP4K4	3			0.0	Toxicity	1	1	anastrozole;exemestane	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184987378	
1184987397	rs6901146		3			0.0	Other	1	1	anastrozole;exemestane	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184987397	
1184987471	rs1611115	DBH	3			1.5	Other	1	1	Analgesics;Antiinflammatory agents, non-steroids;Ergot alkaloids;opioids;sumatriptan	Substance Withdrawal Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184987471	
1184987488	rs6265	BDNF	3			1.5	Other	1	1	Analgesics;Antiinflammatory agents, non-steroids;Ergot alkaloids;opioids;sumatriptan		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184987488	
1184987503	rs6275	DRD2	3		Tier 1 VIP	1.5	Other	1	1	Analgesics;Antiinflammatory agents, non-steroids;Ergot alkaloids;opioids;sumatriptan		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184987503	
1185002351	rs7200749	VKORC1	3		Tier 1 VIP	3.0	Dosage	1	1	acenocoumarol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1185002351	
1185002357	rs61742245	VKORC1	3		Rare Variant; Tier 1 VIP	3.0	Dosage	1	1	acenocoumarol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1185002357	
1185002363	rs55894764	VKORC1	3		Tier 1 VIP	3.0	Dosage	1	1	acenocoumarol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1185002363	
1185002369	rs17878544	VKORC1	3		Tier 1 VIP	3.0	Dosage	1	1	acenocoumarol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1185002369	
1184996903	HLA-B*15:02:01	HLA-B	1A		Tier 1 VIP	305.75	Toxicity	4	7	oxcarbazepine	Stevens-Johnson Syndrome	2022-02-28	https://www.pharmgkb.org/clinicalAnnotation/1184996903	Pediatric
1184764228	rs9469003	CYCSP5	3			0.0	Toxicity	1	2	allopurinol	Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184764228	
1185000534	rs2472677	NR1I2	3			7.0	Metabolism/PK	4	4	atazanavir	Acquired Immunodeficiency Syndrome;HIV Infections;nephrolithiasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1185000534	
1184764213	rs3815087	PSORS1C1	4			-2.5	Toxicity	2	3	allopurinol	Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184764213	
1451760701	CYP1A2*1A, CYP1A2*1F	CYP1A2	3			1.25	Metabolism/PK	5	6	clozapine	schizoaffective disorder;Schizophrenia	2022-04-22	https://www.pharmgkb.org/clinicalAnnotation/1451760701	
1444666212	HLA-DQB1*05:01:01:01	HLA-DQB1	3			5.5	Toxicity	1	2	nevirapine	Drug Hypersensitivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666212	
1444666674	rs12819505	WNT5B	3			3.0	Efficacy	1	1	Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666674	
1444666681	rs10878232	WIF1	3			3.0	Efficacy	1	1	Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666681	
1444666688	rs11868547	AXIN2	3			3.0	Efficacy	1	1	Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666688	
1444666695	rs4541111	AXIN2	3			3.0	Efficacy	1	1	Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666695	
1444666886	rs1052555	ERCC2	3			5.0	Efficacy	1	2	Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666886	
1444694602	rs1045642	ABCB1	3		Tier 1 VIP	0.5	Efficacy	2	2	tacrolimus	Colitis, Ulcerative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444694602	
1444694616	rs1045642	ABCB1	3		Tier 1 VIP	1.5	Toxicity	1	1	tacrolimus	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444694616	Pediatric
1444703076	rs4244285	CYP2C19	3		Tier 1 VIP	2.0	Metabolism/PK	1	1	etravirine	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703076	
1444704105	rs396991	FCGR3A	3			1.25	Other	1	1	antithymocyte globulin	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704105	
1444704118	rs402007	ADAMTS1	3			2.5	Efficacy	1	1	hmg coa reductase inhibitors		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704118	
1444933020	rs3745274	CYP2B6	3		Tier 1 VIP	2.0	Dosage	1	1	propofol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444933020	
1445400703	rs4986790	TLR4	3			1.75	Efficacy	1	1	Pertussis vaccines		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445400703	Pediatric
1444666198	HLA-DRB1*03:01	HLA-DRB1	3			1.75	Toxicity	1	1	carbamazepine	Maculopapular Exanthema	2022-11-08	https://www.pharmgkb.org/clinicalAnnotation/1444666198	
1445402201	rs17143212	ABCB5	3			1.75	Toxicity	1	1	haloperidol	Psychotic Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445402201	
1444694609	rs1045642	ABCB1	4		Tier 1 VIP	-6.5	Toxicity	6	7	tacrolimus	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444694609	Pediatric
1444704097	rs35599367	CYP3A4	4		Tier 1 VIP	-0.25	Efficacy	2	2	simvastatin	Chronic Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704097	
1185235008	rs35303484	CYP2B6	3		Rare Variant; Tier 1 VIP	1.75	Metabolism/PK	4	4	efavirenz	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1185235008	Pediatric
1444608132	rs2010963	VEGFA	3			5.0	Efficacy	1	2	bevacizumab;pegaptanib;ranibizumab	Choroidal Neovascularization	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444608132	
1444608139	HLA-C*06:02:01:01	HLA-C	3			5.25	Efficacy	1	2	ustekinumab	Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444608139	
1444608175	rs76387818	DPYD	3		Tier 1 VIP	5.0	Toxicity	1	3	capecitabine	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444608175	
1444666091	UGT1A1*60	UGT1A1	3		Tier 1 VIP	4.0	Efficacy	1	2	irinotecan	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666091	
1444666855	rs1045642	ABCB1	3		Tier 1 VIP	2.25	Toxicity	1	1	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666855	
1444667305	rs17160359	ABCB1	3		Rare Variant; Tier 1 VIP	0.0	Efficacy	1	1	capecitabine;fluorouracil	Neoplasm Metastasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444667305	
1444667322	rs2289310	DLG5	3			0.0	Efficacy	1	1	capecitabine;fluorouracil	Neoplasm Metastasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444667322	
1444702664	rs3761847	TRAF1	3			2.25	Efficacy	2	2	adalimumab;etanercept;infliximab;Tumor necrosis factor alpha (TNF-alpha) inhibitors	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444702664	
1445401406	rs1045642	ABCB1	3		Tier 1 VIP	5.25	Toxicity	3	4	sunitinib	Carcinoma, Renal Cell	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401406	
1445402226	rs1138272	GSTP1	3		Tier 1 VIP	0.25	Efficacy	3	3	cisplatin	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445402226	Pediatric
1446897342	rs2835859	KCNJ6	3			2.75	Dosage	1	1	fentanyl	Pain, Postoperative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446897342	
1446897485	rs699947	VEGFA	3			3.0	Efficacy	2	2	bevacizumab;capecitabine;fluorouracil;irinotecan;leucovorin;oxaliplatin	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446897485	
1446899695	rs2789047		3			0.0	Metabolism/PK	1	1	vancomycin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446899695	
1446903540	rs34548976		3			0.0	Efficacy	1	1	adrenergics, inhalants	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446903540	Pediatric
1446903556	rs56113850	CYP2A6	3		Tier 1 VIP	1.25	Metabolism/PK	2	2	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446903556	
1446903563	rs12461964		3			1.25	Dosage	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446903563	
1446903570	rs113288603		3			0.0	Metabolism/PK	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446903570	
1446903577	rs7541245	FMO5	3			2.75	Efficacy	1	1	metformin	Diabetes Mellitus	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446903577	
1446904604	rs11623866	FNTB	3			3.0	Efficacy	1	1	carboplatin;lonafarnib;paclitaxel	Ovarian Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446904604	
1446908543	rs1044396	CHRNA4	3			3.0	Efficacy	1	1	varenicline	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446908543	
1446908568	rs1051730	CHRNA3	3			2.75	Toxicity	1	1	Opium alkaloids and derivatives	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446908568	
1445401915	rs1045642	ABCB1	4		Tier 1 VIP	-1.5	Dosage;Metabolism/PK	6	7	carbamazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401915	
1446904693	rs4124874	UGT1A1	3		Tier 1 VIP	0.25	Toxicity	1	1	deferasirox	Drug Toxicity;Thalassemia	2021-03-25	https://www.pharmgkb.org/clinicalAnnotation/1446904693	Pediatric
1446903527	rs1872328	ACYP2	3			4.75	Toxicity	4	4	cisplatin	Brain Neoplasms;Deafness;Ototoxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446903527	Pediatric
1184749208	rs1045642	ABCB1	3		Tier 1 VIP	2.75	Efficacy	1	1	vincristine	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184749208	Pediatric
1184756443	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*18, CYP2D6*21, CYP2D6*44	CYP2D6	3		Tier 1 VIP	0.5	Other	4	6	debrisoquine;dextromethorphan;sparteine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184756443	
1184756890	HLA-DQB1*05:02:01	HLA-DQB1	3			2.5	Toxicity	1	1	allopurinol	Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184756890	
1184756894	HLA-DRB1*15:02:01	HLA-DRB1	3			0.0	Toxicity	1	1	allopurinol	severe cutaneous adverse reactions	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184756894	
1184756898	HLA-DRB1*13:02:01	HLA-DRB1	3			0.0	Toxicity	1	1	allopurinol	severe cutaneous adverse reactions	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184756898	
1184757151	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*36, CYP2D6*40, CYP2D6*42, CYP2D6*56	CYP2D6	3		Tier 1 VIP	0.625	Other	4	5	dextromethorphan		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184757151	Pediatric
1184987055	rs12595985	FTO	3			1.5	Toxicity	1	1	atenolol	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184987055	
1184987062	rs9940629	FTO	3			1.5	Toxicity	1	1	atenolol	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184987062	
1184987556	rs6305	HTR2A	3			1.5	Toxicity	1	1	Analgesics;Antiinflammatory agents, non-steroids;Ergot alkaloids;opioids;sumatriptan		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184987556	
1184987573	rs4680	COMT	3		Tier 1 VIP	2.0	Other	1	1	Analgesics;Antiinflammatory agents, non-steroids;Ergot alkaloids;opioids;sumatriptan		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184987573	
1184989651	rs2647087		3			4.0	Toxicity	1	1	azathioprine;mercaptopurine	Drug Toxicity;Inflammatory Bowel Diseases;Pancreatitis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184989651	
1184989663	HLA-DRB1*07:01:01:01	HLA-DRB1	3			0.0	Toxicity	1	1	azathioprine;mercaptopurine	Drug Toxicity;Inflammatory Bowel Diseases;Pancreatitis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184989663	
1184989676	HLA-DQA1*02:01	HLA-DQA1	3			0.0	Toxicity	1	1	azathioprine;mercaptopurine	Drug Toxicity;Inflammatory Bowel Diseases;Pancreatitis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184989676	
1446897495	rs3025039	VEGFA	3			1.25	Efficacy	3	3	bevacizumab	Breast Neoplasms;Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446897495	
1446908580	rs10937158	ABCC5	3			3.25	Toxicity	1	1	fluorouracil;irinotecan;leucovorin	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446908580	
1446908587	rs2292997		3			2.5	Toxicity	1	1	fluorouracil;irinotecan;leucovorin	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446908587	
1446908594	rs225440	ABCG1	3			3.25	Toxicity	1	1	fluorouracil;irinotecan;leucovorin	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446908594	
1446908603	rs11122576	AGT	3			0.0	Efficacy	1	2	amlodipine;chlorthalidone;lisinopril		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446908603	
1446908615	rs11122576	AGT	3			0.0	Efficacy	1	2	amlodipine;chlorthalidone;lisinopril		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446908615	
1446908622	rs3749438	ABCC5	3			3.25	Toxicity	1	1	fluorouracil;irinotecan;leucovorin	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446908622	
1446908672	rs12746200	PLA2G4A	3			3.0	Toxicity	1	1	acetaminophen;aspirin;diclofenac;propionic acid derivatives;Pyrazolones		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446908672	
1446908679	rs1805034	TNFRSF11A	3			2.5	Toxicity	1	1	acetaminophen;aspirin;diclofenac;propionic acid derivatives;Pyrazolones		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446908679	
1446908686	rs2228246	PLCG1	3			2.5	Toxicity	1	1	acetaminophen;aspirin;diclofenac;propionic acid derivatives;Pyrazolones		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446908686	
1444842040	CYP2C19*1, CYP2C19*2	CYP2C19	4		Tier 1 VIP	-0.25	Metabolism/PK	2	2	carisoprodol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444842040	
1451506746	rs139945292		3			1.5	Toxicity	1	1	Beta Blocking Agents		2021-09-28	https://www.pharmgkb.org/clinicalAnnotation/1451506746	
1444668292	rs2683511	SP1	3			4.5	Efficacy;Metabolism/PK	1	2	metformin	Diabetes Mellitus	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444668292	
1444668298	rs784892	AMHR2	3			3.0	Efficacy;Metabolism/PK	2	3	metformin	Diabetes Mellitus	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444668298	
1444668306	rs149711321	PPARA	3			2.75	Efficacy;Metabolism/PK	1	1	metformin	Diabetes Mellitus	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444668306	
1444673002	rs1529927	SLC12A3	3			4.0	Efficacy	2	2	bumetanide;furosemide;torasemide		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444673002	
1444673123	rs4680	COMT	3		Tier 1 VIP	2.0	Toxicity	1	1	haloperidol	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444673123	
1184755711	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*7, CYP2D6*8, CYP2D6*11, CYP2D6*12, CYP2D6*41, CYP2D6*59, CYP2D6*62	CYP2D6	3		Tier 1 VIP	1.25	Other	8	14	sparteine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184755711	
1184987911	rs2266782	FMO3	3			1.5	Other	1	1	itopride		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184987911	
1184987918	rs2266780	FMO3	3			1.5	Other	1	1	itopride		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184987918	
1444667292	rs3218592	REV3L	3		Rare Variant	0.0	Efficacy	1	1	capecitabine;fluorouracil	Neoplasm Metastasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444667292	
1444673130	rs212091	ABCC1	3			2.25	Efficacy	1	1	lamivudine;lopinavir;ritonavir;zidovudine	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444673130	
1444673197	rs13207351	VEGFA	3			2.25	Efficacy	1	1	docetaxel	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444673197	
1444673209	rs1570360	VEGFA	3			3.5	Efficacy	2	2	docetaxel	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444673209	
1444680145	rs12248560	CYP2C19	3		Tier 1 VIP	0.75	Metabolism/PK	2	2	busulfan	hemopoietic stem cell transplant	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444680145	Pediatric
1444700452	rs1059288	TAPBP	3			3.0	Toxicity	1	1	aspirin	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700452	
1444700466	rs2071888	TAPBP	3			3.0	Toxicity	1	1	aspirin	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700466	
1444700550	rs10871454	STX4	3			2.5	Dosage	1	1	phenprocoumon		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700550	
1444700558	rs4086116	CYP2C9	3		Tier 1 VIP	2.5	Dosage	1	1	phenprocoumon		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700558	
1444700566	rs10912675	FMO1	3			1.5	Other	1	1	nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700566	
1444700574	rs7877	FMO1	3			1.5	Other	1	1	nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700574	
1444700581	rs10931910	AOX1	3			1.75	Metabolism/PK	1	1	XK469		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700581	
1444700903	rs10306135	PTGS1	3			3.25	Toxicity	1	1	Antiinflammatory agents, non-steroids	Acute coronary syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700903	
1444700916	rs1042580	THBD	3			2.5	Toxicity	1	1	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700916	
1444700950	rs10711	CDK1	3			3.5	Toxicity	1	1	radiotherapy	pneumonitis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700950	
1444700958	rs10771973	FGD4	3			3.0	Toxicity	1	1	paclitaxel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700958	
1444700970	rs11125035	PRKCE	3			3.0	Toxicity	1	1	radiotherapy		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700970	
1444700983	rs1799983	NOS3	3			1.5	Efficacy	1	1	Ace Inhibitors, Plain;Angiotensin II Antagonists;Beta Blocking Agents;digoxin;diuretics;spironolactone	Heart Failure	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700983	
1444700991	rs1800629	TNF	3			0.75	Toxicity	2	2	ethambutol;isoniazid;pyrazinamide;rifampin	Toxic liver disease;Tuberculosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700991	
1444672993	rs1128503	ABCB1	4		Tier 1 VIP	-11.875	Dosage;Metabolism/PK	19	22	tacrolimus	Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444672993	Pediatric
1451506740	rs139945292		3			1.5	Efficacy	1	1	Beta Blocking Agents		2021-09-28	https://www.pharmgkb.org/clinicalAnnotation/1451506740	
1184749403	SLCO1B1*1, SLCO1B1*14	SLCO1B1	3		Tier 1 VIP	3.5	Efficacy	1	1	fluvastatin	Hypercholesterolemia	2021-10-12	https://www.pharmgkb.org/clinicalAnnotation/1184749403	
1444668477	rs13266634	SLC30A8	3			2.75	Efficacy	1	1	insulin recombinant;zinc acetate		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444668477	
1444673032	rs2054675	CYP2B6	3		Tier 1 VIP	2.5	Toxicity	1	1	nevirapine	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444673032	
1444673039	rs3786547	CYP2B6	3		Tier 1 VIP	2.5	Toxicity	1	1	nevirapine	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444673039	
1444673046	rs3787429	HRH3	3			0.25	Efficacy	2	2	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444673046	
1444673053	rs3787430	HRH3	3			3.0	Efficacy	1	1	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444673053	
1444673060	rs1800470	TGFB1	3			2.75	Efficacy	1	1	rituximab	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444673060	
1444700775	rs12221497	NR1H3	3			2.25	Toxicity	1	1	verapamil	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700775	
1185003571	rs1801274	FCGR2A	3			4.75	Efficacy	2	4	trastuzumab	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1185003571	
1184996860	HLA-B*57:01:01	HLA-B	1A		Tier 1 VIP	105.75	Toxicity	1	3	flucloxacillin	drug-induced liver injury	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184996860	
1444699308	rs267606619	MT-RNR1	1A		Rare Variant; Tier 1 VIP	102.75	Toxicity	8	9	aminoglycoside antibacterials	Ototoxicity	2021-06-15	https://www.pharmgkb.org/clinicalAnnotation/1444699308	Pediatric
1444699743	rs267606618	MT-RNR1	1A		Rare Variant; Tier 1 VIP	102.0	Toxicity	3	4	aminoglycoside antibacterials	Ototoxicity	2021-06-15	https://www.pharmgkb.org/clinicalAnnotation/1444699743	
1184749271	rs4728709	ABCB1	3		Tier 1 VIP	3.0	Toxicity	1	1	vincristine	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184749271	Pediatric
1184753976	CYP2C19*1, CYP2C19*14, CYP2C19*23	CYP2C19	3		Tier 1 VIP	0.0	Metabolism/PK	1	2	clopidogrel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184753976	
1185002307	rs7200749	VKORC1	3		Tier 1 VIP	2.0	Dosage	1	1	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1185002307	
1444672968	GSTT1 non-null, GSTT1 null	GSTT1	3			2.0	Efficacy	1	1	imatinib	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444672968	
1444700860	rs7699188	ABCG2	3		Tier 1 VIP	6.0	Efficacy;Toxicity	1	2	fluorouracil;irinotecan;leucovorin	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700860	
1444702764	rs1799964	TNF	3			2.5	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Spondylitis, Ankylosing	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444702764	
1444876859	rs12979860	IFNL3;IFNL4	3			2.0	Efficacy	1	1	deleobuvir;faldaprevir	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444876859	
1445401325	rs10210302	ATG16L1	3			2.75	Efficacy	1	1	adalimumab	Crohn Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401325	
1445401377	rs1042713	ADRB2	3		Tier 1 VIP	1.75	Dosage	2	2	ephedrine;phenylephrine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401377	
1445401389	rs1137101	LEPR	3			2.5	Toxicity	1	1	valproic acid	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401389	
1445401399	rs1800497	ANKK1	3			2.5	Toxicity	1	1	valproic acid	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401399	
1445401824	rs1113129	CYP2C8	3		Tier 1 VIP	2.0	Toxicity	1	1	paclitaxel	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401824	
1444702725	rs1061170	CFH	4			-7.5	Efficacy	10	11	bevacizumab;ranibizumab	Macular Degeneration	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444702725	
1445401817	rs1934951	CYP2C8	4		Tier 1 VIP	-0.5	Toxicity	2	3	paclitaxel	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401817	
1445401831	rs13181	ERCC2	4			-0.75	Toxicity	2	3	docetaxel	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401831	
1139506787	CYP2A6*1, CYP2A6*1x2, CYP2A6*2, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10, CYP2A6*11, CYP2A6*12, CYP2A6*13, CYP2A6*14, CYP2A6*15, CYP2A6*17, CYP2A6*19, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*38, CYP2A6*46	CYP2A6	1B		Tier 1 VIP	36.0	Metabolism/PK	27	40	nicotine	Tobacco Use Disorder	2022-09-29	https://www.pharmgkb.org/clinicalAnnotation/1139506787	
1445400186	rs1801086	RYR1	1A		Rare Variant; Tier 1 VIP	101.25	Toxicity	11	12	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445400186	Pediatric
1451678240	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15	SLCO1B1	1A		Tier 1 VIP	105.5	Toxicity	8	9	rosuvastatin	statin-related myopathy	2022-02-14	https://www.pharmgkb.org/clinicalAnnotation/1451678240	
1451678600	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	1A		Tier 1 VIP	102.0	Toxicity	2	4	fluvastatin		2022-02-15	https://www.pharmgkb.org/clinicalAnnotation/1451678600	
1451678620	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15	SLCO1B1	1A		Tier 1 VIP	101.625	Metabolism/PK	4	6	fluvastatin		2022-02-10	https://www.pharmgkb.org/clinicalAnnotation/1451678620	
1184755382	HLA-DRB1*03:01	HLA-DRB1	3			3.0	Toxicity	1	1	allopurinol	severe cutaneous adverse reactions	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184755382	
1445401186	rs13253389	NAT1	3			2.0	Metabolism/PK	1	1	cotinine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401186	Pediatric
1445401193	rs10161126	MVK	3			3.25	Efficacy	1	1	alendronate	Bone Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401193	
1446846513	rs2229774	RARG	3			0.0	Toxicity	1	1	anthracyclines and related substances	cardiotoxicity;Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446846513	Pediatric
1446900938	rs408626	DHFR	3			5.5	Efficacy;Toxicity	1	2	methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446900938	Pediatric
1446901291	rs1126647	CXCL8	3			1.75	Toxicity	1	1	sunitinib	Carcinoma, Renal Cell	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446901291	
1446901311	rs1800925	IL13	3			2.25	Toxicity	1	2	sunitinib	Carcinoma, Renal Cell	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446901311	
1185000213	rs776746	CYP3A5	4		Tier 1 VIP	-1.5	Toxicity	4	4	tacrolimus	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1185000213	Pediatric
1445400222	rs193922772	RYR1	1A		Rare Variant; Tier 1 VIP	102.5	Toxicity	11	12	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445400222	Pediatric
1445400232	rs193922802	RYR1	1A		Rare Variant; Tier 1 VIP	101.0	Toxicity	9	11	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445400232	Pediatric
1445400247	rs193922816	RYR1	1A		Rare Variant; Tier 1 VIP	103.0	Toxicity	9	10	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445400247	Pediatric
1451681540	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15	SLCO1B1	1A		Tier 1 VIP	110.625	Metabolism/PK	9	10	simvastatin;simvastatin acid		2022-02-14	https://www.pharmgkb.org/clinicalAnnotation/1451681540	Pediatric
1184996891	HLA-B*13:01:01	HLA-B	3		Tier 1 VIP	3.25	Toxicity	1	1	trichloroethylene	Drug Hypersensitivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184996891	
1184996897	HLA-B*13:02:01	HLA-B	3		Tier 1 VIP	3.25	Toxicity	1	1	oxcarbazepine	Maculopapular Exanthema	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184996897	
1185000260	rs776746	CYP3A5	3		Tier 1 VIP	1.25	Toxicity	1	1	tacrolimus	Toxic liver disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1185000260	Pediatric
1185000350	rs10929303	UGT1A1	3		Tier 1 VIP	1.75	Toxicity	1	1	atazanavir;ritonavir	HIV Infections;nephrolithiasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1185000350	
1185000362	rs1042640	UGT1A1	3		Tier 1 VIP	2.25	Toxicity	1	1	atazanavir;ritonavir	HIV Infections;nephrolithiasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1185000362	
1185000369	rs8330	UGT1A1	3		Tier 1 VIP	1.75	Toxicity	1	1	atazanavir;ritonavir	HIV Infections;nephrolithiasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1185000369	
1444673379	rs12505410	ABCG2	3		Tier 1 VIP	2.0	Efficacy	1	1	imatinib	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444673379	
1444673386	rs13120400	ABCG2	3		Tier 1 VIP	2.0	Efficacy	1	1	imatinib	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444673386	
1444673412	rs2725252	ABCG2	3		Tier 1 VIP	2.0	Efficacy	1	1	imatinib	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444673412	
1444700808	rs12806698	RRM1	3			3.0	Toxicity	1	1	gemcitabine;Platinum compounds	Mesothelioma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700808	
1444700867	rs1544410	VDR	3			3.0	Toxicity	1	1	peginterferon alfa-2a;ribavirin	Hepatitis C	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700867	
1444700874	rs1611115	DBH	3			2.25	Efficacy	1	1	levodopa	Cocaine-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444700874	
1444702778	rs2857657	CCL2	3			3.0	Efficacy	1	1	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444702778	
1444702784	rs4586	CCL2	3			4.125	Efficacy	2	2	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444702784	
1444702792	rs4795893	CCL2	3			4.125	Efficacy	2	2	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444702792	
1444703171	rs1800795	IL6	3			2.0	Efficacy	1	1	adalimumab;etanercept;infliximab	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703171	
1444703258	rs4460839	DRD2	3		Tier 1 VIP	0.0	Efficacy	1	1	Selective serotonin reuptake inhibitors	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703258	
1444703430	rs7917432	ABCC2	3			2.0	Toxicity	1	1	tenofovir	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703430	
1444703438	rs757639	OCRL	3			2.0	Toxicity	1	1	tenofovir	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703438	
1444703446	rs7912580		3			0.0	Efficacy	1	1	haloperidol	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703446	
1444703453	rs7912580		3			0.0	Efficacy	1	1	olanzapine;quetiapine;risperidone;ziprasidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703453	
1444703487	rs7551789	PTGER3	3			1.5	Toxicity	1	1	aspirin	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703487	
1444703495	rs4292	ACE	3		Tier 1 VIP	2.25	Toxicity	1	1	aspirin	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703495	
1444704089	rs296766	AQP2	3			3.25	Toxicity	1	1	thiazolidinediones	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704089	
1444705174	rs760761	DTNBP1	3			0.0	Efficacy	1	1	citalopram	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444705174	
1445401804	rs4880	SOD2	3			2.0	Toxicity	1	1	paclitaxel	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401804	
1445401838	rs3212986	ERCC1	3			2.75	Toxicity	1	1	docetaxel	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401838	
1445401847	rs3212986	ERCC1	3			2.0	Toxicity	1	1	paclitaxel	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401847	
1445401853	rs11615	ERCC1	3			1.75	Toxicity	1	1	docetaxel	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401853	
1445401880	rs776746	CYP3A5	3		Tier 1 VIP	5.5	Dosage;Metabolism/PK	4	6	carbamazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401880	
1445401952	rs1057868	POR	3			2.5	Efficacy	1	1	atorvastatin	familial hypercholesterolemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401952	Pediatric
1445402033	rs1128503	ABCB1	3		Tier 1 VIP	1.25	Efficacy	3	3	cytarabine	Leukemia, Myeloid, Acute	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445402033	
1445402085	rs6295	HTR1A	3			2.0	Efficacy	1	1	clozapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445402085	
1446898009	rs10305420	GLP1R	3			2.25	Efficacy	1	1	liraglutide	Obesity;Polycystic Ovary Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446898009	
1446898016	rs6923761	GLP1R	3			0.0	Efficacy	1	1	liraglutide	Obesity;Polycystic Ovary Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446898016	
1444703480	rs7624766		4			-1.0	Efficacy	2	2	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444703480	
1446897666	rs1933437	FLT3	3			6.5	Toxicity	4	4	sunitinib	Leukopenia;Myelosuppression;Neutropenia;Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446897666	
1445400206	rs118192122	RYR1	1A		Rare Variant; Tier 1 VIP	103.0	Toxicity	18	19	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445400206	Pediatric
1451677518	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15	SLCO1B1	1A		Tier 1 VIP	103.5	Toxicity	1	2	lovastatin	statin-related myopathy	2022-02-15	https://www.pharmgkb.org/clinicalAnnotation/1451677518	
1451678188	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15	SLCO1B1	1A		Tier 1 VIP	103.5	Metabolism/PK	2	3	lovastatin;lovastatin acid		2022-02-15	https://www.pharmgkb.org/clinicalAnnotation/1451678188	
1444703273	rs3742106	ABCC4	3			4.5	Metabolism/PK	2	2	tenofovir	HIV Infections	2022-04-22	https://www.pharmgkb.org/clinicalAnnotation/1444703273	
1451761240	rs9349256	ABCC10	3			0.25	Toxicity	2	2	tenofovir disoproxil fumarate	HIV Infections;nephrotoxicity	2022-04-22	https://www.pharmgkb.org/clinicalAnnotation/1451761240	
1451677736	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15	SLCO1B1	1A		Tier 1 VIP	106.0	Toxicity	20	21	atorvastatin		2022-02-15	https://www.pharmgkb.org/clinicalAnnotation/1451677736	
1445401303	rs10737062	CAMK1D	3			2.75	Efficacy	1	1	losartan	Essential hypertension	2022-12-02	https://www.pharmgkb.org/clinicalAnnotation/1445401303	
1445401296	rs10752271	CAMK1D	3			2.75	Efficacy	1	1	losartan	Essential hypertension	2022-12-02	https://www.pharmgkb.org/clinicalAnnotation/1445401296	
1451761248	rs3742106	ABCC4	3			2.0	Toxicity	1	1	tenofovir disoproxil fumarate	HIV Infections;nephrotoxicity	2022-04-22	https://www.pharmgkb.org/clinicalAnnotation/1451761248	
1447990846	rs2965667		3			1.0	Other	2	2	Antiinflammatory agents, non-steroids;aspirin	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447990846	
1448100067	rs4796793	STAT3	3			2.75	Efficacy	1	1	interferons	Carcinoma, Renal Cell	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100067	
1448100194	rs2831440		3			0.0	Efficacy	1	1	antidepressants	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100194	
1448602108	rs2942857	UGT2B10	3			3.0	Metabolism/PK	1	2	cotinine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448602108	
1448613237	rs181781	IL3	3			2.25	Metabolism/PK	1	1	tacrolimus	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448613237	
1448613363	rs57731889	PEAR1	3			3.25	Efficacy	1	1	clopidogrel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448613363	
1451678626	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15	SLCO1B1	1A		Tier 1 VIP	101.25	Toxicity	2	3	fluvastatin	statin-related myopathy	2022-02-15	https://www.pharmgkb.org/clinicalAnnotation/1451678626	
1451678460	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15	SLCO1B1	1A		Tier 1 VIP	102.0	Toxicity	3	5	pravastatin	statin-related myopathy	2022-02-15	https://www.pharmgkb.org/clinicalAnnotation/1451678460	
1451678112	rs4149056	SLCO1B1	1A		Tier 1 VIP	103.5	Metabolism/PK	2	3	lovastatin;lovastatin acid		2022-02-10	https://www.pharmgkb.org/clinicalAnnotation/1451678112	
1451678210	rs4149056	SLCO1B1	1A		Tier 1 VIP	102.5	Metabolism/PK	2	3	pitavastatin		2022-02-15	https://www.pharmgkb.org/clinicalAnnotation/1451678210	
1448427005	rs1128503	ABCB1	3		Tier 1 VIP	3.0	Toxicity	2	2	gefitinib	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448427005	
1448633833	CYP2B6*1, CYP2B6*6	CYP2B6	3		Tier 1 VIP	2.25	Toxicity	1	1	ethambutol;isoniazid;pyrazinamide;rifampin	Tuberculosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448633833	
1448634522	rs2032582	ABCB1	3		Tier 1 VIP	2.5	Toxicity	1	1	clopidogrel	Coronary Artery Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448634522	
1448258741	rs4149056	SLCO1B1	3		Tier 1 VIP	2.5	Toxicity	1	1	sorafenib	Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448258741	
1448423682	rs11209026	IL23R	3			3.0	Toxicity	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448423682	
1448423689	rs3087243	CTLA4	3			2.5	Toxicity	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448423689	
1448423696	rs651630	SLC12A8	3			2.5	Toxicity	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448423696	
1448423703	rs10782001	FBXL19	3			2.5	Toxicity	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448423703	
1448428937	rs75995567	AOX1	3			1.75	Dosage	1	1	allopurinol;febuxostat	Gout	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448428937	
1448428944	rs3731722	AOX1	3			2.25	Dosage	1	1	allopurinol;febuxostat	Gout	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448428944	
1448522754	rs11126740	CTNNA2	3			3.0	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448522754	
1448522760	rs96844	MAP3K1	3			3.5	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448522760	
1448525745	HLA-A*11:01:01	HLA-A	3			3.25	Toxicity	2	2	carbamazepine	Drug Hypersensitivity;Epidermal Necrolysis, Toxic;erythema exudativum multiforme;Maculopapular Exanthema;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448525745	
1448525750	HLA-B*38:01:01	HLA-B	3		Tier 1 VIP	3.75	Toxicity	1	1	lamotrigine	Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448525750	
1448525763	HLA-C*08:01	HLA-C	3			3.25	Toxicity	1	1	carbamazepine	Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448525763	
1448525768	HLA-C*08:01	HLA-C	3			6.0	Toxicity	2	2	phenytoin	Epidermal Necrolysis, Toxic;Maculopapular Exanthema;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448525768	
1448526098	rs11265618	IL6R	3			2.75	Efficacy	1	1	tocilizumab	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448526098	
1448530595	rs3761548	FOXP3	3			2.5	Toxicity	1	1	tacrolimus	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448530595	
1448600720	rs7512462	SLC26A9	3			2.5	Efficacy	1	1	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448600720	Pediatric
1448427833	rs1045642	ABCB1	3		Tier 1 VIP	0.5	Efficacy	2	2	granisetron	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448427833	
1448532002	rs149104283		3			0.0	Toxicity	1	1	clozapine	Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448532002	
1448532196	rs1045642	ABCB1	3		Tier 1 VIP	0.0	Metabolism/PK	1	1	rivaroxaban		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448532196	
1448532202	rs2032582	ABCB1	3		Tier 1 VIP	0.0	Metabolism/PK	1	1	dabigatran		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448532202	
1448532211	rs2032582	ABCB1	3		Tier 1 VIP	0.0	Metabolism/PK	1	1	rivaroxaban		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448532211	
1449565416	rs544027339	CYP2C9	3		Rare Variant; Tier 1 VIP	0.25	Toxicity	1	1	phenytoin	Drug Toxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449565416	Pediatric
1449565422	rs1029359343	CYP2C9	3		Rare Variant; Tier 1 VIP	0.25	Toxicity	1	1	phenytoin	Drug Toxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449565422	Pediatric
1449575674	rs1184321568	DPYD	3		Rare Variant; Tier 1 VIP	0.0	Other	1	1	fluorouracil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449575674	
1449575645	rs56005131	DPYD	1A		Rare Variant; Tier 1 VIP	100.0	Other	1	2	fluorouracil		2021-05-25	https://www.pharmgkb.org/clinicalAnnotation/1449575645	
1448525458	rs1799732	DRD2	3		Tier 1 VIP	2.0	Toxicity	1	1	levodopa	Parkinson Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448525458	
1448615589	rs4986893	CYP2C19	3		Rare Variant; Tier 1 VIP	1.5	Toxicity	1	2	phenytoin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448615589	
1448617146	rs2032582	ABCB1	3		Tier 1 VIP	2.5	Toxicity	1	1	atazanavir	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448617146	
1448615575	rs1045642	ABCB1	4		Tier 1 VIP	-8.75	Efficacy	18	19	clopidogrel	platelet reactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448615575	
1448525452	rs6280	DRD3	3			5.0	Toxicity	2	2	levodopa	gastrointestinal toxicity;Hallucinations;Parkinson Disease	2021-12-08	https://www.pharmgkb.org/clinicalAnnotation/1448525452	
1448613032	rs2266782	FMO3	3			1.0	Metabolism/PK	1	1	sulindac		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448613032	
1448613038	rs2266780	FMO3	3			1.0	Metabolism/PK	1	1	sulindac		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448613038	
1448616855	rs1048977	CDA	3			2.75	Toxicity	1	1	capecitabine	Hyperbilirubinemia;Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448616855	
1451510621	rs1045642	ABCB1	3		Tier 1 VIP	3.0	Toxicity	1	1	rivaroxaban		2021-09-30	https://www.pharmgkb.org/clinicalAnnotation/1451510621	
1451510641	rs4148738	ABCB1	3		Tier 1 VIP	2.75	Toxicity	1	1	apixaban		2021-09-30	https://www.pharmgkb.org/clinicalAnnotation/1451510641	
1448605577	HLA-B*35:05:01	HLA-B	3		Tier 1 VIP	3.5	Toxicity	1	1	minocycline	drug-induced liver injury	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448605577	
1448613011	rs7968606	ANKS1B	3			2.0	Efficacy	1	1	amisulpride	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448613011	
1448615153	rs727479	CYP19A1	3			2.0	Efficacy	1	1	anastrozole	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448615153	
1448634786	rs1801252	ADRB1	3		Tier 1 VIP	3.5	Toxicity	1	1	Beta Blocking Agents	major adverse cardiac events (mace)	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448634786	
1450374895	rs2070762	TH	3			3.5	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450374895	Pediatric
1448602934	rs10741657	CYP2R1	3			3.0	Efficacy	1	1	peginterferon alfa-2b;ribavirin	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448602934	
1448612776	rs13144136	CLNK	3			0.0	Efficacy	1	1	Antihypertensives	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448612776	
1449166396	rs1045642	ABCB1	3		Tier 1 VIP	4.0	Efficacy;Metabolism/PK	2	2	omeprazole	Gastroesophageal Reflux	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449166396	Pediatric
1448428030	rs2306283	SLCO1B1	4		Tier 1 VIP	-1.25	Toxicity	3	3	irinotecan	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448428030	
1448635217	NUDT15*1, NUDT15*2, NUDT15*3	NUDT15	1A		Tier 1 VIP	208.125	Dosage	5	9	mercaptopurine	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-05-24	https://www.pharmgkb.org/clinicalAnnotation/1448635217	Pediatric
1451510840	rs9958628	ARHGAP28	3			1.25	Toxicity	1	1	pegaspargase		2021-09-30	https://www.pharmgkb.org/clinicalAnnotation/1451510840	
1448604251	rs2032582	ABCB1	3		Tier 1 VIP	0.0	Metabolism/PK	3	3	methadone	Opioid-Related Disorders	2021-11-19	https://www.pharmgkb.org/clinicalAnnotation/1448604251	
1448624874	rs2254638	N6AMT1	3			0.0	Efficacy	2	3	clopidogrel	major adverse cardiac events (mace)	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448624874	
1447949171	HLA-B*15:13:01	HLA-B	3		Tier 1 VIP	3.75	Toxicity	1	1	phenytoin	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447949171	
1448267381	rs72800847	STX1B	3			2.25	Dosage	1	1	warfarin	heart valve replacement	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448267381	
1448267389	rs3826041	CYP1A1	3			2.25	Dosage	1	1	warfarin	heart valve replacement	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448267389	
1448267397	rs2304429	DNMT3A	3			2.25	Dosage	1	1	warfarin	heart valve replacement	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448267397	
1448617231	rs1131882	TBXA2R	3			2.5	Efficacy;Toxicity	1	1	aspirin	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448617231	
1448635185	rs746071566	NUDT15	3		Rare Variant; Tier 1 VIP	0.25	Dosage;Toxicity	1	1	mercaptopurine	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448635185	Pediatric
1448635612	GSTM1 non-null, GSTM1 null	GSTM1	3			1.0	Toxicity	1	2	nevirapine	Epidermal Necrolysis, Toxic;HIV Infections;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448635612	
1449190330	rs1022563	PDYN	3			1.75	Toxicity	2	2	opioids	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449190330	
1449190339	rs1997794	PDYN	3			1.75	Toxicity	2	2	opioids	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449190339	
1448635585	rs3745274	CYP2B6	4		Tier 1 VIP	-2.75	Toxicity	5	6	nevirapine	drug reaction with eosinophilia and systemic symptoms;HIV Infections;Stevens-Johnson Syndrome;Toxic liver disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448635585	
1448632697	rs738409	PNPLA3	3			5.0	Toxicity	2	2	asparaginase;cyclophosphamide;daunorubicin;prednisolone;vincristine	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448632697	Pediatric
1451510921	HLA-DQB1*02:02	HLA-DQB1	3			1.25	Toxicity	1	1	pegaspargase		2021-09-30	https://www.pharmgkb.org/clinicalAnnotation/1451510921	
1447981289	rs4292394	UGT2B7	3			3.25	Efficacy;Toxicity	1	1	methadone	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447981289	
1447982825	rs374150125	NT5C1A	3		Rare Variant	0.0	Other	1	2	cladribine;fluorouracil;gemcitabine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447982825	
1447983050	rs7091672	EIF3A	3			3.25	Toxicity	1	1	Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447983050	
1447986967	rs11649514	PRKCB	3			2.5	Toxicity	1	1	atenolol	Hyperglycemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447986967	
1447986986	rs72551330	UGT1A9	3		Rare Variant	1.5	Metabolism/PK	1	1	sulfinpyrazone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447986986	
1447952921	rs1884613	HNF4A	3			1.5	Metabolism/PK	1	1	efavirenz	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447952921	
1447953109	rs6493497	CYP19A1	3			5.0	Toxicity	1	2	exemestane;letrozole	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447953109	
1447953130	rs4149056	SLCO1B1	3		Tier 1 VIP	3.25	Toxicity	1	1	enalapril	Essential hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447953130	
1447953250	rs2032582	ABCB1	3		Tier 1 VIP	2.0	Efficacy	1	1	modafinil	Narcolepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447953250	
1447960436	rs1801253	ADRB1	3		Tier 1 VIP	1.5	Dosage	1	1	catecholamines	Coronary Artery Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960436	
1447960509	rs3740065	ABCC2	3			3.25	Efficacy	2	2	tamoxifen	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960509	
1447960745	rs130072	CCHCR1	3			3.25	Toxicity	1	1	nevirapine	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960745	
1447960775	rs2073724	TCF19	3			3.25	Toxicity	1	1	nevirapine	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960775	
1447961115	rs17495520		3			0.0	Efficacy	1	1	salbutamol	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447961115	
1447961122	rs1419555		3			0.0	Efficacy	1	1	salbutamol	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447961122	
1447962603	rs1057868	POR	3			1.5	Metabolism/PK	1	1	nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447962603	
1447962649	rs34993780	UGT1A9	3		Rare Variant	0.0	Metabolism/PK	1	1	SN-38		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447962649	
1447962843	rs1128503	ABCB1	3		Tier 1 VIP	4.0	Efficacy	2	2	simvastatin	Hypercholesterolemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447962843	
1447964136	rs2031920	CYP2E1	4			-5.0	Toxicity	17	17	Drugs For Treatment Of Tuberculosis	Tuberculosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447964136	Pediatric
1447963096	rs3754446	GSTM1	3			0.0	Metabolism/PK	1	1	busulfan	Leukemia, Myeloid, Acute	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963096	
1447964236	rs6551665	ADGRL3	3			1.0	Efficacy	7	7	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447964236	Pediatric
1447987005	rs2307424	NR1I3	3			2.625	Metabolism/PK	3	4	efavirenz	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447987005	
1447987030	rs3003596	NR1I3	3			1.0	Metabolism/PK	1	1	efavirenz	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447987030	
1447987045	rs3814055	NR1I2	3			1.0	Metabolism/PK	1	1	carbamazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447987045	
1447987052	rs2461817	NR1I2	3			1.75	Metabolism/PK	1	1	carbamazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447987052	
1447987059	rs7643645	NR1I2	3			1.25	Metabolism/PK	1	1	carbamazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447987059	
1447987066	rs28365063	UGT2B7	3			1.5	Metabolism/PK	1	1	carbamazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447987066	
1447987073	rs4803381	CYP2A6	3		Tier 1 VIP	1.5	Metabolism/PK	2	2	nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447987073	
1447987101	rs2740574	CYP3A4	3		Tier 1 VIP	1.25	Metabolism/PK	1	1	carbamazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447987101	
1447987113	rs4803381	CYP2A6	3		Tier 1 VIP	1.75	Efficacy	1	1	bupropion;Drugs used in nicotine dependence	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447987113	
1448102470	rs8105790	IFNL3	3			5.5	Efficacy	2	2	peginterferon alfa-2a;peginterferon alfa-2b;ribavirin	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448102470	
1448427398	rs5370	EDN1	3			3.0	Efficacy	1	1	bevacizumab	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448427398	
1448427405	rs3025039	VEGFA	3			2.5	Efficacy	1	1	bevacizumab	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448427405	
1448522766	rs2546890	IL12B	3			3.0	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448522766	
1448522772	rs6908425	CDKAL1	3			2.5	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448522772	
1448522778	rs12191877	HLA-C	3			2.0	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448522778	
1448522784	rs9304742	ZNF816	3			2.5	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448522784	
1450373755	rs12148896	SLC28A1	3			2.75	Toxicity	1	1	gemcitabine	Neutropenia;Pancreatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450373755	
1450373761	rs3825876	SLC28A1	3			2.75	Toxicity	1	1	gemcitabine	Neutropenia;Pancreatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450373761	
1447987094	rs1128503	ABCB1	4		Tier 1 VIP	-2.0	Metabolism/PK	4	4	carbamazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447987094	
1447963234	rs1076560	DRD2	3		Tier 1 VIP	5.5	Toxicity	2	2	cocaine	Cocaine-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963234	
1447986998	rs1695	GSTP1	3		Tier 1 VIP	0.5	Toxicity	4	4	cisplatin	Medulloblastoma;Neoplasms;Ototoxicity;Testicular Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447986998	Pediatric
1451510926	HLA-DRB1*07:01:01:01	HLA-DRB1	3			0.0	Toxicity	1	1	pegaspargase		2021-09-30	https://www.pharmgkb.org/clinicalAnnotation/1451510926	
1448099568	rs2291075	SLCO1B1	3		Tier 1 VIP	2.5	Efficacy	1	1	cytarabine;daunorubicin;etoposide;mitoxantrone	Leukemia, Myeloid, Acute	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448099568	Pediatric
1448099745	rs1799732	DRD2	3		Tier 1 VIP	3.0	Toxicity	4	5	antipsychotics	Psychotic Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448099745	
1448102463	rs7248668	IFNL3	3			5.5	Efficacy	2	2	peginterferon alfa-2a;peginterferon alfa-2b;ribavirin	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448102463	
1448102490	rs4803217	IFNL3	3			5.0	Efficacy	3	3	peginterferon alfa-2a;peginterferon alfa-2b;ribavirin	Hepatitis C;HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448102490	
1448124590	rs11568658	ABCC4	3			2.0	Toxicity	1	1	valganciclovir	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448124590	
1448124604	rs2229109	ABCB1	3		Tier 1 VIP	2.5	Toxicity	1	1	valganciclovir	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448124604	
1448125853	rs776746	CYP3A5	3		Tier 1 VIP	2.0	Metabolism/PK	1	1	imatinib	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448125853	
1448265174	rs11125	LGALS3	3			4.0	Toxicity	1	1	Antibiotics	Hypersensitivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448265174	
1448602385	rs11124945	PLEKHH2	3			0.0	Toxicity	1	1	atenolol;verapamil	Diabetes Mellitus;Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448602385	
1448603291	rs2295632	FAAH	3			3.0	Toxicity	1	1	morphine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448603291	Pediatric
1449576307	rs261316	ALDH1A2	3			0.0	Efficacy	1	1	atenolol;hydrochlorothiazide	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449576307	
1449576551	rs7604115	UGT1A3	3			2.0	Metabolism/PK	1	1	montelukast	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449576551	
1449576557	UGT1A3*1, UGT1A3*2	UGT1A3	3			2.0	Metabolism/PK	1	1	montelukast	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449576557	
1449576566	rs704212	ABCC9	3			2.0	Metabolism/PK	1	1	montelukast	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449576566	
1449715913	rs1045642	ABCB1	3		Tier 1 VIP	2.0	Toxicity	1	1	fentanyl	Pain, Postoperative;Respiratory Insufficiency	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449715913	
1449715919	rs2032582	ABCB1	3		Tier 1 VIP	0.0	Toxicity	1	1	fentanyl	Pain, Postoperative;Respiratory Insufficiency	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449715919	
1449715928	rs1128503	ABCB1	3		Tier 1 VIP	0.0	Toxicity	1	1	fentanyl	Pain, Postoperative;Respiratory Insufficiency	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449715928	
1449716035	rs7583431	ATF2	3			2.75	Efficacy	1	1	fentanyl	Pain, Postoperative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449716035	
1449747892	rs4646450	CYP3A5;ZSCAN25	3		Tier 1 VIP	4.75	Metabolism/PK	2	2	tacrolimus	Kidney Transplantation;liver transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449747892	
1449747954	CYP3A5*1, CYP3A5*3	CYP3A5	3		Tier 1 VIP	2.0	Toxicity	1	1	tacrolimus	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449747954	
1449751564	rs12248560	CYP2C19	3		Tier 1 VIP	2.75	Efficacy	1	1	phenazepam	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449751564	
1450815160	rs785423	TJP1	3			0.0	Efficacy	1	1	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450815160	
1449576572	CYP2C8*1, CYP2C8*3, CYP2C8*4	CYP2C8	3		Tier 1 VIP	3.5	Metabolism/PK	1	2	montelukast	Asthma	2021-05-18	https://www.pharmgkb.org/clinicalAnnotation/1449576572	
1451825200	rs1799971	OPRM1	3			2.0	Toxicity	1	1	naloxone;oxycodone	Erythema	2022-07-13	https://www.pharmgkb.org/clinicalAnnotation/1451825200	
1451825220	rs4680	COMT	3		Tier 1 VIP	3.0	Toxicity	1	1	naloxone;oxycodone	Vomiting	2022-07-13	https://www.pharmgkb.org/clinicalAnnotation/1451825220	
1451825226	rs4680	COMT	3		Tier 1 VIP	2.5	Toxicity	1	1	naloxone;oxycodone	Erythema	2022-07-13	https://www.pharmgkb.org/clinicalAnnotation/1451825226	
1447954390	rs75039782	CFTR	3	Yes: Level of evidence set to 3. Ataluren is a drug for the treatment of Duchenne muscular dystrophy caused by a nonsense mutation and not indicated in CF treatment.	Rare Variant; Tier 1 VIP	4.0	Other	2	2	ataluren	Cystic Fibrosis	2021-03-29	https://www.pharmgkb.org/clinicalAnnotation/1447954390	Pediatric
1447954397	rs77010898	CFTR	3	Yes: Level of evidence set to 3. Ataluren is a drug for the treatment of Duchenne muscular dystrophy caused by a nonsense mutation and not indicated in CF treatment.	Rare Variant; Tier 1 VIP	4.5	Other	4	4	ataluren	Cystic Fibrosis	2021-03-29	https://www.pharmgkb.org/clinicalAnnotation/1447954397	Pediatric
1447949632	rs1540339	VDR	3			2.5	Efficacy	1	1	selective beta-2-adrenoreceptor agonists	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447949632	
1447954525	rs13431554	IRS1	3			3.0	Efficacy	1	1	clopidogrel	Coronary Artery Disease;Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447954525	
1447959694	rs4278350		3			2.5	Efficacy	1	1	interferon beta-1a;interferon beta-1b	Multiple Sclerosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447959694	
1447959700	rs10494227	ZNF697	3			2.5	Efficacy	1	1	interferon beta-1a;interferon beta-1b	Multiple Sclerosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447959700	
1447959717	rs760316	FHIT	3			2.5	Efficacy	1	1	interferon beta-1a;interferon beta-1b	Multiple Sclerosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447959717	
1447959724	rs1448673		3			2.5	Efficacy	1	1	interferon beta-1a;interferon beta-1b	Multiple Sclerosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447959724	
1447960623	rs5186	AGTR1	3			1.75	Efficacy	1	1	losartan		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960623	
1447960874	rs1128503	ABCB1	3		Tier 1 VIP	1.0	Metabolism/PK	1	1	tipifarnib	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960874	
1447962620	rs1544410	VDR	3			2.5	Efficacy	1	1	conjugated estrogens;medroxyprogesterone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447962620	
1447962768	rs705379	PON1	3			2.25	Efficacy	2	2	atorvastatin;simvastatin	Hypercholesterolemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447962768	
1447962855	rs1128503	ABCB1	3		Tier 1 VIP	2.0	Toxicity	1	1	simvastatin	Hypercholesterolemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447962855	
1447962874	rs4244285	CYP2C19	3		Tier 1 VIP	4.75	Metabolism/PK	2	3	nelfinavir	HIV Infections;Pancreatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447962874	
1447962927	CYP2B6*27, CYP2B6*28	CYP2B6	3		Tier 1 VIP	0.0	Other	1	2	efavirenz		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447962927	
1447963219	rs292449	NEDD4L	3			2.25	Efficacy	1	1	hydrochlorothiazide		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963219	
1447963846	rs4341	ACE	3		Tier 1 VIP	2.5	Toxicity	1	1	Thiazides, plain	Diabetes Mellitus	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963846	
1447963991	rs3789243	ABCB1	3		Tier 1 VIP	3.5	Efficacy	2	3	antiepileptics	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963991	
1447964250	rs1947275	ADGRL3	3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447964250	Pediatric
1447987080	rs4148740	ABCB1	3		Tier 1 VIP	1.0	Metabolism/PK	1	1	carbamazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447987080	
1448102306	rs4673	CYBA	3			4.0	Efficacy;Toxicity	2	2	doxorubicin;idarubicin	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448102306	
1448103875	rs2234693	ESR1	3			2.25	Toxicity	1	1	methamphetamine	Psychotic Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448103875	
1448109754	rs2305364	SLC28A1	4			-1.5	Toxicity	2	2	anthracyclines and related substances	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448109754	Pediatric
1448257149	rs41301394	POR	3			2.75	Dosage	1	1	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448257149	
1448109591	rs316019	SLC22A2	4			-1.0	Toxicity	2	2	anthracyclines and related substances	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448109591	Pediatric
1447964041	rs1041983	NAT2	3		Tier 1 VIP	3.0	Toxicity	1	1	ethambutol;isoniazid;pyrazinamide;rifampin	Toxic liver disease;Tuberculosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447964041	
1451511220	rs3758149	GGH	3			1.0	Metabolism/PK	1	1	methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-10-01	https://www.pharmgkb.org/clinicalAnnotation/1451511220	Pediatric
1448101278	rs684513	CHRNA5	3			1.5	Toxicity	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448101278	
1448101285	rs1695	GSTP1	3		Tier 1 VIP	0.0	Toxicity	3	3	isoniazid;rifampin	drug-induced liver injury;Tuberculosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448101285	
1448101408	rs3806596	UGT1A3	3			5.75	Efficacy;Metabolism/PK	3	3	deferasirox	beta-Thalassemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448101408	Pediatric
1448101436	rs13120400	ABCG2	3		Tier 1 VIP	4.25	Efficacy;Metabolism/PK	3	3	deferasirox	beta-Thalassemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448101436	Pediatric
1447962661	rs72551344	UGT1A9	3		Rare Variant	0.0	Metabolism/PK	1	1	SN-38		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447962661	
1447962737	rs688	LDLR	3			2.75	Efficacy	1	1	lovastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447962737	
1447963042	rs1800497	ANKK1	3			4.5	Efficacy	2	2	antipsychotics;aripiprazole;risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963042	
1447963570	HLA-DRB1*16:01:01	HLA-DRB1	3			2.5	Toxicity	1	1	flupirtine	drug-induced liver injury	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963570	
1447979493	rs2010963	VEGFA	3			4.5	Efficacy	1	2	sorafenib	Carcinoma, Hepatocellular	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447979493	
1447979500	rs4604006		3			5.5	Efficacy	1	2	sorafenib	Carcinoma, Hepatocellular	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447979500	
1447979507	rs2070744	NOS3	3			5.75	Efficacy	1	2	sorafenib	Carcinoma, Hepatocellular	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447979507	
1447979514	rs1799983	NOS3	3			5.5	Efficacy	1	2	sorafenib	Carcinoma, Hepatocellular	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447979514	
1447980904	rs1045642	ABCB1	3		Tier 1 VIP	2.0	Toxicity	1	1	Antivirals for treatment of HIV infections, combinations;Drugs For Treatment Of Tuberculosis	HIV Infections;Tuberculosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447980904	
1447980911	rs3745274	CYP2B6	3		Tier 1 VIP	2.0	Toxicity	1	1	Antivirals for treatment of HIV infections, combinations;Drugs For Treatment Of Tuberculosis	HIV Infections;Tuberculosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447980911	
1448100326	rs61361928	UGT2B7	3		Rare Variant	0.0	Metabolism/PK	1	1	ticagrelor	Acute coronary syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100326	
1448100712	rs1128503	ABCB1	3		Tier 1 VIP	2.5	Toxicity	1	1	codeine	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100712	
1448101238	rs1799964	TNF	3			2.25	Toxicity	1	1	stavudine	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448101238	
1448101271	rs637137	CHRNA5	3			2.0	Toxicity	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448101271	
1448102497	rs8113007		3			3.0	Efficacy	1	1	peginterferon alfa-2b;ribavirin	Hepatitis C;HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448102497	
1448102543	rs10877012	CYP27B1	3			0.5	Efficacy	2	2	peginterferon alfa-2b;ribavirin	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448102543	
1448102666	rs2498804		3			2.5	Efficacy	1	1	carboplatin;cisplatin	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448102666	
1448122847	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	3		Tier 1 VIP	4.0	Dosage	1	2	warfarin	Atrial Fibrillation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448122847	
1448125544	rs11549465	HIF1A	3			2.75	Efficacy	1	1	axitinib;sorafenib		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448125544	
1447963662	rs2231142	ABCG2	4		Tier 1 VIP	-0.25	Toxicity	4	4	gefitinib	Lung Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963662	
1447987235	rs11947402	TSPAN5	4			-0.5	Other	1	2	citalopram;escitalopram	Depressive Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447987235	
1451516314	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	3		Tier 1 VIP	0.5	Dosage	12	13	phenprocoumon		2021-10-05	https://www.pharmgkb.org/clinicalAnnotation/1451516314	Pediatric
1447961108	rs17701271		3			0.0	Efficacy	1	1	salbutamol	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447961108	
1447963860	rs5443	GNB3	3			2.5	Toxicity	1	1	Thiazides, plain	Diabetes Mellitus	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963860	
1447964142	rs113993960	CFTR	3		Rare Variant; Tier 1 VIP	2.25	Efficacy	1	1	cysteamine	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447964142	
1447964278	rs1355368	ADGRL3	3			2.5	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447964278	Pediatric
1447964324	rs4271002	NAT2	3		Tier 1 VIP	2.25	Toxicity	1	1	aspirin	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447964324	
1447983184	rs370457585	NT5C1A	3		Rare Variant	0.0	Other	1	1	cladribine;fluorouracil;gemcitabine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447983184	
1448098793	rs17021408		3			0.0	Toxicity	1	1	cyclophosphamide;cytarabine;daunorubicin;dexamethasone;doxorubicin;methotrexate;pegaspargase;prednisone;thioguanine;vincristine	Osteonecrosis;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448098793	Pediatric
1448102432	rs10853728		3			6.5	Efficacy	1	2	peginterferon alfa-2b;ribavirin	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448102432	
1448102477	rs28416813	IFNL3	3			5.0	Efficacy	2	2	peginterferon alfa-2a;peginterferon alfa-2b;ribavirin	Hepatitis C, Chronic;HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448102477	
1448112196	rs2011425	UGT1A4	3			1.75	Metabolism/PK	2	2	tamoxifen	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448112196	
1183679785	rs746647	CCHCR1	3			3.25	Toxicity	1	1	nevirapine	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183679785	
1447964187	rs78655421	CFTR	1A		Rare Variant; Tier 1 VIP	206.0	Efficacy	5	8	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447964187	
1451516322	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	3		Tier 1 VIP	4.25	Metabolism/PK	3	3	phenprocoumon		2021-10-05	https://www.pharmgkb.org/clinicalAnnotation/1451516322	
1449296314	rs1801133	MTHFR	3		Tier 1 VIP	0.125	Metabolism/PK	1	1	folic acid		2022-02-25	https://www.pharmgkb.org/clinicalAnnotation/1449296314	
1451809140	HLA-B*15:02:01	HLA-B	2A		Tier 1 VIP	11.25	Toxicity	4	5	antiepileptics	Epidermal Necrolysis, Toxic;Maculopapular Exanthema;severe cutaneous adverse reactions;Stevens-Johnson Syndrome	2022-06-22	https://www.pharmgkb.org/clinicalAnnotation/1451809140	
1447946212	rs17602729	AMPD1	3			4.5	Toxicity	1	2	regadenoson		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447946212	
1447946219	rs2231135	ABCG2	3		Tier 1 VIP	2.25	Toxicity	1	1	methotrexate	Osteosarcoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447946219	
1447946226	rs1650723	DHFR	3			2.25	Toxicity	1	1	methotrexate	Osteosarcoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447946226	
1447946233	rs1053129	DHFR	3			2.25	Efficacy	1	1	methotrexate	Osteosarcoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447946233	
1447960468	rs183484	RRM1	3			0.5	Efficacy	2	2	gemcitabine	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960468	
1447960554	rs4344	ACE	3		Tier 1 VIP	2.25	Efficacy	1	1	ramipril	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960554	
1447960566	rs4359	ACE	3		Tier 1 VIP	2.75	Efficacy	1	1	ramipril	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960566	
1447960649	rs5186	AGTR1	3			1.5	Efficacy	1	1	perindopril	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960649	
1447960850	rs3780126	GGH	3			1.5	Efficacy	1	1	bevacizumab;pemetrexed	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960850	
1447961178	rs712830	EGFR	3			2.25	Toxicity	1	1	cetuximab;irinotecan;leucovorin;tegafur	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447961178	
1447961337	rs878567	HTR1A	3			3.0	Toxicity	1	1	methamphetamine	Substance-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447961337	
1447962751	rs662	PON1	3			4.25	Efficacy	3	3	atorvastatin;simvastatin	Hypercholesterolemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447962751	
1447963255	rs7142143	PYGL	3			0.0	Efficacy	1	1	asparaginase;dexamethasone;methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963255	Pediatric
1447981070	rs800292	CFH	3			2.5	Efficacy	1	1	bevacizumab		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447981070	
1447981158	rs6600879	UGT2B7	3			3.25	Efficacy;Toxicity	1	1	methadone	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447981158	
1447981207	rs6600880	UGT2B7	3			3.25	Efficacy;Toxicity	1	1	methadone	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447981207	
1447981222	rs4554144	UGT2B7	3			3.25	Efficacy;Toxicity	1	1	methadone	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447981222	
1447981250	rs11940316	UGT2B7	3			3.25	Efficacy;Toxicity	1	1	methadone	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447981250	
1447981259	rs7438135	UGT2B7	3			3.25	Efficacy;Toxicity	1	1	methadone	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447981259	
1448423795	rs4818	COMT	3		Tier 1 VIP	3.0	Efficacy	1	1	quetiapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448423795	
1448426938	HLA-DRB1*04:01:01	HLA-DRB1	3			2.75	Efficacy	1	1	interferon beta-1a	Multiple Sclerosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448426938	
1448426944	HLA-B*15:01:01:01	HLA-B	3		Tier 1 VIP	2.75	Efficacy	1	1	interferon beta-1a	Multiple Sclerosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448426944	
1447981089	rs11200638	HTRA1	4			-2.75	Efficacy	4	4	bevacizumab;ranibizumab	Macular Degeneration	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447981089	
1451511240	rs1544105	FPGS	3			0.25	Metabolism/PK	3	3	methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-12-13	https://www.pharmgkb.org/clinicalAnnotation/1451511240	Pediatric
1448109812	rs2108623	CYP4F2	4		Tier 1 VIP	-1.0	Toxicity	2	2	anthracyclines and related substances	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448109812	Pediatric
1447982582	rs2231142	ABCG2	3		Tier 1 VIP	5.5	Efficacy	3	3	allopurinol	Gout	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447982582	
1447981268	rs7662029	UGT2B7	3			3.25	Efficacy;Toxicity	1	1	methadone	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447981268	
1447986938	CYP3A5*1, CYP3A5*3	CYP3A5	3		Tier 1 VIP	2.0	Metabolism/PK	4	4	midazolam		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447986938	
1447987087	rs4148739	ABCB1	3		Tier 1 VIP	1.0	Metabolism/PK	1	1	carbamazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447987087	
1447987264	rs875858	VAC14	3			0.0	Toxicity	1	1	docetaxel	Prostatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447987264	
1448099430	rs80223967		3			0.0	Toxicity	1	1	cyclophosphamide;cytarabine;daunorubicin;dexamethasone;doxorubicin;methotrexate;pegaspargase;prednisone;thioguanine;vincristine	Osteonecrosis;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448099430	Pediatric
1448099454	rs72552713	ABCG2	3		Rare Variant; Tier 1 VIP	0.125	Metabolism/PK	1	1	sulfasalazine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448099454	
1448100187	rs2112460	CACNA1A	3			0.0	Efficacy	1	1	antidepressants	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100187	
1448103832	rs16969968	CHRNA5	3			2.5	Other	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448103832	
1448103839	rs1051730	CHRNA3	3			2.5	Other	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448103839	
1448103846	rs5275	PTGS2	3			2.75	Efficacy	1	1	capecitabine;oxaliplatin	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448103846	
1448103882	rs12364283	DRD2	3		Tier 1 VIP	1.75	Other	1	1	amphetamine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448103882	
1448103889	rs11788456	GRIN3A	3			1.5	Other	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448103889	
1448103910	rs2070995	KCNJ6	3			2.25	Other	1	1	methadone	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448103910	
1448103942	rs578776	CHRNA3	3			0.5	Other	1	2	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448103942	
1448103949	rs615470	CHRNA5	3			0.5	Other	1	2	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448103949	
1448103956	rs684513	CHRNA5	3			1.0	Other	1	2	cocaine	Cocaine-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448103956	
1448103963	rs4402960	IGF2BP2	3			1.5	Efficacy	1	1	repaglinide	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448103963	
1448103973	rs1470579	IGF2BP2	3			1.5	Efficacy	1	1	repaglinide	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448103973	
1448104005	rs2975226	SLC6A3	3			3.0	Efficacy	1	1	clozapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448104005	
1448104022	rs1205	CRP	3			2.75	Efficacy	1	1	rosuvastatin	Coronary Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448104022	
1448104029	rs2808630		3			2.75	Efficacy	1	1	rosuvastatin	Coronary Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448104029	
1448104036	rs1125394	DRD2	3		Tier 1 VIP	3.0	Other	1	1	cocaine	Cocaine-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448104036	
1448112147	rs4149056	SLCO1B1	3		Tier 1 VIP	1.5	Toxicity	1	1	cyclophosphamide;docetaxel;doxorubicin;epirubicin;fluorouracil	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448112147	
1448256864	rs50872	ERCC2	3			3.5	Toxicity	1	1	Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448256864	
1448256872	rs7170924	IL16	3			2.5	Toxicity	1	1	Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448256872	
1448256881	rs1128503	ABCB1	3		Tier 1 VIP	6.0	Toxicity	1	2	Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448256881	
1447963011	rs1127354	ITPA	4			-2.25	Toxicity	4	4	mercaptopurine	Myelosuppression;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963011	Pediatric
1448109578	rs17863783	UGT1A6	4			-2.0	Toxicity	2	2	anthracyclines and related substances	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448109578	Pediatric
1448109598	rs1149222	ABCB4	4			-1.0	Toxicity	2	2	anthracyclines and related substances	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448109598	Pediatric
1448109605	rs4148808	ABCB4	4			-1.5	Toxicity	2	2	anthracyclines and related substances	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448109605	Pediatric
1448109802	rs2019604	SPG7	4			-1.25	Toxicity	2	2	anthracyclines and related substances	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448109802	Pediatric
1451511344	rs1051296	SLC19A1	3		Tier 1 VIP	1.5	Metabolism/PK	1	1	methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-10-01	https://www.pharmgkb.org/clinicalAnnotation/1451511344	Pediatric
1447982688	rs11253043	AKR1C4	3			0.0	Metabolism/PK	1	1	exemestane		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447982688	
1447982723	rs3750920	TOLLIP	3			1.75	Efficacy	1	1	acetylcysteine	Pulmonary Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447982723	
1447982732	rs7772821	TAAR6	3			2.0	Efficacy	1	1	corticosteroids	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447982732	
1447952936	rs6108160	PLCB1	3			3.0	Efficacy	1	1	Selective serotonin reuptake inhibitors	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447952936	
1447953072	rs183205964	TYMS	3		Rare Variant; Tier 1 VIP	3.0	Toxicity	1	1	capecitabine;fluorouracil;tegafur	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447953072	
1447953116	rs6314	HTR2A	3			1.75	Efficacy	1	1	olanzapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447953116	
1447953123	rs7958904	HOTAIR	3			2.75	Efficacy	1	1	Platinum compounds	Lung Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447953123	
1447953162	rs2513265		3			1.375	Efficacy	1	1	antipsychotics	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447953162	
1447953171	rs619586	MALAT1	3			2.25	Efficacy	1	1	Platinum compounds	Lung Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447953171	
1447953178	rs2839698	H19	3			2.25	Efficacy	1	1	Platinum compounds	Lung Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447953178	
1447953192	rs1800544	ADRA2A	3			2.75	Efficacy	1	1	Selective serotonin reuptake inhibitors	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447953192	
1447953212	rs6983267		3			2.25	Efficacy	1	1	Platinum compounds	Lung Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447953212	
1447953263	rs2075572	OPRM1	3			0.0	Toxicity	1	1	methadone	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447953263	
1447953270	rs1799971	OPRM1	3			0.0	Toxicity	1	1	methadone	Opioid-Related Disorders;Sleep Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447953270	
1447953277	rs2813543	ESR1	3			2.5	Toxicity	1	1	exemestane	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447953277	
1447953311	rs1875705	GRID2	3			0.0	Efficacy	1	1	risperidone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447953311	
1447953328	rs4135385	CTNNB1	3			4.0	Efficacy;Toxicity	1	2	cyclophosphamide;dexamethasone;lenalidomide;thalidomide	Multiple Myeloma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447953328	
1447953340	rs4533622	CTNNB1	3			3.5	Efficacy;Toxicity	1	2	lenalidomide;thalidomide	Multiple Myeloma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447953340	
1447953347	rs2069062	GRM7	3			1.75	Efficacy	1	1	risperidone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447953347	
1447959508	rs4880	SOD2	3			3.0	Toxicity	1	1	asparaginase	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447959508	
1447959731	rs10819043	GAPVD1	3			2.5	Efficacy	1	1	interferon beta-1a;interferon beta-1b	Multiple Sclerosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447959731	
1447959738	rs2291858	GAPVD1	3			2.5	Efficacy	1	1	interferon beta-1a;interferon beta-1b	Multiple Sclerosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447959738	
1447960211	rs1045642	ABCB1	3		Tier 1 VIP	0.0	Efficacy	1	1	Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960211	
1447961194	rs8192719	CYP2B6	3		Tier 1 VIP	1.75	Metabolism/PK	1	1	efavirenz	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447961194	
1447962703	rs4986910	CYP3A4	3		Rare Variant; Tier 1 VIP	2.75	Efficacy	1	1	fluvastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447962703	
1447963070	rs2869950	CHRNB4	3			0.0	Toxicity	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963070	
1447964331	rs2854744	IGFBP3	3			3.0	Efficacy	1	1	fluorouracil	Stomach Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447964331	
1447982739	rs76088846	CYP2D6	3		Rare Variant; Tier 1 VIP	0.0	Metabolism/PK	1	1	bufuralol;dextromethorphan		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447982739	
1447982674	rs62621365	AKR1C3	3			0.0	Metabolism/PK	1	1	exemestane		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447982674	
1447982754	rs750996195	CYP2D6	3		Rare Variant; Tier 1 VIP	0.0	Metabolism/PK	1	1	bufuralol;dextromethorphan		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447982754	
1447982761	rs745746329	CYP2D6	3		Rare Variant; Tier 1 VIP	0.0	Metabolism/PK	1	1	bufuralol;dextromethorphan		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447982761	
1447983170	rs2396185	INSR	3			0.0	Efficacy	1	1	topiramate		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447983170	
1447983177	rs28399504	CYP2C19	3		Rare Variant; Tier 1 VIP	0.5	Metabolism/PK	1	1	mephenytoin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447983177	
1447986872	rs16969968	CHRNA5	3			3.0	Metabolism/PK	2	2	cotinine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447986872	
1447986902	rs57064725	PSMA4	3			0.0	Metabolism/PK	1	1	cotinine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447986902	
1447986910	rs7170068	CHRNA3	3			0.0	Metabolism/PK	1	1	cotinine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447986910	
1447986925	rs10851907	CHRNB4	3			0.0	Metabolism/PK	1	1	cotinine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447986925	
1448103860	rs5443	GNB3	3			1.5	Toxicity	1	1	methadone	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448103860	
1448103928	rs3814055	NR1I2	3			3.5	Toxicity	1	1	flucloxacillin	Toxic liver disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448103928	
1448104043	rs6279	DRD2	3		Tier 1 VIP	1.75	Other	1	1	olanzapine	Bipolar Disorder;Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448104043	
1448104050	rs6275	DRD2	3		Tier 1 VIP	1.75	Other	1	1	olanzapine	Bipolar Disorder;Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448104050	
1447991854	CYP2D6*1, CYP2D6*1xN	CYP2D6	4		Tier 1 VIP	-0.5	Efficacy	1	4	dolasetron;granisetron	Postoperative Nausea and Vomiting	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447991854	
1447983144	rs1800012	COL1A1	3			1.5	Toxicity	1	1	valproic acid	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447983144	
1447983151	rs200148		3			0.0	Toxicity	1	1	amlodipine;chlorthalidone;lisinopril	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447983151	
1447983163	rs2070296	NRP1	3			2.75	Efficacy	1	1	ranibizumab	Macular Degeneration	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447983163	
982045465	rs9934438	VKORC1	3		Tier 1 VIP	1.5	Efficacy	1	1	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982045465	
1447946114	rs179008	TLR7	3			2.5	Efficacy	1	1	imiquimod	Carcinoma, Basal Cell	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447946114	
1447946169	rs4646437	CYP3A4	3		Tier 1 VIP	2.0	Metabolism/PK	1	1	voriconazole	Mycoses	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447946169	
1447960484	rs2070744	NOS3	3			2.0	Efficacy	1	1	enalapril	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960484	
1447960502	rs2242046	SLC28A1	3			1.75	Toxicity	1	1	gemcitabine	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960502	
1447960582	rs719235	GGH	3			2.5	Toxicity	1	1	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960582	
1447960656	rs5186	AGTR1	3			2.0	Efficacy	1	1	losartan	Liver Cirrhosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960656	
1447960663	rs699	AGT	3			2.0	Efficacy	1	1	quinapril	Coronary Artery Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960663	
1447960716	rs2125739	ABCC10	3			2.0	Metabolism/PK	1	1	nevirapine	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960716	
1447960731	rs1265112	CCHCR1	3			3.25	Toxicity	1	1	nevirapine	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960731	
1447962710	rs1800588	LIPC	3			5.5	Efficacy	1	2	fluvastatin;simvastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447962710	
1447962723	rs1800588	LIPC	3			0.25	Efficacy	2	2	pravastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447962723	
1447963247	rs11716445	RHOA	3			3.0	Efficacy	1	1	pravastatin;simvastatin	Hypercholesterolemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963247	
1447979532	rs8192725	CYP2A6	3		Tier 1 VIP	0.125	Other	1	2	tegafur		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447979532	
1447979541	rs8192720	CYP2A6	3		Tier 1 VIP	1.0	Other	1	2	tegafur		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447979541	
1447979548	rs28399433	CYP2A6	3		Tier 1 VIP	0.125	Other	1	2	tegafur		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447979548	
1447981410	rs10916852	SH2D5	3			1.75	Efficacy	1	1	gemcitabine	Pancreatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447981410	
1447981430	rs7543016	CMPK1	3			1.75	Efficacy	1	1	gemcitabine	Pancreatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447981430	
1447981440	rs35687416	CMPK1	3			3.25	Efficacy	1	1	gemcitabine	Pancreatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447981440	
1447981457	rs12507552	DCTD	3			2.75	Efficacy	1	1	gemcitabine	Pancreatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447981457	
1447981465	rs274717	TENT4A	3			0.0	Efficacy	1	1	gemcitabine	Pancreatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447981465	
1447981474	rs274713	TENT4A	3			1.75	Efficacy	1	1	gemcitabine	Pancreatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447981474	
1447983137	rs12143842		3			0.0	Efficacy	1	1	amlodipine;chlorthalidone;lisinopril		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447983137	
1447987124	rs2819742	RYR2	3			0.5	Toxicity	3	3	atorvastatin;simvastatin	Cardiovascular Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447987124	
1448123001	rs1045642	ABCB1	3		Tier 1 VIP	1.75	Efficacy	1	1	losartan	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448123001	
1448123060	CYP2C9*1, CYP2C9*3, CYP2C9*13	CYP2C9	3		Tier 1 VIP	3.0	Metabolism/PK	1	2	zafirlukast		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448123060	
1448124426	rs2298383	ADORA2A;ADORA2A-AS1	3			2.75	Toxicity	1	1	methotrexate	Hematologic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448124426	Pediatric
1448265017	rs117648444	IFNL3;IFNL4	3			3.5	Efficacy	1	1	peginterferon alfa-2a;peginterferon alfa-2b;ribavirin	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448265017	
1448266396	rs35599367	CYP3A4	3		Tier 1 VIP	2.0	Metabolism/PK	1	1	risperidone	Bipolar Disorder;Depression;Substance-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448266396	
1448266413	rs1523130	NR1I2	3			2.0	Metabolism/PK	1	1	risperidone	Bipolar Disorder;Depression;Substance-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448266413	
1448266429	rs2276707	NR1I2	3			1.5	Metabolism/PK	1	1	risperidone	Bipolar Disorder;Depression;Substance-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448266429	
1451662923	CYP2A6*1, CYP2A6*4, CYP2A6*5, CYP2A6*6, CYP2A6*7, CYP2A6*9, CYP2A6*10, CYP2A6*12, CYP2A6*17, CYP2A6*18, CYP2A6*19, CYP2A6*20	CYP2A6	3		Tier 1 VIP	3.125	Metabolism/PK	12	14	coumarin		2022-09-29	https://www.pharmgkb.org/clinicalAnnotation/1451662923	
1447960204	rs1042714	ADRB2	3		Tier 1 VIP	2.5	Toxicity	1	1	atenolol;metoprolol	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960204	
1447963598	HLA-DQB1*05:02:01	HLA-DQB1	3			2.5	Toxicity	1	1	flupirtine	drug-induced liver injury	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963598	
1447980691	rs3735451	CYP3A4	3		Tier 1 VIP	4.5	Toxicity	1	2	methadone	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447980691	
1447983909	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	3		Tier 1 VIP	1.5	Metabolism/PK	1	1	tolperisone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447983909	
1447983940	rs762551	CYP1A2	3			1.5	Metabolism/PK	1	1	carbamazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447983940	Pediatric
1447983949	rs77107237		3			0.0	Metabolism/PK	1	1	cotinine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447983949	
1448531661	rs17501331	ABCC1	3			1.75	Toxicity	1	1	irinotecan	Colorectal Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448531661	
1448567797	rs1057868	POR	3			1.5	Metabolism/PK	1	2	sirolimus	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448567797	
1450930440	rs508448	OPRD1	3			2.25	Other	1	1	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450930440	
1450931410	rs2074957	PIP5K1C	3			0.0	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450931410	
1447960257	rs1061170	CFH	4			-1.25	Efficacy	3	3	photodynamic therapy	Macular Degeneration	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960257	
1448567803	CYP3A4*1, CYP3A4*22	CYP3A4	4		Tier 1 VIP	-1.0	Metabolism/PK	1	2	sirolimus		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448567803	
1447963078	rs578776	CHRNA3	3			3.25	Efficacy;Toxicity	7	8	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963078	
1451810680	rs2292596	AHRR	3			0.0	Efficacy	1	1	methotrexate	Arthritis, Rheumatoid	2022-06-24	https://www.pharmgkb.org/clinicalAnnotation/1451810680	
1448098376	rs16935279		3			0.0	Metabolism/PK	1	1	antiepileptics	Psychotic Disorders;Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448098376	
1448099118	rs11045819	SLCO1B1	3		Tier 1 VIP	0.125	Metabolism/PK	1	1	rifampin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448099118	
1448102644	rs2299939	PTEN	3			2.5	Toxicity	1	1	carboplatin;cisplatin	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448102644	
1448107270	rs2523864	HCG22	3			1.25	Toxicity	1	1	triamcinolone	Retinal Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448107270	
1448107277	rs3873352	HCG22	3			2.25	Toxicity	1	1	triamcinolone	Retinal Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448107277	
1448263285	rs1042718	ADRB2	3		Tier 1 VIP	3.0	Toxicity	1	1	fentanyl;propofol;remifentanil;sevoflurane	Hypotension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448263285	
1447963604	rs12718541	DDC	3			2.5	Toxicity	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963604	
1447963644	rs265976	DRD1	3			0.25	Efficacy	1	1	clozapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963644	
1447963688	rs324420	FAAH	3			2.75	Toxicity	1	1	cannabinoids	Substance-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963688	
1447963713	rs7973796	PMCH	3			1.5	Toxicity	1	1	olanzapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963713	
1447990902	rs699947	VEGFA	3			2.75	Efficacy	1	1	enalapril	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447990902	
1448097768	rs232043	RRM1	3			3.0	Efficacy	1	1	cisplatin;gemcitabine	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448097768	
1448097775	rs720106	RRM1	3			3.0	Efficacy	1	1	cisplatin;gemcitabine	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448097775	
1448098213	rs9725457	NR1I3	3			2.5	Toxicity	1	1	docetaxel	Anemia;Nasopharyngeal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448098213	
1448605477	rs8450	CRTC2	3			5.75	Toxicity	1	2	cyclosporine;tacrolimus	Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448605477	
1448613108	HLA-DRB1*01:01:01, HLA-DRB1*04:06:01	HLA-DRB1	3			3.5	Toxicity	1	1	atorvastatin;fluvastatin;hmg coa reductase inhibitors;pravastatin;rosuvastatin;simvastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448613108	
1447963979	rs1128503	ABCB1	4		Tier 1 VIP	-6.5	Efficacy	7	7	antiepileptics	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963979	Pediatric
1447987204	rs7754840	CDKAL1	3			3.25	Efficacy	1	1	Dipeptidyl peptidase 4 (DPP-4) inhibitors	Diabetes Mellitus	2021-12-03	https://www.pharmgkb.org/clinicalAnnotation/1447987204	
1447979749	rs113993960	CFTR	1A		Rare Variant; Tier 1 VIP	123.375	Efficacy	11	16	ivacaftor / lumacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447979749	Pediatric
1447980699	rs4646440	CYP3A4	3		Tier 1 VIP	4.5	Toxicity	1	2	methadone	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447980699	
1447980706	rs4646437	CYP3A4	3		Tier 1 VIP	2.5	Toxicity	1	1	methadone	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447980706	
1447980713	rs2246709	CYP3A4	3		Tier 1 VIP	4.5	Toxicity	1	2	methadone	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447980713	
1447980724	rs16909440	OR52E2	3			2.5	Efficacy	1	1	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447980724	
1447980740	rs11869731	ASIC2	3			3.0	Efficacy	1	1	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447980740	
1447980753	rs16973410		3			2.5	Efficacy	1	1	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447980753	
1447980767	rs1800012	COL1A1	3			2.0	Dosage	1	1	somatropin recombinant		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447980767	
1447980857	UGT1A4*1a, UGT1A4*3a	UGT1A4	3			1.5	Metabolism/PK	1	1	testosterone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447980857	
1447980875	rs28371706	CYP2D6	3		Tier 1 VIP	1.5	Metabolism/PK	1	1	nevirapine	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447980875	Pediatric
1447980897	rs77010898	CFTR	3		Rare Variant; Tier 1 VIP	0.0	Efficacy	1	1	curcumin;ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447980897	
1447990296	rs4386686		3			0.0	Other	1	3	endoxifen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447990296	
1447991104	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	3		Tier 1 VIP	0.125	Metabolism/PK	1	1	brivaracetam		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447991104	
1448112052	rs6296	HTR1B	3			1.75	Toxicity	1	1	citalopram	Anxiety Disorders;Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448112052	Pediatric
1448256890	rs12621220	IL1B	3			0.0	Toxicity	1	1	Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448256890	
1448256898	rs1143623	IL1B	3			0.0	Toxicity	1	1	Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448256898	
1448276370	rs3759467		3			2.5	Efficacy	1	1	rituximab	Vasculitis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448276370	
1448428918	rs34650714	UGT1A1;UGT1A10;UGT1A3;UGT1A4;UGT1A5;UGT1A6;UGT1A7;UGT1A8;UGT1A9	3		Tier 1 VIP	2.25	Dosage	1	1	allopurinol;febuxostat	Gout	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448428918	
1447980849	UGT1A4*1a, UGT1A4*1b, UGT1A4*2	UGT1A4	3			1.25	Metabolism/PK	2	2	lamotrigine	Epilepsy	2021-04-20	https://www.pharmgkb.org/clinicalAnnotation/1447980849	
1447963821	rs2727786	APOA1	3			2.0	Efficacy	1	1	fenofibrate	Hypertriglyceridemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963821	
1447963829	rs320	LPL	3			2.0	Efficacy	1	1	fenofibrate	Hypertriglyceridemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963829	
1447964002	rs1801282	PPARG	3			1.25	Toxicity	1	1	olanzapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447964002	
1447964164	rs705379	PON1	3			1.0	Efficacy	1	1	atorvastatin	Hypercholesterolemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447964164	
1447989777	rs115632870	DPYD	3		Rare Variant; Tier 1 VIP	1.75	Other	1	1	fluorouracil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447989777	
1447989796	rs72728438	DPYD	3		Tier 1 VIP	1.25	Other	1	1	fluorouracil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447989796	
1447989803	rs2847153	TYMS	3		Tier 1 VIP	2.5	Efficacy	1	1	fluorouracil	Pancreatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447989803	
1448101213	rs2072658	CHRNB2	3			1.25	Other	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448101213	
1448258734	rs2306283	SLCO1B1	3		Tier 1 VIP	3.0	Toxicity	1	1	sorafenib	Diarrhea	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448258734	
1448259025	rs1870377	KDR	3			5.0	Toxicity	1	2	sorafenib	hand-foot syndrome;Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448259025	
1448260752	HLA-B*51:01:01	HLA-B	3		Tier 1 VIP	3.75	Toxicity	1	1	clindamycin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448260752	
1447989732	rs72549306	DPYD	1A		Rare Variant; Tier 1 VIP	100.0	Other	2	4	fluorouracil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447989732	
1447989739	rs78060119	DPYD	1A		Rare Variant; Tier 1 VIP	98.75	Toxicity	2	3	fluorouracil	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447989739	Pediatric
1447953199	rs1800544	ADRA2A	3			1.5	Efficacy	1	1	milnacipran	Depressive Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447953199	
1447953354	rs3087403	REV1	3			2.75	Efficacy	1	1	cisplatin	Osteosarcoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447953354	
1447960352	rs12118636		3			2.75	Efficacy	1	1	carboplatin;cisplatin;gemcitabine	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960352	
1447963674	rs2036657	ARRB2	3			0.0	Toxicity	1	1	methamphetamine	Substance-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963674	
1447963798	rs1801058	GRK4	3			0.5	Efficacy	1	2	metoprolol	hypertensive nephrosclerosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963798	
1448262537	rs1061781	B4GALT2	3			3.0	Efficacy	1	1	clopidogrel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448262537	
1447979561	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10, CYP2A6*11, CYP2A6*18, CYP2A6*19, CYP2A6*46	CYP2A6	3		Tier 1 VIP	6.375	Metabolism/PK	8	13	tegafur	Neoplasms	2022-09-29	https://www.pharmgkb.org/clinicalAnnotation/1447979561	
1447989784	rs56038477	DPYD	1A		Tier 1 VIP	208.5	Toxicity	8	10	fluorouracil	Neoplasms	2022-10-27	https://www.pharmgkb.org/clinicalAnnotation/1447989784	
1447989671	rs72549303	DPYD	1A		Tier 1 VIP	100.125	Other	3	4	fluorouracil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447989671	
1447989678	rs72549309	DPYD	1A		Rare Variant; Tier 1 VIP	100.125	Other	2	3	fluorouracil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447989678	
1447989706	rs1801266	DPYD	1A		Rare Variant; Tier 1 VIP	100.125	Other	3	5	fluorouracil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447989706	
1447989723	rs1801268	DPYD	1A		Rare Variant; Tier 1 VIP	100.125	Other	2	3	fluorouracil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447989723	
1451829900	rs7662029	UGT2B7	3			2.0	Metabolism/PK	1	1	buprenorphine / naloxone	Opioid-Related Disorders	2022-07-21	https://www.pharmgkb.org/clinicalAnnotation/1451829900	
1451832220	rs7439366	UGT2B7	3			0.0	Metabolism/PK	1	1	buprenorphine / naloxone	Opioid-Related Disorders	2022-07-25	https://www.pharmgkb.org/clinicalAnnotation/1451832220	
1447960245	rs1060896	SLC28A2	3			2.5	Efficacy;Toxicity	2	3	gemcitabine	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960245	
1447963227	rs2283265	DRD2	3		Tier 1 VIP	4.5	Toxicity	2	3	cocaine	Cocaine-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963227	
1447963432	rs699	AGT	3			2.5	Efficacy	1	1	Ace Inhibitors, Plain	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963432	
1447964123	rs4646244	NAT2	3		Tier 1 VIP	4.75	Toxicity;Metabolism/PK	1	3	ethambutol;isoniazid;pyrazinamide;rifampin	Tuberculosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447964123	
1447964264	rs6813183	ADGRL3	3			2.5	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447964264	Pediatric
1448256091	rs10948059	GNMT	3			5.5	Toxicity	1	2	mercaptopurine	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448256091	Pediatric
1448266177	rs4273729		3			4.0	Efficacy	3	3	peginterferon alfa-2a;peginterferon alfa-2b;ribavirin	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448266177	
1448423763	rs5993883	COMT	3		Tier 1 VIP	3.0	Efficacy	1	1	quetiapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448423763	
1448423788	rs6269	COMT	3		Tier 1 VIP	3.0	Efficacy	1	1	quetiapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448423788	
1448424039	rs17268282	ABCC4	3			1.375	Efficacy	1	1	furosemide	Heart Failure	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448424039	
1448431545	rs887829	UGT1A1	3		Tier 1 VIP	1.0	Dosage	3	3	warfarin	heart valve replacement	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448431545	Pediatric
1447953029	rs193922770	RYR1	1A		Rare Variant; Tier 1 VIP	101.0	Toxicity	7	8	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447953029	
1447990050	rs1803274	BCHE	3			6.5	Efficacy	4	6	rivastigmine	Alzheimer Disease;Lewy Body Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447990050	
1448097405	rs717620	ABCC2	3			2.25	Efficacy	1	1	tamoxifen	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448097405	
1448097600	rs3806596	UGT1A3	3			3.5	Toxicity	1	1	atazanavir;ritonavir	HIV Infections;Hyperbilirubinemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448097600	
1448099125	rs2306283	SLCO1B1	3		Tier 1 VIP	0.125	Metabolism/PK	1	1	rifampin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448099125	
1448256689	rs8192675	SLC2A2	3			0.0	Efficacy	1	1	metformin	Diabetes Mellitus	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448256689	
1448266663	rs247616		3			0.0	Efficacy	1	1	hmg coa reductase inhibitors		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448266663	
1448266838	rs15524	CYP3A5	3		Tier 1 VIP	1.0	Metabolism/PK	1	2	carbamazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448266838	
1448526040	rs10485058	OPRM1	3			1.5	Efficacy	2	2	methadone	Opioid-Related Disorders	2022-02-11	https://www.pharmgkb.org/clinicalAnnotation/1448526040	
1447963063	rs73748206	FKBP5	3			0.0	Other	1	2	gemcitabine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963063	
1447964091	rs2740574	CYP3A4	3		Tier 1 VIP	2.5	Dosage	1	1	atorvastatin;simvastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447964091	
1447980968	rs594709	SLC22A1	3			1.25	Efficacy	1	1	metformin	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447980968	
1447983057	rs4752219	EIF3A	3			2.75	Toxicity	1	1	Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447983057	
1447983064	rs4752220	EIF3A	3			2.75	Toxicity	1	1	Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447983064	
1447983818	rs1045642	ABCB1	3		Tier 1 VIP	2.5	Dosage	1	1	antipsychotics	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447983818	
1448098947	rs4148386	ABCC2	3			1.0	Metabolism/PK	1	1	carbamazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448098947	
1448262901	rs2108622	CYP4F2	3		Tier 1 VIP	2.5	Efficacy	1	1	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448262901	
1448262908	rs11676382	GGCX	3			3.0	Efficacy	1	1	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448262908	
1447960179	rs1042713	ADRB2	3		Tier 1 VIP	1.5	Efficacy	1	1	Ace Inhibitors, Plain;Angiotensin II Antagonists;Beta Blocking Agents;digoxin;diuretics;spironolactone	Heart Failure	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960179	
1447960218	rs1045642	ABCB1	3		Tier 1 VIP	1.0	Metabolism/PK	1	1	voriconazole		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960218	
1447960225	rs1048101	ADRA1A	3			2.75	Efficacy	1	1	nifedipine	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960225	
1447960387	rs17661089		3			3.5	Efficacy	1	1	carboplatin;cisplatin;docetaxel;paclitaxel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960387	
1447960403	rs451774	GPX5	3			2.75	Efficacy	1	1	carboplatin;cisplatin;gemcitabine	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960403	
1447960599	rs5186	AGTR1	3			2.0	Efficacy	1	1	nitrendipine	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960599	
1447960795	rs2562519	POLR3G	3			3.25	Toxicity	1	1	nevirapine	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960795	
1447960803	rs6545803		3			3.25	Toxicity	1	1	nevirapine	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960803	
1447961322	rs778293	DAOA	3			2.75	Toxicity	1	1	methamphetamine	Psychotic Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447961322	
1448432217	rs2228014	CXCR4	3			3.0	Efficacy	1	1	bevacizumab	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448432217	
1449191564	rs397508139	CFTR	3		Rare Variant; Tier 1 VIP	0.0	Efficacy	1	1	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191564	
1449191574	rs77409459	CFTR	3		Rare Variant; Tier 1 VIP	0.0	Efficacy	1	1	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191574	
1449191643	rs121908753	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191643	
1449191649	rs74551128	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191649	
1449191664	rs397508288	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191664	
1449191682	rs397508442	CFTR	1A		Rare Variant; Tier 1 VIP	200.25	Efficacy	2	4	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191682	
1447961371	rs8187725	SLC22A3	3		Rare Variant	1.5	Metabolism/PK	1	1	catecholamines;metformin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447961371	
1447961389	rs2056527		3			6.0	Efficacy	1	2	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447961389	
1447963004	rs2032582	ABCB1	3		Tier 1 VIP	1.0	Metabolism/PK	1	1	cyclosporine;dicloxacillin	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963004	
1447963049	rs1805094	LEPR	3			1.25	Efficacy	1	1	atorvastatin	Acute coronary syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963049	
1447963442	rs2290573	ULK3	3			2.5	Efficacy	1	1	imatinib	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963442	
1449191708	rs150212784	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191708	
1449191722	rs397508513	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191722	
1447963458	rs2240017	TBX21	3			2.5	Efficacy	1	1	corticosteroids	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963458	Pediatric
1447963681	rs4790694	ARRB2	3			1.5	Toxicity	1	1	methamphetamine	Substance-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963681	
1447964010	rs36118214	CYP2B6	3		Tier 1 VIP	1.5	Metabolism/PK	1	1	efavirenz	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447964010	
1447964025	rs1045642	ABCB1	3		Tier 1 VIP	0.75	Toxicity	3	3	Drugs For Treatment Of Tuberculosis;isoniazid	Tuberculosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447964025	
1449191734	rs121909020	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191734	
1447982712	rs777560972	CYP2D6	3		Rare Variant; Tier 1 VIP	0.0	Metabolism/PK	1	1	bufuralol;dextromethorphan		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447982712	
1449191670	rs1800100	CFTR	3		Rare Variant; Tier 1 VIP	0.0	Efficacy	1	1	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191670	
1449191676	rs397508435	CFTR	3		Rare Variant; Tier 1 VIP	0.0	Efficacy	1	1	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191676	
1449191698	rs1800111	CFTR	3		Rare Variant; Tier 1 VIP	0.0	Efficacy	1	1	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191698	
1449191752	rs186045772	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191752	
1449191716	rs397508510	CFTR	3		Rare Variant; Tier 1 VIP	0.0	Efficacy	1	1	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191716	
1449191728	rs121909019	CFTR	3		Rare Variant; Tier 1 VIP	0.0	Efficacy	1	1	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191728	
1447990192	rs2571598	ACHE	3			1.75	Efficacy	1	1	rivastigmine	Alzheimer Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447990192	
1447990224	rs12806698	RRM1	3			0.75	Efficacy	4	4	gemcitabine;Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447990224	
1448101220	rs2229959	CHRNA4	3			0.25	Other	2	2	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448101220	
1448101260	rs3743078	CHRNA3	3			2.0	Toxicity	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448101260	
1448103818	rs10494366	NOS1AP	3			0.0	Toxicity	1	1	Dihydropyridine derivatives		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448103818	
1448256718	rs3025040	VEGFA	3			2.25	Toxicity	1	1	sorafenib	Carcinoma, Hepatocellular;hand-foot syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448256718	
1448256734	rs17180299		3			0.0	Metabolism/PK	1	1	methadone	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448256734	
1448264356	HLA-DRB1*04:03:01	HLA-DRB1	3			3.5	Toxicity	1	1	oxcarbazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448264356	
1448422839	rs1800469	TGFB1	3			2.5	Toxicity	1	1	irinotecan	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448422839	
1448422846	rs3087465	TGFBR2	3			2.5	Toxicity	1	1	irinotecan	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448422846	
1448109612	rs2235047	ABCB1	4		Tier 1 VIP	-1.25	Toxicity	2	2	anthracyclines and related substances	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448109612	Pediatric
1447949639	rs2239179	VDR	3			3.0	Efficacy	1	1	selective beta-2-adrenoreceptor agonists	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447949639	
1451810960	CYP2C9*1, CYP2C9*3	CYP2C9	3		Tier 1 VIP	0.0	Toxicity	1	1	phenytoin	Stevens-Johnson Syndrome	2022-06-24	https://www.pharmgkb.org/clinicalAnnotation/1451810960	
1447963182	rs11568482	SLC22A8	3		Rare Variant	1.5	Metabolism/PK	1	2	cefotaxime		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963182	
1447963701	rs2740574	CYP3A4	3		Tier 1 VIP	2.0	Toxicity	1	1	tamoxifen	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963701	
1447983217	rs199695765	CPA2	3		Rare Variant	3.0	Toxicity	1	1	asparaginase	Pancreatitis;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447983217	
1448262915	rs699664	GGCX	3			2.0	Efficacy	1	1	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448262915	
1448423436	rs12436663	PRORP	3			2.5	Efficacy	1	1	zileuton	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448423436	
1448427972	rs1439050	NTRK2	3			2.75	Toxicity	1	1	antidepressants	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448427972	
1448428108	rs1334802	GRIK3	3			3.0	Toxicity	1	1	antipsychotics	Psychotic Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448428108	
1448428117	rs363341	SLC18A2	3			3.0	Toxicity	1	1	antipsychotics	Psychotic Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448428117	
1448428124	rs1124491	DRD2	3		Tier 1 VIP	3.0	Toxicity	1	1	antipsychotics	Psychotic Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448428124	
1448428151	rs9567733	HTR2A	3			3.0	Toxicity	1	1	antipsychotics	Psychotic Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448428151	
1448428239	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	3		Tier 1 VIP	1.5	Dosage;Metabolism/PK	1	2	valproic acid	Bipolar Disorder;Psychotic Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448428239	
1448531639	rs12720066	ABCB1	3		Tier 1 VIP	1.75	Toxicity	1	1	irinotecan	Colorectal Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448531639	
1448531652	rs6498588	ABCC1	3			1.75	Metabolism/PK	1	1	SN-38	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448531652	
1448531802	rs3743527	ABCC1	3			1.75	Toxicity	1	1	irinotecan	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448531802	
1447960443	rs1801253	ADRB1	3		Tier 1 VIP	1.0	Efficacy	1	1	Ace Inhibitors, Plain;Angiotensin II Antagonists;Beta Blocking Agents;digoxin;diuretics;spironolactone	Heart Failure	2021-06-29	https://www.pharmgkb.org/clinicalAnnotation/1447960443	
1451666140	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	3		Tier 1 VIP	0.0	Toxicity	1	1	nicotine	Tobacco Use Disorder	2022-09-29	https://www.pharmgkb.org/clinicalAnnotation/1451666140	
1447952004	rs2199939	ABCG2	3		Tier 1 VIP	0.0	Efficacy	1	1	rosuvastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447952004	
1447959745	rs10760397	GAPVD1	3			2.5	Efficacy	1	1	interferon beta-1a;interferon beta-1b	Multiple Sclerosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447959745	
1447959752	rs3133084		3			2.5	Efficacy	1	1	interferon beta-1a;interferon beta-1b	Multiple Sclerosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447959752	
1447962730	rs4341	ACE	3		Tier 1 VIP	2.75	Efficacy	1	1	pravastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447962730	
1448097455	rs10934498	NR1I2	3			2.5	Metabolism/PK	1	1	irinotecan	Colonic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448097455	
1448098299	rs75114882	NR1I3	3			1.5	Toxicity	1	1	docetaxel	Nasopharyngeal Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448098299	
1448102324	rs187238	IL18	3			2.5	Efficacy	1	1	interferons;ribavirin	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448102324	
1448102337	rs1946518	IL18	3			2.5	Efficacy	1	1	interferons;ribavirin	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448102337	
1448102346	rs1805128	KCNE1	3		Rare Variant	3.25	Toxicity	1	1	amiodarone;Antibiotics;antipsychotics;diuretics;quinidine;sotalol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448102346	
1448102407	rs6280	DRD3	3			1.75	Toxicity	1	1	methamphetamine	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448102407	
1448102422	rs1799752	ACE	3		Tier 1 VIP	3.5	Efficacy	1	1	fluoxetine;sertraline	Depressive Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448102422	
1448265266	rs3213094	IL12B	3			1.75	Efficacy	1	1	ustekinumab	Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448265266	
1448265280	rs610604	TNFAIP3	4			-1.25	Efficacy	2	2	ustekinumab	Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448265280	
1448104059	rs5569	SLC6A2	4			-0.75	Efficacy	11	12	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448104059	Pediatric
1448102439	rs11881222	IFNL3	2A			11.5	Efficacy	4	4	peginterferon alfa-2a;peginterferon alfa-2b;ribavirin	Hepatitis C;HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448102439	
1451834440	rs1045642	ABCB1	3		Tier 1 VIP	3.0	Toxicity	1	1	tramadol	Opioid-Related Disorders	2022-07-28	https://www.pharmgkb.org/clinicalAnnotation/1451834440	
1448423855	rs121909011	CFTR	3		Rare Variant; Tier 1 VIP	1.5	Efficacy	2	2	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448423855	
1448531857	rs12566888	PEAR1	3			2.0	Efficacy	1	1	ticagrelor		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448531857	
1448531862	rs12041331	PEAR1	3			3.0	Efficacy	1	2	ticagrelor		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448531862	
1448531868	rs4661012	PEAR1	3			1.5	Efficacy	1	1	ticagrelor		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448531868	
1448616179	TPMT*1, TPMT*3A	TPMT	3		Tier 1 VIP	0.0	Toxicity	1	3	cisplatin	Ototoxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448616179	
1448616865	rs12119882	DPYD	3		Tier 1 VIP	2.75	Toxicity	1	1	capecitabine	Hyperbilirubinemia;Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448616865	
1447953291	rs3957356	GSTA1	3			2.25	Efficacy	1	1	cyclophosphamide	Lupus Nephritis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447953291	
1447953304	rs6295	HTR1A	3			4.5	Efficacy	2	2	milnacipran	Depressive Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447953304	
1447960327	rs11710163	RAF1	3			3.5	Efficacy	1	1	carboplatin;cisplatin;docetaxel;gemcitabine;paclitaxel	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960327	
1447960335	rs11854484	SLC28A2	3			2.25	Efficacy	1	1	gemcitabine	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960335	
1447960371	rs16886403	MAP3K1	3			3.0	Efficacy	1	1	carboplatin;cisplatin;docetaxel;paclitaxel	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960371	
1447960379	rs17309872	ACSS2	3			3.0	Efficacy	1	1	carboplatin;cisplatin;docetaxel;gemcitabine;paclitaxel	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960379	
1447964346	rs2960436		3			3.0	Efficacy	1	1	fluorouracil	Stomach Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447964346	
1447984146	rs2032582	ABCB1	3		Tier 1 VIP	2.5	Dosage	1	1	antipsychotics	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447984146	
1447990143	rs1057910	CYP2C9	3		Tier 1 VIP	6.0	Efficacy;Metabolism/PK	2	5	irbesartan	Essential hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447990143	
1447990283	rs639174	DROSHA	3			2.5	Toxicity	1	1	cyclophosphamide;cytarabine;daunorubicin;mercaptopurine;methotrexate;prednisone;vincristine	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447990283	Pediatric
1448097681	rs3093105	CYP4F2	3		Tier 1 VIP	0.0	Metabolism/PK	1	1	vitamin e		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448097681	
1448097711	rs4492666	CMPK1	3			2.5	Efficacy	1	1	cisplatin;gemcitabine	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448097711	
1448097718	rs2284449	RRM1	3			3.0	Efficacy	1	1	cisplatin;gemcitabine	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448097718	
1448100861	rs2413739	PACSIN2	3			2.0	Toxicity	1	2	mercaptopurine;methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100861	Pediatric
1448100874	rs324650	CHRM2	3			2.5	Other	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100874	
1448100887	rs10994982	ARID5B	3			1.0	Metabolism/PK	1	1	methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100887	Pediatric
1448102273	CYP2D6*1, CYP2D6*10	CYP2D6	3		Tier 1 VIP	3.0	Metabolism/PK	1	5	berberine;coptisine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448102273	
1448616900	rs4149178	SLC22A7	3			2.75	Toxicity	1	1	capecitabine	Diarrhea;Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448616900	
1450932374	rs1801131	MTHFR	3		Tier 1 VIP	3.5	Toxicity	11	13	capecitabine;fluorouracil;leucovorin;oxaliplatin	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450932374	
1448423861	rs77932196	CFTR	1A		Rare Variant; Tier 1 VIP	201.25	Efficacy	3	6	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448423861	
1448104189	CYP2B6*1, CYP2B6*4, CYP2B6*6, CYP2B6*18	CYP2B6	2A		Tier 1 VIP	13.625	Metabolism/PK	9	12	methadone	Heroin Dependence;Opioid-Related Disorders	2021-05-18	https://www.pharmgkb.org/clinicalAnnotation/1448104189	
1451868500	rs3740563	GRK5	3			4.0	Efficacy	1	1	Beta Blocking Agents	Coronary Artery Disease	2022-08-24	https://www.pharmgkb.org/clinicalAnnotation/1451868500	
1447953102	rs10514475		3			3.0	Efficacy	1	1	Selective serotonin reuptake inhibitors	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447953102	
1447960191	rs1042714	ADRB2	3		Tier 1 VIP	0.5	Efficacy	1	1	terbutaline		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960191	
1447961166	rs2293347	EGFR	3			4.5	Efficacy	1	2	gefitinib	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447961166	
1447961329	rs881152	DUSP1	3			0.75	Efficacy	1	3	salbutamol	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447961329	
1447964292	rs734644	ADGRL3	3			2.5	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447964292	Pediatric
1447983071	rs1409314	EIF3A	3			3.25	Toxicity	1	1	Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447983071	
1447983078	rs10510050	EIF3A	3			3.25	Toxicity	1	1	Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447983078	
1448100229	rs1433099	LDLR	3			0.0	Efficacy	1	1	pravastatin	Vascular Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100229	
1448102633	rs2699887	PIK3CA	3			2.5	Toxicity	1	1	carboplatin;cisplatin	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448102633	
1448125537	rs2071559	KDR	3			5.75	Efficacy	3	4	sorafenib	Carcinoma, Hepatocellular;Carcinoma, Renal Cell	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448125537	
1448262922	rs11676382	GGCX	3			3.0	Efficacy	1	1	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448262922	
1448525395	rs4819554	IL17RA	3			3.0	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448525395	
1448615167	rs1008805	CYP19A1	3			2.5	Toxicity	1	1	anastrozole	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448615167	
1448109558	rs17645700		4			-1.25	Toxicity	2	2	anthracyclines and related substances	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448109558	Pediatric
1448109783	rs4148350	ABCC1	4			-1.75	Toxicity	2	2	anthracyclines and related substances	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448109783	Pediatric
1451666355	rs72549435	CYP2A6	3		Rare Variant; Tier 1 VIP	0.0	Metabolism/PK	1	1	nicotine		2022-02-01	https://www.pharmgkb.org/clinicalAnnotation/1451666355	
1451815200	CYP2C9*1, CYP2C9*2	CYP2C9	3		Tier 1 VIP	1.75	Toxicity	1	1	ketoprofen	Dyspepsia;Pain, Postoperative	2022-06-30	https://www.pharmgkb.org/clinicalAnnotation/1451815200	
1451868400	rs10787959	GRK5	3			3.5	Efficacy	1	1	Beta Blocking Agents	Coronary Artery Disease	2022-08-24	https://www.pharmgkb.org/clinicalAnnotation/1451868400	
1447961129	rs10511905		3			0.0	Efficacy	1	1	salbutamol	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447961129	
1447961136	rs1663330		3			0.0	Efficacy	1	1	salbutamol	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447961136	
1447961144	rs1663332		3			0.0	Efficacy	1	1	salbutamol	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447961144	
1448100630	rs6277	DRD2	4		Tier 1 VIP	-1.25	Efficacy	2	2	methadone	Substance-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100630	
1447961151	rs518350		3			0.0	Efficacy	1	1	salbutamol	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447961151	
1447961158	rs6002674		3			0.0	Efficacy	1	1	salbutamol	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447961158	
1447962744	rs5925	LDLR	3			2.75	Efficacy	1	1	lovastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447962744	
1447963611	rs351855	FGFR4	3			1.75	Efficacy	1	1	cyclophosphamide;fluorouracil;methotrexate	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963611	
1447981346	rs61886492	FOLH1	3			1.25	Toxicity	1	1	mercaptopurine;methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447981346	Pediatric
1447987211	rs7756992	CDKAL1	3			3.25	Efficacy	1	1	Dipeptidyl peptidase 4 (DPP-4) inhibitors	Diabetes Mellitus	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447987211	
1447987227	rs11580409	ERICH3	3			2.5	Efficacy	1	1	citalopram;escitalopram	Depressive Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447987227	
1447990925	rs885036	MGAT4A	3			2.25	Efficacy	1	1	bevacizumab;capecitabine;cetuximab;oxaliplatin	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447990925	
1448097805	rs3832043	UGT1A9	3			1.5	Metabolism/PK	1	1	mycophenolic acid	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448097805	
1448097837	rs1803274	BCHE	3			2.0	Other	1	1	cocaine	Cocaine-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448097837	
1448100644	rs1804645	NCOA1	3			1.0	Toxicity	1	5	tamoxifen	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100644	
1448100661	rs10509373	LRMDA	3			3.75	Efficacy	1	1	tamoxifen	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100661	
1448100687	rs2717162	GALR1	3			5.75	Efficacy	1	2	bupropion	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100687	
1448100695	rs2717162	GALR1	3			1.5	Efficacy	2	3	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100695	
1448100751	rs2269879	DOT1L	3			1.0	Efficacy	1	2	hydrochlorothiazide	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100751	
1448100777	rs1544410	VDR	3			4.25	Metabolism/PK	1	4	midazolam		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100777	
1448100786	rs4516035	VDR	3			3.25	Metabolism/PK	1	3	midazolam		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100786	
1448100804	rs11568820	VDR	3			1.25	Metabolism/PK	1	2	midazolam		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100804	
1451646580	rs5326	DRD1	3			3.0	Dosage	1	1	methadone	Heroin Dependence	2022-01-12	https://www.pharmgkb.org/clinicalAnnotation/1451646580	
1451868520	rs11198893	GRK5	3			4.0	Efficacy	1	1	Beta Blocking Agents	Coronary Artery Disease	2022-08-24	https://www.pharmgkb.org/clinicalAnnotation/1451868520	
1451868540	rs4752292	GRK5	3			3.5	Efficacy	1	1	Beta Blocking Agents	Coronary Artery Disease	2022-08-24	https://www.pharmgkb.org/clinicalAnnotation/1451868540	
1448265557	rs7958375	CUX2	3			0.0	Toxicity	1	1	rifampin	Tuberculosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448265557	
1448265565	rs10946739	RIPOR2	3			0.0	Toxicity	1	1	rifampin	Tuberculosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448265565	
1448265573	rs10946737	RIPOR2	3			2.25	Toxicity	2	2	Drugs For Treatment Of Tuberculosis;rifampin	Tuberculosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448265573	
1448265581	rs320003	AGBL4	3			0.0	Toxicity	1	1	rifampin	Tuberculosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448265581	
1448265598	rs319952	AGBL4	3			0.0	Toxicity	1	1	rifampin	Tuberculosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448265598	
1448427559	rs1045642	ABCB1	3		Tier 1 VIP	4.5	Toxicity	2	2	clozapine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448427559	
1448427566	GSTM1 non-null, GSTM1 null	GSTM1	3			2.75	Toxicity	1	1	clozapine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448427566	
1448427588	GSTT1 non-null, GSTT1 null	GSTT1	3			2.75	Toxicity	1	1	clozapine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448427588	
1448532190	rs1045642	ABCB1	3		Tier 1 VIP	0.0	Metabolism/PK	1	1	dabigatran		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448532190	
1448613357	rs41273215	PEAR1	3			2.25	Efficacy	1	1	clopidogrel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448613357	
1448616690	HLA-C*06:02:01:01	HLA-C	3			3.0	Efficacy	1	1	methotrexate	Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448616690	
1448635176	rs766023281	NUDT15	3		Rare Variant; Tier 1 VIP	0.25	Dosage;Toxicity	1	1	mercaptopurine	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448635176	Pediatric
1445401427	rs11854484	SLC28A2	3			2.5	Toxicity	1	1	peginterferon alfa-2b;protease inhibitors;ribavirin	Hepatitis C	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401427	
1447953284	rs462779	REV3L	3			2.25	Efficacy	1	1	cisplatin	Osteosarcoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447953284	
1447962613	rs340874	PROX1	3			2.0	Toxicity	1	1	atenolol	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447962613	
1447962862	rs113646094	ABCC2	3			1.0	Metabolism/PK	1	2	pravastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447962862	
1447963853	rs5186	AGTR1	3			2.5	Toxicity	1	1	Thiazides, plain		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963853	
1447979272	rs2234693	ESR1	3			2.0	Efficacy	1	1	leflunomide	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447979272	
1447979279	rs6962291	TBXAS1	3			1.75	Toxicity	1	3	aspirin	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447979279	
1447980677	rs1799978	DRD2	3		Tier 1 VIP	3.25	Dosage	1	1	methadone	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447980677	
1447981282	rs7439366	UGT2B7	3			3.25	Efficacy;Toxicity	1	1	methadone	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447981282	
1447981372	rs4655226	CDA	3			1.0	Metabolism/PK	1	1	difluorodeoxyuridine	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447981372	
1447981385	rs3750117	NT5C3A	3			1.0	Metabolism/PK	1	1	gemcitabine	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447981385	
1447990324	rs784888	SP1	3			2.5	Efficacy;Metabolism/PK	2	3	metformin	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447990324	
1448097693	rs895819	MIR27A	3			3.5	Toxicity	4	5	capecitabine;fluorouracil	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448097693	
1450821121	rs1126742	CYP4A11	3			2.25	Efficacy	1	1	amiloride;spironolactone	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450821121	
1447987018	rs28365062	UGT2B7	4			-3.25	Metabolism/PK	6	6	efavirenz	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447987018	
1448109565	rs4261716	UGT1A6	4			-1.25	Toxicity	2	2	anthracyclines and related substances	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448109565	Pediatric
1447981275	rs7668258	UGT2B7	3			3.25	Efficacy	1	1	methadone	Opioid-Related Disorders	2021-11-03	https://www.pharmgkb.org/clinicalAnnotation/1447981275	
1448102294	rs3957357	GSTA1	3			1.0	Efficacy	2	2	cyclophosphamide;doxorubicin;prednisone;rituximab;vincristine	Lymphoma, Large B-Cell, Diffuse	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448102294	
1448102368	rs671	ALDH2	3		Rare Variant	2.0	Other	1	1	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448102368	
1448259308	rs11543791	ESR1	3		Rare Variant	1.75	Efficacy	1	1	raloxifene	Menopause;Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448259308	
1448531674	rs35621	ABCC1	3			1.25	Metabolism/PK	1	1	SN-38	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448531674	
1448568152	rs10995	VASP	3			0.0	Efficacy	1	1	hydrochlorothiazide	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448568152	
1448109707	rs4877847	SLC28A3	4			-1.25	Toxicity	2	2	anthracyclines and related substances	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448109707	Pediatric
1448263578	rs628031	SLC22A1	3			1.25	Metabolism/PK	2	2	lamotrigine	Epilepsy	2021-04-20	https://www.pharmgkb.org/clinicalAnnotation/1448263578	
1448102550	rs2228570	VDR	3			6.0	Efficacy	2	2	peginterferon alfa-2b;ribavirin	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448102550	
1447960458	rs1805054		3			2.0	Toxicity	1	1	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960458	
1447990940	rs696692	ERICH3	3			0.0	Efficacy	1	1	citalopram;escitalopram	Depressive Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447990940	
1448616678	rs3761548	FOXP3	3			2.5	Efficacy	1	1	methotrexate	Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448616678	
1449144364	rs1611255		3			0.0	Efficacy	1	1	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449144364	
1451666660	rs2231142	ABCG2	1A		Tier 1 VIP	115.625	Metabolism/PK	11	12	rosuvastatin		2022-02-14	https://www.pharmgkb.org/clinicalAnnotation/1451666660	
1448100955	rs8192935	CES1	3			1.25	Metabolism/PK	1	1	dabigatran	Atrial Fibrillation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100955	
1448101044	rs4958381	GRIA1	3			1.75	Toxicity	1	1	asparaginase	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448101044	
1447960411	rs1799808	PROC	3			1.75	Dosage	1	1	phenprocoumon		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960411	
1447960633	rs5186	AGTR1	3			1.75	Efficacy	1	1	angiotensin II		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960633	
1447961057	rs1044457	CMPK1	3			2.5	Efficacy	3	3	gemcitabine	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447961057	
1447962674	rs35350960	UGT1A9	3		Rare Variant	0.0	Metabolism/PK	1	1	SN-38		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447962674	
1447981296	rs6600893	UGT2B7	3			3.5	Efficacy;Toxicity	1	1	methadone	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447981296	
1447981313	rs4148157	ABCG2	3		Tier 1 VIP	1.75	Metabolism/PK	1	1	topotecan	Brain Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447981313	Pediatric
1447982768	rs7311358	SLCO1B3	3			2.5	Toxicity	1	2	carboplatin;paclitaxel	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447982768	
1447990044	rs1799853	CYP2C9	3		Tier 1 VIP	1.5	Efficacy	1	1	irbesartan		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447990044	
1448100437	rs510432	ATG5	3			2.25	Efficacy	1	1	adalimumab	Inflammatory Bowel Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100437	
1448100444	rs1076560	DRD2	3		Tier 1 VIP	0.0	Efficacy	1	1	rasagiline	Parkinson Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100444	
1448100451	rs10945919		3			2.75	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100451	
1448100464	rs2283265	DRD2	3		Tier 1 VIP	2.5	Efficacy	1	1	rasagiline	Parkinson Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100464	
1448100471	rs2585428	CYP24A1	3			2.0	Metabolism/PK	1	1	telaprevir	Hepatitis C	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100471	
1448100508	rs6923761	GLP1R	3			2.0	Efficacy	1	1	sitagliptin;vildagliptin	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100508	
1448100514	rs2514036	ACY3	3			0.0	Efficacy	1	1	bisoprolol	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100514	
1448100552	rs9282564	ABCB1	3		Tier 1 VIP	0.75	Metabolism/PK	3	3	tacrolimus	Kidney Transplantation;lung transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100552	
1448100567	rs3740066	ABCC2	3			0.625	Metabolism/PK	3	3	mycophenolic acid	Organ Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100567	
1448100942	rs4148738	ABCB1	3		Tier 1 VIP	0.0	Metabolism/PK	1	1	dabigatran	Atrial Fibrillation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100942	
1448101059	rs557881	SLC6A12	3			2.5	Toxicity	1	1	aspirin	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448101059	
1448101073	rs2228075	IMPDH1	3			2.25	Toxicity	1	1	mycophenolate mofetil	Organ Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448101073	Pediatric
1448101086	rs622342	SLC22A1	3			3.5	Dosage;Toxicity	1	2	amantadine;Anticholinergics;Dopamine agonists;levodopa;selegiline	Parkinson Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448101086	
1448101102	rs12042763	PTGS2	3			2.5	Efficacy	1	1	aspirin	Prostatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448101102	
1448100501	rs2071197	HNF4A	4			-0.5	Efficacy;Metabolism/PK	2	3	lamotrigine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100501	
1448101114	rs676210	APOB	3			2.5	Efficacy	1	1	fenofibrate	Hypertriglyceridemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448101114	
1448101149	rs16969968	CHRNA5	3			2.75	Toxicity	1	1	Opium alkaloids and derivatives	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448101149	
1448101163	rs660652	CHRNA5	3			2.25	Toxicity	1	1	nicotine;Opium alkaloids and derivatives	Pain;Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448101163	
1448101175	rs2072660	CHRNB2	3			1.75	Toxicity	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448101175	
1448101202	rs760370	SLC29A1	3			2.0	Efficacy	1	1	peginterferon alfa-2a;peginterferon alfa-2b;ribavirin	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448101202	
1448101252	rs3813567	CHRNB4	3			2.0	Toxicity	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448101252	
1448102446	rs4803219	IFNL3	3			5.5	Efficacy	2	2	peginterferon alfa-2a;peginterferon alfa-2b;ribavirin	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448102446	
1448104353	rs2010963	VEGFA	3			1.75	Efficacy	1	1	capecitabine;oxaliplatin	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448104353	
1448266599	rs2302489	KLRD1	3			2.75	Efficacy	1	1	adalimumab;certolizumab pegol;etanercept;glucocorticoids;infliximab;methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448266599	
1448266609	rs7301582	KLRC1	3			2.25	Efficacy	1	1	adalimumab;certolizumab pegol;etanercept;glucocorticoids;infliximab;methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448266609	
1450826553	rs28363170	SLC6A3	3			2.0	Other	1	1	ethanol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450826553	
1448100487	rs2231142	ABCG2	3		Tier 1 VIP	3.75	Metabolism/PK	4	5	lamotrigine	Epilepsy	2021-04-20	https://www.pharmgkb.org/clinicalAnnotation/1448100487	
1448100494	rs3114020	ABCG2	3		Tier 1 VIP	1.25	Metabolism/PK	2	2	lamotrigine	Epilepsy	2021-04-20	https://www.pharmgkb.org/clinicalAnnotation/1448100494	
1448101182	rs2072661	CHRNB2	3			3.0	Efficacy;Toxicity	4	5	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448101182	
1449164133	rs11168292	VDR	3			3.0	Dosage	1	1	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449164133	
1449164149	rs11168293	VDR	3			3.0	Dosage	1	1	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449164149	
1449164155	rs4760658	VDR	3			3.0	Dosage	1	1	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449164155	
1448525559	rs1021737	CTH	3			3.0	Toxicity	1	1	busulfan;cyclophosphamide	hemopoietic stem cell transplant	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448525559	Pediatric
1448612662	rs2741049	UGT1A10;UGT1A7;UGT1A8;UGT1A9	3			2.0	Efficacy	1	1	oxcarbazepine	Epilepsy;Seizures	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448612662	
1448612682	rs308395	FGF2	3			2.0	Efficacy	1	1	lenalidomide;thalidomide	Multiple Myeloma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448612682	
1448613243	rs4553808	CTLA4	3			4.0	Metabolism/PK	1	2	tacrolimus	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448613243	
1448614963	rs3834939	SLCO1A2	3			2.0	Metabolism/PK	1	1	rocuronium		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448614963	
1448615614	rs10774053	CACNA1C	3			1.5	Toxicity	1	1	ritodrine	adverse events;Premature Birth	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448615614	
1448617757	rs2740574	CYP3A;CYP3A4	3		Tier 1 VIP	0.375	Metabolism/PK	1	1	atazanavir		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448617757	
1448633935	rs1060467	CYP4F11	3			2.25	Dosage	1	1	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448633935	
1448634752	rs2273697	ABCC2	3			3.875	Metabolism/PK	4	5	cyclosporine;mycophenolic acid	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448634752	
1449164121	rs2645400	GATA4	3			0.0	Dosage	2	2	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449164121	
1449164127	rs4841588	GATA4	3			0.0	Dosage	2	2	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449164127	
1450374089	rs1042028	SULT1A1	3			1.75	Efficacy	1	1	acetaminophen	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450374089	
1447960238	rs1051740	EPHX1	3			5.25	Efficacy	2	3	phenprocoumon		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960238	
1447960930	rs1799732	DRD2	3		Tier 1 VIP	3.0	Efficacy	1	1	bupropion	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960930	
1447960937	rs1799732	DRD2	3		Tier 1 VIP	3.25	Efficacy	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960937	
1447963057	rs2853826		3			2.0	Toxicity	1	1	efavirenz;lopinavir;Nucleoside and nucleotide reverse transcriptase inhibitors;ritonavir	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447963057	
1447990235	rs72558187	CYP2C9	3		Rare Variant; Tier 1 VIP	4.5	Metabolism/PK	1	3	irbesartan		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447990235	
1447990245	rs118204423	RYR1	3		Rare Variant; Tier 1 VIP	0.25	Toxicity	1	2	succinylcholine;volatile anesthetics	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447990245	
1448097556	rs7586110	UGT1A7	3			3.5	Toxicity	1	1	atazanavir;ritonavir	HIV Infections;Hyperbilirubinemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448097556	
1448097574	rs17868323	UGT1A7	3			3.5	Toxicity	1	1	atazanavir;ritonavir	HIV Infections;Hyperbilirubinemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448097574	
1448097587	rs17863778	UGT1A7	3			3.5	Toxicity	1	1	atazanavir;ritonavir	HIV Infections;Hyperbilirubinemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448097587	
1448100201	rs4532	DRD1	3			2.5	Other	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100201	
1448100313	rs28365063	UGT2B7	4			-0.25	Metabolism/PK	3	3	lamotrigine	Epilepsy	2021-04-20	https://www.pharmgkb.org/clinicalAnnotation/1448100313	
1448100208	rs686	DRD1	3			3.0	Other	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100208	
1448100215	rs17587100	INSIG2	3			0.0	Toxicity	2	2	antipsychotics	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100215	
1448100222	rs2071303	HFE	3			2.75	Efficacy	1	1	adalimumab	Crohn Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100222	
1448100242	rs2738466	LDLR	3			0.0	Efficacy	1	1	pravastatin	Vascular Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100242	
1448100249	rs6092	SERPINE1	3			2.75	Toxicity	1	1	dexamethasone	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100249	Pediatric
1448100257	rs1800795	IL6	3			2.25	Toxicity	1	1	peginterferon alfa-2b;ribavirin	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100257	
1448100265	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	3			0.0	Toxicity	1	1	peginterferon alfa-2b;ribavirin	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100265	
1448100296	rs3814637	CYP2C19	3		Tier 1 VIP	5.25	Dosage	2	2	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100296	
1448100306	rs3765534	ABCC4	3			2.5	Toxicity	2	2	azathioprine;mercaptopurine	Inflammatory Bowel Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100306	
1448100334	rs56324128	CYP3A4	3		Rare Variant; Tier 1 VIP	0.0	Metabolism/PK	1	1	ticagrelor	Acute coronary syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100334	
1448100340	rs62471956	CYP3A43	3			0.0	Metabolism/PK	1	1	ticagrelor	Acute coronary syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100340	
1448100347	rs4149056	SLCO1B1	3		Tier 1 VIP	0.0	Metabolism/PK	1	1	ticagrelor	Acute coronary syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100347	
1448100354	rs113681054	SLCO1B1	3		Tier 1 VIP	0.0	Metabolism/PK	1	1	ticagrelor	Acute coronary syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100354	
1448100361	rs12201199	TPMT	3		Tier 1 VIP	2.25	Other	2	2	mercaptopurine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100361	Pediatric
1451666740	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	1A		Tier 1 VIP	107.625	Metabolism/PK	5	11	fluvastatin		2022-02-15	https://www.pharmgkb.org/clinicalAnnotation/1451666740	
1451773100	rs10494366	NOS1AP	3			1.5	Toxicity	1	1	digoxin	Shortened QT interval	2022-05-06	https://www.pharmgkb.org/clinicalAnnotation/1451773100	
1448123834	rs2535629	ITIH3	3			1.5	Efficacy	1	1	clozapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448123834	
1448264343	HLA-B*15:01:01:01	HLA-B	3		Tier 1 VIP	3.0	Toxicity	1	1	oxcarbazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448264343	
1449146785	rs2228000	XPC	3			1.5	Toxicity	1	2	Platinum compounds	Carcinoma, Non-Small-Cell Lung;gastrointestinal toxicity;Hematologic Diseases;Leukopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449146785	
1449146832	rs9394992	SLC29A1	3			3.25	Efficacy	1	1	tipiracil hydrochloride;trifluridine	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449146832	
1449146840	rs760370	SLC29A1	3			3.25	Efficacy	1	1	tipiracil hydrochloride;trifluridine	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449146840	
1449147022	rs12979860	IFNL3;IFNL4	3			2.5	Efficacy	1	1	sofosbuvir;velpatasvir;voxilaprevir	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449147022	
1451702280	rs71647871	CES1	3		Rare Variant	0.0	Metabolism/PK	1	1	sacubitril		2022-03-03	https://www.pharmgkb.org/clinicalAnnotation/1451702280	
1449147609	rs2740574	CYP3A4	3		Tier 1 VIP	1.0	Efficacy	1	2	buprenorphine	Pain	2022-09-29	https://www.pharmgkb.org/clinicalAnnotation/1449147609	
1447990578	rs2306283	SLCO1B1	3		Tier 1 VIP	1.5	Metabolism/PK	2	2	mycophenolic acid	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447990578	
1448099059	rs1891059		3			0.0	Toxicity	1	1	cyclophosphamide;cytarabine;daunorubicin;dexamethasone;doxorubicin;methotrexate;pegaspargase;prednisone;thioguanine;vincristine	Osteonecrosis;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448099059	Pediatric
1448099065	rs10898815	NUMA1	3			2.25	Efficacy	1	1	calcium channel blockers	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448099065	
1448099080	rs588076	PICALM	3			2.25	Efficacy	1	1	calcium channel blockers	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448099080	
1448099093	rs117532069	DOK5	3			0.0	Toxicity	1	1	cyclophosphamide;cytarabine;daunorubicin;dexamethasone;doxorubicin;methotrexate;pegaspargase;prednisone;thioguanine;vincristine	Osteonecrosis;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448099093	Pediatric
1448099100	rs11868035	SREBF1	3			1.0	Toxicity	1	1	hmg coa reductase inhibitors	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448099100	
1448104372	rs2032582	ABCB1	3		Tier 1 VIP	3.25	Toxicity	1	1	atorvastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448104372	
1448257263	rs17126068	DDHD1	3			0.0	Dosage	1	1	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448257263	
1448257270	rs2288344	NEDD4	3			0.0	Dosage	1	1	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448257270	
1448257290	rs4379440	ASPH	3			0.0	Efficacy	1	1	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448257290	
1448259317	rs1042597	UGT1A8	3			1.75	Efficacy	1	1	raloxifene	Menopause;Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448259317	
1448260762	HLA-B*15:27:01	HLA-B	3		Tier 1 VIP	2.75	Toxicity	1	1	clindamycin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448260762	
1448264186	rs10846744	SCARB1	3			2.5	Efficacy	1	1	peginterferon alfa-2a;ribavirin	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448264186	
1448519686	CYP3A4*1, CYP3A4*22	CYP3A4	3		Tier 1 VIP	2.0	Metabolism/PK	1	1	exemestane	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448519686	
1448615137	rs1045642	ABCB1	3		Tier 1 VIP	2.0	Toxicity	1	1	anastrozole	Arthralgia;Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448615137	
1448615147	rs2032582	ABCB1	3		Tier 1 VIP	1.5	Metabolism/PK	1	1	anastrozole	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448615147	
1448124242	rs2046934	P2RY12	3			1.75	Efficacy	2	2	clopidogrel	major adverse cardiac events (mace)	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448124242	
1448124216	rs1330344	PTGS1	3			2.25	Efficacy	1	1	clopidogrel	major adverse cardiac events (mace)	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448124216	
1183532576	rs429358	APOE	3			2.5	Efficacy	1	1	simvastatin	Myocardial Infarction	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183532576	
1447982779	rs717620	ABCC2	3			0.0	Toxicity	1	1	atazanavir;lopinavir;ritonavir;tenofovir		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447982779	
1447982788	rs567606867	CYP2D6	3		Rare Variant; Tier 1 VIP	0.0	Metabolism/PK	1	1	bufuralol;dextromethorphan		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447982788	
1447982797	rs4149117	SLCO1B3	3			5.0	Toxicity	2	2	carboplatin;paclitaxel	Lung Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447982797	
1447982804	rs371793722	CYP2D6	3		Rare Variant; Tier 1 VIP	0.0	Metabolism/PK	1	1	bufuralol;dextromethorphan		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447982804	
1447982811	rs138417770	CYP2D6	3		Rare Variant; Tier 1 VIP	0.0	Metabolism/PK	1	1	bufuralol;dextromethorphan		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447982811	
1447982818	rs201045130	NT5C1A	3		Rare Variant	0.0	Other	1	1	cladribine;fluorouracil;gemcitabine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447982818	
1447982832	rs1695	GSTP1	3		Tier 1 VIP	2.75	Efficacy	1	1	dimethyl fumarate	Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447982832	
1447982843	rs6924995		3			0.0	Efficacy	1	1	simvastatin	Hypercholesterolemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447982843	
1448103935	rs10494366	NOS1AP	3			1.75	Efficacy	1	1	repaglinide	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448103935	
1448264329	HLA-B*40:02:01	HLA-B	3		Tier 1 VIP	4.0	Toxicity	1	1	oxcarbazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448264329	
1448265605	rs393994	AGBL4	3			0.0	Toxicity	1	1	rifampin	Tuberculosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448265605	
1448636111	rs11506105	EGFR	3			3.0	Efficacy	1	1	peginterferon alfa-2a;peginterferon alfa-2b;ribavirin	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448636111	
1450933001	rs7041	GC	3			2.0	Efficacy	1	1	deferasirox	beta-Thalassemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450933001	
1450933052	rs610604	TNFAIP3	3			2.0	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Arthritis, Psoriatic;Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450933052	
1450933104	rs2159140	MAP2K4	3			1.75	Toxicity	1	1	ethanol	Alcoholism;Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450933104	
1450933110	rs2271339	ADGRL3	3			2.0	Toxicity	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450933110	
1450934055	rs2231137	ABCG2	3		Tier 1 VIP	3.75	Dosage	1	1	imatinib	Drug Toxicity;Gastrointestinal Stromal Tumors	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450934055	
1450934203	rs121908547	SCN4A	3		Rare Variant	0.0	Efficacy	1	1	mexiletine	Myotonic Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450934203	
1450934656	rs869312138	GLA;HNRNPH2	3			0.0	Efficacy	1	1	migalastat	Fabry Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450934656	
1043880143	rs708272	CETP	3			2.5	Efficacy	1	1	hmg coa reductase inhibitors	Coronary Artery Disease	2021-06-10	https://www.pharmgkb.org/clinicalAnnotation/1043880143	
1451702428	HLA-B*07:02:01	HLA-B	3		Tier 1 VIP	2.75	Toxicity	1	1	sulfamethoxazole / trimethoprim	Respiratory Insufficiency	2022-03-03	https://www.pharmgkb.org/clinicalAnnotation/1451702428	Pediatric
1447946124	rs361525	TNF	3			2.25	Efficacy	1	1	infliximab		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447946124	
1447947019	rs3814055	NR1I2	3			5.25	Metabolism/PK	3	4	tacrolimus		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447947019	
1447960269	rs1065634	NRAS	3			2.75	Efficacy	1	1	carboplatin;cisplatin;gemcitabine	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960269	
1447960309	rs1143634	IL1B	3			1.5	Efficacy	1	1	infliximab	Crohn Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960309	
1447964180	rs6493497	CYP19A1	3			0.0	Efficacy	1	1	anastrozole;exemestane;letrozole	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447964180	
1447990932	rs442767	DHFR	3			1.75	Toxicity	1	1	methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447990932	Pediatric
1448100089	rs713729	PICK1	3			4.0	Other	1	2	methamphetamine	Substance-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100089	
1448100103	rs521093		3			0.0	Efficacy	1	1	antidepressants	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100103	
1448100110	rs231775	CTLA4	3			2.25	Toxicity	1	1	cyclosporine	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100110	
1448100117	rs49411	FHIT	3			0.0	Efficacy	1	1	antidepressants	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100117	
1448100132	rs672170	RGS17	3			0.0	Efficacy	1	1	antidepressants	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100132	
1448100139	rs16873129	RAPGEF5	3			0.0	Efficacy	1	1	antidepressants	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100139	
1448100146	rs2299267	PON2	3			0.0	Efficacy	1	1	antidepressants	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100146	
1448100158	rs4737771	CRH	3			0.0	Efficacy	1	1	antidepressants	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100158	
1448100165	rs10997242	CTNNA3	3			0.0	Efficacy	1	1	antidepressants	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100165	
1448100173	rs2532560	PARP11	3			0.0	Efficacy	1	1	antidepressants	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100173	
1448100180	rs9315310	NBEA	3			0.0	Efficacy	1	1	antidepressants	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100180	
1448100521	rs3814995	NPHS1	3			0.0	Efficacy	1	1	losartan	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100521	
1448258925	rs717620	ABCC2	3			1.75	Toxicity	1	1	sorafenib	Exanthema	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448258925	
1451702465	HLA-C*07:02:01:01	HLA-C	3			2.75	Toxicity	1	1	sulfamethoxazole / trimethoprim	Respiratory Insufficiency	2022-03-03	https://www.pharmgkb.org/clinicalAnnotation/1451702465	Pediatric
1447960948	rs1019385	GRIN2B	3			5.0	Dosage	1	2	valproic acid	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447960948	
1447961028	rs1799929	NAT2	3		Tier 1 VIP	7.25	Toxicity	8	9	Drugs For Treatment Of Tuberculosis	Tuberculosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447961028	Pediatric
1447961074	rs992160	CDC5L	3			2.5	Efficacy	1	1	gemcitabine	Pancreatic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447961074	
1447961344	rs846664	TAS2R16	3			1.5	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447961344	
1448099908	rs5985	F13A1	3			2.75	Efficacy	1	1	photodynamic therapy	Choroidal Neovascularization	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448099908	
1448532313	rs12979860	IFNL3;IFNL4	3			3.5	Efficacy	1	1	ledipasvir;sofosbuvir	Hepatitis C, Chronic;Recurrence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448532313	
1449156809	rs1611131	DBH	3			3.0	Toxicity	1	1	opioids	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156809	
1449156815	rs2070762	TH	3			1.0	Toxicity	2	2	opioids	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156815	
1447948727	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	3		Tier 1 VIP	2.5	Toxicity	5	5	gefitinib	Adenocarcinoma;Carcinoma, Non-Small-Cell Lung;Drug Toxicity;Exanthema;Toxic liver disease	2021-04-23	https://www.pharmgkb.org/clinicalAnnotation/1447948727	
1447990855	rs6500843	RBFOX1	3			1.75	Efficacy	1	1	antineoplastic agents	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447990855	
1448098232	rs2502815	NR1I3	3			2.5	Toxicity	1	1	docetaxel	Anemia;Nasopharyngeal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448098232	
1448098287	rs2501873	NR1I3	3			2.0	Toxicity	1	1	docetaxel	Anemia;Nasopharyngeal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448098287	
1448098293	rs10538494	NR1I3	3			2.5	Toxicity	1	1	docetaxel	Anemia;Nasopharyngeal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448098293	
1448098304	rs3732359	NR1I2	3			2.0	Toxicity	1	1	docetaxel	Anemia;Nasopharyngeal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448098304	
1448098315	rs3732360	NR1I2	3			2.0	Toxicity	1	1	docetaxel	Anemia;Nasopharyngeal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448098315	
1448098320	rs3814058	NR1I2	3			2.5	Toxicity	1	1	docetaxel	Anemia;Nasopharyngeal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448098320	
1448098325	rs11185647	RXRA	3			2.0	Toxicity	1	1	docetaxel	Anemia;Nasopharyngeal Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448098325	
1448098354	rs1536475	RXRA	3			1.5	Toxicity	1	1	docetaxel	Nasopharyngeal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448098354	
1448099112	rs79085477	BMP7	3			0.0	Toxicity	1	1	cyclophosphamide;cytarabine;daunorubicin;dexamethasone;doxorubicin;methotrexate;pegaspargase;prednisone;thioguanine;vincristine	Osteonecrosis;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448099112	Pediatric
1448099135	rs141059755	LINC00251	3		Rare Variant	0.0	Toxicity	1	1	cyclophosphamide;cytarabine;daunorubicin;dexamethasone;doxorubicin;methotrexate;pegaspargase;prednisone;thioguanine;vincristine	Osteonecrosis;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448099135	Pediatric
1448099156	rs2273618	HNF4A	3			2.0	Toxicity	1	1	docetaxel	Anemia;Nasopharyngeal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448099156	
1448099162	rs3746574	HNF4A	3			1.5	Toxicity	1	1	docetaxel	Anemia;Nasopharyngeal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448099162	
1448099178	rs6130615	HNF4A	3			1.5	Toxicity	1	1	docetaxel	Anemia;Nasopharyngeal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448099178	
1448099320	rs2234753	RXRA	3			1.5	Toxicity	1	1	docetaxel	Anemia;Nasopharyngeal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448099320	
1448276473	rs4149056	SLCO1B1	3		Tier 1 VIP	2.25	Efficacy	1	1	rosiglitazone	Diabetes Mellitus, Type 2	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448276473	
1448099149	rs2032582	ABCB1	3		Tier 1 VIP	1.0	Efficacy	2	3	tramadol	Fractures, Bone;Pain;Pain, Postoperative	2021-04-08	https://www.pharmgkb.org/clinicalAnnotation/1448099149	
1447954378	rs113993959	CFTR	3	Yes: Level of evidence set to 3. Ataluren is a drug for the treatment of Duchenne muscular dystrophy caused by a nonsense mutation and not indicated in CF treatment.	Rare Variant; Tier 1 VIP	4.5	Other	4	4	ataluren	Cystic Fibrosis	2021-03-29	https://www.pharmgkb.org/clinicalAnnotation/1447954378	Pediatric
1183491175	rs776746	CYP3A5	3		Tier 1 VIP	2.5	Efficacy	1	1	rosuvastatin	Myocardial Infarction	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183491175	
1444843613	rs12980275	IFNL3	3			6.5	Efficacy	7	7	peginterferon alfa-2a;peginterferon alfa-2b;ribavirin	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444843613	
1448099168	rs6413517	RXRA	3			1.5	Toxicity	1	1	docetaxel	Anemia;Nasopharyngeal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448099168	
1448099784	rs12613732	GALNT14	3			2.0	Efficacy	1	1	cisplatin;fluorouracil;mitoxantrone	Carcinoma, Hepatocellular	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448099784	
1448099828	rs1801157	CXCL12	3			2.25	Efficacy	1	1	alemtuzumab;chlorambucil;cyclophosphamide;fludarabine;prednisone;rituximab;vincristine	Leukemia, Lymphocytic, Chronic, B-Cell	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448099828	
1448568208	rs2227983	EGFR	3			1.5	Efficacy	2	2	cetuximab	Head and Neck Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448568208	
1448624484	rs11636687		3			0.5	Toxicity	1	2	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Leukopenia;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448624484	
1451673180	rs199515342	CYP2A6	3		Rare Variant; Tier 1 VIP	0.0	Metabolism/PK	1	1	nicotine		2022-02-07	https://www.pharmgkb.org/clinicalAnnotation/1451673180	
1448632491	rs35112940	CD33	3			2.0	Efficacy	1	1	gemtuzumab ozogamicin	Leukemia, Myeloid, Acute	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448632491	Pediatric
1451673200	rs571335587	CYP2A6	3		Rare Variant; Tier 1 VIP	0.0	Metabolism/PK	1	1	nicotine		2022-02-07	https://www.pharmgkb.org/clinicalAnnotation/1451673200	
1451703980	HLA-C*06:02:01:01, HLA-C*07:27:01, HLA-C*08:01	HLA-C	2B			10.5	Toxicity	2	4	sulfamethoxazole / trimethoprim	Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2022-03-03	https://www.pharmgkb.org/clinicalAnnotation/1451703980	
1447949088	rs3077	HLA-DPA1	3			2.5	Efficacy	1	1	peginterferon alfa-2b	Hepatitis B, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447949088	
1448098975	rs2228171	LRP2	3			2.25	Toxicity	1	1	cisplatin	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448098975	Pediatric
1448099022	rs3957357	GSTA1	3			1.75	Metabolism/PK	1	1	busulfan	Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448099022	Pediatric
1448103867	rs4305746	TAAR6	3			1.75	Efficacy	1	1	aripiprazole	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448103867	
1448126020	rs1870377	KDR	3			5.0	Efficacy	1	2	sorafenib	Carcinoma, Hepatocellular	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448126020	
1448522748	rs2916205	PGLYRP4	3			2.0	Efficacy	1	1	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Psoriasis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448522748	
1448532363	rs8099917	IFNL3;IFNL4	3			2.5	Efficacy	1	1	ledipasvir;sofosbuvir	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448532363	
1449156167	HLA-B*35:10	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156167	
1449156175	HLA-C*04:01:01:01	HLA-C	2B			17.0	Toxicity	8	9	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Exanthema;Hypersensitivity;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156175	
1449156051	HLA-B*67:01:01	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-11-30	https://www.pharmgkb.org/clinicalAnnotation/1449156051	
1451704000	HLA-B*13:01:01, HLA-B*15:02:01, HLA-B*38:02:01	HLA-B	2A		Tier 1 VIP	11.5	Toxicity	2	4	sulfamethoxazole / trimethoprim	Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2022-03-03	https://www.pharmgkb.org/clinicalAnnotation/1451704000	
1448112486	rs11052877	CD69	3			2.75	Efficacy	1	1	tocilizumab	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448112486	
1448112493	rs4910008	GALNT18	3			1.75	Efficacy	1	1	tocilizumab	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448112493	
1451704080	NAT2*4, NAT2*5A, NAT2*5B, NAT2*6A, NAT2*6B, NAT2*7A, NAT2*7B, NAT2*14A, NAT2*14B	NAT2	3		Tier 1 VIP	2.25	Toxicity	6	6	sulfamethoxazole / trimethoprim	adverse events;Hypersensitivity;severe cutaneous adverse reactions	2022-06-13	https://www.pharmgkb.org/clinicalAnnotation/1451704080	Pediatric
1447991729	rs57098334	SLC6A4	3			2.75	Efficacy	1	1	paroxetine	Depression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447991729	
1448426887	CYP1A1*1, CYP1A1*2A	CYP1A1	3			1.0	Metabolism/PK	1	1	granisetron		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448426887	
1451674140	rs61605570	CYP2A6	3		Rare Variant; Tier 1 VIP	0.0	Metabolism/PK	1	1	nicotine		2022-02-08	https://www.pharmgkb.org/clinicalAnnotation/1451674140	
1451674148	rs768416963	CYP2A6	3		Rare Variant; Tier 1 VIP	0.0	Metabolism/PK	1	1	nicotine		2022-02-08	https://www.pharmgkb.org/clinicalAnnotation/1451674148	
1451704120	rs1799931	NAT2	3		Tier 1 VIP	0.5	Toxicity	2	2	sulfamethoxazole / trimethoprim	adverse events;Hypersensitivity	2022-03-03	https://www.pharmgkb.org/clinicalAnnotation/1451704120	Pediatric
1450932250	rs4986893	CYP2C19	3		Rare Variant; Tier 1 VIP	1.0	Toxicity	1	1	ethambutol;isoniazid;pyrazinamide;rifampin	Maculopapular Exanthema;Tuberculosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450932250	
1448603625	rs1800896	IL10	4			-0.75	Metabolism/PK	2	2	tacrolimus	Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448603625	
982043234	rs1937840	AKR1C3	3			3.0	Efficacy	1	1	docetaxel;doxorubicin	Breast Neoplasms	2021-12-06	https://www.pharmgkb.org/clinicalAnnotation/982043234	
1185012209	HLA-A*24:02:01:01	HLA-A	3			5.875	Toxicity	5	5	carbamazepine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome	2022-01-10	https://www.pharmgkb.org/clinicalAnnotation/1185012209	
982029200	rs11572080	CYP2C8	3		Tier 1 VIP	1.5	Dosage	1	1	repaglinide		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982029200	
982042110	rs2010851	WNT5B	3			2.0	Other	1	1	fluorouracil	Colonic Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982042110	
1043873018	rs12800734	GRIK4	3			2.25	Efficacy	1	1	antidepressants	Depressive Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043873018	
1043880392	rs4918758	CYP2C9	3		Tier 1 VIP	3.75	Dosage	2	2	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043880392	
1183615090	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*8, CYP2C9*13, CYP2C9*59, CYP2C9*62	CYP2C9	3		Tier 1 VIP	7.125	Metabolism/PK	6	12	losartan		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183615090	
1183618204	rs34130495	SLC22A1	3			1.5	Other	1	1	tramadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183618204	
1183631792	rs11144870	RFK	3			0.0	Efficacy	1	1	citalopram;escitalopram	Depressive Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183631792	
1183693485	rs1049353	CNR1	3			1.0	Toxicity	3	3	aripiprazole;clozapine;haloperidol;olanzapine;quetiapine;risperidone	Autism Spectrum Disorder;Psychotic Disorders;Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183693485	Pediatric
1184512433	rs7856096	FPGS	3			5.75	Dosage	1	2	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184512433	
1185000451	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	3		Tier 1 VIP	2.5	Metabolism/PK	2	2	atazanavir;ritonavir	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1185000451	
1185012258	HLA-B*18:01:01	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	amoxicillin;clavulanate		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1185012258	
1445400672	rs2770150	TLR4	3			2.5	Efficacy	1	1	Pertussis vaccines		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445400672	Pediatric
1446898324	rs2279343	CYP2B6	3		Tier 1 VIP	0.25	Efficacy	1	2	bupropion	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446898324	
1446899639	rs11155012	ECT2L	3			1.75	Efficacy	1	1	anthracyclines and related substances	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446899639	
1448112600	rs7937567	CSNK2A3;GALNT18	3			2.25	Efficacy	1	1	cisplatin	Urinary Bladder Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448112600	
1448112607	rs10964552	MLLT3	3			2.25	Efficacy	1	1	cisplatin	Urinary Bladder Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448112607	
1448112614	rs244898	RARS	3			2.25	Efficacy	1	1	cisplatin	Urinary Bladder Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448112614	
1448567993	rs1800896	IL10	3			1.25	Metabolism/PK	1	1	sirolimus	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448567993	
1449576983	rs3828743	DSE;TSPYL1	3			5.0	Efficacy	1	2	abiraterone;prednisolone	Prostatic Neoplasms	2022-02-15	https://www.pharmgkb.org/clinicalAnnotation/1449576983	
1451704127	rs1799930	NAT2	3		Tier 1 VIP	0.0	Toxicity	2	2	sulfamethoxazole / trimethoprim	adverse events;Hypersensitivity	2022-03-03	https://www.pharmgkb.org/clinicalAnnotation/1451704127	Pediatric
1448616381	rs4788863	SLC16A5	3			1.75	Toxicity	2	2	cisplatin	Neoplasms;Ototoxicity;Testicular Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448616381	Pediatric
1449140069	rs6785049	NR1I2	3			3.0	Toxicity;Metabolism/PK	1	2	sirolimus;temsirolimus	gastrointestinal toxicity;Myelosuppression;Urinary Bladder Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449140069	
1449140085	rs2032582	ABCB1	3		Tier 1 VIP	1.0	Metabolism/PK	1	1	sirolimus;temsirolimus	hematopoietic stem cell transplantation;Kidney Transplantation;Urinary Bladder Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449140085	
1450815120	rs8050896		3			0.0	Efficacy	1	1	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450815120	
1450823713	rs2514218	DRD2	3		Tier 1 VIP	1.5	Toxicity	1	1	aripiprazole	Psychomotor Agitation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450823713	Pediatric
1446897383	rs4646	CYP19A1	3			5.75	Efficacy	2	2	tamoxifen	Breast Neoplasms;Menopause	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446897383	
1450931979	rs2242480	CYP3A4	3		Tier 1 VIP	2.5	Efficacy	1	1	fentanyl	Pain, Postoperative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450931979	
982030836	rs10929302	UGT1A1	2A		Tier 1 VIP	11.75	Toxicity	7	8	irinotecan	Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982030836	
982030854	rs9606186	COMT	3		Tier 1 VIP	2.25	Efficacy	2	3	risperidone	Schizophrenia	2021-12-03	https://www.pharmgkb.org/clinicalAnnotation/982030854	
1183491446	rs20455	KIF6	3			4.0	Efficacy	3	3	atorvastatin	Coronary Disease;Hypercholesterolemia;Myocardial Infarction	2022-04-05	https://www.pharmgkb.org/clinicalAnnotation/1183491446	
1447990271	rs274622	GRM3	3			2.5	Other	1	1	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447990271	
1448255939	rs1800629	TNF	3			2.25	Toxicity	1	1	sorafenib	Carcinoma, Hepatocellular;hand-foot syndrome	2022-09-22	https://www.pharmgkb.org/clinicalAnnotation/1448255939	
1447990913	rs885036	MGAT4A	3			2.25	Efficacy	1	1	bevacizumab;capecitabine;oxaliplatin	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447990913	
1448097822	rs16973225		3			2.0	Other	1	1	Antiinflammatory agents, non-steroids;aspirin	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448097822	
1448098339	rs11185648		3			1.5	Toxicity	1	1	docetaxel	Nasopharyngeal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448098339	
1444706164	rs2291073	SLCO1B1	3		Tier 1 VIP	2.75	Efficacy	1	1	lovastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444706164	
1444706201	rs4149032	SLCO1B1	3		Tier 1 VIP	0.0	Metabolism/PK	1	1	rifampin	Tuberculosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444706201	
1444842113	HLA-C*14:03	HLA-C	3			3.25	Toxicity	1	1	ticlopidine	Toxic liver disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444842113	
1444842126	UGT1A1*1, UGT1A1*6, UGT1A1*28, UGT1A1*37	UGT1A1	3		Tier 1 VIP	2.75	Toxicity	2	2	pazopanib	Carcinoma, Renal Cell	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444842126	
1447813727	rs74795342		3			1.5	Efficacy	1	1	lithium	Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447813727	
1447943591	rs1045642	ABCB1	3		Tier 1 VIP	1.75	Efficacy	1	1	agomelatine	Depressive Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447943591	
1447949305	rs1045642	ABCB1	3		Tier 1 VIP	0.5	Toxicity	1	2	tacrolimus	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447949305	
1447952819	rs1059150	ATP5F1E	3		Rare Variant	2.5	Efficacy	1	1	adalimumab;certolizumab pegol;etanercept;glucocorticoids;infliximab;methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447952819	
1447952825	rs1072388	GRIN2B	3			0.0	Efficacy	1	1	clozapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447952825	
1447952831	rs1264457	HLA-E	3			2.0	Efficacy	1	1	adalimumab;certolizumab pegol;etanercept;glucocorticoids;infliximab;methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447952831	
1447964542	rs1128503	ABCB1	3		Tier 1 VIP	2.25	Toxicity	1	1	capecitabine	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447964542	
1447979295	rs1137101	LEPR	3			0.75	Toxicity	1	2	antipsychotics		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447979295	
1448098344	rs62576288	RXRA	3			1.5	Toxicity	1	1	docetaxel	Nasopharyngeal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448098344	
1448099574	rs2291075	SLCO1B1	3		Tier 1 VIP	2.5	Efficacy	1	1	cytarabine;daunorubicin;etoposide;mitoxantrone	Leukemia, Myeloid, Acute	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448099574	Pediatric
1448100125	rs766127	MTRF1L	3			0.0	Efficacy	1	1	antidepressants	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100125	
1448100235	rs1799852	TF	3			0.0	Efficacy	1	1	adalimumab	Crohn Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100235	
1448100826	rs7349683	EPHA5	3			2.0	Toxicity	4	4	paclitaxel	Breast Neoplasms;Ovarian Neoplasms;Peripheral Nervous System Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448100826	
1448104015	rs2606345	CYP1A1	3			5.0	Efficacy	2	2	carbamazepine;phenobarbital;phenytoin;valproic acid	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448104015	
1448259106	rs4291	ACE	3		Tier 1 VIP	2.0	Efficacy	1	1	captopril	Alzheimer Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448259106	
1448276321	rs79206939	FTO	3		Rare Variant	3.75	Toxicity	1	1	azathioprine;mercaptopurine	Irritable Bowel Syndrome;Leukopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448276321	
1448615319	rs1045642	ABCB1	3		Tier 1 VIP	1.0	Toxicity	1	1	clopidogrel	Coronary Disease;Hemorrhage	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448615319	
1448616890	rs2270860	SLC22A7	3			2.75	Toxicity	1	1	capecitabine	Drug Toxicity;Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448616890	
1444706245	rs4363657	SLCO1B1	4		Tier 1 VIP	-2.0	Toxicity	2	2	simvastatin	Muscular Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444706245	
1446899702	rs7661530	KCNIP4	4			-2.0	Toxicity	2	2	Ace Inhibitors, Plain		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446899702	
1444672986	rs3135506	APOA5	3	Yes: Assigned level 3. All papers seem to be from the same group.		8.0	Efficacy	3	4	fenofibrate	Hypertriglyceridemia	2021-03-29	https://www.pharmgkb.org/clinicalAnnotation/1444672986	
1447961082	rs112445441	KRAS	3	Yes: While the variant is rare in the population overall it is not a rare mutation within cancers (see VIP). The FDA label contraindicates use in KRAS variants and so is not attached and also why this should be level 3.	Rare Variant	3.125	Efficacy	8	8	cetuximab	Colorectal Neoplasms	2021-03-29	https://www.pharmgkb.org/clinicalAnnotation/1447961082	
1447990255	rs11676382	GGCX	3			3.75	Dosage	9	9	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447990255	
1444842106	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*29	CYP2C9	1A		Tier 1 VIP	104.125	Metabolism/PK	3	6	flurbiprofen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444842106	
1447681932	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*31, CYP2D6*35, CYP2D6*41	CYP2D6	1A		Tier 1 VIP	116.4375	Metabolism/PK	12	21	metoprolol	Hypertension	2021-04-30	https://www.pharmgkb.org/clinicalAnnotation/1447681932	
1448265356	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	4		Tier 1 VIP	-0.875	Toxicity	2	3	valproic acid	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448265356	Pediatric
1447990789	rs4880	SOD2	3			0.0	Other	1	1	methotrexate		2021-08-25	https://www.pharmgkb.org/clinicalAnnotation/1447990789	
1451674160	rs1302192284	CYP2A6	3		Rare Variant; Tier 1 VIP	0.0	Metabolism/PK	1	1	nicotine		2022-02-08	https://www.pharmgkb.org/clinicalAnnotation/1451674160	
1451674200	rs137904044	CYP2A6	3		Rare Variant; Tier 1 VIP	0.0	Metabolism/PK	1	1	nicotine		2022-02-08	https://www.pharmgkb.org/clinicalAnnotation/1451674200	
1451674220	rs114558780	CYP2A6	3		Rare Variant; Tier 1 VIP	0.0	Metabolism/PK	1	1	nicotine		2022-02-08	https://www.pharmgkb.org/clinicalAnnotation/1451674220	
1448634065	rs4646316	COMT	3		Tier 1 VIP	0.25	Toxicity	1	1	cisplatin	Neoplasms;nephrotoxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448634065	
1448634071	rs9332377	COMT	3		Tier 1 VIP	0.25	Toxicity	1	1	cisplatin	Neoplasms;nephrotoxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448634071	
1448634742	rs717620	ABCC2	3			3.0	Metabolism/PK	1	2	cyclosporine;mycophenolic acid	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448634742	
1451674180	rs111869995	CYP2A6	3		Rare Variant; Tier 1 VIP	0.0	Metabolism/PK	1	1	nicotine		2022-02-08	https://www.pharmgkb.org/clinicalAnnotation/1451674180	
1451674240	rs200554095	CYP2A6	3		Rare Variant; Tier 1 VIP	0.0	Metabolism/PK	1	1	nicotine		2022-02-08	https://www.pharmgkb.org/clinicalAnnotation/1451674240	
1451674260	rs772964366	CYP2A6	3		Rare Variant; Tier 1 VIP	0.0	Metabolism/PK	1	1	nicotine		2022-02-08	https://www.pharmgkb.org/clinicalAnnotation/1451674260	
982031723	rs6431558	UGT1A8	3			1.0	Other	1	1	ABT-751	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982031723	
1183606758	rs2238032	CACNA1C	3			6.75	Efficacy	2	4	calcium channel blockers	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183606758	
1448616882	rs4678145	UMPS	3			3.25	Toxicity	1	1	capecitabine	Asthenia;Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448616882	
1448616922	rs699517	TYMS	3		Tier 1 VIP	5.5	Toxicity	1	2	capecitabine	Asthenia;Nausea;Neoplasms;Vomiting	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448616922	
1450943780	rs36217263	KL	3			2.75	Efficacy	1	1	Beta Blocking Agents		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450943780	
1444694588	rs1045642	ABCB1	4		Tier 1 VIP	-11.125	Dosage;Metabolism/PK	47	52	tacrolimus	Organ Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444694588	Pediatric
1448640301	rs3918290	DPYD	4		Rare Variant; Tier 1 VIP	-3.5	Efficacy	3	4	fluorouracil	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448640301	Pediatric
655385129	rs3846662	HMGCR	3			0.0	Other	1	1	simvastatin	Cardiovascular Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385129	
655385409	rs1801252	ADRB1	3		Tier 1 VIP	0.0	Efficacy	4	4	metoprolol	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385409	
1043872988	rs861539	KLC1;XRCC3	3			2.5	Efficacy	1	1	fluorouracil;irinotecan;leucovorin	Colorectal Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1043872988	
1183605989	rs2239128	CACNA1C	3			2.5	Efficacy	1	3	calcium channel blockers	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183605989	
1183606395	rs2239050	CACNA1C	3			3.0	Efficacy	1	3	calcium channel blockers		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183606395	
1183700517	rs11080344	NOS2	3			0.75	Toxicity	2	2	isoniazid;rifampin	Toxic liver disease;Tuberculosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183700517	
1444704963	rs3761422	ADORA2A	3			0.0	Toxicity	1	1	caffeine	Anxiety Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704963	
1448125499	rs2257212	SLC15A2	3			2.5	Efficacy	1	1	sorafenib	Carcinoma, Hepatocellular	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448125499	
1449003940	rs111618861		3		Rare Variant	0.0	Toxicity	1	1	Antithyroid Preparations	Agranulocytosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449003940	
1449157000	rs1129844	CCL11	3			2.75	Toxicity	1	1	methadone	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449157000	
1449157284	rs678849	OPRD1	3			0.25	Efficacy	1	2	methadone	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449157284	
1449162591	rs6853	MYD88	3			3.25	Toxicity	1	1	fentanyl		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449162591	
1449164443	rs12979860	IFNL3;IFNL4	3			2.75	Efficacy	1	1	peginterferon alfa-2a;peginterferon alfa-2b	Myeloproliferative Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449164443	
1449167245	rs2886059	ALDH1L1	3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449167245	Pediatric
1449191952	rs113993960	CFTR	3		Rare Variant; Tier 1 VIP	0.0	Toxicity	1	1	ivacaftor / lumacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191952	
1449192683	rs75527207	CFTR	3		Rare Variant; Tier 1 VIP	1.5	Efficacy	1	1	ivacaftor;tezacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449192683	Pediatric
1449269278	rs2108622	CYP4F2	4		Tier 1 VIP	-3.0	Other	5	6	warfarin	over-anticoagulation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449269278	
1449271075	rs112783657	CBR3	3			0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449271075	
981201946	rs1801158	DPYD	1A		Tier 1 VIP	87.75	Toxicity	13	14	fluorouracil	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981201946	
1450810975	rs894160	PLIN1	3			3.0	Toxicity	1	1	rosiglitazone	Diabetes Mellitus, Type 2;Weight gain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450810975	
981201962	rs1801159	DPYD	1A		Tier 1 VIP	86.75	Toxicity	13	16	fluorouracil	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981201962	
1450928601	rs12041331	PEAR1	3			1.75	Efficacy	1	1	aspirin;clopidogrel;prasugrel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450928601	
1445401793	rs1801160	DPYD	1A		Tier 1 VIP	101.25	Other	6	7	fluorouracil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401793	
1450936735	rs1229984	ADH1B	3			0.0	Metabolism/PK	1	1	acetaldehyde		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936735	
827843617	rs3918290	DPYD	1A		Rare Variant; Tier 1 VIP	255.75	Toxicity	52	62	fluorouracil	Neoplasms	2021-05-24	https://www.pharmgkb.org/clinicalAnnotation/827843617	Pediatric
1450944540	rs1128503	ABCB1	3		Tier 1 VIP	0.25	Toxicity	1	1	cyclosporine	hematopoietic stem cell transplantation;Neurotoxicity Syndromes	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450944540	
1450945347	rs1047303	HSD3B1	3			3.25	Efficacy	1	1	glucocorticoids	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450945347	
1451674300	rs758479488	CYP2A6	3		Rare Variant; Tier 1 VIP	0.0	Metabolism/PK	1	1	nicotine		2022-02-08	https://www.pharmgkb.org/clinicalAnnotation/1451674300	
1451674308	rs145157460	CYP2A6	3		Rare Variant; Tier 1 VIP	0.0	Metabolism/PK	1	1	nicotine		2022-02-08	https://www.pharmgkb.org/clinicalAnnotation/1451674308	
1451526333	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15	SLCO1B1	1A		Tier 1 VIP	222.75	Toxicity	14	19	simvastatin	statin-related myopathy	2022-02-14	https://www.pharmgkb.org/clinicalAnnotation/1451526333	
637880087	rs316019	SLC22A2	3			1.0	Toxicity	3	3	cisplatin	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/637880087	
1450812229	rs2236857	OPRD1	3			0.5	Toxicity	3	3	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450812229	
1450813775	rs1799732	DRD2	3		Tier 1 VIP	2.25	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450813775	
1450815148	rs2164660	PDE4D	3			0.0	Efficacy	1	1	quetiapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450815148	
1450820507	rs3845446	CACNA1E	3			0.5	Dosage	2	2	fentanyl	Pain, Postoperative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450820507	
1450959466	rs76394784	PAH	3		Rare Variant	0.0	Metabolism/PK	1	1	carbocisteine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450959466	
1450959472	rs138809906	PAH	3		Rare Variant	0.0	Metabolism/PK	1	1	l-phenylalanine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450959472	
1451674315	rs148693084	CYP2A6	3		Rare Variant; Tier 1 VIP	0.0	Metabolism/PK	1	1	nicotine		2022-02-08	https://www.pharmgkb.org/clinicalAnnotation/1451674315	
613978931	rs3812718	SCN1A	2B			15.25	Dosage	6	7	carbamazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/613978931	
1183630664	rs55886062	DPYD	1A		Rare Variant; Tier 1 VIP	206.25	Toxicity	13	15	fluorouracil	Neoplasms	2021-05-24	https://www.pharmgkb.org/clinicalAnnotation/1183630664	
1043859155	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	1A		Tier 1 VIP	203.8125	Metabolism/PK	13	19	clomipramine	Depressive Disorder, Major;Mental Disorders	2021-04-23	https://www.pharmgkb.org/clinicalAnnotation/1043859155	
1447814391	rs201279313	SLC25A31	3			0.0	Efficacy	1	1	atenolol;hydrochlorothiazide;metoprolol	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447814391	
1448266008	rs77010898	CFTR	3		Rare Variant; Tier 1 VIP	1.0	Efficacy	1	2	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448266008	
1448266986	rs316019	SLC22A2	3			5.0	Toxicity	1	2	Platinum compounds	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448266986	
1448531101	rs8192950	CES1	3			2.25	Efficacy	1	1	clopidogrel	Constriction, Pathologic;Ischemic Attack, Transient;Stroke	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448531101	
1448573523	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	3		Tier 1 VIP	0.375	Metabolism/PK	1	1	3,4-methylenedioxymethamphetamine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448573523	
1450963020	rs1799793	ERCC2	3			2.0	Toxicity	1	1	Platinum compounds	Carcinoma, Non-Small-Cell Lung;pneumonitis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450963020	
1450963060	rs1799793	ERCC2	3			2.5	Toxicity	1	1	Platinum compounds	adverse events;Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450963060	
1451674360	rs1303839356	CYP2A6	3		Rare Variant; Tier 1 VIP	0.0	Metabolism/PK	1	1	nicotine		2022-02-08	https://www.pharmgkb.org/clinicalAnnotation/1451674360	
1451674380	rs778019189	CYP2A6	3		Rare Variant; Tier 1 VIP	0.0	Metabolism/PK	1	1	nicotine		2022-02-08	https://www.pharmgkb.org/clinicalAnnotation/1451674380	
655384666	rs429358	APOE	3			2.25	Toxicity	1	1	Antivirals for treatment of HIV infections, combinations;ritonavir	HIV Infections;Hyperlipidemias	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384666	
1184757183	CYP2D6*1, CYP2D6*7, CYP2D6*10, CYP2D6*12, CYP2D6*14, CYP2D6*17, CYP2D6*18, CYP2D6*27, CYP2D6*29, CYP2D6*36, CYP2D6*37, CYP2D6*39, CYP2D6*40, CYP2D6*47, CYP2D6*48, CYP2D6*49, CYP2D6*50, CYP2D6*51, CYP2D6*53, CYP2D6*54, CYP2D6*55, CYP2D6*57, CYP2D6*62, CYP2D6*71, CYP2D6*72, CYP2D6*75, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*92, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*96, CYP2D6*97, CYP2D6*98, CYP2D6*114	CYP2D6	3		Tier 1 VIP	0.0	Other	14	43	bufuralol;dextromethorphan		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184757183	
1447521683	rs7412	APOE	3			1.75	Efficacy	1	1	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447521683	
1448999856	CYP2D6*1, CYP2D6*10, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*92, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*96, CYP2D6*97, CYP2D6*98	CYP2D6	3		Tier 1 VIP	0.0	Metabolism/PK	1	3	tolterodine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448999856	
1450975180	rs429358	APOE	3			1.75	Efficacy	1	1	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450975180	
655384733	rs7294	VKORC1	1B		Tier 1 VIP	43.25	Dosage	21	22	warfarin		2021-11-19	https://www.pharmgkb.org/clinicalAnnotation/655384733	
1183704228	rs9934438	VKORC1	2A		Tier 1 VIP	13.75	Dosage	9	9	acenocoumarol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183704228	
655387652	rs1799978	DRD2	4		Tier 1 VIP	-1.0	Efficacy	4	4	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655387652	
1447673005	rs9923231	VKORC1	1B		Tier 1 VIP	26.0	Toxicity	17	17	warfarin	over-anticoagulation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447673005	Pediatric
655385024	rs2359612	VKORC1	1B		Tier 1 VIP	38.25	Dosage	14	15	warfarin		2021-11-19	https://www.pharmgkb.org/clinicalAnnotation/655385024	
655386075	rs1045642	ABCB1	3		Tier 1 VIP	2.0	Efficacy	4	5	cytarabine	Leukemia, Myeloid, Acute	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386075	
1183684172	rs2032582	ABCB1	3		Tier 1 VIP	5.25	Efficacy	4	5	cytarabine;daunorubicin;dexrazoxane;idarubicin	Leukemia, Myeloid, Acute	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183684172	
1183703296	CYP2C9*1, CYP2C9*3, CYP2C9*13	CYP2C9	1A		Tier 1 VIP	107.0	Metabolism/PK	2	6	lornoxicam		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183703296	
1451092460	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	1A		Tier 1 VIP	104.0	Metabolism/PK	2	4	tenoxicam		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451092460	
1451092541	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	1A		Tier 1 VIP	103.5	Metabolism/PK	2	4	piroxicam		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451092541	
1451092677	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*13	CYP2C9	1A		Tier 1 VIP	207.5	Metabolism/PK	5	7	meloxicam		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451092677	
1451092720	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	1A		Tier 1 VIP	109.5	Metabolism/PK	5	9	ibuprofen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451092720	
1451674409	rs374515279	CYP2A6	3		Rare Variant; Tier 1 VIP	0.0	Metabolism/PK	1	1	nicotine		2022-02-08	https://www.pharmgkb.org/clinicalAnnotation/1451674409	
1451674424	rs145308399	CYP2A6	3		Rare Variant; Tier 1 VIP	0.0	Metabolism/PK	1	1	nicotine		2022-02-08	https://www.pharmgkb.org/clinicalAnnotation/1451674424	
1451674418	rs777098658	CYP2A6	3		Rare Variant; Tier 1 VIP	0.0	Metabolism/PK	1	1	nicotine		2022-02-08	https://www.pharmgkb.org/clinicalAnnotation/1451674418	
1447959515	rs1042713	ADRB2	3		Tier 1 VIP	1.75	Efficacy	1	1	propranolol	Liver Cirrhosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447959515	
1447672658	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	1A		Tier 1 VIP	139.75	Toxicity	29	34	warfarin	over-anticoagulation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447672658	Pediatric
1447672988	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	1A		Tier 1 VIP	342.375	Toxicity	33	50	warfarin	Hemorrhage	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447672988	Pediatric
1446907373	CYP3A5*1, CYP3A5*3	CYP3A5	3		Tier 1 VIP	2.0	Metabolism/PK	1	1	cilostazol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446907373	
1447813861	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	3		Tier 1 VIP	1.625	Metabolism/PK	2	2	atazanavir		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447813861	
1448426877	CYP3A5*1, CYP3A5*3	CYP3A5	3		Tier 1 VIP	1.0	Metabolism/PK	1	1	granisetron		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448426877	
1449003986	CYP3A5*1, CYP3A5*3	CYP3A5	3		Tier 1 VIP	1.5	Dosage	2	2	oxycodone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449003986	
1449005135	CYP3A5*1, CYP3A5*3	CYP3A5	4		Tier 1 VIP	-1.75	Toxicity	1	2	cyclosporine;tacrolimus	Kidney Transplantation;transplant rejection	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449005135	
1449165704	CYP3A5*1, CYP3A5*3	CYP3A5	3		Tier 1 VIP	4.0	Metabolism/PK	11	12	cyclosporine	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449165704	Pediatric
1449309910	CYP3A5*1, CYP3A5*3	CYP3A5	3		Tier 1 VIP	1.5	Metabolism/PK	1	1	tacrolimus	Nephrotic Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449309910	Pediatric
1449716378	CYP3A5*1, CYP3A5*3	CYP3A5	3		Tier 1 VIP	2.0	Toxicity	2	2	fentanyl	Neoplasms;Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449716378	
1450812401	CYP3A5*1, CYP3A5*3	CYP3A5	3		Tier 1 VIP	2.5	Metabolism/PK	1	1	nimodipine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450812401	
1450812594	CYP3A5*1, CYP3A5*3	CYP3A5	3		Tier 1 VIP	1.0	Metabolism/PK	1	1	dextropropoxyphene		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450812594	
1450371828	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	3		Tier 1 VIP	0.75	Efficacy;Metabolism/PK	1	6	maraviroc	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450371828	
1449713943	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	3		Tier 1 VIP	7.875	Metabolism/PK	5	6	fentanyl	Pain;Pain, Postoperative	2022-02-10	https://www.pharmgkb.org/clinicalAnnotation/1449713943	Pediatric
1448423466	CYP3A5*1, CYP3A5*3	CYP3A5	3		Tier 1 VIP	2.25	Toxicity	1	1	carboplatin;paclitaxel	Leukopenia;Neutropenia;Ovarian Neoplasms	2022-06-13	https://www.pharmgkb.org/clinicalAnnotation/1448423466	
1451100007	rs324498	PTPRD	3			0.0	Efficacy	1	1	Antihypertensives	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451100007	
1451100053	rs11749255		3			0.0	Efficacy	1	1	Antihypertensives	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451100053	
1451100080	rs6487504		3			0.0	Efficacy	1	1	Antihypertensives	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451100080	
1451100120	CYP2D6*1, CYP2D6*9, CYP2D6*29	CYP2D6	3		Tier 1 VIP	3.0	Metabolism/PK	1	2	fentanyl		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451100120	
1451103240	rs4149117	SLCO1B3	3			2.5	Efficacy	1	1	mycophenolic acid	lung transplantation;overall survival	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451103240	
1451100100	rs2740574	CYP3A;CYP3A4	3		Tier 1 VIP	1.5	Metabolism/PK	1	1	fentanyl		2021-05-18	https://www.pharmgkb.org/clinicalAnnotation/1451100100	
1451103560	rs6473797	OPRK1	3			2.75	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451103560	
1449188311	rs1799971	OPRM1	4			-19.75	Toxicity	25	26	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449188311	Pediatric
1450811261	rs1229984	ADH1B	3			7.25	Toxicity	3	3	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450811261	
1451110071	rs61826952	RABGAP1L	3			2.5	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451110071	
1451110320	rs2838956	SLC19A1	3		Tier 1 VIP	0.0	Toxicity	1	1	methotrexate	adverse events;Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451110320	
1184989990	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	3			7.375	Efficacy	8	10	fluvoxamine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184989990	
1444704359	rs4149056	SLCO1B1	3		Tier 1 VIP	7.5	Metabolism/PK	7	7	lopinavir	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444704359	Pediatric
1451116100	rs4149056	SLCO1B1	3		Tier 1 VIP	1.0	Metabolism/PK	1	1	amprenavir	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451116100	
1450812488	rs1799971	OPRM1	3			0.125	Toxicity	4	8	opioids	adverse events;Nausea;Vomiting	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450812488	
1451117640	rs12521868	C5orf56	3			3.0	Efficacy	1	1	hydrochlorothiazide	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451117640	
1451117646	rs1275988	KCNK3	3			3.0	Efficacy	1	1	candesartan	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451117646	
1451118241	rs1378942	CSK	3			3.0	Efficacy	1	1	hydrochlorothiazide	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451118241	
1451118277	rs12579720	PDE3A	3		Rare Variant	3.0	Efficacy	1	1	hydrochlorothiazide	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451118277	
1451118320	rs6722745	SULT1C3	3			3.0	Efficacy	1	1	candesartan	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451118320	
1451118326	rs4387287	STN1	3			3.0	Efficacy	1	1	atenolol	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451118326	
1451118332	rs8068318	TBX2	3			3.0	Efficacy	1	1	atenolol	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451118332	
1451118338	rs932764	PLCE1	3			3.0	Efficacy	1	1	hydrochlorothiazide	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451118338	
1451118340	rs10995311	ADO	3			3.0	Efficacy	1	1	hydrochlorothiazide	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451118340	
1451119080	rs147451859	PPCDC	3			0.0	Toxicity	1	1	docetaxel;FEC100;gemcitabine;trastuzumab;zoledronate	Amenorrhea	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451119080	
1451119086	rs17587029		3			0.0	Toxicity	1	1	docetaxel;FEC100;gemcitabine;trastuzumab;zoledronate	Amenorrhea	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451119086	
981238341	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*4, CYP2C9*5, CYP2C9*6, CYP2C9*8, CYP2C9*11	CYP2C9	1A		Tier 1 VIP	675.75	Dosage	130	215	warfarin	Cardiovascular Diseases	2021-10-05	https://www.pharmgkb.org/clinicalAnnotation/981238341	Pediatric
1451120960	rs2133896	ANKS1B	3			2.5	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451120960	
1451120980	rs2133896	ANKS1B	3			2.5	Toxicity	1	1	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451120980	
1451123020	rs910080	PDYN	3			0.75	Toxicity	1	1	opioids	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451123020	
1451123321	CYP2B6*1, CYP2B6*6	CYP2B6	3		Tier 1 VIP	1.0	Metabolism/PK	1	1	artemether		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451123321	
1451125512	rs9262132	ATAT1	3			2.5	Toxicity	1	1	carboplatin;gemcitabine	Carcinoma, Non-Small-Cell Lung;Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451125512	
1451125518	rs886423		3			2.5	Toxicity	1	1	carboplatin;gemcitabine	Carcinoma, Non-Small-Cell Lung;Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451125518	
1451125520	rs9262143	PPP1R18	3			2.5	Toxicity	1	1	carboplatin;gemcitabine	Carcinoma, Non-Small-Cell Lung;Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451125520	
1451125526	rs886424		3			2.5	Toxicity	1	1	carboplatin;gemcitabine	Carcinoma, Non-Small-Cell Lung;Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451125526	
1451125532	rs3130985	CDSN;PSORS1C1	3			2.5	Toxicity	1	1	carboplatin;gemcitabine	Carcinoma, Non-Small-Cell Lung;Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451125532	
1451125538	rs1049709	HLA-C	3			2.5	Toxicity	1	1	carboplatin;gemcitabine	Carcinoma, Non-Small-Cell Lung;Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451125538	
1451125544	rs3094086	MUCL3	3			2.5	Toxicity	1	1	carboplatin;gemcitabine	Carcinoma, Non-Small-Cell Lung;Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451125544	
981203689	rs717620	ABCC2	3			0.75	Toxicity	5	5	tenofovir	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981203689	
1451125564	rs3130907	HCP5	3			2.5	Toxicity	1	1	carboplatin;gemcitabine	Carcinoma, Non-Small-Cell Lung;Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451125564	
1451125570	rs11229	PRRC2A	3			2.5	Toxicity	1	1	carboplatin;gemcitabine	Carcinoma, Non-Small-Cell Lung;Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451125570	
1451125580	rs1800629	TNF	3			2.5	Toxicity	1	1	carboplatin;gemcitabine	Carcinoma, Non-Small-Cell Lung;Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451125580	
1451125600	rs10885	PRRC2A	3			2.5	Toxicity	1	1	carboplatin;gemcitabine	Carcinoma, Non-Small-Cell Lung;Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451125600	
1451125620	rs3115672	MSH5	3			2.5	Toxicity	1	1	carboplatin;gemcitabine	Carcinoma, Non-Small-Cell Lung;Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451125620	
1451125640	rs10491684	DOCK8	3			2.5	Toxicity	1	1	carboplatin;gemcitabine	Carcinoma, Non-Small-Cell Lung;Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451125640	
1451125646	rs1058932	CYP2C8	3		Tier 1 VIP	2.5	Toxicity	1	1	carboplatin;gemcitabine	Carcinoma, Non-Small-Cell Lung;Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451125646	
1451125660	rs11572078	CYP2C8	3		Tier 1 VIP	2.5	Toxicity	1	1	carboplatin;gemcitabine	Carcinoma, Non-Small-Cell Lung;Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451125660	
1451125666	rs6119	SERPINA5	3			2.5	Toxicity	1	1	carboplatin;gemcitabine	Carcinoma, Non-Small-Cell Lung;Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451125666	
1451125672	rs6504649	XYLT2	3			2.5	Toxicity	1	1	carboplatin;gemcitabine	Carcinoma, Non-Small-Cell Lung;Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451125672	
1451125680	rs6113	SERPINA5	3			2.5	Toxicity	1	1	carboplatin;gemcitabine	Carcinoma, Non-Small-Cell Lung;Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451125680	
1451125687	rs6118	SERPINA5	3			2.5	Toxicity	1	1	carboplatin;gemcitabine	Carcinoma, Non-Small-Cell Lung;Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451125687	
1451125693	rs73450548	ETS2	3			2.5	Toxicity	1	1	carboplatin;gemcitabine	Carcinoma, Non-Small-Cell Lung;Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451125693	
1451544841	rs1801253	ADRB1	4		Tier 1 VIP	-3.25	Efficacy	4	4	Beta Blocking Agents	Cardiomyopathy, Dilated;Heart Failure	2021-10-15	https://www.pharmgkb.org/clinicalAnnotation/1451544841	Pediatric
1451544860	rs61767072	ADRA2C	3			3.0	Efficacy	2	3	Beta Blocking Agents	Cardiomyopathy, Dilated;Death	2021-10-15	https://www.pharmgkb.org/clinicalAnnotation/1451544860	Pediatric
1451544880	rs1042713	ADRB2	4		Tier 1 VIP	-3.0	Efficacy	4	5	Beta Blocking Agents	Cardiomyopathy, Dilated;Heart Failure	2021-10-15	https://www.pharmgkb.org/clinicalAnnotation/1451544880	Pediatric
1451544980	rs10799590	CNIH3	3			2.5	Toxicity	1	1	opioids	Opioid-Related Disorders	2021-10-15	https://www.pharmgkb.org/clinicalAnnotation/1451544980	
1451547422	rs1544105	FPGS	3			2.25	Efficacy	1	1	methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-10-18	https://www.pharmgkb.org/clinicalAnnotation/1451547422	Pediatric
1451137080	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	1A		Tier 1 VIP	102.0625	Metabolism/PK	2	4	dexlansoprazole		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451137080	
1451135569	CYP2C8*1, CYP2C8*3, CYP2C8*4	CYP2C8	3		Tier 1 VIP	3.0	Metabolism/PK	2	4	diclofenac		2021-05-18	https://www.pharmgkb.org/clinicalAnnotation/1451135569	
1451548374	rs4149009	SLCO1A2	3			0.5	Metabolism/PK	2	2	methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-12-13	https://www.pharmgkb.org/clinicalAnnotation/1451548374	Pediatric
1451139061	CYP2C19*1, CYP2C19*2	CYP2C19	3		Tier 1 VIP	2.25	Metabolism/PK	1	1	dipyrone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451139061	
1451139070	NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*14	NAT2	3		Tier 1 VIP	2.25	Metabolism/PK	1	1	dipyrone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451139070	
1451139660	NAT2*4, NAT2*5, NAT2*6, NAT2*7	NAT2	3		Tier 1 VIP	6.3125	Metabolism/PK	16	18	hydralazine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451139660	
1451140140	CYP2C9*1, CYP2C9*3	CYP2C9	3		Tier 1 VIP	0.25	Toxicity	2	2	indomethacin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451140140	
1451139160	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*29	CYP2C9	4		Tier 1 VIP	-0.125	Metabolism/PK	3	3	naproxen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451139160	
1451905680	HLA-DRB1*04:02:01	HLA-DRB1	3			1.25	Toxicity	1	1	clozapine	Agranulocytosis	2022-10-06	https://www.pharmgkb.org/clinicalAnnotation/1451905680	
1451143820	NAT2*5, NAT2*6, NAT2*7, NAT2*14	NAT2	3		Tier 1 VIP	1.0	Toxicity	5	5	hydralazine	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451143820	
1451952760	rs4035887	EPAS1	3			1.5	Toxicity	1	2	sorafenib	Drug Toxicity	2022-11-30	https://www.pharmgkb.org/clinicalAnnotation/1451952760	
1451954480	rs4864950	KDR	3			0.75	Toxicity	1	2	regorafenib	Drug Toxicity	2022-12-02	https://www.pharmgkb.org/clinicalAnnotation/1451954480	
1451952780	rs4864950	KDR	3			3.5	Toxicity	1	1	sorafenib	Drug Toxicity	2022-11-30	https://www.pharmgkb.org/clinicalAnnotation/1451952780	
1451952700	rs444904	PIK3R5	3			1.5	Toxicity	1	2	sorafenib	Hypertension	2022-11-30	https://www.pharmgkb.org/clinicalAnnotation/1451952700	
1451954520	rs10958704		3			3.0	Toxicity	1	1	sorafenib	Drug Toxicity	2022-12-02	https://www.pharmgkb.org/clinicalAnnotation/1451954520	
1451954540	rs1868089	EPAS1	3			3.0	Toxicity	1	1	sorafenib	Drug Toxicity	2022-12-02	https://www.pharmgkb.org/clinicalAnnotation/1451954540	
1451152706	CYP2D6*1, CYP2D6*4	CYP2D6	3		Tier 1 VIP	0.0	Metabolism/PK	2	2	ethylmorphine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451152706	
1451954560	rs7557402	EPAS1	2B		Rare Variant	3.0	Toxicity	1	1	sorafenib	Drug Toxicity	2022-12-02	https://www.pharmgkb.org/clinicalAnnotation/1451954560	
1451158880	rs36120609	GSTM3	3			4.25	Toxicity	2	4	cisplatin;cyclophosphamide	Drug Toxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451158880	
1451158887	rs36120609	GSTM3	3			2.5	Metabolism/PK	1	2	olanzapine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451158887	
1451159780	rs371194629	HLA-G	3			2.5	Efficacy	2	2	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451159780	
1451162662	UGT1A1*1, UGT1A1*28	UGT1A1	3		Tier 1 VIP	0.0	Metabolism/PK	1	1	clozapine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451162662	
1451162986	UGT1A1*1, UGT1A1*28	UGT1A1	3		Tier 1 VIP	1.75	Efficacy	1	1	raloxifene	bone density	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451162986	
1451163060	UGT1A1*1, UGT1A1*28	UGT1A1	3		Tier 1 VIP	1.5	Metabolism/PK	2	3	raloxifene	Osteoporosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451163060	
1451165201	UGT1A1*1, UGT1A1*28	UGT1A1	3		Tier 1 VIP	3.0	Toxicity	1	1	tranilast	Hyperbilirubinemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451165201	
1451165381	UGT1A1*1, UGT1A1*6, UGT1A1*27, UGT1A1*28	UGT1A1	3		Tier 1 VIP	5.25	Toxicity	2	2	nilotinib	Hyperbilirubinemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451165381	
1451204520	UGT1A1*1, UGT1A1*28	UGT1A1	3		Tier 1 VIP	2.75	Toxicity	2	2	sorafenib	Carcinoma, Hepatocellular;Hyperbilirubinemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451204520	
1451206982	UGT1A1*1, UGT1A1*28	UGT1A1	1A		Tier 1 VIP	203.75	Dosage	10	12	irinotecan		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451206982	
1451954568	rs11125039	PRKCE	3			2.5	Toxicity	1	1	sorafenib	Hypertension	2022-12-02	https://www.pharmgkb.org/clinicalAnnotation/1451954568	
1451954620	rs11651488	MAP2K6	3			3.0	Toxicity	1	1	sorafenib	Diarrhea	2022-12-02	https://www.pharmgkb.org/clinicalAnnotation/1451954620	
1451954626	rs17682789	CDH13	3			3.0	Toxicity	1	1	sorafenib	Diarrhea	2022-12-02	https://www.pharmgkb.org/clinicalAnnotation/1451954626	
1451954640	rs9927200	WWOX	3			3.0	Toxicity	1	1	sorafenib	Diarrhea	2022-12-02	https://www.pharmgkb.org/clinicalAnnotation/1451954640	
1451212480	rs9282564	ABCB1	3		Tier 1 VIP	2.5	Toxicity	1	1	opioids	Death;Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451212480	
1451212500	rs4680	COMT	3		Tier 1 VIP	3.0	Toxicity	1	1	opioids	Death;Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451212500	
1451212540	rs62103056		3			0.0	Efficacy	1	1	tafenoquine	Malaria	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451212540	
1451212440	UGT1A1*1, UGT1A1*28	UGT1A1	4		Tier 1 VIP	-0.25	Metabolism/PK	2	2	carvedilol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451212440	
1451163884	UGT1A1*1, UGT1A1*6, UGT1A1*28, UGT1A1*36, UGT1A1*37	UGT1A1	1A		Tier 1 VIP	135.25	Toxicity	17	23	atazanavir;atazanavir / ritonavir	HIV Infections;Hyperbilirubinemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451163884	Pediatric
1451954600	rs1346563	ADAMTS18	3			3.0	Toxicity	1	1	sorafenib	Hypertension	2022-12-02	https://www.pharmgkb.org/clinicalAnnotation/1451954600	
1450823852	rs1800497	ANKK1;DRD2	3		Tier 1 VIP	2.5	Toxicity	1	1	nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450823852	Pediatric
1450823858	rs1800497	DRD2	3		Tier 1 VIP	3.0	Toxicity	1	1	nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450823858	Pediatric
1451151340	rs1042522	TP53	3			2.75	Toxicity	5	6	antineoplastic agents	Drug Toxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451151340	
1451151380	rs1042522	TP53	3			5.0	Efficacy	4	4	Platinum compounds	overall survival	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451151380	
1451215020	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	1B		Tier 1 VIP	27.375	Toxicity	24	29	FOLFIRI;irinotecan	Diarrhea	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451215020	Pediatric
1451549101	rs11280056	ENOSF1;TYMS	3		Tier 1 VIP	3.25	Toxicity	3	3	methotrexate	gastrointestinal toxicity;mucositis;Neutropenia;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-10-19	https://www.pharmgkb.org/clinicalAnnotation/1451549101	Pediatric
1451954607	rs2330951	EGFR	3			2.5	Toxicity	1	1	sorafenib	Hypertension	2022-12-02	https://www.pharmgkb.org/clinicalAnnotation/1451954607	
1450929222	rs1045642	ABCB1	3		Tier 1 VIP	5.75	Dosage	4	4	fentanyl	Pain;Pain, Postoperative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450929222	Pediatric
1451114600	rs45445694	TYMS	3		Tier 1 VIP	1.75	Toxicity	14	14	fluorouracil	Drug Toxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451114600	
1451114960	rs45445694	TYMS	3		Tier 1 VIP	3.25	Efficacy	13	13	fluorouracil;FOLFIRI;FOLFOX	overall survival;progression-free survival	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451114960	
1451243628	rs9923231	VKORC1	3		Tier 1 VIP	7.25	Toxicity	7	7	acenocoumarol	Hemorrhage	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451243628	
1451244448	rs17244841	HMGCR	3			2.5	Efficacy	1	1	simvastatin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451244448	
1184133833	CYP2B6*1, CYP2B6*4, CYP2B6*6, CYP2B6*9, CYP2B6*18, CYP2B6*28	CYP2B6	1A		Tier 1 VIP	361.5	Metabolism/PK	44	69	efavirenz	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184133833	Pediatric
1451208740	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	2A		Tier 1 VIP	24.875	Metabolism/PK	14	16	SN-38		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451208740	Pediatric
1451236700	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*13	CYP2C9	1A		Tier 1 VIP	207.875	Metabolism/PK	7	16	celecoxib		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451236700	Pediatric
1451237940	rs9923231	VKORC1	1A		Tier 1 VIP	117.0	Dosage	10	11	phenprocoumon		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451237940	Pediatric
1451242500	CYP2B6*1, CYP2B6*6, CYP2B6*26	CYP2B6	1A		Tier 1 VIP	200.5	Dosage	4	6	efavirenz	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451242500	
1451243676	rs9923231	VKORC1	2A		Tier 1 VIP	8.25	Toxicity	3	4	phenprocoumon	Hemorrhage;over-anticoagulation;time above therapeutic range	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451243676	
1451244040	rs9934438	VKORC1	2A		Tier 1 VIP	9.25	Dosage	4	4	phenprocoumon		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451244040	Pediatric
1451245360	rs1051266	SLC19A1	2A		Tier 1 VIP	14.125	Efficacy	9	10	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451245360	
1451250540	rs121434569	EGFR	2B		Rare Variant	8.75	Efficacy	16	16	gefitinib	Carcinoma, Non-Small-Cell Lung;Drug Resistance	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451250540	
1451251080	CYP3A4*1, CYP3A4*3, CYP3A4*20, CYP3A4*22	CYP3A4	2A		Tier 1 VIP	9.75	Dosage	8	8	tacrolimus	Kidney Transplantation;Organ Transplantation	2021-05-20	https://www.pharmgkb.org/clinicalAnnotation/1451251080	Pediatric
1451237200	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C, TPMT*9	TPMT	1A		Tier 1 VIP	221.25	Dosage	20	27	mercaptopurine	dose reduction	2021-06-08	https://www.pharmgkb.org/clinicalAnnotation/1451237200	Pediatric
1451237326	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	1A		Tier 1 VIP	109.125	Dosage	9	11	azathioprine	dose reduction	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451237326	Pediatric
1451237240	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C, TPMT*6	TPMT	1A		Tier 1 VIP	122.25	Toxicity	37	43	azathioprine	Leukopenia;Myelosuppression	2022-04-13	https://www.pharmgkb.org/clinicalAnnotation/1451237240	Pediatric
1450929125	rs1051730	CHRNA3	3			2.5	Dosage	2	2	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450929125	
1450929131	rs1051730	CHRNA3	3			2.0	Other	1	1	nicotine	Pregnancy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450929131	
1451954660	rs917881	EGFR	3			1.5	Toxicity	1	2	sorafenib	Diarrhea	2022-12-02	https://www.pharmgkb.org/clinicalAnnotation/1451954660	
1451954683	rs12948059	MAP2K6	3			2.5	Toxicity	1	1	sorafenib	Drug Toxicity	2022-12-02	https://www.pharmgkb.org/clinicalAnnotation/1451954683	
1450811960	rs648007	OPRM1	3			3.25	Efficacy	1	1	ethanol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450811960	
1450930542	rs16872401		3			2.25	Efficacy	1	1	atenolol	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450930542	
1449645543	rs1293732453	SULT1A3	3		Rare Variant	0.0	Metabolism/PK	1	1	tapentadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645543	
1449645555	rs1328799050	SULT1A3	3		Rare Variant	0.0	Metabolism/PK	1	1	acetaminophen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645555	
1449645561	rs1328799050	SULT1A3	3		Rare Variant	0.0	Metabolism/PK	1	1	morphine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645561	
1449645567	rs1328799050	SULT1A3	3		Rare Variant	0.0	Metabolism/PK	1	1	tapentadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645567	
1449645573	rs1328799050	SULT1A3	3		Rare Variant	0.0	Metabolism/PK	1	1	o-desmethyltramadol;tramadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645573	
1449733531	rs8124728	SAMHD1	3			2.75	Toxicity	1	1	stavudine	HIV Infections;Peripheral Nervous System Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449733531	
1450811948	rs524731	OPRM1	3			3.25	Efficacy	1	1	ethanol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450811948	
1450812260	rs2236861	OPRD1	3			1.0	Toxicity	2	2	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450812260	
1451952740	rs12366035	VEGFB	3			1.5	Toxicity	1	2	sorafenib	Drug Toxicity	2022-11-30	https://www.pharmgkb.org/clinicalAnnotation/1451952740	
1451954700	rs315498		3			3.0	Toxicity	1	1	sorafenib	Drug Toxicity	2022-12-02	https://www.pharmgkb.org/clinicalAnnotation/1451954700	
1451954720	rs9973653	EPAS1	3			3.0	Toxicity	1	1	sorafenib	Drug Toxicity	2022-12-02	https://www.pharmgkb.org/clinicalAnnotation/1451954720	
1449003966	rs4720833	MAFK	3			0.75	Toxicity	2	2	isoniazid	drug-induced liver injury;Toxic liver disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449003966	
1449167106	rs17685420	PEBP4	3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449167106	Pediatric
1449167120	rs3210967	ZDHHC7	3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449167120	Pediatric
1449167147	rs10413455	ZNF134	3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449167147	Pediatric
1449167178	rs2071421	ARSA	3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449167178	Pediatric
1449167200	rs12302749	SPSB2	3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449167200	Pediatric
1449167211	rs10420097	ZNF211	3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449167211	Pediatric
1449167228	rs3810818	CORO7	3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449167228	Pediatric
1449167256	rs9901675	FXR2	3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449167256	Pediatric
1449167267	rs4805162	ZNF565	3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449167267	Pediatric
1449167278	rs4562	ELP5	3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449167278	Pediatric
1449168649	rs61908411	ANO2	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168649	
1449168656	rs7316769		3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168656	
1449168663	rs7306991		3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168663	
1449715840	rs540825	OPRM1	3			2.0	Toxicity	1	1	fentanyl	Vomiting	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449715840	
1450810399	rs648893	OPRM1	3			0.0	Toxicity	1	1	opioids	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450810399	
1450930833	rs7178270	CHRNB4	3			3.0	Toxicity	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450930833	
1449167469	rs11552708	SENP3	3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449167469	Pediatric
1449167480	rs1061735	ESYT2	3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449167480	Pediatric
1449167495	rs11553441	RRP7A	3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449167495	Pediatric
1449167512	rs362272	HTT	3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449167512	Pediatric
1449167529	rs757978	FARP2	3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449167529	Pediatric
1449167546	rs17279558	GGH	3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449167546	Pediatric
1449167557	rs3761372		3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449167557	Pediatric
1449167584	rs2013169	PURA	3			0.0	Efficacy	1	1	methylphenidate	Attention Deficit Disorder with Hyperactivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449167584	Pediatric
1449168093	rs9310657	ZNF385D	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168093	
1449168330	rs9310658	ZNF385D	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168330	
1449168337	rs7616119	ZNF385D	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168337	
1449168343	rs7653345	ZNF385D	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168343	
1449168350	rs9819548	ZNF385D	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168350	
1449168357	rs13093500	ZNF385D	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168357	
1449168454	rs4639250	TTC37	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168454	
1449168461	rs9369266	TREML4	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168461	
1450812253	rs1534891	CSNK1E	3			0.0	Toxicity	2	2	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450812253	
1449171009	rs2740574	CYP3A4	3		Tier 1 VIP	2.25	Dosage	2	2	buprenorphine	Opioid-Related Disorders	2021-05-18	https://www.pharmgkb.org/clinicalAnnotation/1449171009	
1449168468	rs13204353	TREML4	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168468	
1449168475	rs10123866	INVS	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168475	
1449168482	rs7472	TEX10	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168482	
1449168489	rs10124893	TEX10	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168489	
1449168496	rs7035619	TEX10	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168496	
1449168503	rs6479008	TEX10	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168503	
1449168510	rs10989064	TEX10	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168510	
1449168517	rs3124955	FCN2	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168517	
1449168524	rs3128624	FCN2	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168524	
1449168531	rs61908402	ANO2	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168531	
1449168538	rs61908403	ANO2	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168538	
1449168545	rs61908404	ANO2	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168545	
1449168552	rs61908405	ANO2	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168552	
1449168559	rs17724452	ANO2	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168559	
1449168565	rs17724464	ANO2	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168565	
1449168572	rs17786394	ANO2	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168572	
1449168579	rs17786400	ANO2	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168579	
1449168586	rs61908406	ANO2	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168586	
1449168593	rs17786412	ANO2	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168593	
1449168600	rs61908407	ANO2	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168600	
1449168607	rs61908408	ANO2	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168607	
1449168614	rs61908409	ANO2	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168614	
1449168691	rs12595802	ATP10A	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168691	
1449168698	rs3889402	MIEF2	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168698	
1449168705	rs12603700	MIEF2	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168705	
1449168712	rs56355515	MIEF2	3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168712	
1449168719	rs58042962		3			0.0	Efficacy	1	1	duloxetine	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449168719	
1449566334	HLA-A*24:02:01:01	HLA-A	3			2.25	Toxicity	1	1	phenytoin	Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449566334	Pediatric
1450808778	rs1800497	DRD2	3		Tier 1 VIP	2.0	Toxicity	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450808778	
1449296086	CYP3A4*1, CYP3A4*18, CYP3A4*36	CYP3A4	2A		Tier 1 VIP	8.875	Dosage	9	10	fentanyl	Pain, Postoperative	2022-03-23	https://www.pharmgkb.org/clinicalAnnotation/1449296086	
1450814192	rs671531	OPRM1	3			1.75	Efficacy	1	1	highly active antiretroviral therapy (haart)	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450814192	
1450814424	rs1801131	MTHFR	3		Tier 1 VIP	2.75	Efficacy	2	2	l-methylfolate;Vitamin B-complex, Incl. Combinations	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450814424	Pediatric
1450814430	rs1801133	MTHFR	3		Tier 1 VIP	2.75	Efficacy	2	2	l-methylfolate;Vitamin B-complex, Incl. Combinations	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450814430	
1450814563	rs11503014	GABRA2	3			2.0	Toxicity	1	1	cocaine	Cocaine-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450814563	
1450815114	rs6688363	ATP1A2	3			0.0	Efficacy	1	1	olanzapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450815114	
1450815136	rs17382202	PDE4D	3			0.0	Efficacy	1	1	quetiapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450815136	
1450928823	rs2036527	CHRNA5	3			2.25	Efficacy	1	1	varenicline	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450928823	
1450929143	rs1051730	CHRNA3	3			2.5	Toxicity	1	1	nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450929143	
1450929810	rs1045642	ABCB1	3		Tier 1 VIP	2.0	Dosage	2	2	oxycodone	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450929810	
1450934868	rs1718125	P2RX7	3			0.25	Dosage	2	2	fentanyl	Pain, Postoperative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450934868	
1449161121	rs1800896	IL10	3			3.0	Toxicity	1	1	Antiinflammatory agents, non-steroids		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449161121	
1449715590	rs7439366	UGT2B7	3			1.0	Efficacy	2	2	fentanyl	Pain, Postoperative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449715590	
1449748202	rs20455	KIF6	3			1.5	Efficacy	1	2	rosuvastatin	Hypercholesterolemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449748202	
1450376319	rs78239784	CFHR4	3			3.0	Toxicity	1	1	phenytoin	Maculopapular Exanthema	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450376319	
1450809657	rs5443	GNB3	3			3.5	Efficacy	1	1	sibutramine	Obesity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450809657	
1450810375	rs495491	OPRM1	3			1.25	Toxicity	2	2	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450810375	Pediatric
1450811942	rs553202	OPRM1	3			3.25	Efficacy	1	1	ethanol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450811942	
1450812204	rs694066	GAL	3			0.0	Toxicity	1	1	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450812204	
1450812241	rs3778151	OPRM1	3			1.5	Toxicity	3	3	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450812241	
1450812247	rs6473797	OPRK1	3			0.0	Toxicity	1	1	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450812247	
1450813875	rs8109525	CYP2B6	3		Tier 1 VIP	2.75	Efficacy	1	1	bupropion	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450813875	
1450933023	rs1544410	VDR	3			2.0	Efficacy	1	1	deferasirox	beta-Thalassemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450933023	
1450935050	HLA-A*32:01:01	HLA-A	3			3.0	Toxicity	2	2	vancomycin	drug reaction with eosinophilia and systemic symptoms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450935050	
1450806640	rs1799972	OPRM1	4			-1.5	Toxicity	2	2	opioids	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450806640	
1450806626	rs1799971	OPRM1	4			-5.5	Toxicity	11	12	opioids	Opioid-Related Disorders	2021-04-05	https://www.pharmgkb.org/clinicalAnnotation/1450806626	Pediatric
1450935200	rs2740574	CYP3A4	3		Tier 1 VIP	0.0	Metabolism/PK	2	2	cyclosporine	Kidney Transplantation	2021-05-13	https://www.pharmgkb.org/clinicalAnnotation/1450935200	
1450811641	rs1128503	ABCB1	4		Tier 1 VIP	-2.25	Dosage	4	4	methadone	Heroin Dependence;Opioid-Related Disorders	2022-01-10	https://www.pharmgkb.org/clinicalAnnotation/1450811641	
1449188689	rs1799971	OPRM1	3			1.75	Metabolism/PK	1	1	cotinine;nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449188689	
1449188695	rs12209447	OPRM1	3			2.25	Metabolism/PK	1	1	cotinine;nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449188695	
1449188749	rs563649	OPRM1	3			2.25	Metabolism/PK	1	1	cotinine;nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449188749	
1449188755	rs2075572	OPRM1	3			1.75	Metabolism/PK	1	1	cotinine;nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449188755	
1449190104	rs1045642	ABCB1	3		Tier 1 VIP	1.75	Toxicity	1	1	antineoplastic agents	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449190104	
1449190397	rs62638690	OPRM1	3		Rare Variant	3.0	Toxicity	1	1	cocaine;heroin	Cocaine-Related Disorders;Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449190397	
1449190422	rs1076560	DRD2	3		Tier 1 VIP	3.5	Other	3	3	opioids	Heroin Dependence;Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449190422	
1449271003	rs117341846	PIK3R2	3			0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449271003	
1449271039	rs55633228	PIK3R2	3		Rare Variant	0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449271039	
1450808106	rs9479757	OPRM1	3			2.0	Dosage	1	1	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450808106	
1450813540	rs72552266	CYP2A13	3		Rare Variant	2.5	Toxicity	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450813540	
1450934191	rs886043595	SCN4A	3		Rare Variant	0.0	Efficacy	1	1	mexiletine	Myotonic Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450934191	
1449275238	rs1799971	OPRM1	4			-4.0	Toxicity	12	12	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449275238	
1450809583	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*62	CYP2C9	3		Tier 1 VIP	0.875	Metabolism/PK	3	6	tolbutamide		2021-05-18	https://www.pharmgkb.org/clinicalAnnotation/1450809583	
1450813547	CYP2A6*1, CYP2A6*1x2, CYP2A6*2	CYP2A6	3		Tier 1 VIP	3.0	Toxicity	1	2	nicotine	Tobacco Use Disorder	2022-09-29	https://www.pharmgkb.org/clinicalAnnotation/1450813547	
1450811035	rs104894021	KCNH2	3		Rare Variant	0.0	Efficacy	1	2	disopyramide	short qt syndrome 1	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450811035	
1450811044	rs104894021	KCNH2	3		Rare Variant	0.0	Efficacy	1	2	quinidine	short qt syndrome 1	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450811044	
1450811267	rs2031920	CYP2E1	3			0.0	Toxicity	3	4	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450811267	
1450811379	CYP2B6*1, CYP2B6*6	CYP2B6	3		Tier 1 VIP	1.25	Efficacy	2	2	bupropion	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450811379	
1450811954	rs548646	OPRM1	3			3.25	Efficacy	1	1	ethanol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450811954	
1450811966	rs3778148	OPRM1	3			3.25	Efficacy	1	1	ethanol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450811966	
1450811978	rs2075572	OPRM1	3			3.25	Efficacy	1	1	ethanol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450811978	
1450811984	rs681243	OPRM1	3			3.25	Efficacy	1	1	ethanol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450811984	
1450815104	rs813676	TJP1	3			0.0	Efficacy	1	1	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450815104	
1450815154	rs711355	TJP1	3			0.0	Efficacy	1	1	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450815154	
1450815172	rs2636719	PPA2	3			0.0	Efficacy	1	1	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450815172	
1450826899	rs1799971	OPRM1	3			2.75	Dosage	1	1	alfentanil	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450826899	
1450826919	rs1799971	OPRM1	3			2.25	Dosage	1	1	codeine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450826919	
1450826949	rs1799971	OPRM1	3			1.75	Efficacy	6	6	fentanyl	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450826949	
1450929037	rs795484	TAOK3	3			2.5	Dosage	1	1	opioids	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450929037	
1450929137	rs1051730	CHRNA3	3			3.0	Other	1	1	Drugs used in nicotine dependence;nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450929137	
1450933011	rs1983023	UGT1A3	3			2.5	Efficacy	1	1	deferasirox	beta-Thalassemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450933011	
1450935856	rs144928727	CYP2C19	3		Rare Variant; Tier 1 VIP	0.125	Metabolism/PK	1	1	mephenytoin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450935856	
1450936159	rs765399160	SULT1A1	3		Rare Variant	0.0	Metabolism/PK	1	1	desmethylnaproxen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936159	
1450936211	rs1042028	SULT1A1	3			0.0	Metabolism/PK	1	1	acetaminophen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936211	
1450936236	rs1042008	SULT1A1	3		Rare Variant	0.0	Metabolism/PK	1	1	acetaminophen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936236	
1450936248	rs1042008	SULT1A1	3		Rare Variant	0.0	Metabolism/PK	1	1	desmethylnaproxen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936248	
1450936266	rs767487725	SULT1A1	3		Rare Variant	0.0	Metabolism/PK	1	1	desmethylnaproxen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936266	
1450936278	rs758145522	SULT1A1	3		Rare Variant	0.0	Metabolism/PK	1	1	tapentadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936278	
1450936290	rs544820732	SULT1A1	3		Rare Variant	0.0	Metabolism/PK	1	1	acetaminophen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936290	
1450936320	rs552524124	SULT1A1	3		Rare Variant	0.0	Metabolism/PK	1	1	desmethylnaproxen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936320	
1450936577	rs28362731	AQP1	3			2.5	Toxicity	1	1	cisplatin	Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936577	
1450936592	rs1049305	AQP1	3			2.0	Toxicity	1	1	cisplatin	Anemia;Mesothelioma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936592	
1450826957	rs1799971	OPRM1	3			1.0	Efficacy	5	5	morphine	Pain;Pain, Postoperative	2021-04-09	https://www.pharmgkb.org/clinicalAnnotation/1450826957	Pediatric
1450929798	rs1045642	ABCB1	4		Tier 1 VIP	-3.5	Dosage	6	6	methadone	Heroin Dependence;Opioid-Related Disorders	2022-01-10	https://www.pharmgkb.org/clinicalAnnotation/1450929798	
1450929792	rs1045642	ABCB1	3		Tier 1 VIP	3.0	Dosage	2	2	methadone	Pain	2022-01-12	https://www.pharmgkb.org/clinicalAnnotation/1450929792	
1450826969	rs1799971	OPRM1	3			0.5	Dosage	3	3	oxycodone	Pain;Pain, Postoperative	2022-02-10	https://www.pharmgkb.org/clinicalAnnotation/1450826969	
1449003759	rs710446	KNG1	3			2.5	Toxicity	1	1	hormonal contraceptives for systemic use		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449003759	
1449003777	rs2289252	F11	3			3.0	Toxicity	1	1	hormonal contraceptives for systemic use		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449003777	
1449003799	rs4379368	SUGCT	3			2.5	Toxicity	1	1	hormonal contraceptives for systemic use		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449003799	
1449003805	rs56392308	ABO	3			3.0	Toxicity	1	1	hormonal contraceptives for systemic use		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449003805	
1449270985	rs41412545	INSR	3			0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449270985	
1449270991	rs118129530	PIK3R2	3			0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449270991	
1449270997	rs56022120	PIK3R2	3			0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449270997	
1449271009	rs117951771	PIK3R2	3		Rare Variant	0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449271009	
1449271015	rs148235907	PIK3R2	3			0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449271015	
1449271021	rs138602176	PIK3R2	3			0.0	Toxicity	1	1	cyclophosphamide;epirubicin;fluorouracil	Breast Neoplasms;Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449271021	
1449271288	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	3			2.5	Efficacy	1	1	buprenorphine;methadone	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449271288	
1450375065	rs238406	ERCC2	3			3.0	Toxicity	1	1	bleomycin;cisplatin;etoposide	Leukopenia;Testicular Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450375065	
1450807362	rs2075572	OPRM1	3			2.25	Toxicity	1	1	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450807362	
1450822690	rs678849	OPRD1	3			3.5	Toxicity	1	1	cocaine	Cocaine-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450822690	
1450822710	SLCO1B1*1, SLCO1B1*15	SLCO1B1	3		Tier 1 VIP	3.5	Toxicity	1	1	rifampin	drug-induced liver injury	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450822710	
1450823123	rs562859	OPRM1	3			3.5	Toxicity	1	1	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450823123	
1450823150	rs9478495		3			3.5	Toxicity	1	1	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450823150	
1450932256	rs9332096	CYP2C9	3		Tier 1 VIP	3.5	Toxicity	2	2	ethambutol;isoniazid;pyrazinamide;rifampin	Maculopapular Exanthema;Tuberculosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450932256	
1450936183	rs28374453	NPIPB8;SULT1A1	3			0.0	Metabolism/PK	1	1	desmethylnaproxen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936183	
1450936224	rs72547527	SULT1A1	3		Rare Variant	0.0	Metabolism/PK	1	1	desmethylnaproxen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936224	
1450936230	rs72547527	SULT1A1	3		Rare Variant	0.0	Metabolism/PK	1	1	tapentadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936230	
1450936254	rs767487725	SULT1A1	3		Rare Variant	0.0	Metabolism/PK	1	1	acetaminophen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936254	
1449310414	CYP2D6*1, CYP2D6*2xN	CYP2D6	3		Tier 1 VIP	0.0	Toxicity	1	1	hydrocodone	Drug Toxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449310414	
1449565774	CYP2C9*1, CYP2C9*19, CYP2C9*27, CYP2C9*36, CYP2C9*40, CYP2C9*41, CYP2C9*47, CYP2C9*49, CYP2C9*51, CYP2C9*53, CYP2C9*54, CYP2C9*56	CYP2C9	3		Tier 1 VIP	0.0	Metabolism/PK	2	12	phenytoin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449565774	
1449645356	rs767263838	SULT1A3	3		Rare Variant	0.0	Metabolism/PK	1	1	acetaminophen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645356	
1449645398	rs757573592	SULT1A3	3		Rare Variant	0.0	Metabolism/PK	1	1	tapentadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645398	
1449645404	rs757573592	SULT1A3	3		Rare Variant	0.0	Metabolism/PK	1	1	o-desmethyltramadol;tramadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645404	
1449645414	rs776817009	SULT1A3	3		Rare Variant	0.0	Metabolism/PK	1	1	acetaminophen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645414	
1449645420	rs776817009	SULT1A3	3		Rare Variant	0.0	Metabolism/PK	1	1	tapentadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645420	
1449645426	rs776817009	SULT1A3	3		Rare Variant	0.0	Metabolism/PK	1	1	o-desmethyltramadol;tramadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645426	
1449645549	rs1293732453	SULT1A3	3		Rare Variant	0.0	Metabolism/PK	1	1	o-desmethyltramadol;tramadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449645549	
1449752831	HLA-A*24:02:01:01	HLA-A	3			0.0	Toxicity	1	1	dapsone	Drug Hypersensitivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449752831	
1449752836	HLA-DRB1*15:01:01:01, HLA-DRB1*16:02:01	HLA-DRB1	3			0.0	Toxicity	1	2	dapsone	Drug Hypersensitivity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449752836	
1450810363	rs3778156	OPRM1	3			3.25	Toxicity	1	1	opioids	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450810363	Pediatric
1450811346	rs1799971	OPRM1	3			1.5	Efficacy	1	1	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450811346	
1450812210	rs510769	OPRM1	3			3.5	Toxicity	2	2	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450812210	
1450812223	rs3766951	OPRD1	3			3.0	Toxicity	2	2	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450812223	
1450824225	rs429358	APOE	3			3.0	Efficacy	1	1	hmg coa reductase inhibitors	Alzheimer Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450824225	
1450824473	rs3778150	OPRM1	3			2.25	Efficacy	1	1	ethanol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450824473	
1450826931	rs1799971	OPRM1	3			3.625	Dosage	9	9	fentanyl	Pain;Pain, Postoperative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450826931	
1450826975	rs1799971	OPRM1	3			1.25	Dosage	4	4	sufentanil	Pain;Pain, Postoperative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450826975	
1449266588	rs1045642	ABCB1	3		Tier 1 VIP	5.625	Metabolism/PK	7	8	methadone	Opioid-Related Disorders	2021-04-01	https://www.pharmgkb.org/clinicalAnnotation/1449266588	
1449266582	rs7439366	UGT2B7	3			1.5	Metabolism/PK	1	1	(R)-methadone;methadone;S-EDDP	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449266582	
1450931850	CYP3A4*1, CYP3A4*3, CYP3A4*20, CYP3A4*22, CYP3A4*36	CYP3A4	3		Tier 1 VIP	2.75	Metabolism/PK	5	5	fentanyl		2022-03-23	https://www.pharmgkb.org/clinicalAnnotation/1450931850	Pediatric
1449311670	rs1128503	ABCB1	3		Tier 1 VIP	2.0	Efficacy	1	1	propofol;remifentanil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449311670	Pediatric
1450815098	rs10170310	SPOPL	3			0.0	Efficacy	1	1	olanzapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450815098	
1450931960	rs5441	GNB3;P3H3	3			2.75	Efficacy	1	1	sertraline	Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450931960	
1450934500	rs869312136	GLA;HNRNPH2	3			0.0	Efficacy	1	1	migalastat	Fabry Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450934500	
1450934662	rs398123217	GLA	3			0.0	Efficacy	1	1	migalastat	Fabry Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450934662	
1450936314	rs552524124	SULT1A1	3		Rare Variant	0.0	Metabolism/PK	1	1	acetaminophen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936314	
1450936557	rs1049305	AQP1	3			2.5	Toxicity	1	1	cisplatin	Mesothelioma;Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936557	
1450936586	rs1049305	AQP1	3			2.0	Toxicity	1	1	cisplatin	Alopecia;Mesothelioma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450936586	
1449003875	rs2233945	PSORS1C1	3			2.5	Efficacy	1	1	etanercept	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449003875	
1449003881	rs12459249		3			0.0	Metabolism/PK	1	1	nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449003881	
1449003918	rs199564443	FOXF2	3			0.0	Toxicity	1	1	Antithyroid Preparations	Agranulocytosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449003918	
1449003926	rs1071816	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	Antithyroid Preparations	Agranulocytosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449003926	
1449003946	HLA-B*08:01:01	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	Antithyroid Preparations	Agranulocytosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449003946	
1449003951	HLA-B*27:05:02	HLA-B	3		Tier 1 VIP	0.0	Toxicity	1	1	Antithyroid Preparations	Agranulocytosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449003951	
1449191764	rs34911792	CFTR	3		Rare Variant; Tier 1 VIP	0.0	Efficacy	1	1	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191764	
1449191874	rs397508453	CFTR	3		Rare Variant; Tier 1 VIP	2.0	Efficacy	1	1	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191874	Pediatric
1449192420	rs74551128	CFTR	3		Rare Variant; Tier 1 VIP	0.25	Efficacy	1	1	ivacaftor / lumacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449192420	
1449192431	rs397508602	CFTR	3		Rare Variant; Tier 1 VIP	0.25	Efficacy	1	1	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449192431	
1449192570	rs121909047	CFTR	3		Rare Variant; Tier 1 VIP	0.0	Efficacy	2	2	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449192570	
1450809956	rs2075572	OPRM1	3			2.25	Toxicity	1	1	methamphetamine	methamphetamine dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450809956	
1450811519	CYP2B6*1, CYP2B6*6	CYP2B6	3		Tier 1 VIP	2.125	Metabolism/PK	2	2	cotinine;nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450811519	
1450812410	rs2239128	CACNA1C	3			1.5	Efficacy	1	1	nimodipine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450812410	
1450815130	rs2980976	TNFRSF11A	3			0.0	Efficacy	1	1	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450815130	
1450826981	rs1799971	OPRM1	3			2.25	Efficacy	1	1	acetaminophen;tramadol	neuropathic pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450826981	
1450826963	rs1799971	OPRM1	4			-1.75	Metabolism/PK	3	3	morphine		2021-04-16	https://www.pharmgkb.org/clinicalAnnotation/1450826963	
1449717812	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*10	CYP2D6	3		Tier 1 VIP	2.875	Dosage	3	4	carvedilol	Heart Failure	2021-04-22	https://www.pharmgkb.org/clinicalAnnotation/1449717812	
1449191758	rs75541969	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191758	
1449191770	rs11971167	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191770	
1449266594	rs9282564	ABCB1	3		Tier 1 VIP	1.5	Metabolism/PK	1	1	methadone	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449266594	
1450808823	rs1799971	OPRM1	3			3.75	Toxicity	4	5	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450808823	
1450934668	rs397515874	GLA	3		Rare Variant	0.0	Efficacy	1	1	migalastat	Fabry Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450934668	
1450934711	rs727504348	GLA	3			0.0	Efficacy	1	1	migalastat	Fabry Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450934711	
1450935171	rs1799971	OPRM1	3			2.75	Toxicity	1	1	tianeptine	Depressive Disorder, Major;suicidal ideation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450935171	
1450959380	rs5030843	PAH	3		Rare Variant	0.0	Metabolism/PK	1	1	l-phenylalanine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450959380	
1450959386	rs75193786	PAH	3		Rare Variant	0.0	Metabolism/PK	1	1	carbocisteine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450959386	
1450959460	rs5030843	PAH	3		Rare Variant	0.0	Metabolism/PK	1	1	carbocisteine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450959460	
1450959480	rs138809906	PAH	3		Rare Variant	0.0	Metabolism/PK	1	1	carbocisteine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450959480	
1450959486	rs5030849	PAH	3		Rare Variant	0.0	Metabolism/PK	1	1	l-phenylalanine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450959486	
1450959492	rs5030849	PAH	3		Rare Variant	0.0	Metabolism/PK	1	1	carbocisteine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450959492	
1450959498	rs62516101	PAH	3		Rare Variant	0.0	Metabolism/PK	1	1	carbocisteine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450959498	
1450959500	rs62516101	PAH	3		Rare Variant	0.0	Metabolism/PK	1	1	l-phenylalanine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450959500	
1450959506	rs5030858	PAH	3		Rare Variant	0.0	Metabolism/PK	1	1	l-phenylalanine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450959506	
1450959524	rs5030858	PAH	3		Rare Variant	0.0	Metabolism/PK	1	1	carbocisteine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450959524	
1450959530	rs5030860	PAH	3		Rare Variant	0.0	Metabolism/PK	1	1	carbocisteine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450959530	
1450959540	rs5030860	PAH	3		Rare Variant	0.0	Metabolism/PK	1	1	l-phenylalanine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450959540	
1450959560	rs76394784	PAH	3		Rare Variant	0.0	Metabolism/PK	1	1	l-phenylalanine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450959560	
1451101225	rs72732317		3			1.5	Metabolism/PK	1	1	o-desmethyltramadol;tramadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451101225	
1451101231	rs184199168	RGL4	3		Rare Variant	1.5	Metabolism/PK	1	1	o-desmethyltramadol;tramadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451101231	
1451101242	rs62435418	ICA1	3			1.5	Metabolism/PK	1	1	o-desmethyltramadol;tramadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451101242	
1451101248	rs79983226	HCN1	3			1.5	Metabolism/PK	1	1	o-desmethyltramadol;tramadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451101248	
1451101280	rs9384825	RFPL4B	3			1.5	Metabolism/PK	1	1	o-desmethyltramadol;tramadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451101280	
1451101400	rs4643	PGM1	3			1.5	Metabolism/PK	1	2	acetaldehyde		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451101400	
1451101406	rs671	ALDH2	3		Rare Variant	4.0	Metabolism/PK	1	2	ethanol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451101406	
1451103260	rs4149117	SLCO1B3	3			2.0	Efficacy	1	1	mycophenolic acid	chronic lung allograft dysfunction;lung transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451103260	
1451103280	rs7311358	SLCO1B3	3			3.0	Efficacy	1	1	mycophenolic acid	lung transplantation;overall survival	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451103280	
1451103320	rs4149117	SLCO1B3	3			2.5	Efficacy	1	1	mycophenolic acid	lung transplantation;transplant rejection	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451103320	
1451103340	rs7311358	SLCO1B3	3			2.5	Efficacy	1	1	mycophenolic acid	lung transplantation;transplant rejection	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451103340	
1451103360	rs7311358	SLCO1B3	3			0.0	Efficacy	1	1	mycophenolic acid	chronic lung allograft dysfunction;lung transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451103360	
1451105061	rs222749	TRPV1	3			2.5	Efficacy	1	1	botulinum toxin type a	Migraine NOS	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451105061	
1451105080	rs3781719	CALCA	3			2.0	Efficacy	1	1	botulinum toxin type a	Migraine NOS	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451105080	
1451105180	rs4149032	SLCO1B1	3		Tier 1 VIP	2.25	Metabolism/PK	1	1	letermovir		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451105180	
1451105200	rs4149056	SLCO1B1	3		Tier 1 VIP	2.25	Metabolism/PK	1	1	letermovir		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451105200	
1451105206	rs4148323	UGT1A1	3		Rare Variant; Tier 1 VIP	1.75	Metabolism/PK	1	1	letermovir		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451105206	
1451105228	rs12364283	DRD2	3		Tier 1 VIP	3.5	Toxicity	1	1	heroin	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451105228	
1450826987	rs1799971	OPRM1	3			7.0	Dosage	8	9	opioids	Pain;Pain, Postoperative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450826987	
1451106200	rs45545233	SLC4A1	3			0.0	Efficacy	1	1	atenolol;metoprolol	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451106200	
1451106206	rs294610		3			0.0	Efficacy	1	1	atenolol;metoprolol	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451106206	
1451106265	rs9828223		3			2.25	Efficacy	1	1	adalimumab	Crohn Disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451106265	
1451106460	rs2251214	SYT1	3			3.5	Toxicity	1	1	cocaine	Cocaine-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451106460	
1451106705	rs28363170	SLC6A3	3			2.5	Efficacy	1	1	disulfiram	Cocaine-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451106705	
1451107342	rs1042713	ADRB2	3		Tier 1 VIP	1.75	Efficacy	1	1	atenolol;metoprolol	Tachycardia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451107342	
1451107360	rs1042714	ADRB2	3		Tier 1 VIP	1.75	Efficacy	1	1	atenolol;metoprolol	Tachycardia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451107360	
1451112120	CYP4F2*1, CYP4F2*3	CYP4F2	3		Tier 1 VIP	2.0	Metabolism/PK	1	1	Vitamin K1		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451112120	
1451114072	rs679899	APOB	3			3.0	Toxicity	1	1	warfarin	heart valve replacement;Hemorrhage	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451114072	
1451114080	rs1367117	APOB	3			3.0	Toxicity	1	1	warfarin	heart valve replacement;Hemorrhage	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451114080	
1451116049	rs776746	CYP3A;CYP3A5;ZSCAN25	3		Tier 1 VIP	1.25	Metabolism/PK	1	1	lopinavir	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451116049	
1451116107	CYP3A4*1, CYP3A4*22	CYP3A4	3		Tier 1 VIP	1.5	Metabolism/PK	2	2	lopinavir	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451116107	
1451117560	rs1446468		3			3.0	Efficacy	1	1	metoprolol	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451117560	
1451117580	rs757081	NUCB2	3			3.0	Efficacy	1	1	hydrochlorothiazide	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451117580	
1451117590	rs9306160	RRP1B	3			3.0	Efficacy	1	1	atenolol	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451117590	
1451117620	rs3184504	SH2B3	3			3.0	Efficacy	1	1	candesartan	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451117620	
1451118364	rs10224002	PRKAG2	3			3.0	Efficacy	1	1	hydrochlorothiazide	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451118364	
1451118370	rs740406	DOT1L;PLEKHJ1	3			3.0	Efficacy	1	1	candesartan	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451118370	
1451118760	rs1045642	ABCB1	3		Tier 1 VIP	0.5	Dosage	1	2	remifentanil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451118760	
1451118766	rs1045642	ABCB1	3		Tier 1 VIP	1.5	Efficacy	1	2	remifentanil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451118766	
1451118940	rs114077267	MCOLN1	3			1.5	Toxicity	1	1	opioids	Overdose	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451118940	
1451118946	rs115208233	MCOLN1	3			1.25	Toxicity	1	1	opioids	Overdose	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451118946	
1451118960	rs116181528	MCOLN1	3			1.25	Toxicity	1	1	opioids	Overdose	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451118960	
1451120280	rs1801133	MTHFR	3		Tier 1 VIP	0.25	Toxicity	1	1	phenobarbital;phenytoin	Epilepsy;Psychotic Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451120280	
1451120359	rs2229959	CHRNA4	3			2.5	Toxicity	1	1	nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451120359	
1451120421	rs578776	CHRNA3;CHRNA5	3			2.5	Toxicity	1	1	nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451120421	
1451120427	rs1044396	CHRNA4	3			2.0	Toxicity	1	1	nicotine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451120427	
1451120561	rs28404156	BST1	3			1.5	Efficacy	1	1	Beta blocking agents, selective	Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451120561	
1451120702	rs7720513		3			0.0	Toxicity	1	1	antipsychotics	Weight gain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451120702	
1451120760	rs1525085	DGKB	3			0.0	Toxicity	1	1	antipsychotics	Weight gain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451120760	
1451120986	rs2133896	ANKS1B	3			2.5	Toxicity	1	1	methamphetamine	methamphetamine dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451120986	
1451121780	rs581111	OPRD1	3			2.0	Efficacy	1	1	oxycodone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451121780	
1451121805	rs6848893		3			2.0	Efficacy	1	1	oxycodone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451121805	
1451123485	rs2392165		3			0.0	Efficacy	1	1	budesonide	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451123485	Pediatric
1451124240	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	3			2.0	Toxicity	2	2	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451124240	
1451124260	rs2066713	SLC6A4	3			3.25	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451124260	
1451124280	rs25531	SLC6A4	3			2.75	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451124280	
1451124300	rs4251417	SLC6A4	3			3.25	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451124300	
1450807831	rs1799971	OPRM1	4			-1.5	Toxicity	5	5	cannabinoids;cocaine;ethanol;nicotine;opioids	Substance-Related Disorders	2021-03-31	https://www.pharmgkb.org/clinicalAnnotation/1450807831	
1451120724	rs62097526		3			0.0	Toxicity	1	1	antipsychotics	Weight gain	2021-12-06	https://www.pharmgkb.org/clinicalAnnotation/1451120724	
1451124486	rs7439366	UGT2B7	3			2.0	Efficacy	1	1	morphine	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451124486	
1451124500	rs7439366	UGT2B7	3			1.0	Metabolism/PK	3	3	morphine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451124500	
1451124808	rs6025211		3			2.0	Efficacy	1	1	cisplatin;fluorouracil;mitoxantrone	Liver Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451124808	
1451124852	rs9679162	GALNT14	3			1.75	Efficacy	1	1	cisplatin;fluorouracil	Liver Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451124852	
1451124880	rs9679162	GALNT14	3			1.5	Efficacy	1	1	sorafenib	Hepatitis C;Liver Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451124880	
1451125500	rs2233980	C6orf15	3			2.5	Toxicity	1	1	carboplatin;gemcitabine	Carcinoma, Non-Small-Cell Lung;Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451125500	
1451125506	rs5877	SERPINC1	3			2.5	Toxicity	1	1	carboplatin;gemcitabine	Carcinoma, Non-Small-Cell Lung;Thrombocytopenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451125506	
1451126020	rs11854484	SLC28A2	3			2.75	Toxicity	1	1	tenofovir disoproxil fumarate	HIV Infections;nephrotoxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451126020	
1451126040	rs2248359	CYP24A1	3			2.25	Toxicity	1	1	tenofovir disoproxil fumarate	HIV Infections;nephrotoxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451126040	
1451126064	rs4646536	CYP27B1	3			3.25	Toxicity	1	1	tenofovir disoproxil fumarate	HIV Infections;nephrotoxicity	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451126064	
1451126200	rs2229109	ABCB1	3		Tier 1 VIP	1.75	Efficacy	1	1	temozolomide	Glioma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451126200	
1451126312	rs616147	MOBP	3			2.0	Efficacy	1	1	creatine	Amyotrophic Lateral Sclerosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451126312	
1449163324	rs7439366	UGT2B7	4			-1.25	Dosage	3	4	morphine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449163324	
1451127140	rs901865	HRH1	3			3.0	Toxicity	1	1	desloratadine	sedation;Urticaria	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451127140	
1451129800	rs1034936	CACNA1C	3			2.5	Toxicity	1	1	ethanol	Alcoholism;Bipolar Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451129800	
1451129880	rs6295	HTR1A	3			0.75	Efficacy	1	2	lurasidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451129880	
1451130528	rs3740065	ABCC2	3			2.5	Toxicity	1	1	Drugs For Treatment Of Tuberculosis	Toxic liver disease;Tuberculosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451130528	
1451129680	rs3211371	CYP2B6	4		Tier 1 VIP	-4.75	Metabolism/PK	6	6	efavirenz		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451129680	
1451130640	rs4774388	RORA	3			2.25	Efficacy	1	1	interferon beta-1a	Multiple Sclerosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451130640	
1451131729	rs11227247	RELA	3			2.5	Toxicity	1	1	gefitinib	Carcinoma, Non-Small-Cell Lung;Toxic liver disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451131729	
1451131735	rs2272733	IKBKB	3			2.5	Efficacy	1	1	gefitinib	Carcinoma, Non-Small-Cell Lung;Exanthema	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451131735	
1451131750	rs2151222	IKBKE	3			2.5	Toxicity	1	1	gefitinib	Carcinoma, Non-Small-Cell Lung;Diarrhea	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451131750	
1451131761	rs12142086	IKBKE	3			2.5	Toxicity	1	1	gefitinib	Carcinoma, Non-Small-Cell Lung;Exanthema	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451131761	
1451131767	rs2233406	NFKBIA	3			2.0	Toxicity	1	1	gefitinib	Carcinoma, Non-Small-Cell Lung;Diarrhea	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451131767	
1451131781	rs2233407	NFKBIA	3			2.0	Toxicity	1	1	gefitinib	Carcinoma, Non-Small-Cell Lung;Toxic liver disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451131781	
1451131787	rs9694958	IKBKB	3			2.0	Toxicity	1	1	gefitinib	Carcinoma, Non-Small-Cell Lung;Exanthema	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451131787	
1451131820	rs3748022	IKBKE	3			2.0	Toxicity	1	1	gefitinib	Carcinoma, Non-Small-Cell Lung;Exanthema	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451131820	
1451131840	rs2233409	NFKBIA	3			2.5	Toxicity	1	1	gefitinib	Carcinoma, Non-Small-Cell Lung;Diarrhea	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451131840	
1451131846	rs2053071	NFKBIB;SIRT2	3			2.0	Toxicity	1	1	gefitinib	Toxic liver disease	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451131846	
1451131852	rs2695121	NR1H2	3			2.0	Toxicity	1	1	gefitinib	Carcinoma, Non-Small-Cell Lung;Diarrhea	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451131852	
1451131858	rs577001	TAB2	3			2.0	Toxicity	1	1	gefitinib	Diarrhea	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451131858	
1451131860	rs8904	NFKBIA	3			2.0	Toxicity	1	1	gefitinib	Carcinoma, Non-Small-Cell Lung;Exanthema	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451131860	
1451132040	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	3		Tier 1 VIP	1.0	Metabolism/PK	1	1	progesterone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451132040	
1451134300	rs4633	COMT	3		Tier 1 VIP	2.0	Toxicity	1	1	opioids	Dizziness	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451134300	
1451134540	rs4633	COMT	3		Tier 1 VIP	2.0	Toxicity	1	1	opioids	Sexual Dysfunctions, Psychological	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451134540	
1451135380	rs2032582	ABCB1	3		Tier 1 VIP	0.75	Dosage	2	2	sufentanil	Pain, Postoperative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451135380	
1451133765	rs1045642	ABCB1	3		Tier 1 VIP	2.5	Efficacy	1	1	morphine;nortriptyline	Pain	2021-12-01	https://www.pharmgkb.org/clinicalAnnotation/1451133765	
1451135140	CYP3A4*1, CYP3A4*36	CYP3A4	3		Tier 1 VIP	1.5	Efficacy	1	1	sufentanil		2022-03-23	https://www.pharmgkb.org/clinicalAnnotation/1451135140	
1451135188	CYP3A5*1, CYP3A5*3	CYP3A5	3		Tier 1 VIP	1.5	Dosage	1	1	sufentanil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451135188	
1451135197	rs1323040	OPRM1	3		Rare Variant	2.0	Dosage	1	1	sufentanil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451135197	
1451135400	rs1128503	ABCB1	3		Tier 1 VIP	2.0	Dosage	1	1	sufentanil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451135400	
1451135574	rs2366929	ADGRV1	3			0.0	Toxicity	1	1	opioids	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451135574	
1451136460	rs71647871	CES1	3		Rare Variant	0.0	Metabolism/PK	1	1	heroin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451136460	
1451137805	rs10457090	OPRM1	3			3.25	Toxicity	1	1	opioids	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451137805	
1451137828	rs589046	OPRM1	3			3.25	Toxicity	1	1	opioids	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451137828	
1451138160	rs3749034	GAD1	3			3.0	Dosage	1	1	methadone	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451138160	
1451138166	rs3762556	GAD1	3			3.0	Dosage	1	1	methadone	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451138166	
1451138182	rs769404	GAD1	3			0.5	Dosage	1	2	methadone	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451138182	
1451138494	rs204047	OPRD1	3			2.75	Dosage	1	1	methadone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451138494	
1451138544	rs797397	OPRD1	3			2.25	Metabolism/PK	1	1	methadone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451138544	
1451138560	rs204047	OPRD1	3			2.25	Metabolism/PK	1	1	methadone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451138560	
1451138860	rs3802279	OPRK1	3			2.5	Dosage	1	1	methadone	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451138860	
1451138880	rs3802281	OPRK1	3			2.5	Dosage	1	1	methadone	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451138880	
1451138886	rs963549	OPRK1	3			2.5	Dosage	1	1	methadone	Heroin Dependence	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451138886	
1451139960	rs36024412	CRYBG2	3			0.0	Toxicity	1	1	opioids	Nausea;Vomiting	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451139960	
1451141140	rs168107	CLCC1	3			0.0	Toxicity	1	1	opioids	Nausea;Vomiting	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451141140	
1451141146	rs41269255	POM121L2	3			0.0	Toxicity	1	1	opioids	Nausea;Vomiting	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451141146	
1451141152	rs9393888	ZNF165	3			0.0	Toxicity	1	1	opioids	Nausea;Vomiting	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451141152	
1451141160	rs11882256	MUC16	3			0.0	Toxicity	1	1	opioids	Nausea;Vomiting	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451141160	
1451141166	rs12305038	PDE3A	3			0.0	Toxicity	1	2	opioids	Nausea;Vomiting	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451141166	
1451141180	rs10405238	ZNF568	3			0.0	Toxicity	1	1	opioids	Nausea;Vomiting	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451141180	
1451550960	rs3804100	TLR2	3			2.5	Dosage	1	1	morphine	Pain, Postoperative	2021-10-20	https://www.pharmgkb.org/clinicalAnnotation/1451550960	
1451138140	rs3762555	GAD1	3			3.0	Dosage	1	1	methadone	Heroin Dependence	2021-12-03	https://www.pharmgkb.org/clinicalAnnotation/1451138140	
1451135160	CYP3A4*1, CYP3A4*36	CYP3A4	3		Tier 1 VIP	2.0	Toxicity	1	1	sufentanil	Respiratory Insufficiency	2022-03-23	https://www.pharmgkb.org/clinicalAnnotation/1451135160	
1451144760	rs35599367	CYP3A;CYP3A4	3		Tier 1 VIP	2.0	Metabolism/PK	1	1	alprazolam		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451144760	
1451145100	rs588765	CHRNA5	3			0.0	Toxicity	1	1	cocaine	Cocaine-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451145100	
1451145106	rs16969968	CHRNA3;CHRNA5	3			0.0	Toxicity	1	1	cocaine	Cocaine-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451145106	
1451146140	rs10770141	TH	3			3.0	Toxicity	1	1	opioids	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451146140	
1451146160	rs10770140	TH	3			3.0	Toxicity	1	1	opioids	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451146160	
1451146222	rs1800035	ADRA2A	3			2.75	Efficacy	1	1	dexmedetomidine	Pain, Postoperative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451146222	
1451146241	rs201376588	ADRA2A	3		Rare Variant	2.75	Efficacy	1	1	dexmedetomidine	Pain, Postoperative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451146241	
1451146260	rs775887911	ADRA2A	3		Rare Variant	2.75	Efficacy	1	1	dexmedetomidine	Pain, Postoperative	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451146260	
1451147643	CYP3A4*1, CYP3A4*3, CYP3A4*20, CYP3A4*22	CYP3A4	3		Tier 1 VIP	0.0	Metabolism/PK	1	1	fesoterodine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451147643	
1451147700	CYP3A4*1, CYP3A4*3, CYP3A4*20, CYP3A4*22	CYP3A4	3		Tier 1 VIP	0.0	Metabolism/PK	1	1	imatinib		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451147700	
1451148025	rs933271	COMT;TXNRD2	3		Tier 1 VIP	2.5	Efficacy	1	1	methadone	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451148025	
1451148520	rs4680	COMT	3		Tier 1 VIP	2.5	Toxicity	1	1	opioids	Hyperalgesia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451148520	
1451147720	CYP3A4*1, CYP3A4*20, CYP3A4*22	CYP3A4	1A		Tier 1 VIP	102.0	Metabolism/PK	2	3	quetiapine		2022-03-18	https://www.pharmgkb.org/clinicalAnnotation/1451147720	
1451144780	CYP3A4*1, CYP3A4*22	CYP3A4	3		Tier 1 VIP	1.25	Efficacy	1	2	alprazolam	Alcoholism;Anxiety Disorders	2022-09-23	https://www.pharmgkb.org/clinicalAnnotation/1451144780	
1451141882	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*17, CYP2D6*41	CYP2D6	1A		Tier 1 VIP	101.3125	Metabolism/PK	6	7	hydrocodone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451141882	Pediatric
1451148780	rs780801862	CYP2C9	3		Rare Variant; Tier 1 VIP	0.0	Metabolism/PK	1	1	naproxen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451148780	
1451148820	rs780801862	CYP2C9	3		Rare Variant; Tier 1 VIP	0.0	Metabolism/PK	1	1	phenytoin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451148820	
1451148840	rs780801862	CYP2C9	3		Rare Variant; Tier 1 VIP	0.0	Metabolism/PK	1	1	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451148840	
1451148920	CYP2C9*1, CYP2C9*29	CYP2C9	3		Tier 1 VIP	0.0	Metabolism/PK	1	1	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451148920	
1451149000	rs1042173	SLC6A4	3			2.5	Dosage	1	1	morphine	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451149000	
1451149980	rs6421482	PDE4B	3			1.5	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451149980	
1451149986	rs61767420		3		Rare Variant	1.5	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451149986	
1451149992	rs1260326	GCKR	3			1.5	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451149992	
1451149998	rs494904		3			1.5	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451149998	
1451150020	rs9679319		3			1.5	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451150020	
1451150040	rs13382553	THSD7B	3			1.5	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451150040	
1451150046	rs2673136		3			1.5	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451150046	
1451150060	rs62250713	CADM2	3			1.5	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451150060	
1451150080	rs13129401		3			1.5	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451150080	
1451150086	rs13125415	ADH1C	3			1.5	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451150086	
1451150092	rs13135092	SLC39A8	3			1.5	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451150092	
1451151460	rs2533200	DPP6	3			1.5	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451151460	
1451151466	rs2582405		3			1.5	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451151466	
1451151472	rs7900002		3			1.5	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451151472	
1451151478	rs56722963		3			1.5	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451151478	
1451151484	rs576859	MED19;TMX2	3			1.5	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451151484	
1451151490	rs1783835		3			1.5	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451151490	
1451151496	rs12296477	SLC4A8	3			1.5	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451151496	
1451151500	rs6589386		3			1.5	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451151500	
1451151512	rs8008020		3			1.5	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451151512	
1451151522	rs72768626	TNRC6A	3			1.5	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451151522	
1451151540	rs9937709	FTO	3			1.5	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451151540	
1451151560	rs492602	FUT2	3			1.5	Toxicity	1	1	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451151560	
1451151857	rs6313	HTR2A	3			0.25	Efficacy	2	2	risperidone	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451151857	
1451151920	rs6313	HTR2A	3			2.0	Efficacy	2	3	olanzapine	Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451151920	
1451152801	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	3		Tier 1 VIP	2.5	Toxicity	1	1	hydrocodone	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451152801	
1451152821	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	3		Tier 1 VIP	2.5	Toxicity	1	1	codeine	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451152821	
1451152965	CYP2D6*1, CYP2D6*4	CYP2D6	3		Tier 1 VIP	0.0	Metabolism/PK	1	1	dihydrocodeine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451152965	
1451153940	CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*6	CYP2D6	3		Tier 1 VIP	1.375	Dosage	3	3	methadone	Heroin Dependence;Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451153940	
1451155125	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN	CYP2D6	1A		Tier 1 VIP	200.75	Toxicity	3	5	tramadol	cardiotoxicity;Respiratory Insufficiency	2021-04-29	https://www.pharmgkb.org/clinicalAnnotation/1451155125	Pediatric
1451152827	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	3		Tier 1 VIP	2.5	Toxicity	1	1	oxycodone	Opioid-Related Disorders	2021-04-23	https://www.pharmgkb.org/clinicalAnnotation/1451152827	
1451153920	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*6	CYP2D6	3		Tier 1 VIP	2.25	Metabolism/PK	7	10	methadone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451153920	
1451153963	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*6	CYP2D6	3		Tier 1 VIP	1.125	Efficacy	5	6	methadone	Heroin Dependence;Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451153963	
1451155020	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	1A		Tier 1 VIP	227.1875	Metabolism/PK	29	43	tramadol		2021-10-28	https://www.pharmgkb.org/clinicalAnnotation/1451155020	Pediatric
1451148762	rs780801862	CYP2C9	3		Rare Variant; Tier 1 VIP	0.0	Metabolism/PK	1	1	flurbiprofen		2021-12-03	https://www.pharmgkb.org/clinicalAnnotation/1451148762	
1451154980	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17	CYP2D6	1A		Tier 1 VIP	233.25	Efficacy	13	22	tramadol	Pain;Pain, Postoperative	2022-01-11	https://www.pharmgkb.org/clinicalAnnotation/1451154980	
1451905420	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	3		Tier 1 VIP	2.5	Efficacy	1	1	sulfonamides, urea derivatives	Diabetes Mellitus, Type 2	2022-10-06	https://www.pharmgkb.org/clinicalAnnotation/1451905420	
1451184626	HLA-A*31:01:02	HLA-A	3			0.25	Toxicity	1	1	oxcarbazepine	drug reaction with eosinophilia and systemic symptoms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451184626	Pediatric
1451207020	rs1128503	ABCB1	3		Tier 1 VIP	1.0	Metabolism/PK	2	2	morphine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451207020	
1451207862	CYP3A5*1, CYP3A5*3	CYP3A5	3		Tier 1 VIP	1.5	Metabolism/PK	1	1	dabigatran		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451207862	
1451208240	CYP2D6*1, CYP2D6*10	CYP2D6	3		Tier 1 VIP	2.0	Dosage	1	1	fentanyl		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451208240	
1451208340	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	3		Tier 1 VIP	1.75	Toxicity	1	1	ketoprofen;tramadol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451208340	
1451217440	rs12979860	IFNL3;IFNL4	3			1.0	Efficacy	3	3	peginterferon alfa-2a	Hepatitis B, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451217440	
1451217520	rs12979860	IFNL3;IFNL4	3			2.5	Efficacy	1	1	sofosbuvir	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451217520	
1451217560	rs12979860	IFNL3;IFNL4	3			2.0	Efficacy	1	1	interferons	Hepatitis C	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451217560	
1451223500	rs1799971	OPRM1	3			1.0	Toxicity	2	2	methadone	Neonatal Abstinence Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451223500	Pediatric
1451223520	rs1799971	OPRM1	3			1.25	Toxicity	1	1	morphine	Neonatal Abstinence Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451223520	Pediatric
1451223540	rs2279343	CYP2B6	3		Tier 1 VIP	1.5	Toxicity	1	1	methadone	Neonatal Abstinence Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451223540	Pediatric
1451223580	rs351776	PNOC	3			0.0	Toxicity	1	1	buprenorphine	Neonatal Abstinence Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451223580	Pediatric
1451223586	rs351776	PNOC	3			0.0	Toxicity	1	1	methadone	Neonatal Abstinence Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451223586	Pediatric
1451223592	rs3745274	CYP2A7P1;CYP2B6	3		Tier 1 VIP	1.5	Toxicity	1	1	methadone	Neonatal Abstinence Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451223592	Pediatric
1451161878	CYP2B6*1, CYP2B6*6	CYP2B6	4		Tier 1 VIP	-1.25	Dosage	2	2	methadone	Opioid-Related Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451161878	
1451253260	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*81	CYP2D6	1A		Tier 1 VIP	103.25	Toxicity	9	11	venlafaxine	agitation;Alcohol-Related Disorders;cardiotoxicity;Depression;Depressive Disorder;Depressive Disorder, Major;Drug Toxicity;dysphoria;Edema;Nausea;Obsessive-Compulsive Disorder;Tachycardia;Vomiting	2021-05-04	https://www.pharmgkb.org/clinicalAnnotation/1451253260	
1451217540	rs12979860	IFNL3;IFNL4	3			1.0	Efficacy	1	2	interferons	Hepatitis C	2021-12-03	https://www.pharmgkb.org/clinicalAnnotation/1451217540	
1451163460	CYP2A6*1, CYP2A6*2, CYP2A6*9, CYP2A6*17	CYP2A6	3		Tier 1 VIP	1.375	Metabolism/PK	2	2	metronidazole		2022-09-29	https://www.pharmgkb.org/clinicalAnnotation/1451163460	Pediatric
1451265448	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	1A		Tier 1 VIP	205.375	Toxicity	3	5	imipramine	Depressive Disorder	2021-04-23	https://www.pharmgkb.org/clinicalAnnotation/1451265448	
1451257280	CYP2C8*1, CYP2C8*3	CYP2C8	3		Tier 1 VIP	2.25	Toxicity	2	2	rosiglitazone		2021-05-18	https://www.pharmgkb.org/clinicalAnnotation/1451257280	
1451266120	rs67376798	DPYD	1A		Rare Variant; Tier 1 VIP	104.0	Toxicity	3	4	tegafur	Neoplasms	2021-05-24	https://www.pharmgkb.org/clinicalAnnotation/1451266120	
1451266065	rs3918290	DPYD	1A		Rare Variant; Tier 1 VIP	104.0	Toxicity	3	4	tegafur	Neoplasms	2021-05-24	https://www.pharmgkb.org/clinicalAnnotation/1451266065	
1451266020	rs55886062	DPYD	1A		Rare Variant; Tier 1 VIP	102.25	Toxicity	2	3	tegafur	Neoplasms	2021-05-24	https://www.pharmgkb.org/clinicalAnnotation/1451266020	
1451257700	rs1801394	MTRR	3			4.75	Efficacy	3	3	methotrexate	Arthritis, Juvenile Rheumatoid;Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451257700	Pediatric
1451263060	rs78132896	EPHA7	3			1.625	Toxicity	1	1	warfarin	Hemorrhage	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451263060	
1183680656	rs1057868	POR	4			-0.5	Toxicity	3	3	tacrolimus	Kidney Transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183680656	Pediatric
1451257285	CYP2C8*1, CYP2C8*3	CYP2C8	3		Tier 1 VIP	4.5	Efficacy	3	3	rosiglitazone		2021-12-03	https://www.pharmgkb.org/clinicalAnnotation/1451257285	
1451285000	rs1544410	VDR	3			2.75	Efficacy	1	1	clodronate		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451285000	
1451256440	rs3813929	HTR2C	3			2.75	Toxicity	11	11	olanzapine	Mental Disorders;Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451256440	
1451256448	rs3813929	HTR2C	3			4.0	Toxicity	8	8	risperidone	Mental Disorders;Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451256448	Pediatric
1451256466	rs3813929	HTR2C	3			3.0	Toxicity	5	5	clozapine	Mental Disorders;Schizophrenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451256466	
1451274840	rs1059513	STAT6	3			2.25	Efficacy	1	1	esomeprazole	eosinophilic esophagitis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451274840	Pediatric
1451282140	rs4646	CYP19A1	3			5.0	Efficacy	2	2	tamoxifen	Breast Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451282140	
1451286280	CYP3A5*1, CYP3A5*3	CYP3A5	3		Tier 1 VIP	4.25	Dosage	2	2	sirolimus		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451286280	
1451204660	UGT1A1*1, UGT1A1*28	UGT1A1	1A		Tier 1 VIP	224.0	Toxicity	33	40	FOLFIRI;irinotecan	Neutropenia	2021-04-01	https://www.pharmgkb.org/clinicalAnnotation/1451204660	Pediatric
1451243980	CYP2B6*1, CYP2B6*2, CYP2B6*6, CYP2B6*18, CYP2B6*38	CYP2B6	1A		Tier 1 VIP	211.5	Toxicity	12	14	efavirenz	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451243980	
1451551426	rs11615	ERCC1	3			1.75	Efficacy	1	1	cisplatin;gemcitabine	Carcinoma, Non-Small-Cell Lung	2021-10-20	https://www.pharmgkb.org/clinicalAnnotation/1451551426	
1451551460	rs11615	ERCC1	3			0.0	Efficacy	1	1	cisplatin	Pancreatic Neoplasms	2021-10-20	https://www.pharmgkb.org/clinicalAnnotation/1451551460	
1450813831	rs746071566	NUDT15	3		Rare Variant; Tier 1 VIP	4.0	Toxicity	1	1	azathioprine;mercaptopurine;thioguanine	Inflammatory Bowel Diseases;Myelosuppression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450813831	
1451135100	rs1799971	OPRM1	3			1.25	Efficacy	2	2	oxycodone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451135100	
1451289660	rs59086055	DPYD	1A		Rare Variant; Tier 1 VIP	100.0	Toxicity	1	2	fluorouracil	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451289660	
1451551520	rs3212986	ERCC1	4			-1.25	Efficacy	3	3	cisplatin	Esophageal Neoplasms;Ovarian Neoplasms;Stomach Neoplasms	2021-10-20	https://www.pharmgkb.org/clinicalAnnotation/1451551520	
1451551528	rs2336219	ERCC1	3			0.0	Efficacy	1	1	cisplatin	Ovarian Neoplasms	2021-10-20	https://www.pharmgkb.org/clinicalAnnotation/1451551528	
1451551846	rs11545077	GGH	3			2.5	Efficacy	1	1	methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-10-20	https://www.pharmgkb.org/clinicalAnnotation/1451551846	Pediatric
1451551817	rs3758149	GGH	3			2.5	Efficacy	1	1	methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-10-20	https://www.pharmgkb.org/clinicalAnnotation/1451551817	Pediatric
1451551883	rs11545076	GGH	3			2.5	Efficacy	1	1	methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-10-20	https://www.pharmgkb.org/clinicalAnnotation/1451551883	Pediatric
1451552587	rs3745274	CYP2A7P1;CYP2B6	3		Tier 1 VIP	1.0	Metabolism/PK	1	1	tramadol		2021-10-21	https://www.pharmgkb.org/clinicalAnnotation/1451552587	
1451553326	rs45445694	C18orf56;TYMS	4		Tier 1 VIP	-1.0	Metabolism/PK	2	2	methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-10-21	https://www.pharmgkb.org/clinicalAnnotation/1451553326	Pediatric
1451553595	rs1045642	ABCB1	4		Tier 1 VIP	-1.25	Efficacy	2	3	methotrexate	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-10-21	https://www.pharmgkb.org/clinicalAnnotation/1451553595	Pediatric
1451553580	rs1045642	ABCB1	3		Tier 1 VIP	0.0	Metabolism/PK	5	5	methotrexate	Burkitt Lymphoma;Lymphoma, T-Cell;Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-12-13	https://www.pharmgkb.org/clinicalAnnotation/1451553580	Pediatric
1451566760	rs1800497	ANKK1;DRD2	3		Tier 1 VIP	1.5	Efficacy	1	1	bupropion;naltrexone	Obesity	2021-10-29	https://www.pharmgkb.org/clinicalAnnotation/1451566760	
1451567040	CYP3A4*1, CYP3A4*2, CYP3A4*3, CYP3A4*4, CYP3A4*5, CYP3A4*6, CYP3A4*7, CYP3A4*8, CYP3A4*9, CYP3A4*10, CYP3A4*11, CYP3A4*12, CYP3A4*13, CYP3A4*14, CYP3A4*15, CYP3A4*16, CYP3A4*17, CYP3A4*18, CYP3A4*19, CYP3A4*20, CYP3A4*21, CYP3A4*22, CYP3A4*23, CYP3A4*24, CYP3A4*26, CYP3A4*28, CYP3A4*29, CYP3A4*30, CYP3A4*31, CYP3A4*32, CYP3A4*33, CYP3A4*34	CYP3A4	3		Tier 1 VIP	2.5	Metabolism/PK	2	3	oxycodone		2022-01-13	https://www.pharmgkb.org/clinicalAnnotation/1451567040	
